Report on Federal Awards in Accordance with OMB Circular A-133 June 30, 2012 EIN 042103580
Index June 30, 2012 Page Part I - Financial Statements Report of Independent Auditors... 1 Financial Statements... 2 5 Notes to Financial Statements... 6 33 Part II -... 34 98 Notes to the... 99 101 Part III - Reports on Internal Controls and Compliance Part IV - Findings Report of Independent Auditors on Internal Control over Financial Reporting and on Compliance and Other Matters Based on an Audit of Financial Statements Performed in Accordance with Government Auditing Standards... 102 103 Report of Independent Auditors on Compliance with Requirements That Could Have a Direct and Material Effect on Each Major Program and on Internal Control over Compliance in Accordance with OMB Circular A-133... 104 105 Schedule of Findings and Questioned Costs... 106 111 Summary Schedule of Prior Audit Findings... 112 119 Management s Views and Corrective Action Plan... 120
Part I Financial Statements
Report of Independent Auditors To the Board of Overseers of Harvard College: In our opinion, the accompanying Balance Sheet and the related Statements of Changes in Net Assets with General Operating Account Detail, Changes in Net Assets of the Endowment, and Cash Flows present fairly, in all material respects, the financial position of Harvard University (the University ) at June 30, 2012, and the changes in its net assets of the General Operating Account and endowment funds and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of the University s management. Our responsibility is to express an opinion on these financial statements based on our audit. The prior year summarized comparative information has been derived from the University s fiscal 2011 financial statements, and in our report dated October 28, 2011, we expressed an unqualified opinion on those financial statements. We conducted our audit of these statements in accordance with auditing standards generally accepted in the United States of America and the standards applicable to financial audits contained in Government Auditing Standards, issued by the Comptroller General of the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion. In accordance with Government Auditing Standards, we have also issued our report dated November 2, 2012 on our consideration of the University s internal control over financial reporting and on our tests of its compliance with certain provisions of laws, regulations, contracts and grant agreements and other matters for the year ended June 30, 2012. The purpose of that report is to describe the scope of our testing of internal control over financial reporting and compliance and the results of that testing, and not to provide an opinion on the internal control over financial reporting or on compliance. That report is an integral part of an audit performed in accordance with Government Auditing Standards and should be considered in assessing the results of our audit. Our audit was conducted for the purpose of forming an opinion on the financial statements taken as a whole. The accompanying is presented for purposes of additional analysis as required by U.S. Office of Management and Budget Circular A-133, Audits of States, Local Governments, and Non Profit Organizations, and is not a required part of the financial statements. The information is the responsibility of management and was derived from and relates directly to the underlying accounting and other records used to prepare the financial statements. The Schedule of Expenditures of Federal Awards has been subjected to the auditing procedures applied in the audit of the financial statements and certain additional procedures, including comparing and reconciling such information directly to the underlying accounting and other records used to prepare the financial statements or the financial statements themselves and other additional procedures, in accordance with auditing standards generally accepted in the United States of America. In our opinion, the is fairly stated, in all material respects, in relation to the financial statements taken as a whole. November 2, 2012 PricewaterhouseCoopers LLP, 125 High Street, Boston, MA 02110 T: (617) 530 5000, F: (617) 530 5001, www.pwc.com/us
balance sheets with summarized financial information as of June 30, 2011 harvard university financial statements June 30 In thousands of dollars 2012 2011 ASSETS: Cash $ 155,088 $ 142,503 Receivables, net (Note 6) 227,401 199,231 Prepayments and deferred charges 171,026 163,886 Notes receivable, net (Note 7) 363,566 363,356 Pledges receivable, net (Note 8) 908,558 758,441 Fixed assets, net (Note 9) 5,776,545 5,647,077 Interests in trusts held by others (Note 4) 343,798 351,408 Investment portfolio, at fair value (Notes 3 and 4) 43,385,126 46,817,373 Securities pledged to counterparties, at fair value (Notes 3 and 4) 6,383,535 6,768,202 TOTAL ASSETS 57,714,643 61,211,477 LIABILITIES: Accounts payable 284,250 340,911 Deposits and other liabilities 648,896 679,326 Securities lending and other liabilities associated with the investment portfolio (Notes 3, 4 and 12) 12,294,626 14,335,814 Liabilities due under split interest agreements (Note 11) 670,242 771,568 Bonds and notes payable (Note 12) 6,039,139 6,335,709 Accrued retirement obligations (Note 13) 1,056,015 817,885 Government loan advances (Note 7) 67,044 66,987 TOTAL LIABILITIES 21,060,212 23,348,200 NET ASSETS, attributable to non-controlling interests in the pooled general investment account (Note 3) 1,070,136 832,339 NET ASSETS, attributable to the University 35,584,295 37,030,938 TOTAL LIABILITIES AND NET ASSETS $ 57,714,643 $ 61,211,477 Temporarily Permanently June 30 Unrestricted restricted restricted 2012 2011 NET ASSETS, attributable to the University: General Operating Account (Note 14) $ 2,743,325 $ 1,448,690 $ 96,498 $ 4,288,513 $ 4,500,420 Endowment (Note 10) 5,362,336 19,763,294 5,619,904 30,745,534 32,012,729 Split interest agreements (Note 11) 70,705 479,543 550,248 517,789 TOTAL NET ASSETS $ 8,105,661 $ 21,282,689 $ 6,195,945 $ 35,584,295 $ 37,030,938 The accompanying notes are an integral part of the financial statements.
statements of changes in net assets with general operating account detail with summarized financial information for the year ended June 30, 2011 For the year ended Temporarily Permanently June 30 In thousands of dollars Unrestricted restricted restricted 2012 2011 OPERATING REVENUE: Student income: Undergraduate program $ 264,513 $ 264,513 $ 254,095 Graduate and professional degree programs 432,518 432,518 411,152 Board and lodging 155,417 155,417 149,972 Continuing education and executive programs 281,317 281,317 260,390 Scholarships applied to student income (Note 15) (357,001) (357,001) (335,036) Total student income 776,764 0 0 776,764 740,573 Sponsored support (Note 16): Federal government - direct costs 493,003 493,003 509,958 Federal government - indirect costs 176,560 176,560 176,270 Non-federal sponsors - direct costs 60,750 $ 78,868 139,618 145,044 Non-federal sponsors - indirect costs 15,971 7,472 23,443 20,555 Total sponsored support 746,284 86,340 0 832,624 851,827 Gifts for current use (Note 17) 90,405 198,812 289,217 276,914 Investment income: Endowment returns made available for operations (Note 10) 258,151 1,163,913 1,422,064 1,321,743 goa returns made available for operations 141,804 141,804 148,178 Other investment income 10,318 7,192 17,510 21,624 Total investment income 410,273 1,171,105 0 1,581,378 1,491,545 Other income (Note 18) 557,165 557,165 546,600 Net assets released from restrictions 1,506,745 (1,506,745) 0 0 TOTAL OPERATING REVENUE 4,087,636 (50,488) 0 4,037,148 3,907,459 OPERATING EXPENSES: Salaries and wages 1,497,928 1,497,928 1,420,023 Employee benefits (Note 13) 476,436 476,436 461,010 Depreciation (Note 9) 288,865 288,865 281,027 Interest (Note 12) 287,067 287,067 298,843 Space and occupancy 274,786 274,786 271,853 Supplies and equipment 235,920 235,920 233,655 Scholarships and other student awards (Note 15) 128,993 128,993 116,510 Other expenses (Note 19) 851,703 851,703 824,647 TOTAL OPERATING EXPENSES 4,041,698 0 0 4,041,698 3,907,568 harvard university financial statements NET OPERATING SURPLUS/(DEFICIT) 45,938 (50,488) 0 (4,550) (((109) NON-OPERATING ACTIVITIES: Income from GOA investments 10,938 10,938 20,946 Realized and unrealized (depreciation)/appreciation, net (Note 3) (162,764) (162,764) 649,799 GOA returns made available for operations (141,804) (141,804) (148,178) Change in pledge balances (Note 8) 123,553 123,553 36,616 Change in interests in trusts held by others 8,140 8,140 6,120 Capital gifts for loan funds and facilities (Note 17) 25,969 $ 274 26,243 32,987 Change in retirement obligations (Note 13) (208,814) (208,814) 172,482 Other changes (17,226) (17,226) (51,364) Transfers between GOA and endowment (5,832) 138,971 7,003 140,142 19,090 Transfers between GOA and split interest agreements 12,053 2,182 14,235 14,100 Non-operating net assets released from restrictions 59,664 (50,606) (9,058) 0 0 TOTAL NON-OPERATING ACTIVITIES (465,838) 258,080 401) (207,357) 752,598 GENERAL OPERATING ACCOUNT NET CHANGE DURING THE YEAR (419,900) 207,592 401 (211,907) 752,489 Endowment net change during the year (233,444) (1,445,399) 411,648 (1,267,195) 4,447,700 Split interest agreement net change during the year (Note 11) (3,268) 35,727 32,459 95,816 NET CHANGE DURING THE YEAR, attributable to the University (653,344) (1,241,075) 447,776 (1,446,643) 5,296,005 NET CHANGE IN NET ASSETS, attributable to non-controlling interests in the pooled general investment account 237,797 237,797 235,004 NET CHANGE DURING THE YEAR (415,547) (1,241,075) 447,776 (1,208,846) 5,531,009 Net assets, beginning of year 9,591,344 22,523,764 5,748,169 37,863,277 32,332,268 NET ASSETS, end of year $ 9,175,797 $ 21,282,689 $ 6,195,945 $ 36,654,431 $ 37,863,277 The accompanying notes are an integral part of the financial statements.
statements of changes in net assets of the endowment with summarized financial information for the year ended June 30, 2011 For the year ended Temporarily Permanently June 30 In thousands of dollars Unrestricted restricted restricted 2012 2011 Investment return (Note 3): Income from general investments $ 19,269 $ 84,840 $ 104,109 $ 161,206 Realized and unrealized appreciation/(depreciation), net (15,806) (87,903) (103,709) 5,339,178 Total investment return 3,463 (3,063) 0 400 5,500,384 Endowment returns made available for operations (258,151) (1,163,913) (1,422,064) (1,321,743) Net investment return (254,688) (1,166,976) 0 (1,421,664) 4,178,641 harvard university financial statements Gifts for capital (Note 17) 6,223 17,217 $ 203,054 226,494 212,364 Transfers between endowment and the goa (Note 10) 5,832 (138,971) (7,003) (140,142) (19,090) Capitalization of split interest agreements (Note 11) 18,684 39,583 58,267 56,000 Change in pledge balances (Note 8) 7,761 17,749 25,510 (49,534) Change in interests in trusts held by others (Note 10) 911 (16,661) (15,750) 47,660 Other changes (159,130) 159,220 90 21,659 Net assets released from restrictions (Note 2) 9,189 (24,895) 15,706 0 0 NET CHANGE DURING THE YEAR (233,444) (1,445,399) 411,648 (1,267,195) 4,447,700 Net assets of the endowment, beginning of year 5,595,780 21,208,693 5,208,256 32,012,729 27,565,029 NET ASSETS OF THE ENDOWMENT, end of year $ 5,362,336 $ 19,763,294 $ 5,619,904 $ 30,745,534 $ 32,012,729 The accompanying notes are an integral part of the financial statements.
statements of cash flows For the year ended June 30 In thousands of dollars 2012 2011 CASH FLOWS FROM OPERATING ACTIVITIES: Change in net assets $ (1,208,846) $ 5,531,009 Adjustments to reconcile change in net assets to net cash used in operating activities: Change in net assets, attributable to non-controlling interests in the pooled general investment account (237,797) (235,004) Depreciation 288,865 281,027 Realized and unrealized loss/(gain) on investments, net 154,235 (6,175,282) Change in fair value of interest rate exchange agreements (18,675) (330,270) Change in interests in trusts held by others 7,610 (53,779) Change in liabilities due under split interest agreements (101,326) 65,967 Gifts of securities (83,471) (53,717) Gifts restricted for capital purposes (212,776) (235,636) Loss on redemption of debt 17,185 32,190 Loss on disposal of assets 1,348 35,023 Change in accrued retirement obligations 238,130 (91,308) Changes in operating assets and liabilities: Receivables, net (28,170) 43,243 Prepayments and deferred charges (7,140) 1,625 Pledges receivable, net (150,117) 13,771 Accounts payable (14,666) (42,568) Deposits and other liabilities (30,430) (56) NET CASH USED IN OPERATING ACTIVITIES (1,386,041) (1,213,765) CASH FLOWS FROM INVESTING ACTIVITIES: Loans made to students, faculty, and staff (48,024) (45,987) Payments received on student, faculty, and staff loans 46,383 37,470 Change in other notes receivable 1,431 9,470 Proceeds from the sales of gifts of securities 83,471 53,717 Proceeds from the sales and maturities of investments 46,924,811 72,153,105 Purchases of investments (47,337,633) (69,719,820) Additions to fixed assets (437,673) (445,936) NET CASH (USED IN)/PROVIDED BY INVESTING ACTIVITIES (767,234) 2,042,019 CASH FLOWS FROM FINANCING ACTIVITIES: Change in overdrafts included in accounts payable (24,003) 30,866 Proceeds from the issuance of debt 136,280 1,065,587 Debt repayments (450,035) (1,046,265) Gifts restricted for capital purposes 212,776 235,636 Change associated with securities lending agreements 2,290,785 (1,008,795) Change in government loan advances 57 5,591 NET CASH PROVIDED BY/(USED IN) FINANCING ACTIVITIES 2,165,860 (717,380) harvard university financial statements NET CHANGE IN CASH 12,585 110,874 Cash, beginning of year 142,503 31,629 CASH, end of year $ 155,088 $ 142,503 Supplemental disclosure of cash flow information: Accounts payable related to fixed asset additions $ 44,057 $ 62,049 Cash paid for interest $ 302,149 $ 295,616 The accompanying notes are an integral part of the financial statements.
1. university organization harvard university notes to financial statements Harvard University (the University ) is a private, not-for-profit institution of higher education with approximately 7,250 undergraduate and 13,800 graduate students. Established in 1636, the University includes the Faculty of Arts and Sciences, the School of Engineering and Applied Sciences, the Division of Continuing Education, ten graduate and professional Schools, the Radcliffe Institute for Advanced Study, a variety of research museums and institutes, and an extensive library system to support the teaching and research activities of the Harvard community. The President and Fellows 2. summary of significant accounting policies Basis of presentation The consolidated financial statements present the activities of Harvard University as a whole, including significant affiliated organizations controlled by the University. The financial statements include certain prior year summarized comparative information in total, not by net asset classification. This information is not presented in sufficient detail to conform with generally accepted accounting principles (gaap). Accordingly, such information should be read in conjunction with the University s financial statements for the year ended June 30, 2011, from which the summarized information is derived. Certain prior year amounts have been reclassified to conform to current year presentation. The reclassifications include moving the portion of the endowment payout accounted for in Transfers between goa and endowment in non-operating activities to Endowment returns made available for operations in operating revenues in the Statement of Changes in Net Assets with General Operating Account Detail. This reclassification reduced the prior year operating deficit by $129.7 million. Additionally, the University reclassified $60.7 million of Receivables and $3.8 million of Accounts payable to the Investment portfolio in the Balance Sheets. During a review of its endowment funds, the University noted that there were certain inconsistencies related to the recording of donor directed principal activity. As a result, the University has correctly reclassified $159.2 million from temporarily restricted to permanently restricted in the Other changes line item on the Statement of Changes in Net Assets of the Endowment for the year ended June 30, 2012. This reclassification had no impact on total net assets. Funds transferred to the University on behalf of specific beneficiaries (agency funds) are recorded as assets and liabilities in the Balance Sheets and are not included in the of Harvard College (the Corporation ), a governing board of the University, has oversight responsib ility for all of the University s financial affairs. The Corporation delegates substantial authority to the Schools and departments for the management of their resources and operations. The University includes Harvard Management Company (hmc), a wholly owned subsidiary founded in 1974 to manage the University s investment assets. hmc is governed by a Board of Directors that is appointed by the Corporation. Statements of Changes in Net Assets with General Operating Account Detail. Net asset classifications For the purposes of financial reporting, the University classifies resources into three net asset categories pursuant to any donor-imposed restrictions and applicable law. Accordingly, the net assets of the University are classified in the accompanying financial statements in the categories that follow: unrestricted net assets are not subject to donor-imposed restrictions. Funds invested in fixed assets and unrestricted endowment funds comprise 91% of the University s unrestricted net assets as of June 30, 2012. In addition, this category includes unrestricted gifts and endowment income balances, University-designated loan funds, and other unrestricted current funds. temporarily restricted net assets are subject to legal or donor-imposed stipulations that will be satisfied either by actions of the University, the passage of time, or both. These net assets include gifts donated for a particular purpose, amounts subject to time restrictions such as funds pledged for future payment, or amounts subject to legal restrictions such as portions of otherwise unrestricted capital appreciation and income, which must be reported as temporarily restricted net assets until appropriated for spending in accordance with Massachusetts law. permanently restricted net assets are subject to donor-imposed stipulations that they be invested to provide a perpetual source of income to the University. Generally, donors of these assets require the University to maintain and invest the original contribution in perpetuity, but permit the use of some or all investment returns for general or specific purposes.
Revenues from sources other than contributions are generally reported as increases in unrestricted net assets. Expenses are reported as decreases in unrestricted net assets. Investment returns earned by restricted donor funds are initially classified as temporarily restricted net assets and then reclassified to unrestricted net assets when expenses are incurred for their intended purpose. supplemented with commercial excess insurance above the University s self-insured retention. In addition, the University is self-insured for unemployment, the primary senior health plan, and all health and dental plans for active employees. The University s claims liabilities are recognized as incurred, including claims that have been incurred but not reported, and are included in operating expenses. Unconditional pledges are reported as increases in the appropriate categories of net assets in accordance with donor restrictions. Gains and losses on investments are reported as increases or decreases in unrestricted net assets, unless their use is restricted by donor stipulations or by law. Expirations of temporary restrictions on net assets are reported as reclassifications from temporarily restricted to unrestricted net assets and appear as Net assets released from restrictions and Non-operating net assets released from restrictions in the Statements of Changes in Net Assets. Net operating surplus/(deficit) Revenues earned, expenses incurred, and returns made available for operations for the purpose of teaching, conducting research, and the other programs and services of the University are the components of Net operating surplus/ (deficit) in the Statements of Changes in Net Assets with General Operating Account Detail. Collections The University s vast array of museums and libraries houses priceless works of art, historical treasures, literary works, and artifacts. These collections are protected and preserved for public exhibition, education, research, and the furtherance of public service. They are neither disposed of for financial gain nor encumbered in any manner. Accordingly, such collections are not recorded for financial statement purposes. Insurance programs The University, together with the Harvard-affiliated teaching hospitals, participates in a group captive insurance company, Controlled Risk Insurance Company (crico), to secure limited professional liability, general liability, and medical malpractice insurance for its member shareholders. The University self-insures a portion of its professional liability and general liability programs and maintains a reserve for incurred claims, including those related to Harvard Medical School activities occurring away from the affiliated teaching hospitals. The crico provided malpractice coverage applies with no deductible for medical professionals practicing within Harvard s University Health Services department, the School of Dental Medicine, and the School of Public Health. The University also maintains reserves for the self-insured portion of claims related to automobile liability, property damage, and workers compensation; these programs are Tax-exempt status The University is a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. Use of estimates The preparation of financial statements in accordance with gaap in the United States of America requires management to make estimates and assumptions that affect reported amounts and disclosures. Actual results could differ from those estimates. New accounting pronouncements Effective July 1, 2010, the University adopted asu 2010-06, Improving Disclosures about Fair Value Measurements. asu 2010-06 requires additional disclosures for significant transfers in and out of Levels 1 and 2 and the presentation of gross trading activity within the Level 3 rollforward. Further, asu 2010-06 clarifies existing disclosures to include fair value measurement disclosures for each class of assets and liabilities as well as to require additional disclosures about inputs and valuation techniques utilized to measure fair value for Levels 2 and 3. The effects of adopting this amendment are addressed in Notes 3 and 4. Effective July 1, 2010, the University adopted asu 2010-20, Disclosures about the Credit Quality of Financing Receivables and the Allowance for Credit Losses. asu 2010-20 requires additional disclosures surrounding credit losses on long-term receivables. The effects of adopting this amendment are addressed in Note 7. Effective July 1, 2010, the University retroactively adopted asu 2010-7 Not-for-Profit Entities Mergers and Acquisitions. While the University was not a party to any mergers or acquisitions, the guidance also impacts the financial statement treatment of non-controlling interests in consolidated entities. This guidance requires the University to report non-controlling interests in consolidated entities as a separate component of net assets on the Statement of Financial Position and the change in net assets attributable to the non-controlling interests separately within the Statements of Changes in Net Assets with General Operating Account Detail. The effects of adopting this amendment are addressed in Note 3. harvard university notes to financial statements
3. investments The significant accounting policies of the University related to investments are as follows: by the external advisor along with any relevant market data to measure the investment s fair value as of that date. harvard university notes to financial statements A) Investments are presented at fair value based on trade date positions as of June 30, 2012 and 2011. The University endeavors to utilize all relevant and available information in measuring fair value. B) The preparation of financial statements requires management to make estimates and assumptions about the effects of matters that may be inherently uncertain. Estimates, by their nature, are based on judgment and available information. Changes in assumptions could have a significant effect on the fair value of certain instruments. Actual results could differ from these estimates and could have a material impact on the financial statements. C) Cash and short-term investments are recorded at cost, which approximates fair value, and include cash in bank accounts, institutional money market funds, and other temporary investments held for working capital purposes with maturities of three months or less. Cash and short-term investments do not include cash balances held as collateral. D) Instruments listed or traded on a securities exchange are valued at the last quoted price on the primary exchange where the security is traded. Where no sale has occurred on the valuation date, long positions are valued at the bid price and short positions are valued at the ask price. Restrictions that are attached to a security are factored into the valuation of that security, reflective of the estimated impact of those restrictions. Investments in non-exchange traded debt and equity instruments are primarily valued using inputs provided by independent pricing services or by broker/dealers who actively make markets in these securities. Investments managed by external advisors include investments in private equity, real assets, and certain other investments in limited partnerships and hedge funds classified as domestic equity, high yield, and absolute return. The majority of these external investments are not readily marketable and are reported at fair value utilizing the most current information provided by the external advisor, subject to assessments that the information is representative of fair value and in consideration of any additional factors deemed pertinent to the fair value measurement. The University evaluates its external advisors through a manager due-diligence program executed by hmc, which includes an analysis of an advisor s use of and adherence to fair value principles. In situations where the information provided by the external advisor is deemed to not be representative of fair value as of the measurement date, management will evaluate specific features of the investment and utilize supplemental fair value information provided Fair value measurements of real assets (including direct investments in natural resources and real estate) are based on a combination of information obtained from independent appraisals and/or one or more industry standard valuation techniques (e.g., income approach, market approach, or cost approach). The income approach is primarily based on the investment s anticipated future income using one of two principal methods, the discounted cash flow method or the capitalization method. Inputs and estimates developed and utilized in the income approach may be subjective and require judgment regarding significant matters such as estimating the amount and timing of future cash flows and the selection of discount and capitalization rates that appropriately reflect market and credit risks. The market approach derives investment value through comparison to recent and relevant market transactions with similar investment characteristics. The cost approach is utilized when the cost or the replacement cost amounts are determined to be the best representation of fair value. This method is typically used for newly purchased or undeveloped assets. These valuations are determined by management and subject to review by the hmc Board of Directors. Over the counter derivative products classified as due to/ from brokers include option, swap, credit default, interest rate, and forward contracts. These types of instruments are primarily valued using industry standard models with externally provided inputs or independent broker quotes. Inputs such as prices, spreads, curves, and/or broker quotes are evaluated for source reliability and consistency with industry standards. Counterparty marks obtained and used to determine daily collateral requirements are also used to corroborate input reasonability. Management considers current market conditions including interest rate and credit risks in its evaluation of inputs, pricing methodologies, and models utilized to determine fair values. E) Dividend income is recognized net of applicable withholding taxes on the ex-dividend date. Non-cash dividends are recorded at the fair value of the securities received. Interest income and expenses are recorded net of applicable withholding taxes on the accrual basis of accounting. The University amortizes bond premiums and accretes bond discounts using the effective yield method and when cash collection is expected. F) The University utilizes a number of wholly owned subsidiary entities to support its investment activities. The consolidated financial statements include all assets, liabilities, income, and expenses associated with these entities. All intercompany accounts and transactions have been eliminated during consolidation.
G) The University may enter into repurchase agreements, whereby the University acquires a security (collateral) for cash subject to an obligation by the counterparty to repurchase the security at an agreed-upon price and time. The University requires the fair value of the collateral received to be equal to or in excess of the total amount of the repurchase agreement, including interest. Securities purchased under repurchase agreements are reflected as an asset on the Balance Sheets. Interest earned or paid is recorded as a component of Investment income on the Statements of Changes in Net Assets. Generally, in the event of counterparty default, the University has the right to use the collateral to offset losses incurred. The collateral advanced under security borrowing agreements is in the form of cash. The minimum collateral the University requires by contract on each loaned security is 100% of the fair value of the security loaned. Collateral is exchanged as required by fluctuations in the fair value of the security loaned. H) The Balance Sheets display both the assets and corresponding liabilities generated by reverse repurchase and securities lending transactions. Under the terms of a reverse repurchase agreement, the counterparty takes possession of an underlying security subject to an obligation of the University to repurchase the security at an agreed-upon price and time. The University pays the counterparty interest over the term of the reverse repurchase agreement. The University also separately reports the fair value of assets for which counterparties have the right to pledge or exchange the collateral they have received; assets of the investment portfolio that are unencumbered are included in Investment portfolio, at fair value in the Balance Sheets. Income and expenses related to reverse repurchase and securities lending transactions are included in Income from general investments in the Statements of Changes in Net Assets of the Endowment. These transactions are executed to support the investment activities of hmc. The majority of the University s investments are managed by hmc in the General Investment Account (gia), a pooled fund that consists primarily of endowment assets. Other investments are managed separately from the gia. These investments consist primarily of cash, short-term investments, and fixed income securities (principally government securities) held for the University s working capital and liquidity needs, interest rate contracts on the University s debt portfolio, and publicly traded securities associated with split interest agreements. All investments are measured at fair value using valuation techniques consistent with asc 820 and the accounting policies presented herein. The University s investment holdings as of June 30, 2012 and 2011 are summarized in the following table (in thousands of dollars): 2012 2011 Investment portfolio, at fair value: Pooled general investment account assets 1 $ 47,788,308 $ 51,276,581 Other investments 1,980,353 2,308,994 Investment assets 2 49,768,661 53,585,575 harvard university notes to financial statements Pooled general investment account liabilities (11,912,733) (13,935,246) Interest rate exchange agreements (381,893) (400,568) Investment liabilities (12,294,626) (14,335,814) TOTAL INVESTMENTS 37,474,035 39,249,761 Non-controlling interests attributable to the pooled general investment account (1,070,136) (832,339) TOTAL INVESTMENTS, NET $ 36,403,899 $ 38,417,422 1 Includes securities pledged to counterparties of $6,383,535 and $6,768,202 at June 30, 2012 and 2011, respectively. 2 Investment holdings include cash and cash equivalents that consist principally of deposits that have maturities of 90 days or less. Cash and cash equivalents classified as investments were $926,896 and $1,363,712 at June 30, 2012 and 2011, respectively. A summary of the University s total return on investments for fiscal 2012 and 2011 is presented below (in thousands of dollars): 2012 2011 Return on pooled general investment account: Realized and change in unrealized gains, net $ (141,861) $ 6,100,258 Net investment income 117,569 184,192 Total return on pooled general investment account 1 (24,292) 6,284,450 Return on other investments: Realized and change in unrealized (losses)/gains, net (12,374) 75,024 Net investment income 28,979 35,284 Total return on other investments 16,605 110,308 Realized and unrealized (losses)/gains on interest rate exchange agreements, net (140,219) 7,877 TOTAL RETURN ON INVESTMENTS $ (147,906) $ 6,402,635 1 Net of all internal and external management fees and expenses.
harvard university notes to financial statements The University s investment strategy incorporates a diversified asset allocation approach and maintains, within defined limits, exposure to the movements of the global equity, fixed income, real estate, commodities, and private equity markets. The Policy Portfolio provides hmc with a guide as to the targeted allocation in the core investment portfolio. The Policy Portfolio is the long-term asset mix determined by the hmc Board of Directors and management team that is considered most likely to meet the University s long-term return goals with the designated level of risk. It serves as the benchmark against which the performance of the pooled general investment account is measured. In addition, the University seeks to enhance the returns of certain asset classes through relative strategies designed to capture mispricing in specific financial instruments without changing the fundamental risk profile of the core investment account. The University has various sources of liquidity at its disposal within its investment pools, including approximately $3.8 billion in cash and cash equivalents (including repurchase agreements of $3.0 billion) at June 30, 2012 in the General Investment Account and the General Operating Account. In addition, management estimates that as of June 30, 2012, it could liquidate additional unencumbered US government securities of $1.4 billion within one business day (typical settlement terms) to meet any immediate short-term needs of the University. The pooled general investment account assets and liabilities below have been disaggregated into asset classes based on the exposure of the investment to various markets. Exposure to each asset class is achieved through investments in individual securities, direct investments in special purpose vehicles, and/ or through vehicles advised by external managers. The pooled general investment account assets and liabilities as of June 30, 2012 and 2011 are summarized as follows (in thousands of dollars): 2012 2011 POOLED GENERAL INVESTMENT ACCOUNT ASSETS: Investment assets: Domestic common and convertible equity $ 3,510,380 $ 3,806,649 Foreign common and convertible equity 1,771,081 2,062,218 Domestic fixed income 5,232,751 4,982,365 Foreign fixed income 1,774,283 3,112,809 Emerging market equity and debt 2,959,047 2,411,371 High yield 1,557,938 1,634,649 Absolute return 4,751,754 5,033,413 Private equities 7,095,625 7,262,271 Real assets 1 10,156,008 8,816,619 Inflation-indexed bonds 919,081 1,303,314 Due from brokers 299,518 998,001 Total investment assets 2 40,027,466 41,423,679 Repurchase and securities borrowing agreements 6,002,202 7,765,585 Cash and short-term investments 750,733 941,141 Other assets 3 1,007,907 1,146,176 POOLED GENERAL INVESTMENT ACCOUNT ASSETS 47,788,308 51,276,581 POOLED GENERAL INVESTMENT ACCOUNT LIABILITIES: Investment liabilities: Equity and convertible securities sold, not yet purchased 38,854 358,553 Fixed income securities sold, not yet purchased 3,343,931 4,225,876 Due to brokers 63,512 803,307 Total investment liabilities 3,446,297 5,387,736 Reverse repurchase and securities lending agreements 6,725,670 6,198,268 Other liabilities 4 1,740,766 2,349,242 POOLED GENERAL INVESTMENT ACCOUNT LIABILITIES 11,912,733 13,935,246 Non-controlling interests attributable to the pooled general investment account 1,070,136 832,339 POOLED GENERAL INVESTMENT ACCOUNT NET ASSETS 5 $ 34,805,439 $ 36,508,996 1 Real assets includes investments in natural resources and real estate managed by external advisors of $3,941,571 and $3,650,447 as of June 30, 2012 and 2011, respectively. The remaining balance consists of direct investments in natural resources and real estate held through special purpose vehicles of $6,214,437 and $5,166,172 as of June 30, 2012 and 2011, respectively. 2 Includes fair value of securities pledged to counterparties where the counterparty has the right to sell or repledge the securities of $6,383,535 and $6,768,202 as of June 30, 2012 and 2011, respectively. 3 As of June 30, 2012, other assets consisted primarily of receivables for the sale of securities of $179,148, and assets consolidated under ASC 810 of $426,018. As of June 30, 2011, other assets consisted primarily of receivables for the sale of securities of $748,598, and assets consolidated under ASC 810 of $397,577. 4 As of June 30, 2012, other liabilities consisted primarily of payables for the purchase of securities of $143,644, and other liabilities consolidated under ASC 810 of $1,203,333. As of June 30, 2011, other liabilities consisted primarily of payables for the purchase of securities of $1,433,911, and other liabilities consolidated under ASC 810 of $844,431. 5 The cost of the total pooled general investment account net assets was $33,203,550 and $32,266,809 as of June 30, 2012 and 2011, respectively.
As of June 30, 2012 and 2011, the gia was comprised of the following components (in thousands of dollars): 2012 2011 POOLED GENERAL INVESTMENT ACCOUNT Endowment 1 $ 29,907,024 $ 31,153,645 General operating account 3,792,118 4,202,095 Split interest agreements 761,333 796,563 Other internally designated funds 344,964 356,693 TOTAL POOLED GENERAL INVESTMENT ACCOUNT NET ASSETS $ 34,805,439 $ 36,508,996 1 Includes only the portion of the endowment invested in the GIA and excludes pledges, interests in trusts held by others, other non-gia investments, and GIA income. The asset allocation of the University s investment portfolio involves exposure to a diverse set of markets. The investments within these markets involve various risks such as price, interest rate, market, sovereign, currency, liquidity, and credit risks. Additionally, the gia s investments in real assets, which include investments in natural resources and real estate, expose the University to a unique set of risks such as operational, environmental, and political risks. Furthermore, a component of the investment portfolio s asset allocation includes two diversified funds managed by external advisors, which represent 14% of the gia net asset value ( nav ), in the aggregate. The University anticipates that the value and composition of its investments may, from time to time, fluctuate substantially in response to any or all of the risks described herein. The table on page 24 includes the total fair value of securities pledged to counterparties where the counterparty has the right, by contract or practice, to sell or repledge the securities. The total fair value of securities pledged that cannot be sold or repledged was $56.3 million and $172.6 million as of June 30, 2012 and 2011, respectively. The fair value of collateral accepted by the University was $5,571.8 million and $7,759.8 million as of June 30, 2012 and 2011, respectively. The portion of this collateral that was sold or repledged was $45.3 million and $178.9 million as of June 30, 2012 and 2011, respectively. the University that are required to be presented on the University s balance sheet under gaap. The table on page 24 includes the minority interest portion of real assets of $1,223.4 million and $892.0 million as of June 30, 2012 and 2011, respectively. Other assets include the minority interest portion of cash, receivables, and fixed assets of $56.1 million and $48.6 million as of June 30, 2012 and 2011, respectively. Other liabilities include the minority interest portion of accruals, payables, and debt of $209.4 million and $108.3 million as of June 30, 2012 and 2011, respectively. The net increase in non-controlling interests year over year relates to $78.1 million of new non-controlling interests acquired during the year ended June 30, 2012, and appreciation on existing non-controlling interests of $159.7 million for the year then ended. Other liabilities on page 24 include debt outstanding on consolidated real asset portfolio investments of $979.4 million and $599.9 million as of June 30, 2012 and 2011, respectively. Based on the structure, duration, and nature of the debt being consolidated, the amounts approximate the fair value of the debt as of each reporting period. This debt is specific to real assets held by the investment portfolio, and does not extend to other assets held by the University. harvard university notes to financial statements The University has consolidated certain non-controlling interests relating to its investments in real assets under asu 2010-7. These non-controlling interests represent the minority interest portion of the real assets controlled by
4. fair value of investment assets and liabilities harvard university notes to financial statements The University s investments have been categorized based upon the fair value hierarchy in accordance with asc 820. The asc 820 fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value of investment assets and liabilities into three levels. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under asc 820 are: level 1 Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; level 2 Quoted prices in markets that are not considered to be active or financial instruments for which all significant inputs are observable, either directly or indirectly; level 3 Prices or valuations that require inputs that are significant to the fair value measurement, unobservable and/ or require the University to develop its own assumptions. The level of an asset or liability within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Transfers between levels are recognized at the beginning of the year. Investments that trade in inactive markets, but are valued based on quoted market prices, broker/dealer quotations, or independent pricing services supported by observable inputs are primarily classified within Level 2. These may include non-exchange traded equity and fixed income securities, securities subject to restriction, and certain over the counter derivatives. In evaluating the level at which the University s externally managed investments have been classified within this hierarchy, management has assessed factors including, but not limited to price transparency, the ability to redeem these investments at nav at the measurement date, and the existence or absence of certain restrictions at the measurement date. Investments in externally managed funds generally have limited redemption options for investors and, subsequent to final closing, may or may not permit subscriptions by new or existing investors. These entities may also have the ability to impose gates, lockups, and other restrictions on an investor s ability to readily redeem out of their investment interest in the fund. At June 30, 2012 and 2011, certain externally managed funds where the University has the ability and the right to redeem interests within the next twelve months have been classified as Level 2 investments. The University s Level 3 investments consist almost entirely of investments managed by external advisors, and direct investments in natural resources and real estate. Externally managed investments are generally valued using the most current information received from the external advisor, subject to assessments that the value is representative of fair value and in consideration of any additional factors deemed pertinent to the valuations. Direct investments are primarily valued using a combination of independent appraisals, when available, and/or other industry standard methodologies as applicable. Level 3 investments also include certain over the counter derivative products primarily valued using independent broker quotes. Valuations determined using significant and unobservable inputs or assumptions are subject to additional review and consideration by management; the University strives to corroborate information from third-party sources for relevance and accuracy. Valuation policies for these types of investments are further discussed in Note 3.
The following is a summary of the levels within the fair value hierarchy for those investment assets and liabilities subject to fair value measurement as of June 30, 2012 (in thousands of dollars): Level 1 Level 2 Level 3 Total INVESTMENT ASSETS: Cash and short-term investments $ 926,896 $ 926,896 Domestic common and convertible equity 190,117 $ 1,693,625 $ 1,807,661 3,691,403 Foreign common and convertible equity 82,331 1,056,359 713,439 1,852,129 Domestic fixed income 5,212,122 100,678 319 5,313,119 Foreign fixed income 1,797,397 3,120 1,800,517 Emerging market equity and debt 2,540,972 213,363 204,712 2,959,047 High yield 12,936 962,175 595,763 1,570,874 Absolute return 2,734,708 2,017,046 4,751,754 Private equities 1,952 7,193,196 7,195,148 Real assets 63,430 71,316 10,036,845 10,171,591 Inflation-indexed bonds 936,662 936,662 Due from brokers 30,743 242,474 26,302 299,519 Other investments 19,279 1,321 7,862 28,462 TOTAL INVESTMENT PORTFOLIO ASSETS * 11,812,885 7,081,091 22,603,145 41,497,121 Interests in trusts held by others 343,798 343,798 TOTAL INVESTMENT ASSETS $ 11,812,885 $ 7,081,091 $ 22,946,943 $ 41,840,919 * Excludes repurchase and securities borrowing agreements and other assets of $8,271,540. INVESTMENT LIABILITIES: Equity and convertible securities sold, not yet purchased $ 36,792 $ 2,062 $ 38,854 Fixed income securities sold, not yet purchased 3,233,121 110,810 3,343,931 Due to brokers 6,416 437,719 $ 1,270 445,405 TOTAL INVESTMENT LIABILITIES ** 3,276,329 550,591 1,270 3,828,190 Liabilities due under split interest agreements 670,242 670,242 TOTAL LIABILITIES $ 3,276,329 $ 1,220,833 $ 1,270 $ 4,498,432 ** Includes fair value of interest rate exchange agreements of $381,893 and excludes reverse repurchase and securities lending agreements and other liabilities of $8,466,436. The following is a summary of the levels within the fair value hierarchy for those investment assets and liabilities subject to fair value measurement as of June 30, 2011 (in thousands of dollars): Level 1 Level 2 Level 3 Total INVESTMENT ASSETS: Cash and short-term investments $ 1,363,712 $ 1,363,712 Domestic common and convertible equity 298,522 $ 1,749,239 $ 1,948,111 3,995,872 Foreign common and convertible equity 158,333 1,092,772 886,485 2,137,590 Domestic fixed income 5,064,584 1,969 12,405 5,078,958 Foreign fixed income 3,138,090 3,138,090 Emerging market equity and debt 1,757,074 365,313 288,984 2,411,371 High yield 20,366 776,190 858,459 1,655,015 Absolute return 2,733,664 2,299,749 5,033,413 Private equities 45,020 7,312,137 7,357,157 Real assets 73,736 77,889 8,680,598 8,832,223 Inflation-indexed bonds 1,323,144 1,323,144 Due from brokers 21,813 912,681 63,507 998,001 Other investments 28,856 1,744 3,677 34,277 TOTAL INVESTMENT PORTFOLIO ASSETS * 13,248,230 7,756,481 22,354,112 43,358,823 Interests in trusts held by others 351,408 351,408 TOTAL INVESTMENT ASSETS $ 13,248,230 $ 7,756,481 $ 22,705,520 $ 43,710,231 * Excludes repurchase and securities borrowing agreements and other assets of $10,226,752. harvard university notes to financial statements INVESTMENT LIABILITIES: Equity and convertible securities sold, not yet purchased $ 358,553 $ 358,553 Fixed income securities sold, not yet purchased 4,225,876 4,225,876 Due to brokers 34,513 $ 1,160,179 $ 9,183 1,203,875 TOTAL INVESTMENT LIABILITIES ** 4,618,942 1,160,179 9,183 5,788,304 Liabilities due under split interest agreements 771,568 771,568 TOTAL LIABILITIES $ 4,618,942 $ 1,931,747 $ 9,183 $ 6,559,872 ** Includes fair value of interest rate exchange agreements of $400,568 and excludes reverse repurchase and securities lending agreements and other liabilities of $8,547,510.
The following is a rollforward of Level 3 investments for the year ended June 30, 2012 (in thousands of dollars): harvard university notes to financial statements Beginning Realized Change in Transfer Transfer Ending balance as of gains/ unrealized into out of balance as of July 1, 2011 (losses) gains/(losses)* Purchases Sales Level 3 Level 3** June 30, 2012 INVESTMENT ASSETS: Domestic common and convertible equity $ 1,948,111 $ 134,362 $ 109,828 $ 212,045 $ (653,700) $ 57,015 $ 1,807,661 Foreign common and convertible equity 886,485 38,737 (152,352) 138,770 (238,737) 40,536 713,439 Domestic fixed income 12,405 1,680 111 14,133 (23,498) $ (4,512) 319 Emerging market equity and debt 288,984 (50,485) (93,460) 51,476 (168,518) 176,715 204,712 High yield 858,459 38,501 30,168 86,320 (229,986) 30,738 (218,437) 595,763 Absolute return 2,299,749 255,439 (241,720) 474,511 (986,508) 216,618 (1,043) 2,017,046 Private equities 7,312,137 596,506 (453,981) 991,832 (1,294,758) 41,460 7,193,196 Real assets 8,680,598 72,368 662,569 1,660,883 (1,046,146) 6,573 10,036,845 Due from brokers 63,507 (101) (19,009) (18,095) 26,302 Other investments 3,677 6 4,179 7,862 TOTAL INVESTMENT PORTFOLIO ASSETS 22,354,112 1,087,013 (153,667) 3,629,970 (4,659,946) 569,655 (223,992) 22,603,145 Interests in trusts held by others 351,408 (7,610) 343,798 TOTAL INVESTMENT ASSETS $ 22,705,520 $ 1,087,013 $ (161,277) $ 3,629,970 $ (4,659,946) $ 569,655 $ (223,992) $ 22,946,943 INVESTMENT LIABILITIES: Due to brokers $ 9,183 $ (527) $ (7,913) $ 527 $ 1,270 TOTAL INVESTMENT LIABILITIES $ 9,183 $ (527) $ (7,913) $ 527 $ 1,270 * Total change in unrealized gains/(losses) relating to Level 3 investment assets and investment liabilities still held by the University at June 30, 2012 is $(573,061) and is reflected in Realized and unrealized (depreciation)/appreciation, net in the Statements of Changes in Net Assets. ** Changes in classification for certain externally managed funds from Level 3 to Level 2 are included in the above table as transfers out of Level 3. The following is a rollforward of Level 3 investments for the year ended June 30, 2011 (in thousands of dollars): Beginning Realized Change in Transfer Transfer Ending balance as of gains/ unrealized into out of balance as of July 1, 2010 (losses) gains/(losses)* Purchases Sales Level 3 Level 3** June 30, 2011 INVESTMENT ASSETS: Domestic common and convertible equity $ 1,977,249 $ 111,921 $ 902,554 $ 12,507 $ (292,430) $ (763,690) $ 1,948,111 Foreign common and convertible equity 711,184 (103,157) 555,610 (59,742) (217,410) 886,485 Domestic fixed income 24,613 7,734 (4,024) 25,322 (48,449) $ 7,209 12,405 Foreign fixed income (1,095) 1,095 Emerging market equity and debt 418,433 42,924 53,188 88,054 (677,190) 364,961 (1,386) 288,984 High yield 869,213 (6,474) 118,179 839,377 (270,074) (691,762) 858,459 Absolute return 2,679,639 268,961 277,213 658,737 (1,293,301) (291,500) 2,299,749 Private equities 6,358,302 575,938 949,492 1,100,628 (1,792,791) 165,640 (45,072) 7,312,137 Real assets 6,145,956 156,546 1,274,343 1,893,867 (771,784) (18,330) 8,680,598 Due from brokers 45,973 3,659 325 17,138 (3,554) (34) 63,507 Other investments 3,062 2 613 3,677 TOTAL INVESTMENT PORTFOLIO ASSETS 19,233,624 1,056,959 4,128,588 4,635,630 (5,209,315) 537,810 (2,029,184) 22,354,112 Interests in trusts held by others 297,629 53,779 351,408 TOTAL INVESTMENT ASSETS $ 19,531,253 $ 1,056,959 $ 4,182,367 $ 4,635,630 $ (5,209,315) $ 537,810 $ (2,029,184) $ 22,705,520 INVESTMENT LIABILITIES: Equity and convertible securities sold, not yet purchased $ 209 $ 202 $ (135) $ (276) Fixed income securities sold, not yet purchased 620 (2,104) 548 936 Due to brokers 15,901 898 (151) (1,626) $ (5,839) $ 9,183 TOTAL INVESTMENT LIABILITIES $ 16,730 $ (1,004) $ 262 $ (966) $ (5,839) $ 9,183 * Total change in unrealized gains/(losses) relating to Level 3 investment assets and investment liabilities still held by the University at June 30, 2011 is $2,766,382 and is reflected in Realized and unrealized appreciation/(depreciation), net in the Statements of Changes in Net Assets. ** Changes in classification for certain externally managed funds from Level 3 to Level 2 are included in the above table as transfers out of Level 3.
The University has entered into agreements with private equity and real asset partnerships and other external investment managers, which include commitments to make periodic contributions in the form of cash in future periods. The amounts of these expected disbursements as of June 30, 2012 and 2011 are broken out below (in thousands of dollars): As of June 30, 2012 Remaining unfunded Estimated Fair value* commitments remaining life** Private equities $ 6,494,120 $ 2,382,070 4 10 Real assets 3,214,819 1,606,028 4 10 Other externally managed funds*** 850,114 587,441 2 8 TOTAL $ 10,559,053 $ 4,575,539 As of June 30, 2011 Remaining unfunded Estimated Fair value* commitments remaining life** Private equities $ 6,428,104 $ 2,888,016 5 10 Real assets 2,356,477 2,050,947 5 10 Other externally managed funds*** 1,155,327 490,249 2 8 TOTAL $ 9,939,908 $ 5,429,212 * Represents the fair value of the funded portion of investments with remaining unfunded commitments for each asset class. ** The estimated remaining lives of these funds, expressed in years, are forward-looking projections based on management s estimates and could vary significantly depending on the investment decisions of external managers, changes in the University s investment portfolio, and other circumstances. *** Investments in externally managed funds primarily include exposures to absolute return, domestic, foreign, and emerging equities, and high yield asset classes. The University s interests in many of its partnership investments (primarily private equity and real estate) generally represent commitments that are not subject to redemption; instead the University is a limited partner in funds that invest in private companies or properties, or pursue specific investment strategies. The nature of these investments is that distributions are received through the liquidation of the underlying assets of the partnership. The fair value of the investments in these asset classes has generally been estimated using the University s capital account balance with each partnership, unless management has deemed the nav to be an inappropriate representation of fair value. The University generally classifies its interest in these types of entities as Level 3 investments within the aforementioned fair value hierarchy. harvard university notes to financial statements
5. derivatives harvard university notes to financial statements The University uses a variety of financial instruments with off-balance sheet risk involving contractual or optional commitments for future settlement, which are exchange traded or executed over the counter. These instruments are used in both the core portfolio to increase or decrease exposure to a given asset class and in the relative value strategies, with the goal of enhancing the returns of certain asset classes. The University may also invest in derivative instruments when it believes investments or other derivatives are mispriced in relation to other investments, and the University can benefit from such mispricing. The fair value of these financial instruments is included in the Investment portfolio, at fair value and Securities lending and other liabilities associated with the investment portfolio line items of the Balance Sheets, with changes in fair value reflected as Realized and changes in unrealized appreciation/(depreciation), net within the Statements of Changes in Net Assets. The market risk of a strategy is influenced by the relationship between the financial instruments with off-balance sheet risk and the offsetting positions recorded in the Balance Sheets. The University manages exposure to market risk through the use of industry standard analytical tools that measure the market exposure of each position within a strategy. The strategies are monitored daily, and positions are frequently adjusted in response to changes in the financial markets. Derivative instruments entered into by limited partnerships and commingled investment vehicles pose no direct off-balance sheet risk to the University due to the limited liability structure of the investments. The following table presents the gross fair values and the net profit/(loss) from derivatives by primary risk exposure for the year ended June 30, 2012 (in thousands of dollars): For the year ended As of June 30, 2012 June 30, 2012 Gross Gross derivative derivative Net profit/ Primary risk exposure assets liabilities (loss) Equity instruments: Equity futures $ 3,615 $ 58,307 Equity options $ 58,236 31,730 7,871 Equity exchange agreements 83,168 55,589 (488,127) TOTAL EQUITY INSTRUMENTS 141,404 90,934 (421,949) Fixed income instruments: Fixed income futures 10,069 5,075 (113,800) Fixed income options 5,409 4,194 796 Interest rate exchange agreements 1 776,602 1,070,542 (205,686) Interest rate caps and floors 169,899 172,167 303 TOTAL FIXED INCOME INSTRUMENTS 961,979 1,251,978 (318,387) Commodity instruments: Commodity futures 26,619 30,052 19,898 Commodity options 53,846 41,019 2,706 Commodity exchange agreements 42,660 18,109 (62,253) TOTAL COMMODITY INSTRUMENTS 123,125 89,180 (39,649) Currency instruments: Currency forwards 1,780,893 1,777,928 71,673 Currency options 42,498 11,581 (2,087) Currency exchange agreements 34,649 21,013 4,558 TOTAL CURRENCY INSTRUMENTS 1,858,040 1,810,522 74,144 CREDIT INSTRUMENTS 47,071 34,878 (6,099) TOTAL 3,131,619 3,277,492 $ (711,940) Counterparty netting 2 (2,820,570) (2,820,556) INCLUDED IN INVESTMENT PORTFOLIO, AT FAIR VALUE $ 311,049 $ 456,936 1 Includes $11,531 and $393,424 of gross derivative assets and liabilities, respectively, and a net profit/(loss) of $(140,219), related to interest rate exchange agreements on the University s debt portfolio, further discussed in Note 12. 2 GAAP permits the netting of derivative assets and liabilities and the related cash collateral received and paid when a legally enforceable master netting agreement exists between the University and a derivative counterparty.
The following table presents the gross fair values and the net profit/(loss) from derivatives by primary risk exposure For the year ended for the year ended June 30, 2011 (in thousands of dollars): As of June 30, 2011 June 30, 2011 Gross Gross derivative derivative Net profit/ Primary risk exposure assets liabilities (loss) Equity instruments: Equity futures $ 1,090 $ (400) Equity options $ 37,715 7,894 1,016 Equity exchange agreements 75,846 71,649 675,299 TOTAL EQUITY INSTRUMENTS 113,561 80,633 675,915 Fixed income instruments: Fixed income futures 28,014 17,401 7,376 Fixed income options 6,259 5,033 (3,678) Interest rate exchange agreements 1 662,684 929,106 34,733 Interest rate caps and floors 65,781 67,942 32,692 TOTAL FIXED INCOME INSTRUMENTS 762,738 1,019,482 71,123 Commodity instruments: Commodity futures 9 9 Commodity exchange agreements 6,314 2,204 231,309 COMMODITY INTSTRUMENTS 6,323 2,213 231,309 Currency instruments: Currency forwards 1,663,481 1,686,469 (31,707) Currency options 52,753 32,822 (6,694) Currency exchange agreements 21,852 10,949 11,666 TOTAL CURRENCY INSTRUMENTS 1,738,086 1,730,240 (26,735) CREDIT INSTRUMENTS 48,751 42,226 (24,329) TOTAL 2,669,459 2,874,794 $ 927,283 Counterparty netting 2 (1,662,597) (1,662,058) INCLUDED IN INVESTMENT PORTFOLIO, AT FAIR VALUE $ 1,006,862 $ 1,212,736 harvard university notes to financial statements 1 Includes $8,861 and $409,429 of gross derivative assets and liabilities, respectively, and a net profit/(loss) of $7,877, related to interest rate exchange agreements on the University s debt portfolio, further discussed in Note 12. 2 GAAP permits the netting of derivative assets and liabilities and the related cash collateral received and paid when a legally enforceable master netting agreement exists between the University and a derivative counterparty. The following section details the accounting for each type of derivative contract, as well as the University s intended purpose for entering into each type of derivative instrument. Options The University purchases and sells put and call options to take advantage of mispricing due to expectations in the marketplace of future volatility of the underlying instruments. When purchasing an option, the University pays a premium, which is included in the pooled general investment account table in Note 3 as an asset and subsequently marked-to-market to reflect the current value of the option. Premiums paid for purchased options that expire unexercised are treated as realized losses within the Statements of Changes in Net Assets. When the University sells (writes) a call or put option, an amount equal to the premium received is recorded as a liability in the pooled general investment account table in Note 3 and subsequently marked-to-market to reflect the current fair value of the option written. Premiums received from writing options that expire unexercised are treated as realized gains within the Statements of Changes in Net Assets. When a purchased option is closed before expiration or exercise, the University records a realized gain or loss equal to the difference between the proceeds received upon closing and the premium paid. When a written option is closed before expiration or exercise, the University records a realized gain or loss equal to the difference between the cost to close the option and the premium received from selling the option. During fiscal 2012, the University transacted approximately 500 equity and fixed income option trades with an average transaction size of approximately 2,500 contracts. Additionally, the University transacted approximately 400 currency option contracts with average usd equivalent notional amounts of approximately $23.0 million per contract.
harvard university notes to financial statements During fiscal 2011, the University transacted approximately 500 equity and fixed income option trades with an average transaction size of approximately 3,500 contracts. Additionally, the University transacted approximately 275 currency option contracts with average usd equivalent notional amounts of approximately $25.0 million per contract. Swap contracts The University enters into swap contracts, which are contracts between two parties to exchange future cash flows at periodic intervals based on a notional principal amount. Payments are exchanged at specified intervals, accrued daily commencing with the effective date of the contract and recorded as realized gains or losses. Gains or losses are realized in the event of an early termination of a swap contract. Risks of loss may include unfavorable changes in the returns of the underlying instruments or indexes, adverse fluctuations of interest rates, failure of the counterparty to perform under the terms of the agreement, and lack of liquidity in the market. Collateral in the form of securities or cash may be posted to or received from the swap counterparty in accordance with the terms of the swap contract. Realized gains or losses are recorded within the Statements of Changes in Net Assets on periodic payments received or made on swap contracts and with respect to swaps that are closed prior to termination date. When the University enters into a swap transaction, it may make or receive a payment equal to the value of the swap on the entry date and amortizes such payments to realized gain or loss over the outstanding term of the swap. The terms of the swap contracts can vary, and they are reported at fair value based on a valuation model or a counterparty provided price. The University enters into swap contracts to increase or decrease its exposure to changes in the level of interest rates, underlying asset values and/or credit risk. In the normal course of its trading activities, the University enters into credit default, interest rate, and total return swap contracts. Credit default contracts The University enters into credit derivatives to simulate long and short bond exposure that is either unavailable or considered to be less attractively priced in the bond market, or to hedge exposure obtained in the bond market. The University also uses these derivatives to reduce risk where it has exposure to the issuer, or to take an active long or short position with respect to the likelihood of an event of default. The reference obligation of the derivative can be a single issuer, a basket of issuers, or an index. During fiscal 2012, the University transacted approximately 700 credit default contracts with average notional amounts of approximately $22.0 million. During fiscal 2011, the University transacted approximately 600 credit default contracts with average notional amounts of approximately $11.5 million. In instances where the University has purchased credit protection on an underlying reference obligation, the University is obligated to pay the seller of the credit protection a periodic stream of payments over the term of the contract in return for a contingent payment upon the occurrence of a credit event with respect to the underlying reference obligation. The contingent payment may be a cash settlement or a physical delivery of the reference obligation in return for payment of the face amount of the obligation. The amount paid for purchased protection is typically a nominal percentage of the notional amount. In instances where the University has sold credit protection on an underlying reference obligation, the University receives a fixed rate of income throughout the term of the contract, which typically is between one month and five years, and in some instances up to ten years. In the case where the University sold credit protection, if a credit event occurs, the University may cash settle the contract or pay the purchaser of credit protection the full notional value of the contract in exchange for the reference obligation. As of June 30, 2012, the University s purchased and written credit derivatives had gross notional amounts of $1.8 billion and $0.3 billion, respectively, for total net purchased protection of $1.5 billion in notional value. As of June 30, 2011, the University s purchased and written credit derivatives had gross notional amounts of $2.0 billion and $0.2 billion, respectively, for total net purchased protection of $1.8 billion in notional value.
The table below summarizes certain information regarding credit protection purchased and written as of June 30, 2012 and 2011 (in thousands of dollars): Purchased protection Years to maturity As of June 30, 2012 Written protection Net written Purchased Total Offsetting Net credit Credit rating notional Purchased written purchased written protection on underlying amount* fair value < 5 years 5-10 years notional notional** notional fair value A- to AAA $ 654,143 $ 2,777 $ 75,000 $ 23,000 $ 98,000 $ 12,000 $ 86,000 $ (3,269) BBB- to BBB+ 854,000 769 50,000 50,000 50,000 3,601 Non-investment grade 252,208 31,922 113,042 113,042 12,000 101,042 (23,606) TOTAL $ 1,760,351 $ 35,468 $ 238,042 $ 23,000 $ 261,042 $ 24,000 $ 237,042 $ (23,274) * Amounts shown are net of purchased credit protection that directly offsets written credit protection, as discussed in the note (**) below. ** Offsetting purchased credit derivatives represent the notional amount of purchased credit derivatives to the extent they hedge written credit derivatives with identical underlyings. Purchased protection Years to maturity As of June 30, 2011 Written protection Net written Purchased Total Offsetting Net credit Credit rating notional Purchased written purchased written protection on underlying amount* fair value < 5 years 5-10 years notional notional** notional fair value A- to AAA $ 584,750 $ 194 $ 14,498 $ 26,500 $ 40,998 $ 17,998 $ 23,000 $ 166 BBB- to BBB+ 1,210,115 (271) 28,500 28,500 28,500 (326) Non-investment grade 175,368 32,905 38,581 59,386 97,967 24,250 73,717 (29,735) TOTAL $ 1,970,233 $ 32,828 $ 53,079 $ 114,386 $ 167,465 $ 42,248 $ 125,217 $ (29,895) harvard university notes to financial statements Credit ratings on the underlying reference obligation, together with the period of expiration, are indicators of payment/ performance risk. For example, the seller of credit protection is least likely to pay or otherwise be required to perform where the credit ratings are AAA and the period of expiration is < 5 years. The likelihood of payment or performance is generally greater as the credit ratings fall and period of expiration increases. Interest rate contracts The University enters into interest rate swaps (including swaptions) to hedge certain investment positions against interest rate fluctuations; to benefit from interest rate fluctuations; to obtain better interest rate terms than it would have been able to get without the swap; or to manage the interest, cost, and risk associated with its outstanding debt and to hedge issuance of future debt. Interest rate swaps involve the exchange by the University with another party of its respective commitments to pay or receive interest at specified intervals based on a notional amount of principal. During fiscal 2012, the University transacted approximately 3,500 interest rate swap and cap and floor contracts with average notional amounts of approximately $200.0 million. During fiscal 2011, the University transacted approximately 3,500 interest rate swap and cap and floor contracts with average notional amounts of approximately $400.0 million. Total return swaps The University enters into total return swaps to manage its exposure to market fluctuations in various asset classes. Total return swaps involve commitments to pay interest in exchange for a market linked return, both based on notional amounts. To the extent the total return of the security or index underlying the transaction exceeds or falls short of the offsetting interest rate obligation, the University will receive a payment from or make a payment to the counterparty, respectively. During fiscal 2012, the University transacted approximately 400 commodity swap contracts, 700 equity swap contracts, and 200 currency swap contracts with average notional amounts of approximately $12.0 million,
harvard university notes to financial statements $10.0 million, and $8.0 million, respectively. During fiscal 2011, the University transacted approximately 90 commodity swap contracts, 1,300 equity swap contracts, and 250 currency swap contracts with average notional amounts of approximately $30.0 million, $2.5 million, and $13.0 million, respectively. Forward currency contracts The University enters into forward currency contracts in connection with settling planned purchases or sales of securities, for investment purposes, or to hedge the currency exposure associated with some or all of the University s portfolio securities. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date. The value of a forward currency contract fluctuates with changes in forward currency exchange rates. Forward currency contracts are marked-to-market daily and the change in fair value is recorded by the University as an unrealized gain or loss. Realized gains or losses equal to the difference between the fair value of the contract at the time it was opened and the fair value at the time it was closed are recorded upon delivery or receipt of the currency or, if a forward currency contract is offset by entering into another forward currency contract with the same broker, upon settlement of the net gain or loss. During fiscal 2012, the University transacted approximately 5,700 forward currency contracts with average usd equivalent notional amounts of approximately $3.0 million. During fiscal 2011, the University transacted approximately 5,000 forward currency contracts with average usd equivalent notional amounts of approximately $2.3 million. Futures contracts The University uses futures contracts to manage its exposure to financial markets, including to hedge such exposures. Buying futures tends to increase the University s exposure to the underlying instrument. Selling futures tends to decrease exposure to the underlying instrument. Upon entering into a futures contract, the University is required to deposit with its prime broker an amount of cash or liquid securities in accordance with the initial margin requirements of the broker or exchange. Gains and losses are realized when the contracts expire or are closed. Futures contracts are marked-to-market daily based on settlement prices established by the board of trade or exchange on which they are traded, and an appropriate payable or receivable for the change in fair value is recorded by the University. During fiscal 2012, the University transacted approximately 10,000 futures trades with an average transaction size of approximately 100 contracts. During fiscal 2011, the University transacted approximately 5,000 futures trades with an average transaction size of approximately 100 contracts. Counterparty credit exposure Financial instruments with off-balance sheet risk involve counterparty credit exposure. The policy of the University is to require collateral to the maximum extent possible under normal trading practices. Collateral is moved on a daily basis as required by fluctuations in the market. The collateral is generally in the form of debt obligations issued by the US Treasury. In the event of counterparty default, the University has the right to use the collateral to offset the loss associated with the replacements of the agreements. The University enters into arrangements only with counterparties believed to be creditworthy. Specific credit limits are established for counterparties based on their individual credit ratings. Credit limits are monitored daily by the University and are adjusted according to policy. Some of the financial instruments entered into by the University contain credit-risk-related contingency features that allow the parties to the agreement to demand immediate payment for outstanding contracts and/or collateral. If material credit-risk-related contingency features were triggered on June 30, 2012 and 2011, the additional collateral due to counterparties for derivative contracts would have been $6.4 million and $19.5 million, respectively. 6. receivables The major components of receivables, net of reserves for doubtful accounts of $12.0 million and $13.1 million as of June 30, 2012 and 2011, respectively, were as follows (in thousands of dollars): 2012 2011 Federal sponsored support $ 66,902 $ 63,557 Publications 37,114 31,113 Gift receipts 27,167 7,402 Executive education 23,286 22,978 Non-federal sponsored support 13,450 13,108 Tuition and fees 12,807 12,670 Other 46,675 48,403 TOTAL RECEIVABLES, NET $ 227,401 $ 199,231
7. notes receivable Notes receivable are recorded initially at face value plus accrued interest, which approximates fair value. Notes receivable, and the related allowance for doubtful accounts, were as follows (in thousands of dollars): 2012 2011 Receivable Allowance Net Receivable Allowance Net Student loans: Government revolving $ 80,039 $ 2,619 $ 77,420 $ 80,664 $ 2,509 $ 78,155 Institutional 83,931 2,955 80,976 82,244 2,800 79,444 Federally insured 985 985 1,434 1,434 Total student loans 164,955 5,574 159,381 164,342 5,309 159,033 Faculty and staff loans 187,081 422 186,659 185,788 422 185,366 Other loans 22,393 4,867 17,526 22,932 3,975 18,957 TOTAL $ 374,429 $ 10,863 $ 363,566 $ 373,062 $ 9,706 $ 363,356 Government revolving loans are funded principally with federal advances to the University under the Perkins Loan Program and certain other programs. These advances totaled $67.0 million as of June 30, 2012 and 2011, are classified as liabilities in the Balance Sheets. Interest earned on the revolving and institutional loan programs is reinvested to support additional loans. The repayment and interest rate terms of the institutional loans vary considerably. Faculty and staff notes receivable primarily consists of mortgage and educational loans. Mortgages include shared appreciation loans and loans that bear interest at the applicable federal rate. In addition, certain mortgages bear interest at the current market rate, which may be subsidized for an initial period. The educational loans are primarily zero-interest loans. The University assesses the adequacy of the allowance for doubtful accounts by evaluating the loan portfolio, including such factors as the differing economic risks associated with each loan category, the financial condition of specific borrowers, the economic environment in which the borrowers operate, the level of delinquent loans, the value of any collateral, and, where applicable, the existence of any guarantees or indemnifications. In addition to these factors, the University reviews the aging of the loans receivable and the default rate in comparison to prior years. The allowance is adjusted based on these reviews. The University considers the allowance at June 30, 2012 and 2011 to be reasonable and adequate to absorb potential credit losses inherent in the loan portfolio. harvard university notes to financial statements 8. pledges receivable Unconditional promises to donate to the University in the future are initially recorded at fair value (pledge net of discount) and subsequently amortized over the expected payment period, net of an allowance for uncollectible pledges. Discounts of $34.4 million and $41.8 million for the years ended June 30, 2012 and 2011, respectively, were calculated using discount factors based on the appropriate US Treasury Note rates for pledges received prior to the adoption of asc 820, and using the University s taxable unsecured borrowing rate for pledges received since fiscal 2009. Pledges receivable included in the financial statements as of June 30, 2012 and 2011 are expected to be realized as follows (in thousands of dollars): 2012 2011 Within one year $ 157,294 $ 134,080 Between one and five years 629,175 536,317 More than five years 210,582 193,902 Less: discount and allowance for uncollectible pledges (88,493) (105,858) TOTAL PLEDGES RECEIVABLE, NET $ 908,558 $ 758,441
Pledges receivable as of June 30, 2012 and 2011 have been designated for the following purposes (in thousands of dollars): 2012 2011 General Operating Account balances: Gifts for current use $ 429,859 $ 330,138 Non-federal sponsored grants 106,149 95,768 Loan funds and facilities 62,391 47,886 Total General Operating Account balances 598,399 473,792 Because of uncertainties with regard to realizability and valuation, bequest intentions and other conditional promises are only recognized as assets if and when the specified conditions are met. Non-bequest conditional pledges totaled $63.8 million and $30.4 million as of June 30, 2012 and 2011, respectively. Endowment 310,159 284,649 TOTAL PLEDGES RECEIVABLE, NET $ 908,558 $ 758,441 harvard university notes to financial statements 9. fixed assets Fixed assets are reported at cost or, if a gift, at fair value as of the date of the gift, net of accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The major categories of fixed assets as of June 30, 2012 and 2011 are summarized as follows (in thousands of dollars): Estimated useful life 2012 2011 (in years) Research facilities $ 2,091,652 $ 1,990,895 * Classroom and office facilities 1,572,065 1,324,352 35 Housing facilities 1,173,626 1,150,756 35 Other facilities 526,102 519,968 35 Service facilities 568,626 561,422 35 Libraries 434,622 408,666 35 Museums and assembly facilities 312,214 310,440 35 Athletic facilities 167,427 165,221 35 Land 698,673 695,570 n/a Construction in progress 719,589 807,095 n/a Equipment 950,602 864,903 ** SUBTOTAL AT COST 9,215,198 8,799,288 Less: accumulated depreciation (3,438,653) (3,152,211) FIXED ASSETS, NET $ 5,776,545 $ 5,647,077 * Estimated useful lives of components range from 10 to 45 years. ** Estimated useful lives of equipment range from 3 to 8 years. Certain University facilities are subject to restrictions as to use, structural modifications, and ownership transfer. Included in the fixed asset balances are restricted facilities with a net book value of $226.4 million and $222.3 million as of June 30, 2012 and 2011, respectively. The costs of research facilities are separated into the shell, roof, finishes, fixed equipment, and services. These components are separately depreciated. Equipment includes general and scientific equipment, computers, software, furniture, and vehicles. The University has asset retirement obligations of $61.3 million and $67.4 million, which are included in the Deposits and other liabilities in the Balance Sheets as of June 30, 2012 and 2011, respectively.
10. endowment The University s endowment consists of approximately 12,000 separate funds established over many years for a wide variety of purposes. Endowment fund balances, including funds functioning as endowment, are classified and reported as unrestricted, temporarily restricted, or permanently restricted net assets in accordance with donor specifications and state law. Net unrealized losses on permanently restricted endowment funds are classified as a reduction to unrestricted net assets until such time as the fair value equals or exceeds historic dollar value. Unrestricted net assets were reduced by $23.4 million and $13.1 million for such losses in fiscal 2012 and 2011, respectively. Although funds functioning as endowment are not subject to donor restrictions, decisions to spend their principal require the approval of the Corporation. All but a small fraction of the endowment is invested in the gia (Note 3). The University is also the beneficiary of certain irrevocable trusts held and administered by others. The estimated fair values of trust assets, which include the present values of expected future cash flows from outside trusts and the fair value of the underlying assets of perpetual trusts, are recognized as assets and increases in net assets when the required trust documentation is provided to the University. The fair values of these trusts are provided by the external trustees and are adjusted annually by the University. These are included as Level 3 investments in the fair value hierarchy table in Note 4. The endowment consisted of the following as of June 30, 2012 and 2011 (in thousands of dollars): 2012 2011 Temporarily Permanently Unrestricted restricted restricted Total Total Endowment funds $ (23,417) $ 17,204,271 $ 5,064,566 $ 22,245,420 $ 23,131,202 Funds functioning as endowment 5,385,753 2,511,525 7,897,278 8,288,451 Pledge balances 34,552 275,607 310,159 284,649 Interests in trusts held by others 12,946 279,731 292,677 308,427 TOTAL ENDOWMENT $ 5,362,336 $ 19,763,294 $ 5,619,904 $ 30,745,534 $ 32,012,729 harvard university notes to financial statements The University s endowment distribution policies are designed to preserve the value of the endowment in real terms (after inflation) and generate a predictable stream of available income. Each fall, the Corporation approves the endowment distribution for the following fiscal year. The endowment distribution is based on presumptive guidance from a formula that is intended to provide budgetary stability by smoothing the impact of annual investment gains and losses. The formula s inputs reflect expectations about long-term returns and inflation rates. For fiscal 2012, the endowment distribution approved by the Corporation (prior to decapitalizations) was equal to 4.6% of the fair value of the endowment invested in the gia as of the beginning of the fiscal year. The total endowment distribution made available for operations was $1.4 billion and $1.3 billion in fiscal 2012 and 2011, respectively. Each year the Corporation also approves certain decapitalizations from the endowment to support strategic, mission-critical activities or objectives that are typically one-time or timelimited. These decapitalizations totaled $308.5 million and $105.0 million in fiscal 2012 and 2011, respectively. These additional decapitalizations, in combination with the endowment distribution, resulted in an aggregate payout rate of 5.5% and 5.3% in fiscal 2012 and 2011, respectively.
11. split interest agreements harvard university notes to financial statements Under split interest agreements, donors enter into trust arrangements with the University in which the University receives benefits that are shared with other beneficiaries and institutions. Split interest agreement (sia) investment assets are invested primarily in the gia and publicly traded securities, a small segment is managed by an external advisor, and all are recorded at fair value as discussed in Notes 3 and 4. The publicly traded securities are included as Level 1 and externally managed investments are included as Level 3 investments in the fair value hierarchy table in Note 4. Associated liabilities are recorded at the present value of estimated future payments due to beneficiaries and other institutions. These liabilities were calculated using discount factors based on the appropriate US Treasury Note rates for gifts received prior to the adoption of asc 820, and using the University s current taxable unsecured borrowing rate for gifts received beginning in fiscal 2009. The changes in split interest agreement net assets for fiscal 2012 and 2011 were as follows (in thousands of dollars): 2012 2011 Temporarily Permanently restricted restricted Total Total Investment return: Investment income $ 3,571 $ 10,392 $ 13,963 $ 15,670 Realized and unrealized appreciation/(depreciation), net (7,112) (20,697) (27,809) 193,148 Total investment return (3,541) (10,305) (13,846) 208,818 Gifts for capital (Note 17) * 6,671 13,497 20,168 24,891 Payments to annuitants (14,899) (43,358) (58,257) (58,925) Transfers to endowment (18,684) (39,583) (58,267) (56,000) Transfers between sia and the goa (12,053) (2,182) (14,235) (14,100) Change in liabilities and other adjustments 39,238 117,658 156,896 (8,868) NET CHANGE DURING THE YEAR (3,268) 35,727 32,459 95,816 Total split interest agreement net assets, beginning of year 73,973 443,816 517,789 421,973 TOTAL SPLIT INTEREST AGREEMENT NET ASSETS, end of year $ 70,705 $ 479,543 $ 550,248 $ 517,789 * Shown at net present value. The undiscounted value of these gifts was $51,045 and $41,807 for the years ended June 30, 2012 and 2011, respectively. Split interest agreement net assets as of June 30, 2012 and 2011 consisted of the following (in thousands of dollars): 2012 2011 Split interest agreement investments (Note 3): Charitable remainder trusts $ 786,258 $ 842,092 Charitable lead trusts 115,618 117,115 Charitable gift annuities 213,847 225,335 Pooled income funds 104,767 104,815 Total split interest agreement investments 1,220,490 1,289,357 Liabilities due under split interest agreements: Amounts due to beneficiaries (560,474) (656,138) Amounts due to other institutions (109,768) (115,430) Total liabilities due under split interest agreements (670,242) (771,568) TOTAL SPLIT INTEREST AGREEMENT NET ASSETS, end of year $ 550,248 $ 517,789
12. bonds and notes payable Bonds and notes payable as of June 30, 2012 and 2011 were as follows (in thousands of dollars): Tax-exempt bonds and notes payable: Fiscal year Years to One-year Outstanding principal of issue final maturity * yield ** 2012 *** 2011 **** Variable-rate bonds and notes payable: Series R - daily 2000-2006 20 0.1% $ 131,200 $ 131,200 Series Y - weekly 2000 23 0.1 117,905 117,905 Commercial paper 2012 <1 0.2 288,735 319,681 Total variable-rate bonds and notes payable 0.1 537,840 568,786 Fixed-rate bonds: Series N 1992 8 6.3 79,210 79,109 Series Z 2001 1 5.7 10,143 19,748 Series DD 2002 n/a 5.0 135,071 Series FF 2003 25 5.1 185,154 185,312 Series 2005A 2005 24 4.8 93,049 93,213 Series 2005B 2006 20 4.8 104,324 104,512 Series 2005C 2006 23 4.9 129,469 129,622 Series 2008B 2008 26 4.8 215,829 216,094 Series 2009A 2009 24 5.4 984,205 985,106 Series 2010A 2010 22 4.5 523,579 526,987 Series 2010B 2011 28 4.6 657,918 661,672 Total fixed-rate bonds 5.0 2,982,880 3,136,446 Total tax-exempt bonds and notes payable 4.2 3,520,720 3,705,232 Taxable bonds and notes payable: Series GG2 - weekly 2005 n/a 0.2 24,355 Series 2006A 2006 25 6.3 401,459 401,437 Series 2008A 2008 26 4.9 387,805 387,760 Series 2008C 2008 6 5.3 125,205 125,205 Series 2008D 2009 27 6.1 996,820 1,196,376 Series 2010C 2011 28 4.9 298,105 298,038 Commercial paper 2012 <1 0.2 158,007 44,045 Total taxable bonds and notes payable 5.4 2,367,401 2,477,216 harvard university notes to financial statements Other notes payable Various Various Various 151,018 153,261 TOTAL BONDS AND NOTES PAYABLE 4.7% $ 6,039,139 $ 6,335,709 * The weighted average maturity of the portfolio on June 30, 2012 was 17.8 years. ** Exclusive of interest rate exchange agreements. Inclusive of these agreements, the overall portfolio rate was 5.1%. *** Series N, FF, 2006A, 2008A, 2008D, 2009A and 2010C principal are net of $0.8 million, $1.3 million, $0.5 million, $0.2 million, $3.2 million, $15.8 million and $1.9 million of discounts, respectively. Series 2005A, 2005B, 2005C, 2008B, 2010A and 2010B principal include premiums of $3.9 million, $3.8 million, $3.6 million, $7.0 million, $43.6 million and $56.9 million, respectively. **** Series N, DD, FF, 2006A, 2008A, 2008D, 2009A and 2010C principal are net of $0.9 million, $0.8 million, $1.2 million, $0.6 million, $0.2 million, $3.6 million, $14.9 million and $2.0 million of discounts, respectively. Series Z, 2005A, 2005B, 2005C, 2008B, 2010A and 2010B principal include premiums of $0.01 million, $4.1 million, $4.0 million, $3.7 million, $7.2 million, $47.0 million and $60.6 million, respectively Interest expense related to bonds and notes payable was $285.8 million and $296.4 million for fiscal 2012 and 2011, respectively. The interest expense in the Statement of Changes in Net Assets with General Operating Account Detail includes additional components related to capital leases. Excluding maturity of commercial paper and unamortized discounts and premiums, scheduled principal payments are (in thousands of dollars): Fiscal year Principal payments 2013 $ 345,573 2014 65,935 2015 38,603 2016 38,601 2017 29,724 Thereafter 4,979,013 TOTAL PRINCIPAL PAYMENTS $ 5,497,449
harvard university notes to financial statements In fiscal 2012, the University redeemed Series DD and Series GG2 in full ($135.9 million and $16.6 million, respectively) by exercising the bonds call options and $200.0 million of Series 2008D, scheduled to mature in 2014, by exercising the bond s make-whole call option. The redemption of these bonds was funded with cash on hand. In fiscal 2012, the University entered into a $2.0 billion unsecured, revolving credit facility with a syndicate of banks, of which $1.0 billion expires in January 2013 and $1.0 billion expires in January 2017. There was no outstanding balance on the credit facility at June 30, 2012. In fiscal 2012, the University s AAA/Aaa credit ratings were affirmed with Standard & Poor s and Moody s Investors Service, respectively. As of June 30, 2012, the University had $249.1 million of variable-rate bonds outstanding (excluding commercial paper) with either a daily or weekly interest rate reset, as noted in the bonds and notes payable table on page 39. In the event that the University receives notice of any optional tender on its variable-rate bonds, or if the bonds become subject to mandatory tender, the purchase price of the bonds will be paid from the remarketing of such bonds. However, if the remarketing proceeds are insufficient, the University will have a general obligation to purchase the bonds tendered. In fiscal 2011, the University issued $601.1 million of tax-exempt fixed-rate Series 2010B bonds, and $300.0 million of taxable fixed-rate Series 2010C bonds. The proceeds from these bonds were primarily used for a combination of redemptions, refinancings, and the funding of certain capital projects and acquisitions. In fiscal 2011, the University also redeemed $300.0 million of Series 2008D bonds by exercising the bond s make-whole call option. Interest rate exchange agreements The University has entered into various interest rate exchange agreements in order to manage the interest cost and risk associated with its outstanding debt and to hedge issuance of future debt. The interest rate exchange agreements were not entered into for trading or speculative purposes. Each of these agreements is collateralized, as described in Note 5, and thereby carries liquidity risk to the extent the relevant agreements have negative mark-to-market valuations (pursuant to methodologies described below). In fiscal 2012, the University terminated interest rate exchange agreements with a notional value of $756.0 million, for which it realized a loss of $134.6 million. In addition, interest rate exchange agreements with $207.8 million notional value matured during fiscal 2012. The fair value of interest rate exchange agreements is the estimated amount that the University would have received or (paid), including accrued interest, to terminate the agreements on the dates of the Balance Sheets. The notional amount and fair value of interest rate exchange agreements were $1,075.6 million and $(381.9) million, respectively, as of June 30, 2012 and $2,039.4 million and $(400.6) million, respectively, as of June 30, 2011. The fair value of these agreements is included in the Securities lending and other liabilities associated with the investment portfolio line in the Balance Sheets. The net expense realized related to interest rate exchange agreements was $23.0 million and $36.3 million for fiscal 2012 and 2011, respectively. All unrealized and realized gains and losses and settlements from interest rate exchange agreements are included in the Realized and unrealized (depreciation) / appreciation, net line in the Statements of Changes in Net Assets with General Operating Account Detail. The estimated fair value of the University s outstanding bonds and notes payable, including accrued interest, was $7,213.9 million and $6,854.6 million as of June 30, 2012 and 2011, respectively. NOTIONAL AMOUNT OF INTEREST RATE EXCHANGE AGREEMENTS In thousands of dollars Beginning balance, July 1, 2011 $ 2,039,355 Interest rate exchange agreements terminated/matured (963,800) ENDING BALANCE, JUNE 30, 2012 $ 1,075,555 In July 2012, the University redeemed the remaining $186.5 million outstanding of Series FF by exercising the bond s call option, and funded the redemption with cash. In August 2012, the University obtained reauthorization of its tax-exempt commercial paper program.
13. employee benefits The University offers current employees a choice of health plans, a dental plan, short-term and long-term disability plans, life insurance, tuition assistance, and a variety of other benefits such as subsidized passes for public transportation and for Harvard athletic facilities. In addition, the University has retirement plans covering substantially all employees. The University uses a measurement date of June 30 for its pension and postretirement health plans. Pension benefits All eligible faculty members, staff and hourly employees are covered by retirement programs that include a defined benefit component, a defined contribution component, or a combination of the two. In accordance with the Employee Retirement Income Security Act (erisa) requirements, the University has established a trust to hold plan assets for its defined benefit pension plans. The fair value of the trust s assets was $755.4 million and $746.9 million as of June 30, 2012 and 2011, respectively. During fiscal year 2012, the University used $36.9 million of internally designated funds for a discretionary defined benefit pension plan contribution. The University recorded expenses for its defined contribution plans of $110.3 million and $104.5 million for fiscal 2012 and 2011, respectively. Gross benefits paid for pensions were $41.0 million and $41.3 million as of June 30, 2012 and 2011, respectively. Postretirement health benefits The University provides postretirement health coverage and life insurance to substantially all of its employees. As of June 30, 2012, the University had internally designated and invested $339.0 million to fund the postretirement health benefit accrued liability of $901.5 million. As of June 30, 2011, the University had internally designated and invested $311.9 million to fund an accrued liability of $782.2 million. The following table sets forth the pension and postretirement plans funded status that is reported in the Balance Sheets as of June 30, 2012 and 2011 (in thousands of dollars): Postretirement Pension benefits health benefits 2012 2011 2012 2011 Change in projected benefit obligation: Projected benefit obligation, beginning of year $ 782,567 $ 762,862 $ 782,219 $ 812,336 Service cost 13,514 14,491 32,748 38,091 Interest cost 43,200 44,951 46,628 50,323 Plan participants contributions 3,089 2,876 Plan change * (41,605) Gross benefits paid (41,013) (41,345) (26,660) (22,087) Expected federal subsidy on benefits paid 790 Actuarial (gain)/loss 107,811 1,608 104,261 (99,320) Special termination benefits 3,830 PROJECTED BENEFIT OBLIGATION, end of year 909,909 782,567 901,470 782,219 harvard university notes to financial statements Change in plan assets: Fair value of plan assets, beginning of year 746,901 666,005 Actual return on plan assets 8,768 122,241 Employer contributions 40,708 Gross benefits paid (41,013) (41,345) FAIR VALUE OF PLAN ASSETS, end of year 755,364 746,901 0 0 UNFUNDED STATUS $ (154,545) $ (35,666) $ (901,470) $ (782,219) * The 2012 postretirement current year prior service credit was primarily due to the introduction of a medical deductible and co-insurance and a new cost sharing program for pharmacy. The accumulated benefit obligation associated with pension benefits was $791.5 million and $659.9 million at June 30, 2012 and 2011, respectively. The funded status disclosed above has been prepared in accordance with pension accounting rules. When measured on an irs funding basis, which informs the University s required cash contribution amount, the plan was overfunded at January 1, 2012.
harvard university notes to financial statements Net periodic benefit (income)/cost Components of net periodic benefit (income)/cost recognized in operating activity and other amounts recognized in non-operating activity in unrestricted net assets in the Statements of Changes in Net Assets with General Operating Account Detail are summarized as follows for the years ended June 30 (in thousands of dollars): Postretirement Pension benefits health benefits 2012 2011 2012 2011 Components of net periodic benefit (income)/cost: Service cost $ 13,514 $ 14,491 $ 32,748 $ 38,091 Interest cost 43,200 44,951 46,628 50,323 Expected return on plan assets (48,694) (52,231) Amortization of: Actuarial (gain)/loss 264 (975) (4,227) 2,895 Prior service (credit)/cost (1,247) (4,633) 727 1,411 Transition (asset)/obligation 6,062 6,062 Cost of special termination benefits 3,830 Total net periodic benefit (income)/cost recognized in operating activity 10,867 1,603 81,938 98,782 Other amounts recognized in non-operating activity in unrestricted net assets: Current year actuarial (gain)/loss 147,737 (68,402) 104,261 (99,320) Amortization of: Current year prior service (credit)/cost (41,605) Transition asset/(obligation) (6,062) (6,062) Prior service credit/(cost) 1,247 4,633 (727) (1,411) Actuarial gain/(loss) (264) 975 4,227 (2,895) Total other amounts recognized in non-operating activity* 148,720 (62,794) 60,094 (109,688) Total recognized in Statements of Changes in Net Assets with General Operating Account Detail $ 159,587 $ (61,191) $ 142,032 $ (10,906) Cumulative amounts recognized as non-operating changes in unrestricted net assets are summarized as follows for the years ended June 30 (in thousands of dollars): 2012 2011 2012 2011 Net actuarial (gain)/loss $ 141,160 $ (6,313) $ 89,563 $ (18,926) Prior service (credit)/cost 118 (1,129) (35,529) 741 Transition (asset)/obligation 12,125 Cumulative amounts recognized in unrestricted net assets* $ 141,278 $ (7,442) $ 54,034 $ (6,060) * These amounts totaling $208.8 million in fiscal 2012 and ($172.5) million in fiscal 2011 include gains and losses and other changes in the actuarially determined benefit obligations arising in the current period but that have not yet been reflected within net periodic benefit (income)/cost and are included in the Change in Retirement Obligations line in the Statements of Changes in Net Assets with General Operating Account Detail. The estimated net actuarial gain and prior service credit for the defined benefit plan that will be amortized from unrestricted net assets into net periodic benefit (income)/ cost in fiscal 2013 are $11.9 million and ($0.1) million, respectively. The estimated prior service cost for the postretirement health benefit that will be amortized from unrestricted net assets into net periodic benefit (income)/ cost in fiscal 2013 is ($3.2) million. Assumptions and health care cost trend rates used in determining the year end obligation as well as the net periodic benefit (income)/cost of the pension and postretirement health plans are summarized as follows for fiscal 2012 and 2011: Postretirement Pension benefits health benefits 2012 2011 2012 2011 Weighted-average assumptions used to determine benefit obligation as of June 30: Discount rate 4.45% 5.60% 4.55% 5.80% Rate of compensation increase 4.00% 4.00% 4.00% 4.00% Health care cost trend rate: Initial rate n/a n/a 7.00% 8.50% Ultimate rate n/a n/a 5.00% 5.00% Years to ultimate rate n/a n/a 6 7 Weighted-average assumptions used to determine net periodic benefit (income)/cost: Discount rate 5.60% 6.00% 5.80% 6.00% Expected long-term rate of return on plan assets 7.25% 7.50% n/a n/a Rate of compensation increase 4.00% 4.00% 4.00% 4.00% Health care cost trend rate: Initial rate n/a n/a 8.50% 11.00% Ultimate rate n/a n/a 5.00% 5.00% Years to ultimate rate n/a n/a 7 8
As an indicator of sensitivity, a one percentage point change in assumed health care cost trend rate would affect 2012 as shown in the following table (in thousands of dollars): 1% point 1% point increase decrease Effect on 2012 postretirement health benefits service and interest cost 24,544 (16,218) Effect on postretirement health benefits obligation as of June 30, 2012 190,970 (146,831) The expected return on pension plan assets is determined by utilizing hmc s capital markets model, which takes into account the expected real return, before inflation, for each of the pension portfolio s asset classes, as well as the correlation of any one asset class to every other asset class. This model calculates the real returns and correlations and derives an expected real return for the entire portfolio, Plan assets The actual asset allocation of the investment portfolio for the pension plan at June 30, 2012 and 2011, along with target allocations for June 30, 2013, is as follows: given the percentage weighting allocated to each asset class. After calculating the expected real return, an assessment is made to accommodate the expected inflation rate for the forthcoming period. The final expected return on assets is the aggregate of the expected real return plus the expected inflation rate. 2013 target June 30, 2012 June 30, 2011 Asset allocation by category for pension plan: Equity securities 30 50% 42.0% 48.2% Fixed income securities 30 50 28.6 19.8 Real estate 0 10 6.0 5.9 Commodities 0 10 0.0 1.8 Absolute return 10 30 20.0 22.5 Cash 0 10 3.4 1.8 TOTAL OF ASSET ALLOCATION CATEGORIES 100.0% 100.0% harvard university notes to financial statements The University s investment strategy for the pension portfolio is to manage the assets across a broad and diversified range of investment categories, both domestic and international. The objective is to achieve a risk-adjusted return that is in line with the long-term obligations that the University has to the pension plan beneficiaries. During fiscal year 2012, the University has increased its allocation to fixed income securities to better manage the interest rate volatility associated with its pension obligations. The University expects to continue this strategy in future years. The investment program is also managed to comply with all erisa regulations. The following is a summary of the levels within the fair value hierarchy for the pension plan assets subject to fair value measurement as of June 30, 2012 (in thousands of dollars): Level 1 Level 2 Level 3 Total INVESTMENT ASSETS: Absolute return and special situations funds $ 123,891 $ 24,681 $ 148,572 Cash and short-term investments $ 34,591 34,591 Domestic common and convertible equity 6,777 97,881 104,658 Domestic fixed income 208,820 208,820 Due from broker 235 235 Emerging market equity and debt 51,900 51,900 Foreign common and convertible equity 42,538 46,136 88,674 High yield 4,636 4 4,640 Private equities 68,261 68,261 Real estate 42,918 42,918 TOTAL INVESTMENT ASSETS* $ 344,861 $ 272,544 $ 135,864 $ 753,269 * Excludes investment assets not subject to fair value of $2,095.
The following is a summary of the levels within the fair value hierarchy for the pension plan assets subject to fair value measurement as of June 30, 2011 (in thousands of dollars): harvard university notes to financial statements Level 1 Level 2 Level 3 Total INVESTMENT ASSETS: Absolute return and special situations funds $ 77,766 $ 87,999 $ 165,765 Cash and short-term investments $ 22,814 22,814 Domestic common and convertible equity 19,969 106,123 126,092 Domestic fixed income 100,997 100,997 Emerging market equity and debt 66,471 66,471 Foreign common and convertible equity 50,644 53,229 103,873 High yield 4,544 4,544 Inflation-indexed bonds 38,737 38,737 Private equities 72,717 72,717 Real estate 43,456 43,456 TOTAL INVESTMENT ASSETS* $ 299,632 $ 241,662 $ 204,172 $ 745,466 * Excludes investment assets not subject to fair value of $1,435. The following is a rollforward of Level 3 investments for the year ended June 30, 2012 (in thousands of dollars): Beginning Realized Change in Net transfers Ending balance as of gains/ unrealized out of balance as of July 1, 2011 (losses) gains/(losses) Purchases Sales Level 3 June 30, 2012 INVESTMENT ASSETS: Absolute return and special situations funds $ 87,999 $ 54 $ (2,496) $ 21 $ (1,258) $ (59,639) $ 24,681 Foreign common and convertible equity (4) 4 High yield 4 4 Private equities 72,717 9,179 (1,937) 4,508 (16,206) 68,261 Real estate 43,456 780 2,626 1,445 (5,389) 42,918 TOTAL INVESTMENT ASSETS $ 204,172 $ 10,009 $ (1,803) $ 5,974 $ (22,849) $ (59,639) $ 135,864 The following is a rollforward of Level 3 investments for the year ended June 30, 2011 (in thousands of dollars): Beginning Realized Change in Ending balance as of gains/ unrealized Net transfers balance as of July 1, 2010 (losses) gains/(losses) Purchases Sales into Level 3 June 30, 2011 INVESTMENT ASSETS: Absolute return and special situations funds $ 80,446 $ 4,395 $ 5,101 $ 24,357 $ (26,300) $ 87,999 Domestic fixed income (14) 7 (3) $ 10 Foreign common and convertible equity 1,547 (2,520) 2,594 (1,621) High yield 57 58 (57) (58) Private equities 76,337 8,298 3,312 8,317 (23,547) 72,717 Real estate 39,250 2,258 4,745 1,460 (4,257) 43,456 TOTAL INVESTMENT ASSETS $ 197,637 $ 12,475 $ 15,702 $ 34,134 $ (55,786) $ 10 $ 204,172
Expected future benefit payments There are no expected employer contributions for fiscal 2013 to funded pension or postretirement health benefit plans. The following table summarizes expected benefit payments and subsidies for pension and other postretirement benefits for the University (in thousands of dollars): Expected benefit payments Postretirement Expected Medicare Net Postretirement Fiscal year Pension health Part D subsidies health 2013 $ 49,877 $ 21,484 $ 52 $ 21,432 2014 48,841 23,409 99 23,310 2015 50,191 25,270 150 25,120 2016 53,292 27,169 217 26,952 2017 53,749 29,114 301 28,813 Thereafter 275,244 182,569 3,174 179,395 14. general operating account The goa consists of the general or current funds of the University as well as the assets and liabilities related to student and faculty loans and facilities. The goa accepts, manages, and pays interest on deposits made by University departments; invests surplus working capital; makes loans; and arranges external financing for major capital projects. It is used to manage, control, and execute all University financial transactions, except for those related to investment activities conducted by hmc. The goa consisted of the following as of June 30, 2012 and 2011 (in thousands of dollars): 2012 2011 Temporarily Permanently Unrestricted Restricted Restricted Total Total General Operating Account $ 2,743,325 $ 1,448,690 $ 96,498 $ 4,288,513 $ 4,500,420 harvard university notes to financial statements The temporarily restricted net assets consist primarily of unexpended income, gifts, and pledges. The permanently restricted net assets are loan funds. 15. student financial aid Financial aid granted to students in fiscal 2012 and 2011 is summarized as follows (in thousands of dollars): 2012 2011 Scholarships and other student awards: Scholarships applied to student income $ 357,001 $ 335,036 Scholarships and other student awards paid directly to students 128,993 116,510 Total scholarships and other student awards 485,994 451,546 Student employment 64,088 66,690 Student loans 22,015 22,059 Agency financial aid * 9,158 16,779 TOTAL STUDENT FINANCIAL AID $ 581,255 $ 557,074 * Represents aid from sponsors for which the University acts as an agent for the recipient.
16. sponsored support harvard university notes to financial statements Total expenditures funded by US government sponsors or by institutions that subcontract federally sponsored projects to the University were $669.6 million and $686.2 million in fiscal 2012 and 2011, respectively. The University s principal source of federal sponsored funds is the Department of Health and Human Services. The University also has many non-federal sources of sponsored awards and grants, including corporations, foundations, state and local governments, foreign governments, and research institutes. 17. gifts Gifts that are available for current purposes are classified as either Gifts for current use or Non-federal sponsored grants, as appropriate. Gifts that have been restricted by the donor or designated by the Corporation for facilities, loan funds, endowment, or similar purposes are classified as Gifts for capital. Gifts for current use, non-federal sponsored grants, and gifts for capital are classified as unrestricted, temporarily restricted, or permanently restricted net assets in accordance with donor specifications. Sponsored grants and contracts normally provide for the recovery of direct and indirect costs. The University recognizes revenue associated with direct costs as the related costs are incurred. Recovery of related indirect costs is generally recorded at fixed or predetermined rates negotiated with the federal government and other sponsors. Predetermined federal indirect cost rates have been established for the University Area and the Medical School (including the School of Dental Medicine) through fiscal year 2015. The School of Public Health has predetermined indirect cost rates through fiscal 2013. Funds received for federally sponsored activity are subject to audit. Gifts received for the years ended June 30, 2012 and 2011 are summarized as follows (in thousands of dollars): 2012 2011 Gifts for current use $ 289,217 $ 276,914 Non-federal sponsored grants 88,262 91,980 Gifts for capital: Endowment funds 226,494 212,364 Split interest agreements * 20,168 24,891 Loan funds and facilities 26,243 32,987 Total gifts for capital 272,905 270,242 TOTAL GIFTS $ 650,384 $ 639,136 * Shown at net present value. The gross value of these gifts was $51,045 and $41,807 for the years ended June 30, 2012 and 2011, respectively. 18. other income The major components of other income for the years ended June 30, 2012 and 2011 were as follows (in thousands of dollars): 19. other expenses The major components of other expenses for the years ended June 30, 2012 and 2011 were as follows (in thousands of dollars): 2012 2011 Rental and parking $ 147,373 $ 136,102 Royalties from patents, copyrights, and trademarks 112,814 107,067 Publications 78,086 78,079 Services income 68,080 62,010 Health and clinic fees 51,689 49,878 Sales income 45,605 49,103 Interest income 11,280 10,768 Other student income 5,934 6,711 Other 36,304 46,882 TOTAL OTHER INCOME $ 557,165 $ 546,600 2012 2011 Services purchased $ 424,898 $ 381,536 Subcontract expenses under sponsored projects 160,961 170,297 Travel 79,459 68,020 Publishing 49,579 44,371 Taxes and fees 33,543 30,286 Postage 21,181 22,177 Advertising 19,728 18,876 Insurance 13,212 18,409 Telephone 12,907 12,307 Other 36,235 58,368 TOTAL OTHER EXPENSES $ 851,703 $ 824,647
20. functional classification of operating expenses Operating expenses are allocated functionally on a direct basis. Interest, depreciation, and operations and maintenance expenses are allocated based on square footage. Operating expenses by functional classification for the years ended June 30, 2012 and 2011 were as follows (in thousands of dollars): 2012 2011 Instruction $ 1,063,971 $ 1,016,221 Research 769,077 734,526 Institutional support 657,082 673,424 Academic support 539,516 529,948 Auxiliary services 478,366 455,075 Libraries 237,082 231,629 Student services 167,611 150,235 Scholarships and other student awards 128,993 116,510 TOTAL EXPENSES $ 4,041,698 $ 3,907,568 21. commitments and contingencies Lease commitments The University is the lessee of equipment and space under operating (rental) and capital leases. Rent expense related to leases was $51.8 million and $48.4 million for the years ended June 30, 2012 and 2011, respectively. Future minimum payments under these operating and capital leases are as follows (in thousands of dollars): Operating Capital 2013 $ 58,554 $ 7,050 2014 45,426 7,119 2015 41,518 7,403 2016 31,287 7,711 2017 27,497 7,916 Thereafter 90,320 176,029 TOTAL FUTURE MINIMUM PAYMENTS $ 294,602 $ 213,228 to their net present value. Management is not aware of any existing conditions that it believes are likely to have a material adverse effect on the University s financial position, changes in net assets, or cash flows. Utilities purchase commitments The University has entered into Power Purchase Agreements (PPAs) with a series of utilities providers to purchase natural gas and electricity for various quantities and time periods. As of June 30, 2012, future obligations under the PPAs are as follows (in thousands of dollars): 2013 $ 21,691 2014 14,223 2015 10,800 2016 6,420 2017 3,930 Thereafter 29,685 TOTAL UTILITY FUTURE PURCHASE OBLIGATIONS $ 86,749 harvard university notes to financial statements Fixed asset-related commitments The University has various commitments for capital projects involving construction and renovation of certain facilities, real estate acquisitions, and equipment purchases, for which the outstanding commitments as of June 30, 2012 totaled approximately $301.7 million. Environmental remediation The University is subject to laws and regulations concerning environmental remediation and has established reserves for potential obligations that management considers to be probable and for which reasonable estimates can be made. These estimates may change substantially depending on new information regarding the nature and extent of contamination, appropriate remediation technologies, and regulatory approvals. Costs of future environmental remediation have been discounted General The University is a defendant in various legal actions arising from the normal course of its operations. While it is not possible to predict accurately or determine the eventual outcome of such actions, management believes that the outcome of these proceedings will not have a material adverse effect on the University s financial position, changes in net assets, or cash flows. The University has evaluated subsequent events through November 2, 2012, the date the financial statements were available for issuance.
Part II
Research and Development and Research Training Cluster Direct Awards Agency for International Development Executive Management Education for Emerging Hospital Leaders (USAID) 98.unknown 263-G-00-09-00018-00 No $ 181,799 Subtotal of 98.unknown 98.unknown 181,799 Entrepreneurial Finance Lab Research Initiative 98.001 AID-OAA-G-12-00005 No 4,141 Subtotal of 98.001 98.001 4,141 Total Agency for International Development Direct Awards 185,940 Corporation for National and Community Service Measuring and Explaining Civic Inequality Using CPS Data 94.007 08BIHMA002 No 195,287 Subtotal of 94.007 94.007 195,287 Total Corporation for National and Community Service Direct Award 195,287 Department of Commerce Mapping Regional Innovation Clusters 11.303 99-07-13869 No 902,066 Subtotal of 11.303 11.303 902,066 Emission Rates for CH4 and N2O in California by Location and Sector Inferred using airborne measurements during the NOAA CalNex Study 11.431 NA11OAR4310158 No 1,000 Improving Process-Level Understanding of the Factors Underlying Long-Term Trends and Year-to-Year Variability in Carbon Sequestration of Northeastern Forests 11.431 NA11OAR4310054 No 111,412 Measurements of CH4, CO, CO2, and N2O in CalNex 2010 11.431 NA09OAR4310122 No 47,021 Subtotal of 11.431 11.431 159,433 Increasing the Precision of Astronomical Photometry to Address the Dark Energy Crisis in Fundamental Physics 11.609 70NANB8H8007 No (2,242) Instrumentation to Improve the Precision of Astronomical Photometry: Building the Tools for Addressing the Dark Energy Crisis 11.609 60NANB12D139 No 5,753 Precision Search for an Electric Dipole moment of the Electron using ThO 11.609 60NANB8D8130 No 23,164 Quantum control techniques for diamond-based magnetometers with applications to quantum information processing 11.609 60NANB10D002 No 433,071 Subtotal of 11.609 11.609 459,746 Total Department of Commerce Direct Awards 1,521,245 Department of Defense Investigation of Optical Properties of Black SI 12.unknown W15QKN-07-P-0092 No 74,005 Subtotal of 12.unknown 12.unknown 74,005 Atomistic Modeling of Nanoscale Corrosion Phenomena in Al Alloys and the Influence of Chlorine 12.300 N00014-10-1-0346 No 93,042 Development of Evolvable Sequence-Defined Synthetic Polymers 12.300 N00014-03-1-0749 No (3,936) Discovery of Microbes for the Extraction of Rare Earth Metals 12.300 N00014-11-1-0894 No 102,261 Efficient reasoning from background knowledge and incomplete and inconsistent data 12.300 N00014-12-1-0358 No 25,886 Foundation of Developmental Molecular Self-Assembly 12.300 N00014-10-1-0827 No 189,430 Foundations for the physics-based analysis of natural visual scenes 12.300 N00014-09-1-1022DOD35CAP No 79,298 Human genetic polymorphisms regulating cell and molecular pathways in NIHL 12.300 N000141210170 No 98,169 Label-Free Magnetophoretic Analysis of Blood 12.300 N00173-10-1-G005 No 239,689 Molecular Spintronics: Nanomagnetic Control of Electronic Spins 12.300 N000140910868-DOD35CAP No 204,485 Multiplexed Pathway and Organism Engineering 12.300 N00014-10-1-0144 No 149,055 Noise Induced Hearing Loss Gene Chip 12.300 N00014-11-1-0523 No 330,814 Novel High-Resolution Experimental Approaches to Investigate Nanoscale Corrosion Phenomena in Metals and Alloys 12.300 N00014-07-1-0760 No 11,134 One-Dimensional Nanostructures as Building Blocks for Functional Electronic and Bioelectronic Materials 12.300 N00244-09-1-0078-DOD35CAP No 775,451 Oxide Materials for the Next Generation Thermal Barrier Coatings 12.300 N00014-09-1-1068-DOD35CAP No 79,186 PECASE: Soaring mechanisms for flapping-wing micro air vehicles 12.300 N00014-10-1-0684 No 162,837 Protein Sensors for Voltage and magnetism 12.300 N00014-11-1-0549 No 197,533 Pulmonary and Nasal Drug Delivery for Cochlear Protection against NIHL 12.300 N00014-09-1-1104 No 286,383 Self-Assembly of Large Scale Shape Controlled DNA Nano- Structures 12.300 N00014-11-1-0914 No 126,357 Studies on Functional Oxide Materials and Interfaces Displaying Phase Transitions and Electric Field Effects 12.300 N00014-10-1-0131-DOD35CAP No 90,806 Ultra-fast Correlated Oxide (CO) Switches as Active Components in Radar Systems 12.300 N00014-12-1-0451 No 27,195 Wireless Computing Architectures III 12.300 FA8750-10-2-0180 No 285,136 Subtotal of 12.300 12.300 3,550,211 34
Coherent Molecular Profiling Using Nano- Structured Environments 12.351 HDTRA1-10-1-0046-DOD35CAP No 420,415 Mid-infrared high-power, broadband quantum cascade laser arrays for standoff detection 12.351 HDTRA1-10-1-0031-DOD35CAP No 264,624 Subtotal of 12.351 12.351 685,039 Antiangiogenic Natural Products Targeting Anthrax Toxin 12.420 W81XWH-08-1-0711 No 17,861 BRCA1 Pathway Functionality in Basal-Like Breast Cancer 12.420 W81XWH-08-1-0748 No 5,658 Defining the therapeutic implications of the integrative stress response in TSC 12.420 W81XWH-10-1-0861 No 203,666 Development of Affinity Reagents for Multiplexed, Rapid Diagnosis of Bacterial Infections at the Point-of-Care using Diagnostic Magnetic Resonance 12.420 W81XWH-10-2-0161 No 225,064 Early Life Processes, Endocrine Mediators and Number of Susceptible Cells in Relation to Breast Cancer Risk 12.420 W81XWH-05-1-0314 No (1,155) Experimental Analysis and Computational Modeling of Network States and Drug Responses in the P13K/Akt/mTOR Network 12.420 W81XWH-08-1-0609 No 72,173 Materials to Engineer the Immune System 12.420 W81XWH-09-1-0232 No 193,765 Maternal Fisk Factors for Autism Spectrum Disorders in Children of the Nurses Health Study II 12.420 W81XWH-08-1-0497 No 126,783 Maternal Risk Factors for Autism Spectrum Disorders in Children of the Nurses' Health Study II 12.420 W81XWH-08-1-0499 No 102,154 Microarray and Viral Genome Sample Processing and Analysis Supporting USAMRIID TMTI Development and Characterization of Animal Models for Arenavirus 12.420 W81XWH-10-1-0098 No 389,354 Microarray processing and analysis of biological samples from Non-Human Primate models of viral infections and Human clinical samples supporting USAMRIID grant: Identification of Biomarkers 12.420 W81XWH-11-1-0141 No 193,075 New Methods of Low-Field Magnetic Resonance Imaging for Applications to Traumatic Brain Injury 12.420 W81XWH-11-2-0076 No 907,115 Understanding the Relationship between Normal Mammary Development and Breast Cancer Pathogenesis: The Role of Prostate Derived Ets Factor (PDEF) 12.420 W81XWH-10-1-0029 No 104,260 Subtotal of 12.420 12.420 2,539,773 Bioinspired, Mobile Robots with High Stability, Functionality, and Low Cost 12.431 W911NF-11-1-0094 No 539,112 Cephalopod-Inspired Adaptive Photonic Systems (CINAPSE) 12.431 W911NF-10-1-0113 No 1,238,218 Chemical Communications 12.431 W911NF-07-1-0647 No 639,992 Coherent Instabilities and Self-Mode-Locking in Quantum Cascade Lasers 12.431 W911NF-07-1-0372 No (138) Deep Impurity Band Silicon for Subbandgap Photodetection 12.431 W911NF-12-1-0196 No 10,654 Development of Mesoscale Programmable Matter 12.431 W911NF-08-1-0151 No (3,647) Femtosecond-laser Microstructured Silicon for High-Sensitivity Infrared Photodetectors 12.431 W911NF-05-1-0341 No (253) Fundamental Studies on Confinement Effects in Ionic Conduction Conduction and Inversion Layers in 2-D Single Crystal Free Standing Oxide Membranes 12.431 W911NF-10-1-0515-DOD35CAP No 163,030 Instant Flame Suppression 12.431 W911NF-09-1-0005 No 791,571 Integrated Human Organ-on-Chip Microphysiological Systems 12.431 W911NF-12-2-0036 No 241,337 Measuring, Understanding, and Responding to Covert Social Networks: Passive and Active Tomography 12.431 W911NF-11-1-0036-DOD35CAP No 1,077,626 Multi-Qubit Systems Based on Electron Spins in Coupled Quantum Dots 12.431 W911NF-10-1-0330 No 3,498,942 Novel Therapeutics to Increase Survival in Viral Pneumonias 12.431 W911NF-10-1-0217 No 453,017 Physics-based Approaches to Visual Scene Analysis 12.431 W911NF-08-1-0516-DOD35CAP No 74,582 Programmable Matter 12.431 W911NF-08-1-0143 No 262,779 Scalable Biomarker Discovery for Diverse High-Dimensional Phenotypes 12.431 W911NF-11-1-0429 No 55,693 Shock Response of Dry and Water-Saturated Soils 12.431 W911NF-10-1-0377 No 76,004 Spectral Methods and Inference for the Analysis of Graphs and Networks: New Tools for Massive Data Sets 12.431 W911NF-09-1-0555-DOD35CAP No 249,838 Synthetic Biological Engineering of Photosynthesis 12.431 W911NF-09-1-0226 No 69,171 The Human Microbiome as a Multipurpose Biomarker 12.431 W911NF-11-1-0473 No 10,917 Subtotal of 12.431 12.431 9,448,445 A novel approach to measuring oxygen isotopes in the amino acids in hair 12.630 HM1582-08-1-0024 No 100,208 Biotic Camera for Circular Dichroism Imaging 12.630 HM1582-091-0006 No 16,193 Nanowire Photovoltaic Power Sources for Integrated Nanoelectronic Systems 12.630 HM1582-071-2006 No (1,449) Subtotal of 12.630 12.630 114,952 35
A Comprehensive Study of Aeroelasticity in Flapping-Wing MAVs 12.800 FA9550-09-1-0156-DOD35CAP No 59,454 A High-Temperature Combinatorial Technique for the Thermal Analysis of Materials 12.800 FA9550-08-1-0374 No 37,982 Beam-shaped single mode spiral lasers 12.800 FA9550-08-1-0047-DOD35CAP No 369 Bifunctional catalysts for C02 reduction 12.800 FA9550-11-1-0049-DOD35CAP No 81,179 Bio-Inspired Optics: Offering Physical and Technological Insights in Color and Structure (BIOOPTICS) 12.800 FA9550-09-1-0669-DOD35CAP No 1,638,481 Characterization and control of femtosecond laser pulses for nanofabrication of three-dimensional metamaterials 12.800 FA9550-10-1-0402-DOD35CAP No 51,345 Construction of an Ultra-High Vacuum, Low Temperature Spin-Polarized Scanning Tunneling Microscope to Manipulate and Image Magnetic Nanostructures 12.800 FA9550-06-1-0531 No 178,089 Electrochemical Power Extraction from S. Onidensis at the Single Cell Level 12.800 FA9550-09-1-0586-DOD35CAP No 147,123 Exploratory Phase Transition-Based Switches Using Functional Oxides 12.800 FA9550-08-1-0203 No (3,024) Fabrication and Characterization of Novel Refractory Coatings using Combinatorial Nanocalorimetry 12.800 FA9550-12-1-0098 No 459 Fabrication and Electrical Characterization of Correlated Oxide Field Effect Switches for High Speed Electronics 12.800 FA9550-12-1-0189 No 4,757 High Performance Terahertz Quantum Cascade Nonlinear Optical Sources and Lasers 12.800 FA9550-09-1-0505-DOD35CAP No 203,958 Integrated Nano Optoplasmonics 12.800 FA2386-10-1-4064-DOD35CAP No 120,042 Integrating Programming Language and Operating System Information Security Mechanisms 12.800 FA9550-12-1-0262 No 3,048 Nanofabrication of Three-Dimensional Metamaterials 12.800 FA9550-09-1-0546-DOD35CAP No 259,954 Plasmon-Bolometric Multi-spectral THz Integrated Detector Circuit Utilizing Carbon Nanotubes and Quantum Wires 12.800 FA9550-09-1-0369-DOD35CAP No 176,083 Quantum Control of Light and Matter: from the Macroscopic to the Nano Scale 12.800 FA9550-10-1-0208-DOD35CAP No 907,681 Quantum Simulations of Condensed Matter Systems using Ultra-cold Atomic Gases 12.800 FA9550-07-1-0492 No 1,595,790 Slow Light: Novel Techniques for Optical Signal Processing Based on Stationary Pulses of Light 12.800 FA9550-04-1-0455 No (9,143) Synthesis of One-dimensional Pd (III) Wires 12.800 FA9550-10-1-0170-DOD35CAP No 64,612 The Production and Study of Antiprotons and Cold Antihydrogen 12.800 FA9550-10-1-0107-DOD35CAP No 147,355 The Study and Production of Antiprotons and Cold Anithydrogen 12.800 FA9550-10-1-0107-DOD35CAP No 138,086 Subtotal of 12.800 12.800 5,803,680 Center for Reconfigurable Photonic NEMS 12.910 N66001-10-1-4008-DOD35CAP No 543,068 Continuous Directed Evolution of Synthetic Regulatory Elements for Use in Mammalian Cells 12.910 HR0011-11-2-0003 No 903,099 Development of Novel Quantum Devices Using Nitrogen Vacancy Centers in Diamond 12.910 HR0011-10-1-0073-DOD35CAP No 94,839 Diamond Based Magnetometry for Quantum Information Processing Using Endohedral Fullerenes 12.910 HR0011-09-1-0005 No 690,127 MEMS/NEMS S and T Fundamentals Center: Microfludic Systems for Ultra-Sensitive Biomolecule Detection 12.910 HR0011-06-1-0044 No (2,408) Molecular spintronics:nanomagnetic control of electronic spins 12.910 N66001-091-2104-DOD35CAP No 49,533 New Homotopy Theoretic Methods in Geometry, Topology and Physics 12.910 HR0011-10-1-0054-DOD35CAP No 261,166 Practical Quantum Simulators 12.910 N66001-09-1-2101-DOD35CAP No 61,890 Programmable Inorganic Materials Synthesis with DNA Nano-structures 12.910 N66001-11-1-4136 No 119,417 SERS Engineering Collaboration (SEC) 12.910 FA9550-08-1-0285 No 87,029 Spleen-on-a-Chip Sepsis Therapeutic Device 12.910 N66001-11-1-4180 No 1,808,840 Subtotal of 12.910 12.910 4,616,600 Antidepressants and the risk of self-harm and unintentional injury among young veterans Contract W81XWH-09-1-0717 No 105,274 Bioactive Peptide libraries for rapid identification of Novel therapeutics Contract HDTRA1-12-C-0038 No 35,796 De Novo lipogenesis, fat intake and prostate cancer survival Contract W81XWH-11-1-0529 No 72,625 Design strategies for multi-dimensional synthetic biology Contract HR0011-12-C-0061 No 14,885 Development of Diamond Nanoscale Ma gnetometer Using Quantum Assisted Sensing and Readout Contract HR0011-11-C-0073 No 2,108,201 DNA/RNA Sequencing Contract W81XWH-10-P-0374 No 9,082 Elucidating the Role of a Novel Tumor Suppressor in Breast Cancer Contract W81XWH-11-1-0140 No 38,359 Endangered butterflies as a model system for managing source-sink dynamics on Department of Defense lands Contract W912HQ-11-C-0050 No 620,281 General and Flag Officer Homeland Security Executive Seminar Contract W912SV-11P-0099 No 4,752 Genetic systems for recording misuse and escape of microbes Contract N66001-11-C-4203 No 531,069 Identification of Genes and Compounds that Control the Viability of Cells Lacking Tsc2 Contract W81XWH-10-1-0555 No 4,127 Macrophage Genomic 'Barcodes' for Rapid Identification of Pathogens and Therapeutic Targets Contract HDTRA1-10-C-0052 No 423,901 Phylogenetic Analysis of Human Primary Breast Cancers and Metastases Contract W81XWH-11-1-0146 No 40,890 Roles of SGK Isoform Signaling in Breast Cancer Migration and Invasion Contract W81XWH-10-1-0172 No 41,437 Safe Industrial Organisms Contract N66001-12-C-4040 No 61,932 The Influence of Basement Membrane and Other Extracellular Matrix Components on Response to HER2-Targeted Therapies Contract W81XWH-11-1-0572 No 84,456 The Role of FSP1+ Fibroblasts in Breast Cancer Metastasis Contract W81XWH-09-1-0008 No 1,435 Ultrahigh-Throughput Virus-Host Cell PicoReactor System for Predictive Modeling of Viral Evolution Contract HR0011-11-C-0093 No 2,444,784 Unbiased Combinatorial Genomic Approaches to Identify Alternative Therapeutic Targets within the TSC Signaling Network Contract W81XWH-12-1-0179 No 15,067 Subtotal of Contract Contract 6,658,353 Total Department of Defense Direct Awards 33,491,058 36
Department of Education Advancing Ecosystems Science Education via Situated Collaborative Learning in Multi-User Virtual Environments 84.305A R305A080514-10 No 189,663 Developing more effective test-based accountability by improving validity under high-stakes conditions 84.305A R305A110420-12 No 95,294 Effective Early Childhood Education Programs: Meta-Analytic Lessons from High Quality Program Evaluations 84.305A R305A110035-12 No 203,745 Language Diversity and Literacy Development: Increasing Opportunities-to-Learn in Urban Middle Schools 84.305A R305A080631 No 73,463 NCER-AARW, Goal 3: World Generation: An Efficacy Trial 84.305A R305A090555-12 No 755,014 Preparing to Succeed: An Efficacy Trial of Two Early Childhood Curricula 84.305A R305A090209-10 No 141,705 Studying the Potential of Virtual Performance Assessments for Measuring Student Achievement in Science 84.305A R305A080141 No 126,407 Subtotal of 84.305A 84.305A 1,585,291 National Center for Teacher Effectiveness: Validating Measures of Effective Math Teaching 84.305C R305C090023 No 2,035,011 Subtotal of 84.305A 84.305C 2,035,011 Intended and Unintended Consequences of State High-Stakes Testing: Evidence from Standards-Based Reform in Massachusetts 84.305E R305E100013 No 91,232 Subtotal of 84.305E 84.305E 91,232 Project READS: Using Data to Promote Summer Reading and Close the Achievement Gap for Low-SES Students in North Carolina 84.396B U396B100195 Yes 1,445,430 Subtotal of 84.396B 84.396B 1,445,430 Total Department of Education Direct Awards 5,156,964 Department of Energy Dark Energy Survey Calibration and Software Integration 81.unknown 12-S-28 No 1,694 LSST Detector Test System Development Work 81.unknown 96941 No 140,991 Subtotal of 81.unknown 81.unknown 142,685 Actuation of Bioinspired, Adaptive 'Hairs' Powered by Responsive Hydrogels 81.049 DE-SC0005247 No 630,328 Bystander Effects of Ionizing Radiation 81.049 DE-FG02-05ER64089-007 No 11,928 Detection of Long-Term trends in Carbon Accumulation by Forest in Northeastern U.S. and Determination of Causal Factors 81.049 DE-FG02-07ER64358 No 5,193 Development of new and integrated stable isotope tools for characterizing Nitrogen-Uranium cycling in subsurface environments 81.049 DE-SC0006681 No 44,739 Dynamic Self-Assembly, Emergence, and Complexity 81.049 DE-FG02-00ER45852 No 451,682 Electron Diffraction Determination of Nanoscale Structures 81.049 DE-FG02-01ER45921 No 60,065 Electron Imaging in Graphene 81.049 DE-FG02-07ER46422 No 125,004 Evaluating the Contribution of Climate Forcing and Forest Dynamics to Accelerating Carbon Sequestration by Forest Ecosystems in the Northeastern U.S. 81.049 DE-SC0004985 No 181,442 Hierarchical Petascale Simulation Framework for Stress Corrosion Cracking 81.049 DE-FC02-06ER25790 No 115,189 Improving interannual prediction skill in a changing climate via the identification of compensating coupled model errors 81.049 DE-SC004984 No 244,694 In-situ Generation of Iron-chromium Precipitates for Long Term Immobilization of Chromium at the Hanford 100H Site 81.049 DE-SC0006976 No 25,997 Microbial Ecology, Proteogenomics and Computational Optima 81.049 DE-FG02-02ER63445 No 2,049,006 Modeling, Patterning and Evolving Syntrophic Communities that Link Fermentation to Metal Reduction 81.049 DE-SC0006731 No 112,210 Molecular-scale Understanding of Selective Oxidative Transformations of Alcohols Promoted by Au and Au-based Alloys 81.049 DE-FG-02-84ER13289 No 205,806 Nanoscale Morphology Evolution Under Ion Irradiation 81.049 DE-FG02-06ER46335 No 227,073 Partitioning CO2 fluxes with isotopologue measurements and modeling to understand mechanisms of forest carbon sequestration 81.049 DE-SC0006975 No 27,495 Process Studies of Climatically Relevant Parts of the Aerosol Life Cycle: Chamber Experiments on the Role of Aqueous-Phase Chemistry in CNN Activity of Secondary Organic Aerosol 81.049 DE-SC0006677 No 175,585 Research in High Energy Physics 81.049 DE-FG02-91ER40654 No 1,574,870 Research in High Energy Physics 81.049 DE-SC0007881 No 323,573 Research in Theoretical High Energy Physics 81.049 DE-SC0007870 No 63,624 SISGER: Transport and Imaging of Mesoscopic Phenomena in Single and Bilayer Graphene 81.049 DE-SC0001819 No 423,650 SISGR: Room Temperature Single-Molecule Detection and Imaging by Stimulated Emission Microscopy 81.049 DE-SC0001548 No 214,210 Study of Plant Cell Wall Polymers Affected by Metal Accumulation Using Stimulated Raman Scattering Microscopy 81.049 DE-SC0006732 No 290,571 Surface Studies of Liquid Metals: Electronic and Tokamak Interests 81.049 DE-FG02-88ER45379 No 778 The ARM Climate Research Facility in the Amazon Basin 81.049 DE-SC0006680 No 18,246 Theoretical Studies of Atomic Collision Physics 81.049 DE-FG02-88ER13861 No 94,709 Theory of Electron Imaging in Small Devices 81.049 DE-FG02-08ER46513 No 134,869 Ultracold Molecules: Physics in the Quantum Regime 81.049 DE-FG02-08ER46513 No 100,945 Understanding Jets at The Large Hadron Collider 81.049 DE-SC0003916 No 65,467 Subtotal of 81.049 81.049 7,998,948 37
Hydrogen and its Isotopes at Ultra-High Pressure 81.112 DE-FG52-10NA29656 No 129,662 Planetary Science and Astrophysical Applications of Experimental Studies with the SNL Z facilities 81.112 DE-FG52-09NA29549 No 286,797 Soft X-Ray Shock Loading and Momentum Coupling in Meteorite and Planetary Material 81.112 DE-FG52-09NA29457 No 172,275 Subtotal of 81.112 81.112 588,734 Engineering a Bacterial Reverse Fuel Cell 81.135 DE-AR0000079 No 1,434,036 Subtotal of 81.135 81.135 1,434,036 Attaining the Photometric Precision Required by Future Dark Energy Projects 81.502 DE-FG02-08ER41569 No (255) Subtotal of 81.502 81.502 (255) A Proposal for v Experiment and R and D Work Contract PO 565830 No 990,213 Multi-Family Retrofit Project- Education and Survey Elements Contract 6949533 No 9,799 Subtotal of Contract Contract 1,000,012 Total Department of Energy Direct Awards 11,164,160 Department of Homeland Security Exercise Tolerance as a Predictor of Firefighters' Future Risks 97.unknown EMW-2009-FP-00835 No 240,193 Subtotal of 97.unknown 97.unknown 240,193 FY2011 Homeland Security National Training Grant Program 97.005 EMW-2011-CA-00105 No 183,618 Subtotal of 97.005 97.005 183,618 Predicting Cardiovascular Risk and Fitness in Firefighters 97.044 EMW-2006-FP-01493 No 72,113 Subtotal of 97.044 97.044 72,113 Total Department of Homeland Security Direct Awards 495,924 Department of Housing & Urban Development Benchmarking the Benefits of Green Public Housing: Health, Comfort and Environmental Performance 14.unknown MALIIH-229-10 No 230,310 Subtotal of 14.unknown 14.unknown 230,310 Body Building: Architectural Narratives of Ability and Disability 14.516 H-21606SG No 6,000 The End of Poverty, or the Emergence of the Horizontal Ghetto: Post-public housing spatial concentration and young adult transition in Baltimore 14.516 H-21630SG No 14,860 Subtotal of 14.516 14.516 20,860 Total Department of Housing & Urban Development Direct Awards 251,170 Department of Justice National Executive Institute (NEI) XXXIII, Cycle Two 16.unknown No Award Number No (20) Subtotal of 16.unknown 16.unknown (20) Policing in the New Century: An Executive Session on Public Safety 16.560 2007-IJ-CX-0038 No (1) Policing in the New Century: An Executive Session on Public Safety 16.560 2011-IJ-CX-0025 No 197,350 Subtotal of 16.560 16.560 197,349 Total Department of Justice Direct Awards 197,329 Department of Labor Designing Microfinance to Enable Consumption Smoothing: Evidence from India Contract DOLJ109K31204 No 5,752 Long-Run Effects of a Public Housing Program on Occupational Opportunities and Economic Outcomes Contract DOLB119K32540 No 75,159 Subtotal of Contract Contract 80,911 Total Department of Labor Direct Awards 80,911 Department of the Interior 3D structural velocity model of the Santa Maria basin, California, for improved strong ground motion prediction 15.807 G12AP20020 No 66,280 Subtotal of 15.807 66,280 Monitoring phenology as a method to track ecosystem responses to climate change 15.808 G10AP00129 No 26,073 Subtotal of 15.808 15.808 26,073 Total Department of the Interior Direct Awards 92,353 U.S. Department of State - Bureau of Democracy, Human Rights and Labor Models of Mutual Aid for Internet Robustness 19.345 AID-OAA-A-11-00032 No 29,891 Subtotal of 19.345 19.345 29,891 Total U.S. Department of State - Bureau of Democracy, Human Rights and Labor 29,891 38
Department of Transportation Center of Excellence for Research in the Intermodal Transport Environment (RITE) 20.unknown 07-C-RITE-HU No 168,195 Center of Excellence for Research in the Intermodal Transport Environment (RITE) 20.unknown 10-C-RITE-HU No 161,064 Health Impacts of Aviation-Related Air Pollutants (PARTNER PHASE III-FY10) 20.unknown 09-C-NE-HU No 121,693 Health Impacts of Aviation-Related Air Pollutants (PARTNER Project 11) 20.unknown 07-C-NE-HU No (2,372) Subtotal of 20.unknown 20.unknown 448,580 Public Health Impacts of Noise in National Parks Contract DTRT57-11-P-80046 No 10,517 Sleep and Health Education Program: A Web-Based Sleep Disorders Screening Survey and Education Module on Sleep Health and Safety in the Railroad Industry Contract DTRT57-10-C-10030 No 265,835 Subtotal of Contract Contract 276,352 Total Department of Transportation Direct Awards 724,932 Department of Veterans Affairs Ultraviolet Nursing Home Influenza Prevention (UNHIP) Field Study Contract VA241-12-C-0045 No 6,974 Subtotal of Contract Contract 6,974 Total Department of Veterans Affairs 6,974 Department of Health and Human Services Biological Questionnaire Collection to Study Premenopausal Hormones in Mongolian Women 93.unknown HHSN261200800786P No (21,164) Subtotal of 93.unknown 93.unknown (21,164) Minority Faculty Development Program (MFDP) Cooperative Agreement for Minority Workforce Development 93.004 6 MPCMP051007-05-05 No 48,330 Subtotal of 93.004 93.004 48,330 Impact Evaluation of Combination HIV Prevention Interventions in Botswana 93.067 1U01GH000447-01revised No 882,058 Subtotal of 93.067 93.067 882,058 Lung Cancer Disparities Center: Jointly Addressing Race and Socioeconomic Status 93.077 3P50CA148596-03S1 No 1,934,434 Subtotal of 93.077 93.077 1,934,434 Epidemiological MCH/SPH Institute 93.110 5T03MC07648-06-00 No 26,040 Maternal and Child Health Training Grant 93.110 5T76MC00001-57-00 No 363,500 MCH Distance Learning/Youth Suicide Prevention: Internet-Based Training 93.110 5T02MC09378-03-00 No 8,357 Subtotal of 93.110 93.110 397,897 Air pollution and Parkinson Disease: a GIS-based approach 93.113 5K01ES019183-03 No 92,113 Ambient Particles and Cardiac Vulnerability in Humans 93.113 5P01ES009825-10revised No 277,605 Analysis of High-Dimensional Environmental Health Data 93.113 5R01ES012044-06rev No 75,069 Arsenic Exposure and Birth Outcomes in Bangladesh 93.113 5R01ES015533-05 No 456,024 Cardiovascular Effects of Particles: The Role of Oxidative Stress and Metal Pathways 93.113 5R01ES014663-04rev No 365,028 CBH Partnership on Environmental Public Health Exploration and Mitigation 93.113 5R21ES017948-04 No 480,414 Childhood Dioxin Exposure and Energy Homeostasis Dysregulation 93.113 5R03ES017117-02 No 47,318 Climate Change and Cardiac Vulnerability in Humans 93.113 5R21ES020194-02 No 135,536 Crossover Study on Human Exposure to Phthalates and Male Fertility 93.113 5R01ES017285-03 No 429,227 Design of a high-throughput screen for chemicals that cause meiotic aneuploidy 93.113 1K99ES020353-01 No 58,999 Dioxins and Male Pubertal Growth and Development 93.113 5R01ES014370-05 No (2,985) Dioxins and Male Pubertal Growth and Development 93.113 5R01ES014370-07 No 498,657 DNA methylation and endocrine disrupting chemical exposure in children 93.113 5R21ES019773-02 No 219,001 DNA Methylation as a Biomarker of Exposure and Effect for Particles and Metals 93.113 5R01ES015172-06 No 135,227 Early Life Environmental Toxicant Exposure and Oral Health 93.113 5K99ES019597-02 No 71,649 Epidemiology of Immunotoxicant Exposure in Children 93.113 5R01ES012199-05revised No (1,158) Epidemiology of Immunotoxicant Exposure in Children 93.113 5R01ES012199-07rev No 362,222 Epigenetic Effects of Particles and Metals on Cardiac Health of an Aging Cohort 93.113 5R01ES015172-04 No 21,537 Epigenetic Effects of Prenatal Arsenic Exposure and Fetal Growth 93.113 5K01ES017800-02rev No 21,981 Epigenetic Regulation by Large Non-Coding RNAs in the p53 Mediated DNA Damage Response 93.113 5R01ES020260-02 No 311,982 Graduate Training in Biostatistics 93.113 5T32ES007142-29rev No 551,025 Health Effects of Lifetime Exposure to Food Contaminants 93.113 5R01ES013692-04 No 16,475 39
HSPH NIEHS Center for Environmental Health 93.113 5P30ES000002-49rev No 1,878,179 Human Exposure to Bisphenol A, Phthalates and Fertility, Pregnancy Outcomes 93.113 5R01ES009718-14 No 656,097 Impact of Obesity on Airway Responses to Air Pollution 93.113 5R01ES013307-08 No 387,678 Individual and Community Factors Conveying Vulnerability to Weather Extremes 93.113 1R21ES020695-01 No 53,862 Indoor Air Pollution Interventions for Child Pneumonia in the Gambia 93.113 5R21ES017855-02rev No 210,453 Influence of HFE on metal pharmacokinetics and neurotoxicity 93.113 5K99ES017781-02rev No 52,164 Influence of Iron Status on the Neurotoxicity of Inhaled Manganese 93.113 5R01ES014638-07rev No 220,361 Interdisciplinary Training in Genes and the Environment 93.113 5T32ES016645-05 No 279,512 Liability threshold modeling of genes and environment in case-control studies 93.113 1R21ES020754-01 No 5,792 Maternal Pesticide Exposure and Pregnancy Outcomes 93.113 5R01ES013967-04rev No 135,416 Measurement Errors in Environmental Epidemiology 93.113 5R01ES009411-08 No 607,022 Mercury Associated Neurobehavioral Deficit in Children 93.113 5R01ES009797-11rev No 300,223 Mercury exposure from fish consumption in subsistence fishers in rural Oklahoma 93.113 5R21ES017941-03 No 369,791 Mercury, Selenium, and Risk of Cardiovascular Disease in Women and Men 93.113 5R01ES014433-05 No 750,512 Nano-Scale Tools for Use in Cell Biology 93.113 5R01ES016665-05 No 352,598 Population-Based Study of Environmental Risk Factors for ALS 93.113 5R01ES019188-03 No 506,800 Prenatal Programming of Neonatal Asthma Susceptibility 93.113 5R01ES017588-04 No 636,129 RNAi Screen in Air Pollutant-Enhanced Influenza Infection 93.113 5R21ES019825-02 No 187,475 Scavenger Receptors and Inhaled Particles 93.113 5R01ES011008-10rev No 132,440 Semiparametric Methods for Secondary Outcomes in Case-control Studies 93.113 5R21ES019712-02 No 161,502 Summer Intern Program (SIP) in Environmental Health Sciences 93.113 5R25ES020722-02 No 85,913 The Cardiopulmonary Effects of Particulate Exposure 93.113 5R01ES009860-10 No 440,172 The Role of Ultraviolet Radiation and Skin Pigmentation in Melanoma Development 93.113 1F30ES020663-01 No 18,389 Theory and Methods for Sufficient Cause Interactions 93.113 5R01ES017876-03 No 268,588 Three-generation Human Study of Reproductive Effects of Marine Food Contaminants 93.113 5R01ES014460-05Rev No 359,242 Training Program in Environmental Epidemiology 93.113 5 T32 ES007069-30 No 10,750 Training Program in Environmental Epidemiology 93.113 5T32ES007069-33 No 488,946 Subtotal of 93.113 93.113 14,178,952 A Cognitive Approach to Refine and Enhance Use of a Dental Diagnostic Terminology 93.121 5R01DE021051-03 No 877,191 BMP2 regulation of the intramembranous bone stem cell niche 93.121 5K99DE021069-02 REVISED No 125,637 c-kit Signaling in Osteoclast Function 93.121 5R03DE019819-02 No 88,983 Characterization of cranial dermal bone-specific mirnas 93.121 5R21DE021535-02 No 217,553 Engineering Skeletal Muscle With Biodegradable Hydrogels 93.121 2R01DE013349-12 No 55,793 Engineering Skeletal Muscle With Biodegradable Hydrogels 93.121 5R01DE013349-11 REVISED 2 No 246,657 Polymeric Matrices With Defined Cell Adhesion 93.121 5R37DE013033-13 No 431,058 Programming dendritic cells in concert with morphagen delivery for periodontal regeneration 93.121 5R01DE019917-04 No 730,399 Wnt Signaling in the Induction of New Tooth Formation 93.121 5R00DE019871-04 REVISED No 256,097 Subtotal of 93.121 93.121 3,029,368 Harvard Prevention Research Center on Nutrition and Physical Activity - Category 1 93.135 5U48DP001946-03REV No 1,636,644 Subtotal of 93.135 93.135 1,636,644 National Academic Centers of Excellence on Youth Violence Prevention 93.136 5U49CE000740-05 REVISED No 101,613 Unintentional Poisoning from Prescription Drug Overdoses Among Veterans 93.136 5R21CE001605-02rev No 86,677 Subtotal of 93.136 93.136 188,290 Superfund Metal Mixtures, Biomarkers and Neurodevelopment 93.143 5P42ES016454-03 No 2,907,303 Subtotal of 93.136 93.143 2,907,303 Center of Excellence in Minority Health and Health Disparities 93.157 4 D34HP16868-03-03 No 577,046 Subtotal of 93.157 93.157 577,046 40
Accurate analysis of genome structural variation using large-scale sequence data 93.172 1U01HG006510-01 REVISED No 14,440 Bayesian Inference of Haplotypes and Genetic Interactions 93.172 5R01HG002518-09 REVISED No 146,099 Causal Transcriptional Consequences of Human Genetic Variation (CTCHGV) 93.172 5P50HG005550-02 REVISED No 4,652,320 Computational Haplotype Analysis for SNPs 93.172 5 R01 HG002518-04 (rev) No (1,603) Detecting natural selection by comparing African-ancestry populations 93.172 1R03HG006170-01A1 No 6,248 DNA/Carbon Nanotube Hybrids: Specific Interactions for Sequencing 93.172 5F32HG004692-04 No 18,655 Electronic Sequencing in Nanopores 93.172 5R01HG003703-07 REVISED No 1,603,366 Flybase: A Drosophila Genomic and Genetic Database 93.172 5P41HG000739-20 REVISED No 3,994,840 Insights from ancient and recent population mixture relevant to medical genetics 93.172 1F32HG006411-01 No 38,621 Methods for Genome-wide Association Studies in Admixed Populations 93.172 5R01HG006399-02 No 429,609 New Technologies for Quantitative Phosphorylation Analysis 93.172 5R01HG003456-07 No 547,209 Population Genetics to Improve Homozygosity and Mapping in Admixed Groups 93.172 5F32HG005944-03 No 48,398 Real-time single-molecule nucleic acid sequencing with flurogenic nucleotides 93.172 5R01HG005097-03 REVISED No 808,349 Sequencing regions associated with breast cancer risk in European and African Americans 93.172 1U01HG005922-01 No 131,420 The Protein Complex Map of the Drosophila Proteome 93.172 5R01HG003616-06 REVISED No 336,514 Understanding the Genetic Architecture of Gene Expression Regulation 93.172 5R03HG005732-02 No 61,644 Subtotal of 93.172 93.172 12,836,129 A conditional RNAi approach to find genes required for hearing in mice 93.173 5R21DC011122-02 No 257,762 Biophysics of forward and lateral connections in a genetically-tractable circuit 93.173 5F32DC009538-03 REVISED No (507) Cellular and Molecular Mechanisms of Ear Morphogenesis 93.173 5R01DC007195-08 No 284,931 Characterization of neural circuits mediating social behavior 93.173 5F32DC010089-03 No 53,037 Characterizing Odor Maps in the Olfactory Bulb and Cortex 93.173 5R01DC011558-02 No 448,218 Cortical Organization of Noun and Verb Processing 93.173 5R01DC006842-05 REV No 53,189 Genetic analysis of brain circuits underlying pheromone signaling 93.173 5R01DC009019-04 No 271,001 Genetic Dissection of Auditory Circuit Assembly 93.173 5R01DC009223-04 No 341,049 In Toto Imaging and genomics to Decode Ear Hair Cell Formation and Regeneration 93.173 5R01DC010791-03 REVISED No 392,798 Mechanics of Inner Ear Hair Bundles 93.173 5R03DC010466-03 REVISED No 150,032 Molecular and Cellular Mechanisms of a Neuronal Network that Regulates Olfactory Learning 93.173 5R01DC009852-03 No 473,503 Molecular Basis of Inherited Deafness 93.173 2R01DC002281-14A2 REVISED No 326,691 Molecular Mechanisms of Auditory Transduction 93.173 5R01DC000304-28 No 245,435 Non-Canonical Olfactory and Vomeronasal Receptors 93.173 5R01DC010155-04 No 469,069 Olfactory navigation in Drosophila as a model for multi-sensory integration 93.173 1K99DC012065-01 REVISED No 38,299 Optogenetic Studies of Mouse Olfaction 93.173 5R01DC011291-02 REVISED No 442,141 Streamlined cloning of auditory and vestibular mutants by whole genome sequencing 93.173 1R21DC012097-01 No 188,394 Synaptic and Circuit Mechanisms of Olfactory Processing 93.173 2R01DC008174-06 REVISED No 320,019 The Role of an olfactory-specific histone variant in olfactory development and function 93.173 5R21DC011117-02 No 162,825 The Role of Eya4 in Hearing and Disease 93.173 5R01DC007453-05 No 88,589 Subtotal of 93.173 93.173 5,006,475 Assessment of the Value of Global Polio Vaccination and willingness-to-pay for Vaccines 93.185 5U66IP000169-02rev No (24) Subtotal of 93.185 93.185 (24) Mentoring and Research in Placebo Studies, Asian Medicine, and CAM 93.213 5K24AT004095-05 REVISED No 7,498 Research Training: Complementary and Integrative Medicine 93.213 5T32AT000051-12 REVISED No 275,503 Structural Integration for Chronic Low Back Pain 93.213 5K01AT004916-05 No 151,457 Tai chi, physiologic complexity, and healthy aging 93.213 5R21AT005501-02 REVISED No 93,343 Subtotal of 93.213 93.213 527,801 Health Policy Training Program 93.225 5T32HS000055-19 No 247,487 Subtotal of 93.225 93.225 247,487 Comparative Effectiveness and Safety of Depression Treatments during Pregnancy 93.226 5R01HS018533-04 No 401,713 Factors Associated with Effective Implementation of a Surgical Safety Checklist 93.226 5R18HS019631-03 No 280,152 Pay for Performance in Medicaid: Evidence from the Field 93.226 5R01HS017441-03revised No 312,181 Policy and Demographic Predictors of Medicaid Take-Up Among Non-Elderly Adults 93.226 1R03HS019754-01 No 22,265 Spaced Education to Optimize Prostate Cancer Screening 93.226 5K08HS017147-03 REVISED No 69,050 Subtotal of 93.226 93.226 1,085,361 Finding a Research Path for the Identification of Biomarkers of Sleepiness 93.233 1R13HL104874-01 No 27 Genetics of Sleep in Zebrafish 93.233 5R01HL109525-05 No 393,088 Subtotal of 93.233 93.233 393,115 41
A new approach to mental health: Phenotypes in family genomewide association scans 93.242 5R01MH087590-03S1 No 395,383 Analysis of Multiple Informant Data in Psychiatry 93.242 5R01MH054693-12 REVISED No 245,323 Biological Basis of Schizotypal Personality Disorder 93.242 5 R01 MH052807-15 REVISED No 66,370 Characterizing the Genetic Systems of Autism through Multi-Disease Analysis 93.242 3R01MH090611-03S1 No 624,802 Developing research capacity for mental health interventions for youth in Haiti 93.242 1R21MH093298-01 No 44,062 Effects of HIV and ARV Exposure on Child Health and Neurodevelopment in Botswana 93.242 5R01MH087344-04 No 671,924 Effects of Mental Parity on High-Cost and Severely-ill Individuals 93.242 5R01MH080797-03 REVISED No 242,204 Epidemiology-- National Comorbidity Survey Replication 93.242 5U01MH060220-10 REVISED No 203,482 Event-related Neuroimaging of Human Memory Formation 93.242 5R01MH060941-12 No 538,107 Family Based Prevention of Mental Health Problems in HIV/AIDS Affected Children 93.242 3R34MH084679-02S1 No 167,744 Family Based Tests of Association for Complex Diseases 93.242 5R01MH059532-11rev No 111,958 Genetic Determinants of PTSD in Women 93.242 5R01MH078928-04 No 383,959 Hurricane Katrina Community Advisory Group 93.242 5R01MH081832-03 REVISED No 227,207 Imprinting a connectome: developmental circuit approach to mental illness 93.242 5P50MH094271-02 No 1,350,769 Influences on Psychiatrist Prescribing of Antipsychotics 93.242 1R01MH093359-01A1 No 40,253 Learning and Compression in Human Working Memory 93.242 5R03MH086743-02 REVISED No 52,987 Mental Health Coverage in Health Care Reform 93.242 5R01MH094290-02 No 265,119 Mental Health Spending and Quality of Care 93.242 5R01MH081819-03 REVISED No 428,443 Modeling schizophrenia gamma deficits using cell-specific RNAi knockdown of GAD67 93.242 5R21MH094803-02 No 148,668 Modeling the Impact of HIV Prevention Interventions 93.242 5R01MH087328-03 No 609,235 Neural circuits that regulate dopamine neuron activity 93.242 1R01MH095953-01A1 No 4,986 Neural Dynamics in Schizophrenia 93.242 5R01MH080187-05 No 279,242 Neurogenetics of serotonin regulation: building naturalistic rhesus monkey models 93.242 5 R21 MH077995-02 No (1,488) Neuronal Epigenomic Changes in Neurodevelopment and Disease 93.242 5R01MH094663-02 No 406,534 Neurophysiological Studies of Schizophrenia 93.242 5R01MH040799-25 No 520,065 Novel Statistical Approaches to Mental Health Phenotype Analysis in GWA Studies 93.242 2R01MH081862-04 No 15,185 Novel Statistical Approaches to Mental Health Phenotype Analysis in GWA Studies 93.242 5R01MH081862-02 No 67,469 Novel tools to study circuit function, development, and periods of vulnerability 93.242 5 R21 MH083613-02 No (227) Prevalence and Risk and Preventive Factors for Suicidal Behaviors 93.242 5R01MH077883-03 No 14,386 Quality of Care for Bipolar Disorder 93.242 5K01MH071714-05 REVISED No 105,611 Regulation of Memory by the microrna/risc Pathway 93.242 5R01MH081294-04 REVISED No 341,552 Regulation of neuron and synapse function by neuropeptides 93.242 5R01MH085498-04 No 328,679 Risk Factors for Psychopathology in the WHO WMH Surveys 93.242 5R01MH070884-05 REVISED No 296,736 Social Imprinting in the Development of Major Depression 93.242 5R01MH087544-04 No 325,190 Suicide Attempts and Unintentional Injury Among Older Americans on Psychotropics 93.242 5R01MH085021-03 No 242,321 Synaptic Basis of Sleep Cycle Control 93.242 5R01MH039683-27 REVISED No 349,821 Why Sub-Saharan African Patients Discontinue HIV Care 93.242 5R21MH085557-02 No 108,056 World Congress of Psychiatric Genetics Student Awards 93.242 5R13MH060596-14 No 30,578 Subtotal of 93.242 93.242 10,252,695 HSPH Center for Excellence to Promote a Healthier Workforce 93.262 3U19OH008861-03S1rev No 703,824 Interactions of Biomechanics and Psychosocial Stressors and MSDs in the Modern Office 93.262 5R01OH008781-03rev No 140,697 Lung Disease in Chinese Textile Workers 93.262 5R01OH002421-18rev No (34) The Harvard School of Public Health Center for Work, Health and Wellbeing 93.262 2U19OH008861-05rev No 694,703 The HSPH Education and Research Center for Occupational Safety and Health 93.262 5T42OH008416-08 No 1,330,284 Upper Extremity Dynamics During Keying 93.262 5R01OH008373-04rev No 129,820 Subtotal of 93.262 93.262 2,999,294 Alcohol and Cell Adhesion 93.273 2R01AA012974-11A1 REVISED No 100,145 Alcohol and Cell Adhesion 93.273 5R37AA012974-10 No 155,856 Alcohol and Chronic Disease Among Vulnerable Populations 93.273 5 R01 AA011181-10 No 378 Behavioral Couples Group Therapy for Alcoholic Patients: Clinical and Cost Outcomes 93.273 5R01AA017865-04 No 500,976 Functional genetic evolution of human brain and behavior 93.273 5R01AA019688-03 No 340,942 GABAa receptor subtype mechanisms in nonhuman primate models of alcohol abuse 93.273 5R01AA016179-05 No 108,932 Opioid Receptor Polymorphisms and Nonhuman Primate Models of Alcohol Abuse 93.273 5R01AA016828-04 No 441,641 Patients, Clinics, and Systems: Screening for Alcohol Use 93.273 7K24AA000289-11 REVISED No 67,632 Subtotal of 93.273 93.273 1,716,502 Drug Abuse-related Neurobiology and Genetic Variance Modeled in Rhesus Monkeys 93.277 5K02DA025697-04 No 124,866 Subtotal of 93.277 93.277 124,866 42
Anxiolytic Effects and Abuse of BZ Receptor Ligands 93.279 5R01DA011792-14 No 355,047 Behavioral Couples Therapy for Female Drug-Abusing Patients 93.279 5R01DA025618-04 No 428,756 Biological Prediction of Psychosis Susceptibility among Adolescent Cannabis Users 93.279 5R01DA021576-07 No 126,089 Cannabinoid Inhibition of Divalent Metal Transporter-1 Activity 93.279 5R21DA025573-02rev No 20,881 Developmental Genetics of Serotonin Neuron Subtypes in Brain Reward Circuits 93.279 5R21DA023643-02 REVISED No 3,351 Dopaminergic Enabling of Synaptic Plasticity in Prefrontal Circuits 93.279 5R01DA032283-02 No 410,053 Duration of Behavioral Counseling Treatment Needed to Optimize Smoking Abstinence 93.279 5R01DA012165-10 No 470,606 Epigenetic Regulation of Serotonin: Relevance to HIV and Methamphetamine Abuse 93.279 5R21DA030177-03 No 370,866 Function of RIM-Dependent Synaptic Plasticity in Cocaine-Induced Behaviors 93.279 5K01DA029044-04 No 115,585 HFE: A Genetic Determinant of Olfactory Mn Absorption and Toxicity 93.279 5R03DA027030-02 No 134,769 Methamphetamine and neurodevelopment in adolescent and adult mice 93.279 5R21DA029790-02 No 284,211 Molecular and Genetic Adaptations Associated with Compulsive Cocaine Intake 93.279 5R01DA021420-04 REVISED No 23,954 Monitoring Neural Activity in Freely Behaving Zebrafish Larvae with Bioluminescence 93.279 5R01DA030304-02 No 506,172 Naltrexone and AIDS progression 93.279 1R21DA034420-01 No 1,285 Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation 93.279 1R01DA033795-01 No 706 Nonhuman Primate Models of Reinstated Cocaine Seeking 93.279 5R01DA011054-13 No 338,810 Opioid Patients: Behavioral Family Counseling and Naltrexone 93.279 5R01DA015156-05 No 123,310 Retrograde Signaling by Endogenous Cannabinoids 93.279 5R01DA024090-10 No 406,508 World Congress of Psychiatric Genetics with Emphasis on Genes or Drug Abuse 93.279 5R13DA022792-05 No 24,567 Subtotal of 93.279 93.279 4,145,526 Activity-dependent phosphorylation of MeCP2 93.281 5K08MH090306-03 No 235,725 Function of microtubule plus-end-tracking proteins in the neuronal growth cone 93.281 1K99MH095768-01 No 40,440 Mentoring in Qualitative Methods for Patient-Oriented Research on HIV Care 93.281 5K24MH090894-03 No 110,582 Modifiable Protective Processes in the Mental Health of Refugee Children 93.281 5K01MH077246-05 No 184,482 Subtotal of 93.281 93.281 571,229 Associative representations in parietal cortex 93.282 5F31MH085439-02 No 4,541 Control of Glutamatergic Transmission by Acetylcholine Release in Striatum 93.282 5F31MH093026-02 No 33,056 Etiology of Adolescent Depression: Gene and Social Environment Interactions 93.282 1F31MH088074-02 No 6,254 Health Policy Training Program 93.282 5T32MH019733-18 REVISED No 282,634 Ph.D. Training in Neuroscience 93.282 5T32MH020017-15 No 595,918 Training Program in Psychiatric Genetics and Translational Research 93.282 5T32MH017119-26 No 302,093 Subtotal of 93.282 93.282 1,224,496 Nat Preparedness Leadership Initiative NPLI, A Joint Prog of the Harvard School of Public Health and the Kennedy School of Government 93.283 5U90TP000101-05Rev No 588,180 Subtotal of 93.283 93.283 588,180 Bio-imaging with Isothermal DNA Self-Assembly 93.286 1K99EB015331-01 No 28,900 Building the Hematopoietic Stem Cell Niche 93.286 5R01EB014703-02 No 385,030 Development of hyperpolarized silicon nanoparticles as molecular MRI agents 93.286 5 R21 EB007486-02 No 2 Engineering Microbial Rhodopsins as Optical Voltage Sensors 93.286 5R01EB012498-02 REVISED No 386,549 New Chemical Methods for Molecular Imaging to Impact Clinical Care 93.286 5R01EB013042-02 REVISED No 488,005 Statistical Model of the AIDS Epidemic 93.286 2R56EB006195-19A1rev No 45,230 Subtotal of 93.286 93.286 1,333,716 Functional Activity and Inter-organismal Interactions in the Human Microbiome 93.301 5R01HG005969-03 No 504,847 Subtotal of 93.301 93.301 504,847 Harvard School of Public Health MHIRT Training Program Grant 93.307 7T37MD001449-15rev No 133,320 MassCONECT 4 Kids: Promoting Smoke-Free Homes 93.307 5R24MD002772-05Rev No 549,233 Understanding Disparities in Patient-Centered Hospital Care 93.307 1R01MD006230-01A1 No 26,146 Subtotal of 93.307 93.307 708,699 43
A New Genetic Approach for Studying Prions and other Pathogenic Protein Aggregates 93.310 8DP1AI104284-05 No 1,055,669 Assays for Discovery of Translation Inhibitors 93.310 1R21NS067596-01 No (75,365) Biophysical approaches to complex navigational behaviors in larval Drosophila melanogaster 93.310 8DP1GM105383-05 No 592,525 Cellular Control of Microtubule-based Transport: Unraveling its Molecular Mechanism 93.310 1 DP2 OD004268-01 No 524,072 Discovery metabolite profiling of the prolyl peptidases 93.310 1DP2OD002374-01 No 276,983 Dynamic cellular architecture of bacteria by system-wide super-resolution 93.310 5R01GM096450-02 No 1,062,080 Engineering Bioimaging Probes Based on Triggered Molecular Geometry 93.310 1DP2OD007292-01 No 518,496 Epistatic and Cross Tissue Analysis for Human Gene Expression Traits 93.310 5R01MH090948-02 No 370,886 Expression, Labeling and NMR Structure Determination of Integral Membrane Proteins 93.310 5 R01 GM075879-05 No (217) Functional Metagenomic Reprogramming of the Human Microbiome through Mobilome Engineering 93.310 1DP5OD009172-01 No 157,460 High Resolution Connectomics of Mammalian Neural Circuits 93.310 5R01NS076467-02 No 820,757 Host and Pathogen Evolution in Lassa Fever 93.310 1DP2OD006514-01 Rev5 No 749,064 Imaging the Invisible with no Labels: A Major Opportunity in Biology and Medicine 93.310 5R01EB010244-04 No 820,596 Investigating the role of alternative splicing regulatory networks in nervous system development and function 93.310 1DP5OD009153-01 No 324,411 M.tuberculosis Protease ClpP1P2 - An attractive drug target 93.310 1R21NS067598-01A1 No 158,295 Modeling the Aging Epigenome 93.310 8DP1AG044161-03 No 708,913 Molecule-to-gene approaches to new natural products 93.310 5R01GM086258-04 No 333,963 Nano- and Microelectronic Tools for Interrogating Neuronal Circuits and Networks 93.310 8DP1DA035083-05 REVISED No 526,641 Nanowire Nanoelectronic Cell Assemblies as Hybrid Functional Biomaterials 93.310 8DP1GM105379-05 No 663,498 Optical Sensing of Voltage, ph, and Small Molecules Using Microbial Rhodopsins 93.310 1DP2OD007428-01 No 213,705 Pancreatic Islet Design and Engineering (SysCODE 3 of 10) 93.310 5RL1DK081184-05 No 548,379 Pharmaco Response Signatures and Disease Mechanism 93.310 5U54HG006097-03 No 2,788,184 Quantitative Imaging of Signaling Networks 93.310 5R01GM090317-03 No 834,158 Revealing fear: new methods to study neural circuits, behavior and disease 93.310 1DP2OD007109-01 No 739,660 RNA and Chromatin Formation: From Discovery to Mechanism 93.310 7DP2OD006670-02 No 198,555 Schnurri-3 Inhibitors: specific inducers of adult bone formation 93.310 5R03MH094204-02 No 42,567 Target-Based High-Throughput Screens for Plasmodium falciparum Malaria 93.310 1 R21 NS059404-01 REVISED No 18,997 Variation in M. tuberculosis in response to host selection 93.310 3DP2OD001378-01S1 No 372,189 Watching a vertebrate brain learn and behave in a virtual environment 93.310 8DP1NS082121-02 No 959,231 Subtotal of 93.310 93.310 16,304,352 Harvard Clinical and Translational Science Center (KL2) 93.350 8KL2TR000168-05 No 1,013,725 Harvard Clinical and Translational Science Center (TL1) 93.350 8TL1TR000169-05 No 516,170 Subtotal of 93.350 93.350 1,529,895 HRQOL Impacts of Illness on Family and Caregivers 93.361 7R01NR011880-03rev No 411,912 Subtotal of 93.361 93.361 411,912 Clinical Training in Primate Medicine 93.389 5R25RR024230-03 REVISED No 46,153 Development of Validated Drosophila in Vivo RNAI Models of Human Diseases 93.389 8R24OD011176-02 No 341,009 Establishment of SPF Rhesus Macaque Breeding Colony 93.389 5U42RR016020-10 REVISED No 450,011 New England Primate Research Center Base Grant 93.389 8P51OD011103-51 REVISED No 12,644,594 Research Training in Veterinary and Comparative Pathology 93.389 5T32RR007000-33 No (1,405) Research Training in Veterinary and Comparative Pathology 93.389 8T32OD011064-36 No 327,574 Restrictive Provisions in Faculty Consulting Agreements with Industry (Phase I) 93.389 5R21RR031916-02 No 258,668 Self-Injurious Behavior and Primate Well-Being 93.389 8R24OD011180-15 No 297,441 A Multi-user Super Resolution Microscope for Developmental Biology 93.389 1S10RR029237-01 No 1,044,639 AvanceIII 700MHz NMR spectrometer with cryogenic probe 93.389 1S10RR029236-01 REVISED No 1,154,484 MicroXCT-200 X-ray Scanner 93.389 1S10RR031514-01 No 6,850 Modern Public Health data storage for High volume using the Powervault MD300 93.389 1S10RR031865-01 No 127,396 Spinning Disk Confocal for Live Cell Imaging with Accessories 93.389 1S10RR026436-01 No 10,486 VivaCT 40 Scanner 93.389 1S10RR026556-01A1 No 396,700 Subtotal of 93.389 93.389 17,104,600 NIH Director's Pioneer Award 93.390 5DP1OD000580-05 REVISED No 250,900 Subtotal of 93.390 93.390 250,900 44
Cancer and Changing Trends in US Mortality Inequities: 1960-2004 93.393 5R03CA137666-02 No 1,143 Cell Entry and Spread by Polyoma Virus 93.393 5R01CA082395-10 No 190,583 Circulating Vitamin D Levels and Risk of Breast and Colorectal Cancer: a Pooled Analysis 93.393 5R01CA152071-03 No 849,611 Clinical and Cost-Effectiveness of HPV Vaccination in the US 93.393 5 R01 CA093435-06 No 22,627 Comparative and Cost-Effectiveness of Preventing HPV-Related Diseases 93.393 1R01CA160744-01A1 No 11,445 Design and Characterization of Cigarettes 93.393 5R01CA087477-10rev No 640,576 Design Considerations for Two-Phase Studies 93.393 5R03CA135671-02 No 17,097 Dietary Patterns, Diet Quality and Cancer Risk 93.393 5R01CA095589-09 No 320,280 Discovery, Biology and Risk of Inherited Variants in Breast Cancer 93.393 5U19CA148065-02rev No 1,436,552 Do Medicare Claims Measure Cancer Relapse Patients: An External Validation Study 93.393 5R21CA155351-02 No 165,678 Energy Balance-Related Hormones and Prostate Cancer Incidence and Progression 93.393 5R01CA133891-05 No 461,259 Fractures, Heart Disease, and Stroke on Aromatase Inhibitors 93.393 5R01CA127652-03 No 121,569 Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology 93.393 5K07CA143044-03 No 135,004 Gene-environment EBV Interactions in the Etiology of Nasopharyngeal Carcinoma (NPC) 93.393 5R01CA115873-04 No 290,202 Genetic Susceptibility to Lung Cancer 93.393 5R01CA074386-11 No (7,417) Genome Wide Predictors of Plasma Folate Homocysteine 93.393 5 R03 CA133937-02 No 16,473 Genomic targets of oncoproteins and tumor suppressors 93.393 5R01CA107486-06 No 529,113 Gut microbiota and inflammatory monocytes in colorectal cancer 93.393 5R01CA154426-02 No 451,534 Histone Demethylases and Regulation of Chromatin and Transcription in Eukaryotes 93.393 5R01CA118487-05 REVISED No (76,879) Improving Systems for Colorectal Cancer Screening 93.393 5R01CA112367-04 REVISED No 72,428 Integrative Modeling of Genetic and Epigenetic Variation in Colorectal Cancer 93.393 5R03CA142082-02 No 40,479 Measurement Errors in Cancer Epidemiology 93.393 5R01CA050597-17rev No 551,719 Mechanisms of Eukaryotic Translation Initiation 93.393 2R01CA068262-17 No 245,174 Methods to Identify Genetic Markers That Interact with Multiple Environmental Exposure 93.393 1R21CA165920-01 No 40,013 Molecular and Genetic Analysis of Lung Cancer Survival 93.393 5R01CA092824-09 No 674,519 Population-based assessment of cancer trial generalizability in the elderly 93.393 5R01CA132900-04 No 353,036 Premonopausal Hormone Levels and Risk of Breast Cancer 93.393 5R01CA067262-16 No 514,653 Prospective Studies of Diet and Cancer in Men and Women 93.393 5 P01 CA055075-15rev No (3,856) Prospective Studies of Diet and Cancer in Men and Women 93.393 5U19CA055075-20-Revised No 3,982,303 Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors 93.393 5R01CA122617-07 No 255,729 Risk Factors for Breast Cancer in Younger Nurses 93.393 5 R01 CA050385-20 No (330,996) Risk Factors for Breast Cancer in Younger Nurses 93.393 5R01CA050385-24 No 1,603,214 Statistical Informatics for Cancer Research 93.393 5P01CA134294-04 No 535,833 Statistical Methods for Correlated and High-Dimensional Biomedical Data 93.393 5R37CA076404-14 No 5 Statistical Methods for Correlated and High-Dimensional Biomedical Data 93.393 5R37CA076404-16 No 401,532 Subjective and Behavior Responses to PREP Design and Marketing 93.393 5R01CA125224-04rev No 360,528 Tumor Host Range Mutants of Polyoma and Their Targets 93.393 5R01CA092520-10 No 20,675 Use of Geographic Variations to Estimate Effectiveness with Non-Randomized Data 93.393 5R01CA142744-02 No 548,337 Validity of Diet and Activity Measures in Men 93.393 5U01CA152904-02 No 1,297,483 Subtotal of 93.393 93.393 16,739,258 Influences on Physical Activity of Young Latino Children 93.394 5R21CA131764-02rev No 35,046 Novel Blood Assay for Lung Cancer Detection 93.394 5R21CA143101-02 REVISED No 276,893 Technetium and Rhenium in Nuclear Medicine 93.394 5R01CA119334-31 REVISED No 74,523 Subtotal of 93.394 93.394 386,462 Abrogating human CD59 activity for antibody-based cancer therapy 93.395 5R21CA141324-02 REVISED No 100,622 Applications of Natural Products to Chemical Biology 93.395 5R01CA024487-31 REVISED No (338) Development of Translation Initiation Inhibitors and their Anti-Cancer Activity 93.395 5R01CA121357-05 REVISED No 406,145 International Center for the Evaluation of East Asian Botanicals for Cancer 93.395 5U19CA128534-04 REVISED No 55,142 Mechanistic Pharmacology of Anti-Mitotics and Apoptosis Regulation 93.395 5P01CA139980-03 No 1,889,897 Probing Cell Division with Synthetic Chemistry 93.395 5 P01 CA078048-10 No 513 Synthesis and Study of Natural and Non-natural Antiproliferative Agents 93.395 3R01CA047148-25S1 No 818,656 Targeting Endoplasmic Reticulum Stress Response for cancer Therapy 93.395 1R01CA152312-01A1 REVISED No 331,951 Therapeutic/Toxic Effects of Electron Emitting Nuclides 93.395 5R01CA015523-38 No 688,454 Subtotal of 93.395 93.395 4,291,042 45
Cell and Tumor Genetics of Mitotic Arrest Checkpoints 93.396 5R01CA084179-11 REVISED No 5,218 Cell Death Regulation in Lumen Formation and Oncogenesis 93.396 3R01CA105134-09S1 No 475,848 Contribution of resident stem cells to tumor stroma and vasculature 93.396 5R21CA141130-02 No 89,789 Mitogenic and Oncogenic Regulation of ERK/RSK Signaling 93.396 5R37CA046595-26 No 610,426 Notch Signaling in Mammary Development and Tumorigenesis 93.396 5R01CA098402-10 No 370,484 Structural and Mechanistic Studies of Regulation of let-7 biogenesis by Lin28' 93.396 1R01CA163647-01 No 16,361 Structure and Mechanism in DNA Excision Repair 93.396 5R01CA100742-09 REVISED No 331,065 T-bet and Tumor Immunity 93.396 5R01CA112663-12rev No 219,484 Transcriptional Activator/Coactivator Interactions 93.396 5R01CA127990-05 REVISED No 227,912 Subtotal of 93.396 93.396 2,346,587 Harvard Transdisciplinary Research in Energetics and Cancer 93.397 5U54CA155626-02 No 1,182,140 Subtotal of 93.397 93.397 1,182,140 A Global Screen for Genes Regulating Cdt1 Turnover In Response To DNA Damage 93.398 5F32CA139885-03 No 54,936 Alternative Splicing of Pyruvate Kinase M: Regulation and Significance in Cancer 93.398 5F31CA136322-04 REVISED No 7,200 Biostatistics/Epidemiology Training Grant in Biostatistics 93.398 2T32CA009337-31 No 439,183 Biostatistics/Epidemiology Training Grant in Biostatistics 93.398 5T32CA009337-30 No 46,590 Cellular plasticity and survival mechanisms in medulloblastoma stem cells 93.398 1F31CA165479-01 No 4,547 Exploring the mechanism and function of somatic homolog pairing 93.398 1F32CA157188-01 REVISED No 36,275 Harvard Education Program in Cancer Prevention Control 93.398 5R25CA057711-18 No 587,142 Imaging Dynamic Aspects of Mammary Morphogenesis and Oncogenesis 93.398 5K25CA100290-05 No 56,005 Mitochondrial Apoptotic Sensitivity in Predicting Acute Myeloid Leukemia Response 93.398 5F31CA150562-02 REVISED No 26,363 Modeling Breast Carcinoma in Situ: Implications for Prevention and Control 93.398 5 F32 CA125984-03rev No (475) Molecular analysis of the function of BRCA1-TONSL complexes 93.398 1F30CA167895-01 REVISED No 5,508 Networking organization and dynamics of the Hippo pathway during oncogenesis 93.398 1F32CA165738-01 No 20,590 Nutritional Epidemiology of Cancer Education and Career Development Program 93.398 5R25CA098566-08 No 476,794 Pathobiology of Cancer at the Host and Population Level 93.398 5T32CA009382-30 No 229,124 Program for Training in Cancer Epidemiology 93.398 5 T32 CA009001-33 No 995 Program for Training in Cancer Epidemiology 93.398 5T32CA009001-37 No 763,922 Radiation Biology Training Program 93.398 5 T32 CA009078-35rev No 18,699 Role of IGF-I Receptor Signaling Pathways in Cell Survival and Migration 93.398 5K08CA107231-05 REVISED No (1,314) Somatic Mutation Discovery in Lung Squamous Cell Carcinoma 93.398 5F31CA136180-03 REVISED No 10,811 Studies of Receptor Mediated Signal Transduction Processes in Mammalian Cancer Biology 93.398 1K22CA151918-01A1 No 74,228 Synthetic Biological Devices for Understanding the Effect of Hypoxia on Cancer Cells 93.398 1F32CA154195-01 No 7,283 The Role of Mechanics in Tumor Progression and Malignancy 93.398 5F32CA153802-03 No 51,555 The Role of the Human Holliday Junction Resolvase Component SLX4 in DNA Recombination and Repair 93.398 5F32CA159612-02 No 47,982 Virus-Host Interactions in Cancer 93.398 5 T32 CA009031-33 No 48,693 Subtotal of 93.398 93.398 3,012,636 Prostate Cancer Prevention by n-3 Unsaturated Fatty Acids 93.399 5R01CA101034-04 REVISED No (689) Statistical Methods for Analysis of Failure Time Data 93.399 5R01CA075971-11rev No 63,627 Subtotal of 93.399 93.399 62,938 46
A Multidisciplinary Approach to Elucidating Gene Function in a Model Gram-positive Bacterium 93.701 5RC2GM092616-02 REVISED Yes 665,910 A Systems Approach to Advancing Workforce Inclusion and Diversity 93.701 1DP4GM096852-01 REVISED Yes 773,092 Accounting for confounding bias and heterogeneity in comparative effectiveness 93.701 1RC4MH092717-01 REVISED Yes 480,506 ALSISE: Assessment of Life Science Intermediate School Educators 93.701 5RC1HD063686-02 Yes 245,537 Anatomical and Biochemical Organization of the Retina 93.701 3R01EY000811-38S1 Yes 4,918 Anxiolytic Effects and Abuse of BZ Receptor Ligands 93.701 3R01DA011792-11S1 Yes 32,414 Assessment of Infant Outcomes After in Utero Exposure to Antiretroviral Therapy 93.701 5R01HD056940-02 Yes 817,397 Association of Telomere Length with Colorectal Cancer and Adenoma 93.701 1R03CA139586-02 Yes 9,911 Automated Acquisition of C. elegans Survival Curves with a Flatbed Scanner 93.701 3R03AG032481-02S1 Yes (74) Biochemical dissection of epigenetic inheritance by Polycomb group proteins 93.701 3R01GM078456-04S1 Yes (22,925) Cell Interactions in Development of the Mammalian Kidney 93.701 3R37DK054364-11S1 REVISED Yes 37,527 Chemical Genetic and Biochemical Studies of Mitotic Proteolysis 93.701 3R01GM066492-07S1 Yes 38,127 Clinical and Cost-Effectiveness of HPV Vaccination in the US 93.701 3R01CA093435-06S1 Yes 5,268 Comprehensive Phenotypic Comparison of Normal and Cancer Stem Cells 93.701 5RC2CA148222-02 REVISED Yes 580,271 Cytoskeleton polymerization dynamics in the cell cycle 93.701 3R01GM023928-31S1 Yes 4,675 Deconvolution of metabolic adaptation of endoplasmic reticulum 93.701 1RC4DK090942-01rev Yes 811,342 Detection of Prostate Cancer Genomic Signatures in Blood 93.701 5RC1CA145864-02 Yes 316,339 Development of Electron Microscopy-based Nucleic Acid Polymer Sequencing 93.701 5RC2HG005592-02 REVISED Yes 632,730 Developmental Genetics of Serotonin Neuron Subtypes in Brain Reward Circuits 93.701 3R21DA023643-02S1 Yes 114,185 Dietary Patterns and Risk of Cardiovascular Disease 93.701 5R01HL060712-11rev Yes 61,022 Directed Evolution of a Murine Model of Hepatitis C Virus Replication 93.701 5R21AI068999-02 REVISED Yes 61,999 Discovery of Small Molecules that Restore Methicillin Sensitivity to MRSA 93.701 1F32AI084316-01 REVISED Yes (91) DNA Damage and Neurodegeneration in the Aging Brain 93.701 3P01AG027916-04S2 Yes 95,390 Drug Targets for Tuberculosis 93.701 5R01AI071881-02 Yes (45) Dynamics of Signaling Pathways: Mechanism and Function 93.701 3R01GM083303-02S1 Yes 6,075 Electrical Stimulation of Immediate Early Genes 93.701 3R01NS028829-21S1 Yes (3,554) Electron microscopy studies of novel poliovirus genome-releasing intermediates 93.701 5F32AI081427-02 Yes 4,264 Electronic Sequencing in Nanopores 93.701 3R01HG003703-05S1 Yes 16,425 Engineered in vivo nuclear fusion: application to regenerative medicine 93.701 5RC1DK087006-02 REVISED Yes 153,641 Engineering Skeletal Muscle With Biodegradable Hydrogels 93.701 3R01DE013349-09S1Rev Yes 31,219 Epidemiology-- National Comorbidity Survey Replication 93.701 3U01MH060220-09S1 REVISED Yes 117,728 Epigenetic Analysis of ips Cell Models of Aging and Alzheimer's Disease 93.701 5RC1AG036106-02 Yes 414,697 Establishment of a high throughput screen for the discovery of malaria transmission blocking drugs 93.701 1RC1AI086222-01 Yes 292,244 Establishment of SPF Rhesus Macaque Breeding Colony 93.701 3U42RR016020-08S1 Yes 194,091 Evaluating the Health Benefits of Workplace Policies and Practices - Phase II 93.701 3U01AG027669-05S1 Yes 1,338 Fatty Acids and Major Cardiovascular Outcomes 93.701 3R01HL085710-03S1 Yes 76,579 Ferristatin: A New Small Molecule Inhibitor of Iron Transport 93.701 5RC1DK086774-02-rev Yes 77,252 Flybase: A Drosophila Genomic and Genetic Database 93.701 3P41HG000739-17S1 REVISED Yes 87,983 Forward genetic screens for identifying antimalarial resistance genes 93.701 5R21AI082309-02 Yes 18,159 Functional Analysis of the Proteasome Base 93.701 3R37GM043601-20S1 Yes 79,132 Functional Coupling of Steps in Gene Expression 93.701 3 R01 GM043375-19S1 Yes 1,136 Functional Organization of Visual Area MT 93.701 3R01EY011379-13S2 Yes 65,791 Gene Expression and Regulatory Networks in Human Leukocytes 93.701 5RC2GM093080-02 REVISED Yes 2,980,216 Genome Surveillance for Drug Resistant Malaria 93.701 5R01AI075080-02 Yes 479,539 Glycated CD59 as a Biomarker for Diabetes 93.701 1R56DK089206-01 REVISED Yes 61,829 GWAS on Determinants of HIV-1 Subtype C Infection 93.701 1RC4AI092715-01rev Yes 1,393,787 Harvard University Center for AIDS Research 93.701 3P30AI060354-07S1 Yes 53,227 Identification of Genes and Compounds that Control Beta Cell Replication 93.701 1RC4DK090781-01 REVISED Yes 1,488,186 ImmGen: a gene expression compendium for immune cells 93.701 3R24AI072073-03S1 Yes 100,214 Inhibitors of c-di-gmp synthesis and degradation 93.701 5R01AI079021-02 Yes 45,409 Innovative mouse model to study parathyroids and an application to human disease 93.701 5RC1DK087289-02 Yes 182,756 Language and Risk for Schizophrenia 93.701 5R21MH083205-02 Yes 3,112 Mechanism of Latency of Herpes Simplex Virus 93.701 3P01NS035138-22S1 REVISED Yes 60,600 Mechanistic Analysis of Papillimavirus E2 Functions 93.701 3R01CA116720-04S1 Yes 48,001 Mechanistic Signatures of Drug Responses in Cancer 93.701 5RC2HG005693-02 REVISED Yes 59,952 Meiotic Chromosome Synapsis and Recombination in Yeast 93.701 3R01GM044794-20S1 Yes (66) Mercury, Selenium and Risk of Cardiovascular Disease in Women and Men 93.701 3R01ES014433-03S1revised Yes 176,120 Method for Prediction of Efficacy of Genetic-based Prediction Models of Personalized Medicine with Clinical Avatars 93.701 5R01LM010130-02 REVISED Yes 140,994 47
Microlysis Technology: Enabling Cell Type-Specific Proteomics in Living Tissue 93.701 1RC1HG005354-01 REVISED Yes (31,754) Microlysis Technology: Enabling Cell Type-Specific Proteomics in Living Tissue 93.701 5RC1HG005354-03 REVISED Yes 284,502 Modular Enzymatic Assembly Lines for Antibiotics 93.701 3R01GM020011-38S1 Yes 55 Molecular and Genomic Imaging Center 93.701 3P50HG003170-05S1 REVISED Yes (3,855) Molecular Genetics of HSV DNA Polymerase Gene 93.701 2 R01 AI019838-24A2 REVISED Yes (426) Molecular mechanism of a cellular necrotic cell death pathway 93.701 5R01CA138961-02 Yes 171,882 Monoclonal Antibodies and Genetic Elements for Airway Disease 93.701 5RC1HL100767-02 Yes 215,314 Networking Research Resources Across America 93.701 5U24RR029825-02 REVISED Yes 3,522,139 Neurophysiological Studies of Schizophrenia 93.701 3R01MH040799-23S1 REVISED Yes 86,276 New England Primate Research Center Base Grant 93.701 3P51RR000168-48S4 REVISED Yes 856,215 New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research 93.701 3U54AI057159-06S1 Yes 468,196 Oncogenic Human Papillomavirus Protein Network 93.701 5RC1CA145188-02 Yes 92,390 Oral Cancer Detection Methods in a Community Setting 93.701 3RC2DE020759-02S1 Yes 285,946 p63-dependent Checkpoints in Oocytes 93.701 5R01HD058342-02 Yes 153,317 Personalized Medicine in Comparative Effectiveness 93.701 1RC4CA155940-01rev Yes 193,281 PHACS- Data and Operations Center 93.701 3U01HD052102-06S3rev Yes 1,133,837 Physical Activity and Survival in Cancer Patients 93.701 5R03CA130068-02 Yes 18,734 Plasticity in Airway Smooth Muscles 93.701 5R01HL052760-12 Yes 154,122 Premonopausal Hormone Levels and Risk of Breast Cancer 93.701 3R01CA067262-14S1rev Yes 1,273,431 Preventing the Incidentalome 93.701 5R01LM010125-02 REVISED Yes 225,925 Proliferative control of normal and oncogenically transformed stems cells in vivo 93.701 5R21CA141030-02 Yes (840) Prospective Studies of Diet and Cancer in Men and Women 93.701 3P01CA055075-18S1 Yes 2,104,950 Quantifying post-translational modifications and protein expression by HTP-MS 93.701 1RC4GM096319-01 REVISED Yes 1,380,215 Racial Discrimination and Risk of Chronic Disease 93.701 3R01AG027122-03S1 Yes 60,832 Real-time single-molecule nucleic acid sequencing with flurogenic nucleotides 93.701 3R01HG005097-02S1 Yes 14,783 Regulation of DNA Metabolism During Herpes Simplex Virus-1 Infection 93.701 5F32AI081477-02 Yes 10,461 Regulation of Osteoblast Differentiation by Delta FosB 93.701 3R01AR048218-07S1 REVISED Yes 213,333 Regulation of Xenopus Embryonic Development by TGFbeta Superfamily Ligands and SM 93.701 3R01HD029468-17S1 Yes 18,717 Replication Initiation in Bacteria and Eukaryotes 93.701 3R01GM084162-01A2S1 REVISED Yes 65,080 Role of TBK1 polyubiquitination in innate antiviral immunity 93.701 1R56AI089829-01 Yes (3,293) Selection and the Quality Impact of Nursing Home Ownership 93.701 5R01AG034179-02 Yes 134,660 Short-Term Synaptic Plasticity in the CNS 93.701 3 R37 NS032405-14S1 Yes (3,245) Single Cell, Single Molecule, Digital mrna Profiling with No PCR Amplification 93.701 5RC2HG005613-02 Yes (14,190) Spatiotemporal Maps and Interactions in V1 and V2 Neurons 93.701 5R01EY013135-10 Yes 218,738 Statistical and Data Management Center-Pediatric, Adolescent, and Maternal CTG 93.701 3U01AI068616-04S4Rev Yes 1,171,102 Statistical Methods for Estimation of Copy Number from Next-Generation Sequencing 93.701 5RC1HG005482-02 Yes 235,611 Statistical Methods for population health research on chemical mixtures 93.701 5R01ES012054-08rev Yes 399,372 Subjective and Behavior Responses to PREP Design and Marketing 93.701 3R01CA125224-03S1rev Yes 36,288 Supraresolution 2-photon microscopy in brain tissue 93.701 5RC1NS068917-02 Yes 138,170 Synaptic Vesicle Trafficking in Hippocampal Synapses 93.701 5R01NS039059-11 Yes 1,816 Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates 93.701 3R01GM065865-06S1 Yes 1,923 SysCODE: PMAGE Technology Development (10 of 10) 93.701 3PL1HL092552-02S1 REVISED Yes 4,420 Systems-Level Physiological Basis of Selection and Epistasis in Adaptation 93.701 3R01GM078209-03S1 Yes 68,786 T-bet and Tumor Immunity 93.701 3R01CA112663-10S1 Yes 79,555 Targeted 2nd generation sequencing in phenotyped Framingham and PGP populations 93.701 3R01HL094963-02S1 REVISED Yes 114,591 The population genetics of antibiotic resistance in multi-drug environments 93.701 3R01GM081617-03S1 Yes 8,998 The Protein Complex Map of the Drosophila Proteome 93.701 3R01HG003616-05S1 Yes 81,455 The RNA polymerase II transcription complex 93.701 3R01GM046498-19S1 Yes 20,789 The Zebrafish Connectome 93.701 5RC2NS069407-02 Yes 224,091 Transcriptional Regulation of the Immune Response 93.701 3R01AI032412-24S1rev Yes 65,299 Transcriptional Repression and Activation by YY1 93.701 5R01GM053874-17 REVISED Yes (1) Transgenic Strategy to Map Structure and Function of Neural Circuits in Retina 93.701 5RC1EY020426-02 Yes 213,855 Understanding the malaria-poverty vicious circle 93.701 5R21AI084015-02 Yes 65,096 Use of Electronic Protocols to improve provider and client adherence 93.701 5RC1TW008567-02 Yes 145,516 Using Drosophila for in vivo drug screens to selectively target cancer stem cells 93.701 5RC1CA146268-02 Yes 23,865 Using GWAS Data for Enhanced Mendelian Randomization Studies 93.701 1RC4MH092707-01rev Yes 502,077 Visual Processing in Cerebral Cortex 93.701 3 R01 EY005911-24S1 Yes (1) Fluorescence Microscope for Time-Lapse Imaging of Bacteria 93.701 1S10RR027344-01 Yes 17,056 Orchestra: A high performance biomedical supercomputing collaborative 93.701 1S10RR028832-01 REVISED Yes 1,058,890 Subtotal of 93.701 93.701 32,651,848 Innovation Platform for Substitutable Apps with Access to Networked Healthcare Data 93.728 90TR0001/01 Yes 3,752,833 Subtotal of 93.728 93.728 3,752,833 48
Articulated Robot for Epicardial Interventions 93.837 7R01HL079940-05 REVISED No 85,711 CVD Epidemiology Training Program in Behavior, the Environment and Global Health 93.837 5T32HL098048-04 No 172,140 Defining Genetic Architecture and Pathways of DCM 93.837 5R01HL080494-06 No 324,784 Dietary Etiologies of Heart Disease and Cancer 93.837 5R01HL035464-23 No 666,813 Dietary Fat and HDL Metabolism 93.837 5R01HL095964-03 No 790,313 Endogenous Anti-Inflammatory Lipid Mediators, Fish Oil and Post-Operative Atrial Fibrillation 93.837 1R21HL109924-01A1rev No 45,703 Endothelial Plasticity in Human Disease 93.837 1R01HL112860-01 REVISED No 25,070 Engineering Capillary Networks 93.837 5R01HL069957-07 No 704,669 Estimating Effects of Interventions in Longitudinal Data 93.837 5R01HL080644-08 No 510,284 Fatty Acids and Major Cardiovascular Outcomes 93.837 5R01HL085710-05 No 140,783 Genetic Markers of CHD in Type 2 Diabetes 93.837 5R01HL071981-08 No 775,068 Global Cardiovascular Disease Policy Model for Screening Prevention and Treatment 93.837 5R01HL104284-03 No 198,338 Glycation inactivation of human CD59 and diabetic complications 93.837 1R01HL107762-01A1 REVISED No 193,277 Identifying Ways to Reduce Readmissions Among Minority-Serving U.S. Hospitals 93.837 1R01HL113567-01rev No 21,283 Long Term Outcomes of Open Versus Endovascular AAA Repair 93.837 5R01HL105453-02 No 312,287 Mapping Transcriptional Networks in Cardiac Development 93.837 5U01HL098166-03 No 2,292,388 Molecular Physiology of Pacemaker Channels 93.837 5R01HL070320-09 REVISED No 288,951 Molecular Signaling in Hypertrophic Cardiomyopathy 93.837 5R01HL084553-05 No 187,231 Myocyte Shape in Myofibril Patterning and Contraction 93.837 5R01HL079126-04 No 139,266 NHLBI Short-Term Training Program to Increase Diversity in Health-Related Research 93.837 5R25HL089005-05 No 50,350 Novel Adipokines and Coronary Heart Diseases in U.S. Men and Women with Diabetes 93.837 5K99HL098459-02rev No 121,552 Proximity to Food Establishments and BMI in the Framingham Heart Study 93.837 1R01HL109263-01A1 No 11,944 Statistical methods for rare variant effects in sequencing association studies 93.837 1K99HL113164-01 No 4,812 Structure and function of human phospholamban pentamer 93.837 5R01HL084329-05 No 11,870 SysCODE: PMAGE Technology Development (10 of 10) 93.837 5PL1HL092552-05 No 184,465 The role of nuclear envelope during cardiac morphogenesis 93.837 5F32HL097599-03 No 48,764 Vitamin D supplementations as adjunct to anti-tuberculosis drugs in Mongolia 93.837 5R00HL089710-05 No 30 Subtotal of 93.837 93.837 8,308,146 Asthma Disparities: Advancing Multilevel Causal Models 93.838 5K25HL081275-05rev No 48,506 Factors that Promote and Support Careers of Women of Color in Academic Medicine 93.838 5R01HL101996-04 REVISED No 416,949 Mechanical Stress as a Stimulus for Airway Remodeling 93.838 5R01HL088028-05 No 227,125 Mechanics of Monolayer Migration 93.838 5R01HL107561-02 No 579,312 Mechanobiology of Lung Fibrosis 93.838 5R01HL092961-03 No 489,647 Molecular Epidemiology of ARDS 93.838 5R01HL060710-09rev No 170,365 Molecular Epidemiology of Drug-Resistant Tuberculosis 93.838 sub at no additional cost No 27,417 Obesity and Airway Responsiveness 93.838 5R01HL084044-05 No 359,481 Rho Kinase and Airway Hyperresponsiveness 93.838 5R01HL091933-03 No 459,268 Targeted 2nd generation sequencing in phenotyped Framingham and PGP populations 93.838 5 R01 HL094963-02 No 41,727 The resident cell in the asthmatic airway: a victim of its physical microenvironment 93.838 5R01HL102373-02rev No 430,749 Training in Interdisciplinary Pulmonary Sciences 93.838 5T32HL007118-35 No 241,710 Training in Interdisciplinary Pulmonary Sciences 93.838 5T32HL007118-37 No 314,542 Subtotal of 93.838 93.838 3,806,798 A Training Program in Molecular Hematology 93.839 5T32HL007623-25 REVISED No 396,105 Harvard Stem Cell Institute Training Program for Pre- and Post-Doctoral Fellows 93.839 5T32HL087735-04 No 268,463 Molecular Regulation of Adhesive Integrin Interactions in Erythroblastic Islands 93.839 5R01HL032854-26 REVISED No 320,648 Short and long term depressive symptoms and arrhythmic pathways to stroke 93.839 1F31HL112613-01rev No 16,312 Stem Cell Engagement of the Niche 93.839 5R01HL097794-04 No 1,045,002 The Fanconi anemia pathway: role in DNA interstrand cross-link repair 93.839 5R01HL098316-03 No 506,842 Ubiquitination in erythropoiesis and the pathophysiology of anemia 93.839 1R21HL116210-01A1 No 16,890 Subtotal of 93.839 93.839 2,570,262 49
A Genetic System for the Study of Vertebrate Limb Regeneration 93.846 5R21AR059884-02 No 139,386 Assessment and Evaluation of Hill-type Muscle Models for Predicting In Vivo Force 93.846 5R01AR055648-04 No 534,335 Biogenesis of Extracellular Matrix 93.846 5R01AR036819-27 REVISED No 544,850 BMP-2 Regulation of Bone Homeostasis 93.846 5R01AR055904-04 No 437,013 Calcitonin Regulation of Osteoclast Integrin Functions 93.846 5R01AR049879-10 No 557,467 Characterization of the Insulin to Autophagy Pathway in Muscles 93.846 5R01AR057352-03 No 446,586 Collagen Gene Structure and Expression 93.846 5R01AR036820-27 No 495,647 Creation and Validation of a BMP/TGF-B/Activin Biosensor System 93.846 1R21AR062740-01 No 13,070 Fate mapping superficial zone chondrocytes in articular cartilage 93.846 5R21AR055148-02 No 201,681 From Adhesion to Bone Resorption: The role of Dynamin in Osteoclasts 93.846 5R01AR054450-05 REVISED No 237,784 Genetics of arthritis susceptibility in outbred HS mice 93.846 5R01AR055271-05 No 289,739 Identification of the transcriptional regulators of chondrocyte hypertrophy 93.846 5R01AR055552-03 No 464,765 Molecular and Cellular Mechanisms of Vascular Anomalies 93.846 5P01AR048564-08 No 1,160,556 Molecular Mechanisms that Cause Muscle Atrophy 93.846 5R01AR055255-05 No 343,697 Regulation of Osteoblast Differentiation by Delta FosB 93.846 5R01AR048218-10 No 391,587 Regulation of osteoclast biology by anion exchanger SLC4A2 in mouse and human systems 93.846 1R01AR060363-01A1revised No 101,742 Role of CD48:CD244 Pathway in Systemic Lupus Erythematosus 93.846 5K08AR057861-03 No 68,365 Role of DDR2 in OA-like Pathogenesis in Osteochondrodysplasias 93.846 5R01AR051989-05 No 54,678 Role of TGIF in Wnt-Induced Bone Formation 93.846 5R01AR059070-02 REVISED No 48,823 Role of the C-src proto-oncogene in Osteoclasts 93.846 5 R01 AR042927-16 No 89 Role of Zfp521 in bone formation and anabolic responses 93.846 5R01AR057769-03 No 598,061 Subtotal of 93.846 93.846 7,129,921 Adipose-tissue Tregs and the Immunological Control of Metabolism 93.847 5R01DK092541-02 No 426,474 Aire, a zinc-finger protein that controls autoimmunity 93.847 5R37DK060027-12 No 330,864 Benefits of dietary essential amino acid restriction 93.847 5R01DK090629-02rev No 357,899 Cell Interactions in Development of the Mammalian Kidney 93.847 5R37DK054364-14 No 550,432 Characterization of a Novel Protein Required for Glomural Podocyte Function 93.847 7F32DK085959-02 No 58,408 Chemical Genetics of Iron Transport 93.847 5R01DK064750-07 No 368,927 Developmental Regulation of Bone Morphogenesis 93.847 3P01DK056246-10S1 No (27,573) Developmental Regulation of Bone Morphogenesis 93.847 5P01DK056246-12 REVISED No 1,474,275 Dietary Polyphenols, Urinary Biomarkers and Risk of Type 2 Diabetes 93.847 5R01DK082486-03 No 500,665 Evaluating the Clinical Validity of Novel Gene-Environment Risk Profiles 93.847 5R21DK084529-02 No 176,022 From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis 93.847 5R01DK082448-03 No 274,099 GUDMAP2 - Production of Mouse Strains for Gene Anatomy of the Lower Urinary Tract 93.847 1U01DK094526-01 No 168,871 Human Cell-Based Models of Primary Adipocyte Disorders 93.847 1R01DK095384-01 No 76,654 Inflammatory and stress signaling networks in metabolic disease 93.847 5R01DK052539-15 No 518,912 Lipids, Inflammation and Insulin Action 93.847 5R01DK064360-08rev No 301,835 Molecular control of pancreatic beta cell reprogramming 93.847 5R00DK077445-05 Revised No 203,953 mtorc1 regulation in the liver by metformin, AMPK and energy status 93.847 1F32DK095508-01 No 12,285 Network Analysis of Signal Transduction 93.847 5R01DK088718-03 No 533,805 Nitrergic Neuro-smooth Muscle Transmission in the Gut 93.847 5R01DK062867-08 No 354,797 Novel targets in the regulation of NF-kB and SREBP activity: A two-faceted approach to combat diabetes. 93.847 5K01DK085198-03 No 145,885 Obesity Genes, Energy Regulation in Response to Weight-Loss Diets 93.847 1R01DK091718-01A1 No 22,158 Pathophysiologic Regulation of Fgf-23 in Phosphate Homeostasis: Role of Vitamin D 93.847 2R56DK073944-05A1 No 54,547 Pathophysiologic Regulation of Fgf-23 in Phosphate Homeostasis: Role of Vitamin D 93.847 5R01DK073944-04 No 23,813 PPAR Delta Functions in Liver 93.847 5R01DK075046-05 No 349,020 Programming antigen specific dendritic cells in situ for type 1 diabetes immunotherapy 93.847 1F30DK088518-01 REVISED No 6,990 Proteomics of Pancreatic Fluid and Urine in Chronic Pancreatitis 93.847 7F32DK085835-03 No 9,160 Reconstruction of Human Type 1 Diabetes in Mice 93.847 1R24DK092758-01 No 1,061,294 Reducing disparities in diabetes through expanded insurance coverage 93.847 5R01DK090435-02 No 263,073 Regenerating Beta Cells by Lineage Reprogramming 93.847 3U01DK089536-03S1 No 606,485 Regulation of Triglyceride Metabolism by the transcription factor CREB-H 93.847 5R01DK089211-02 No 198,180 Store-operated camp signling in colon pathophysiology 93.847 5R21DK088197-02 REVISED No 116,561 Training Grant in Academic Nutrition 93.847 5T32DK007703-17Revised No 261,311 Unraveling the interactions between T regulatory cells and the gut microbiota in Health and Disease. 93.847 1F32DK095506-01 No 17,921 Subtotal of 93.847 93.847 9,798,002 In Vivo Interactions of Fgf-23 Klotho and Vitamin D 93.849 5R01DK077276-05 No 250,807 Kidney Molecular Atlas Project 93.849 3U01DK070181-05S1 REVISED No 257,249 Subtotal of 93.849 93.849 508,056 50
Activity-dependent modification of electrical synapse strength 93.853 1R03NS075722-01A1 No 29,738 Adult Neurogenesis after Stroke: The role of SDF-1 in mechanisms of neural repair 93.853 5F30NS070589-02 REVISED No 2,648 Automated and Adaptive Lower Extremity Neuro-Rehabilitation for Stroke 93.853 5F31NS058275-04 No 45,562 Biophysical and neurogenetic analyses of photosensory behavior in Drosophila 93.853 5F31NS073325-02 REVISED No 27,202 Cell Cycle Regulation of Neuronal Apoptosis 93.853 5R01NS047188-04 No 130,050 Cell Interactions Controlling Neural Differentiation 93.853 5R37NS026084-22 No 354,050 Cellular mechanisms of dietary therapy for epilepsy 93.853 5R01NS055031-05 REVISED No 282,334 Circadian Clock of the Paraventricular Nucleus 93.853 5R01NS060860-05 No 284,704 Circadian Clock Regulation of the Mammalian Retina 93.853 5R01NS055831-05 No (42,182) Compartmentation of Neuronal ATP and Metabolic Regulation of Excitability 93.853 5F32NS066613-02 No 52,274 Competition Between Axons at the Neuromuscular Junction 93.853 5R01NS020364-28 REVISED No 77,014 Conversion of fibroblasts to functional spinal motor neurons using defined factors 93.853 5K99NS077435-02 No 63,154 Core Facilities for Analysis of Neural Circuit Structure and Function 93.853 5P30NS062685-04 REVISED No 832,709 Ctip2 Function in Corticospinal Motor Neuron Development 93.853 5F31NS064730-03 No 28,286 Dendritic Ca Signals in Striatal Medium Spiny Neurons 93.853 5R01NS046579-09 No 308,674 Electrical Stimulation of Immediate Early Genes 93.853 5R01NS028829-23 REVISED No 309,258 Extracellular Matrix and Neuromuscular Development 93.853 R37NS019195-30 No 360,869 Fate Specification of Corticospinal Neurons by Cell Autonomous Signaling 93.853 5R01NS062849-05 No 244,746 Functional organization of neural circuits underlying movement control 93.853 1K99NS075136-01 REVISED No 83,209 Fundamental Neurobiology 93.853 5 T32 NS007484-10 No (1,164) Fundamental Neurobiology 93.853 5T32NS007484-13 No 339,743 Gating kinetics of volgate-depentent ion channels in fast-spiking neurons 93.853 5F31NS064630-03 REVISED No 3,600 Generation of Hypocretin Neurons from Narcoleptic Patients 93.853 R21NS071598-02 No 267,580 Genetic and Functional Profile of Serotonergic Neuron Subtypes 93.853 1F31NS073276-01A1 No 8,219 Genetic Modeling for SMA Therapeutic Pathways 93.853 5P01NS066888-03 No 1,472,981 Genome-Wide Light-Inducible Tuning of Transcriptional Network Dynamic 93.853 5R01NS073124-04 No 684,896 Heart-Lung Micromachine for Safety and Efficacy Testing 93.853 5U01NS073474-02 REVISED No 1,504,555 HMS/CHB Center for Neuroscience Research 93.853 5P30NS072030-02 No 277,427 Involvement of motor cortex in the acquisition and production of motor sequences 93.853 1F31NS078942-01 No 5,072 Large-scale connectivity and function in a cortical circuit 93.853 5R01NS075436-02 No 266,678 Maturation and Maintenance of the Postsynaptic Apparatus 93.853 5R01NS059853-05 No 311,760 Mechanism of Latency of Herpes Simplex Virus 93.853 5P01NS035138-24 REVISED No 613,927 Metabolic and KATP channel regulation of the cortical slow oscillation 93.853 5F31NS077633-02 No 26,684 Molecular basis of age-related synaptic alterations 93.853 5F32NS061464-03 No 6,453 Molecular Controls Over Callosal Projection Neuron Subtype Specification and Diversity 93.853 5F31NS073163-02 REVISED No 28,142 Molecular Controls over Induction of Neurogenesis for Brain Repair 93.853 7R01NS045523-9 REVISED No 157,148 Molecular Mechanisms of CTIP2 Function in Corticospinal Motor Neuron Development 93.853 1R01NS075672-01A1 No 107,075 Neural circuits underlying circadian regulation of behavior and physiology 93.853 5F31NS071890-03 No 26,952 Neural mechanisms underlying vocal learning in the songbird 93.853 5R01NS066408-04 No 317,894 Neuronal Activity-Dependent Regulation of MeCP2 93.853 5R01NS048276-08 No 567,582 Neurotrophic Factor Regulation of Gene Expression 93.853 5R01NS045500-26 REVISED No 366,601 Next Generation Brainbow Transgenes for Neural Circuit Analysis 93.853 5U24NS063931-04 No 512,143 NSAIDs, Inflammation and Parkinson's Disease 93.853 5 R01 NS048517-05 No 9,797 Phosphatase regulation of NFKappaB activity 93.853 5R01NS057162-04 REVISED No 219,153 Polymer mediated delivery of sirna for malignant glioma treatment 93.853 5F30NS064686-03 REVISED No 7,200 Pooling of Prospective Studies of Diet, Lifestyle and ALS 93.853 5R01NS072494-02 No 111,134 Pre-Diagnostic Markers of Infection and Risk of MS 93.853 5 R01 NS042194-08 No 32,124 Promoters for Long-Term Expression from HSV-1 Vectors 93.853 5R01NS045855-08 REVISED No 198,288 Prospective Epidemiological Study of ALS 93.853 5R01NS045893-07 No 30,299 Prospective Study of Vitamin D and Multiple Sclerosis 93.853 5R01NS046635-07 No 606,671 Regulation of CNS and Limb Polarity by Sonic Hedgehog 93.853 5R37NS033642-17 REVISED No 511,140 51
Regulation of Neuronal Development by Ubiquitin Pathways 93.853 5R01NS051255-08 No 391,242 Regulation of release probability by tonic presynaptic inhibition 93.853 5F31NS073252-02 No 33,136 Regulation of synapse growth by mtor pathway 93.853 5R01NS052707-04 REVISED No 18,405 Regulation of Synapse Morphogenesis in Drosophila 93.853 5R01NS069695-03 No 309,109 Role of cortical interneurons in synchronization of brain electroencephalogram 93.853 5R01NS064193-03 No 242,324 Role of microrna in axon development 93.853 5F32NS073307-02 No 53,622 Role of Msps and TACC During Axon Guidance 93.853 5F32NS063512-03 No 4,422 Role of Ubiquitin Signaling in Activity-Dependent Dendrite Morphogenesis 93.853 5F31NS068037-03 No 26,917 Roles of SAD kinases in formation and maturation of multiple synaptic types 93.853 5R21NS076880-02 No 176,678 Scalable assays for morphological analysis of mammalian neurons 93.853 5R01NS077907-02 No 470,289 Selective targeting of sodium channel blockers to pain-sensing neurons 93.853 5R01NS064274-04 No 317,199 Short-Term Synaptic Plasticity in the CNS 93.853 2R01NS032405-18A1 REVISED No 94,037 Short-Term Synaptic Plasticity in the CNS 93.853 5R37NS032405-17 REVISED No 451,795 Signal Transduction in Axon Guidance 93.853 5R01NS069913-02 No 308,273 Signal Transduction in Neuron Migration and Axon Guidance 93.853 5 P01 NS040043-10 REVISED. No 52,226 Signal Transduction Pathways Regulating Neuron Differentiation 93.853 5R01NS041021-10 No 235,831 STAT3 Regulation of Glioblastoma Pathogenesis 93.853 5R01NS064007-04 No 347,935 Synaptic Choices in the Retinotectal System 93.853 5R01NS029169-22 No 416,768 Targeted Gene Transfer, to Specific Types of Neurons, with HSV-1 Vectors 93.853 5R01NS057558-05 REVISED No 163,260 Tetrahydrobioperin acts as a pain signaling molecule 93.853 5F31NS068036-03 No 28,507 The role of cortical neuron and circuit function in tau induced neurodegeneration 93.853 5F32NS070544-03 No 49,030 The Role of GABAergic Transmission in the Development of Basal Ganglia Pathways 93.853 5F31NS074842-02 No 35,535 The Role of Semaphorins in Axon and Blood Vessel Guidance 93.853 5R01NS064583-03 No 377,129 Training in Neurostatistics and Neuroepidemiology 93.853 5T32NS048005-08 No 187,494 Two-photon calcium imaging of the effects of cortical microstimulation 93.853 5 R21 NS061203-02 No (371) Urate as a Predictor of Parkinson's Disease Risk and Progression 93.853 5R01NS061858-04 No 646,218 Viral tracing of genetically defined neural circuitry 93.853 5F31NS068012-03 No 25,998 Vitamin D, cigarette smoking, EBV infection and risk of MS progression 93.853 5R01NS071082-02revised No 329,257 Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multiple sclerosis among women in the Finnish Maternity Cohort and their offspring 93.853 5R01NS073633-02 No 236,462 Voltage-Dependent Ion Channels Controlling Firing Patterns of Central Neurons 93.853 5R01NS036855-16 No 534,819 Subtotal of 93.853 93.853 19,635,599 A Cellular Chip for High-Throughput Measurements of Single, Growing Cells 93.855 1R21AI094363-01A1 No 9,682 A double-mimetic inhibitor of HIV-1 entry 93.855 5R01AI080324-04 No 438,022 A functional genomic screen to identify host cell regulators of Trypanosoma cruzi 93.855 5R21AI090366-02 No 167,456 A method for the design of low-cost paper-based point-of-care diagnostic devices 93.855 5F32AI089698-03 No 48,761 A study of the functional determinants of a Plasmodium falciparum invasion ligand 93.855 5F32AI093059-02 No 51,734 Accurate and Efficient Measures for HIV Incidence 93.855 1R01AI097015-01A1 No 21,210 Acinetobactin and C-Glucosylated Enterobactin Siderophores 93.855 5R01AI042738-14 REVISED No 395,325 Alteration of host protein stability by Legionella 93.855 5R21AI096101-02 No 179,783 An HIV Prevention Program for Mochudi, Botswana 93.855 5R01AI083036-03 No 495,788 Analysis of Cellular Events that Allow Papillomavirus Replication 93.855 5F32AI080075-03 No (573) Analytic Methods for HIV Treatment and Co-Factor Effects 93.855 5R37AI032475-18rev No (2) Analytic Methods for HIV Treatment and Co-Factor Effects 93.855 5R37AI032475-21 No 825,335 Anti-viral immune responses in lymph node 93.855 5P01AI078897-05 REVISED No 2,624,172 Biostatistics/Epidemiology Training Grants in AIDS 93.855 5T32AI007358-24 No 389,906 Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU 93.855 5UM1AI069456-06rev No 3,125,632 Chemical Tools for the Study of Dengue Virus Entry 93.855 1R56AI095499-01 No 116,863 Chromatin and Herpes Simplex Virus Latency 93.855 1R01AI099081-01 REVISED No 141,901 Coordinate Regulation of Bacterial Virulence Factors 93.855 5R01AI026289-24 No 558,252 Cross-species transmission and adaptation of primate lentiviruses 93.855 5R01AI083118-03 REVISED No 337,633 52
Cytoadherence and sequestration in malaria transmission stages 93.855 5R01AI077558-03 No 441,799 Cytotoxic T Cell Mediated Immunity to Chlamydia 93.855 2R01AI039558-16A1 REVISED No 745,396 Defining the Mechanism of Action of Sanglifehrin A 93.855 5F32AI080099-03 REVISED No 13,065 Differentiation and Regulation of CTL 93.855 5R01AI072252-05 REVISED No 269,062 Disease Initiation and the Role of DCs in the TRUC model of Ulcerative Colitis 93.855 5K08Al078942-05 No 112,627 Doctoral Training Program in Tropical Diseases 93.855 5T32AI049928-10 No 228,212 Epidemiology of Infectious Diseases and Biodefense 93.855 5 T32 AI07535-10 No (88) Epidemiology of Infectious Diseases and Biodefense 93.855 5T32AI007535-14 No 134,262 Epidemiology of Multidrug-Resistant Tuberculosis in Peru 93.855 5U01AI057786-05 REVISED No 723,555 Factors Mediating Host Resistance to Chlamydia trachomatis 93.855 5R01AI062827-07 No 638,332 Functional analysis of erythrocyte determinants of malaria infection 93.855 5R01AI091787-02 No 328,044 Functional Characterization of HSV-1 DNA Polymerase pren- and N- Terminal Domains 93.855 5F31AI084490-03 No 28,202 Genetic Analysis of Toxinogenesis in Vibrio Cholerae 93.855 5R01AI018045-32 No 758,283 Genetic and Ecological Factors in Transmissibility and Epidemic Cycle of Cholera 93.855 5R01AI070963-04 REVISED No 167,582 Genetic validation of essential asexual stage genes in Plasmodium falciparum 93.855 5R21AI088314-02rev No 186,210 Genetics of Herpesvirus Transformation 93.855 5R01AI063106-30 No 354,406 HAART to Prevent HIV Transmission to Infants in Botswana 93.855 5U01AI066454-06 No 106,437 Harvard Tanzania HIV/AIDS Clinical Trials Unit 93.855 5U01AI069403-06rev No 500,089 Harvard University Center for AIDS Research 93.855 5P30AI060354-09 REVISED No 3,041,649 Herpesviruses as Vaccine Vectors for AIDS 93.855 5P01AI046006-10 REVISED No 339,216 Host Genetics of HIV-1 Subtype C Infection, Progression, and Treatment in Africa 93.855 5R01AI071776-04 No 188,858 Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting 93.855 5R01AI026077-25 No 667,447 Human Decidual Leukocytes and Their Placental Ligands 93.855 5R01AI053330-08 No 459,255 Human Natural Killer Cells: Formation and Structure of Activating Synapses 93.855 5R01AI050207-10 REVISED No 317,399 Identifying and validating new antibiotic targets in cell wall synthesis pathways 93.855 1R01AI099144-01 REVISED No 38,842 Imaging autoimmune disease 93.855 5P01AI054904-09 No 2,376,058 ImmGen: a gene expression compendium for immune cells 93.855 5R24AI072073-05 No 730,808 Immunology and Infectious Diseases 93.855 5T32AI007638-13 No 151,562 In Vivo Function of the B7 Family of Costimulators 93.855 5R37AI038310-18 No 454,296 In vivo role of CTLA-4 in Costimulation and Autoimmunity 93.855 5R01AI040614-15 No 420,779 Infectious Disease and Basic Microbiological Mechanisms 93.855 5T32AI007061-35 No 569,221 Innate Immunity: Signal Transduction and Interferon Gene Regulation 93.855 5R01AI020642-27 No 88,700 International Herpes Vaccine Project 93.855 2R56AI057552-06 REVISED No 42,612 International Herpes Vaccine Project 93.855 5R01AI057552-07 No 322,003 Intrinsic Immunity and AIDS 93.855 1R01AI095092-01A1 REVISED No 155,797 KIR and MHC Class I Immunogenetics in SIV Infection 93.855 1R01AI095098-01A1 No 232,314 Lentiviral Resistance to Tetherin 93.855 1R01AI098485-01A1 No 49,844 Mechanics of Bacterial Swarming 93.855 2R56AI065540-06A1 No 170,562 Mechanics of Bacterial Swarming 93.855 5R01AI065540-05 REVISED No (1) Mechanism of Class III Viral Fusion Proteins 93.855 5F32AI089052-02 REVISED No 25,935 Mechanisms of Capsular Diversity in Streptococcus Pneumoniae 93.855 5R01AI048935-10rev No 346,942 Mechanisms of Lentiviral Resistance to Tetherin 93.855 5R21AI087498-02 REVISED No 186,652 Mechanisms of protective immunity induced by live attenuated SIV vaccines 93.855 5P01AI071306-05 REVISED No 1,947,724 Mechanisms Regulating HSV TK Expression During Infection 93.855 5R01AI026126-18 No 203,887 Methods for Long-Term Follow-Up of HIV-Infected Patients 93.855 5R01AI051164-09rev No 185,172 Methods to Advance the HIV Prevention Research Agenda 93.855 2R01AI051164-10 No 175,368 Methods to find and model predictors of the causal effect of HAART 93.855 1R01AI100762-01 No 32,262 MHC proteins, copolymers and peptide 15mers in EAE 93.855 5R01AI049524-09 No (34,589) Modification of host proteins during Chlamydia infection 93.855 1F32AI094932-01A1 No 20,692 Modulation of the early host response to SIV in pathogenic infection 93.855 5R01AI084810-04 No 1,072,753 Molecular Basis for SIV Pathogenicity 93.855 5R01AI025328-23 No (24,367) Molecular Basis of Viral Infectivity 93.855 5T32AI007245-30 No 477,831 Molecular Biomarkers for Malaria 93.855 1R56AI082589-01rev No 405,878 Molecular Genetics of HSV DNA Polymerase Gene 93.855 5R01AI019838-27 No 467,479 Molecular Mechanisms of Bacterial Pathogenesis 93.855 5R01AI022021-29 No 778,103 Molecular Mechanisms of Rhabdovirus Entry 93.855 5R01AI081842-03 No 235,795 53
Mutational pathways in early HIV infection: novel guide to immunologic analyses 93.855 5R21AI087493-02rev No 183,827 Naive T cell homeostasis: Treg selection and survival 93.855 5R37AI051530-10 REVISED No 441,812 Natural killer cells and control of SIV infection 93.855 5R01AI090735-03 No 837,795 New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research 93.855 5U54AI057159-09 REVISED No 10,236,125 NKT cells as modulators of AIDS vaccine efficacy 93.855 1R01AI102693-01 No 5,053 Novel monitoring strategy and fitness analysis of transmitted HIV drug resistance 93.855 1R56AI089350-01revised No 102,049 Novel Strategy for HIV Drug Resistance Monitoring in Developing Countries 93.855 5R01AI089350-02 No 227,796 Outer Membrane Biogenesis: New Antibiotic Targets 93.855 5R01AI081059-04 REVISED No 415,075 P. Aeruginosa Virulence Determinants 93.855 5R37AI021451-26 No 608,241 Peptidoglycan Biogenesis in Escherichia Coli 93.855 5R01AI083365-03 No 303,392 PhD Program in Immunobiology 93.855 5T32AI007498-15 No 242,281 Poliovirus Cell Entry Pathways 93.855 3R01AI020566-29S1 No 595,865 Pooling HIV Cohorts to Inform Clinical Decision 93.855 5R01AI073127-04 No 130,648 Probing the Biosynthesis of Thiazolyl Peptide Antibiotic Berninamycin A 93.855 1F32AI098147-01 REVISED No 15,938 Program for AIDS Clinical Research Training (PACRT) 93.855 5T32AI007433-20 No 271,423 Protective Immunity Induced by Live Attenuated SIV 93.855 3R01AI062412-05S1 REVISED No 4,758 Randomized Trial of High-Dose Rifampin in Patients with New, Smear-positive TB 93.855 5U01AI091429-02 No 557,540 Regulation of CD28 Signaling in T cells by Cytoplasmic Domain Membrane Binding 93.855 5F31AI091155-03 No 35,236 Regulation of chronic viral infection by co-inhibitory pathways 93.855 5R01AI081846-03 No 140,707 Regulation of Host Innate Immunity Against Viral Infection 93.855 5R01AI087846-03 No 266,653 Regulatory mechanisms of the MDA5-mediated antiviral interferon response 93.855 1R21AI097699-01 REVISED No 19,670 Rhesus Monkey Rhadinovirus Glycoproteins, Entry and Neutralization 93.855 5R01AI072004-05 No 438,433 RNA Processing in Non-Segmented Minus-Strand RNA Viruses 93.855 5R01AI059371-05 REVISED No (288) RNA Processing in Non-Segmented Minus-Strand RNA Viruses 93.855 5R01AI059371-08 No 481,037 Role of host cell metabolism in supporting intracellular Trypanosma cruzi growth 93.855 1R21AI099689-01 No 37,491 Role of TBK1 polyubiquitination in innate antiviral immunity 93.855 5R01AI089829-02 No 464,349 Sensory Transduction in Bacterial Chemotaxis 93.855 5R01AI016478-30Rev No 406 Sensory Transduction in Bacterial Chemotaxis 93.855 5R01AI016478-33 No 747,868 Signaling Networks Controlling Innate Immune Responses to Cytosolic DNA 93.855 1R21AI099860-01 No 24,633 Single nucleotide resolution of the Pseudomonas aeruginosa transcriptome 93.855 5R21AI088060-02 REVISED No 124,611 Statistical and Data Management Center for the AIDS Clinical Trials Group 93.855 5U01AI068634-07 No 14,488,753 Statistical and Data Management Center-Pediatric, Adolescent, and Maternal CTG 93.855 5UM1AI068616-07rev No 8,613,991 Statistical Methods for HIV/AIDS Studies 93.855 5R01AI052817-09 No 341,095 Statistical Methods in AIDS Research 93.855 5R01AI024643-24 No 307,367 Statistical Methods in AIDS Research 93.855 5R37AI024643-22rev No 884 Structural basis for influenza amantadine-resistance 93.855 5R01AI067438-05 No 58,164 Structural Basis of Immune Cell Receptor Function 93.855 5R01AI037581-15 No (4,107) Structural Basis of Immune Cell Receptor Function 93.855 5R01AI037581-17 No 302,085 Synthesis of Antibiotics 93.855 2R56AI048825-11A1 REVISED No 220,882 T Cell Activation in Lymph Nodes 93.855 5R01AI069259-08 No 314,520 T Cell Costimulatory Pathways: Functions and Interactions 93.855 5P01AI056299-09 No 1,709,374 T-bet and the Th1/Th17 balance in Acute HIV infection 93.855 5R21AI087475-02 No 232,744 T-bet regulates CD4 memory to bacterial infection with C. trachomatis 93.855 5F32AI081429-02 No (2) Targeting the outer membrane protein translocation pathways 93.855 1R21AI098696-01 No 20,574 Temporal Requirements for Intracellular Pathogenesis 93.855 5R01AI053669-10 No 364,322 The Mechanisms of IFITM-Mediated Restriction 93.855 1K99AI093679-01 No 83,684 The molecular mechanism of Aire: partnering with DNA-PK 93.855 5R01AI088204-02 REVISED No 469,407 The regulatory function of DNA methylation in Mycobacterium tuberculosis 93.855 5F32AI085911-03 No 39,162 Therapeutic use of an enhanced form of CD4-Ig 93.855 5R01AI091476-02 REVISED No 601,043 Towards a Mouse Model of Complement-Mediated Diseases 93.855 5R01AI061174-05 REVISED No 10,640 Transcriptional Regulation of the Immune Response 93.855 5R01AI032412-25 No (1,329) Transcriptome profiling of Trypanosoma cruzi and its host cell 93.855 5R21AI094195-02 No 193,465 Tyrosine Sulfation in HIV-1 and SIV Entry 93.855 5 R01 AI048425-10 REVISED No (2,738) Urban malaria mapping: a new methodology to assess spatio-temporal trends 93.855 5R03AI094401-02 No 85,202 Validation of Src kinases as Anti-Dengue Viral Targets 93.855 5R01AI076442-05 No 393,467 A gene therapeutic approach to stable suppression of HIV-1 replication 93.855 1P01AI100263-01 No 76,128 Subtotal of 93.855 93.855 79,862,294 HIV Prevention Trials Unit 93.856 3 U01 AI048006-05S1rev No (35,640) International Herpes Vaccine Project 93.856 5R01AI057552-05 REVISED No 141 Subtotal of 93.856 93.856 (35,499) 54
A comparative structural study of ATP-dependent chromatin remodeling 93.859 5R01GM092895-02 No 304,601 An Efficient Cascade Approach to the Total Synthesis of (-)- Nakadomarin A 93.859 5F32GM089024-02 REVISED No 47,587 Analysis of General Transcription Factors in Yeast 93.859 5R01GM045720-20 REVISED No 246,808 Analysis of Hu15, a proteasome-associated ubiquitin ligase 93.859 5F32GM089006-03 No 51,289 Anthranilate-Based Fungal Nonribosomal Peptide Synthetase Assembly Lines 93.859 5F32GM090475-02 REVISED No 21,136 Antibiotic Biosynthesis: Amino Acid Morphing 93.859 5R01GM049338-20 No 385,671 Asymmetric Prins/aza-Prins Cyclization via Thiourea-Anion Binding Catalysis 93.859 5F32GM090477-03 No 48,936 Atomic Resolution in Biological Electron Microscopy 93.859 5P01GM062580-10 No 1,598,605 Biochemical and Genetic Analysis of Yeast Kinetochores 93.859 3R01GM051464-17S1 REVISED No 78,120 Biochemical dissection of epigenetic inheritance by Polycomb group proteins 93.859 5R01GM078456-05 No 85,489 Biochemical Studies of Mitosis 93.859 2R01GM026875-35 No 724,679 Biochemical Studies of Mitosis 93.859 5R01GM026875-34 REVISED No 307,129 Bioinspired Enantioselective Catalytic alpha-alkylation of Aldehydes 93.859 1F32GM100680-01 REVISED No 19,637 Biological Diversity: Generation, Control, and Exploitation 93.859 5P50GM068763-10 No 3,107,675 Biologically Related Iron-Sulfur Chemistry 93.859 5R01GM028856-32 No 539,586 BMAL1 Complexes of the Circadian Clock 93.859 5R01GM095945-02 No 409,772 Capillary Electrophoresis and Protein Biophysics 93.859 5R01GM051559-15 No 27,249 Catalytic, Asymmetric Aziridination using (Salen) metal Catalysts 93.859 5F32GM078783-03Rev2 No (1,483) Cell Cycle proteomics in Xenopus 93.859 1R01GM103785-01 No 18,608 Cell Cycle Regulation 93.859 5R01GM039023-26 No 706,275 Cell Cycle Regulation of Vertebrate DNA Replication 93.859 5R01GM080676-04 REVISED No 142,977 Cellular and Developmental Biology 93.859 5T32GM007226-36 REVISED No 15,250 Characterization of microrna-mediated Repression of Translation Initiation 93.859 5F31GM087947-03 No 28,202 Chemical Biology of Microbial Interspecies Signaling 93.859 5R01GM082137-04 REVISED No 326,750 Chemical Biology Studies of Human Disease-Relevant Small Molecules 93.859 5R01GM090068-03 No 312,035 Chemical Genetic and Biochemical Studies of Mitotic Proteolysis 93.859 5R01GM066492-09 REVISED No 274,285 Chiral Catalysts Designed To Catalyze Organic Reactions 93.859 5R37GM043214-21 REVISED No 382,156 Chiral Catalysts Designed to Catalyze Organic Reactions 93.859 2R01GM043214-22 No 373,362 Chromosome Dynamics in Bacillus Subtills 93.859 5R01GM086466-04 No 364,114 Complex Dynamics in Multisite Phosphorylation 93.859 5R01GM081578-04 REVISED No 286,048 Comprehensive Characterization of Heterochromatin Domains 93.859 5K99GM094291-02 No 50,415 Computation and Mechanical Modeling of Chromosome Dynamics 93.859 5R01GM068956-09 REVISED No 188,723 Conformational Change in Molecular Biology 93.859 3R01GM030804-39S2 No 205,470 Connecting the Genome to the Cytoplasm 93.859 5 R01 GM057476-12 No (25) Correlative cryo-microscopy: a new approach for characterizing the structure and function of intracellular marcromolecular machines in situ 93.859 5R01GM085578-04 No 335,679 Cytoskeleton polymerization dynamics in the cell cycle 93.859 5R01GM023928-32 No 7,218 DdaF: A Novel Condensation Enzyme in Dapdiamide Biosynthesis 93.859 1F32GM087880-01 REVISED No (2) Design Principles of Photobiological Metabolism 93.859 5F32GM093516-03 No 50,468 Designing Polymetallic Clusters to Model the Active site of the FeMo-Cofactor 93.859 5F32GM093574-02 REVISED No 37,856 Detecting Histone Modification Turnover in Living Cells 93.859 5F32GM087860-02 No 4,831 Determining the Mechanism of Cyclin B1 Association with Chromatin 93.859 5F32GM085923-03 REVISED No 10,248 Dissecting the establishment and regulation of human pluripotency 93.859 1P01GM099117-01 Revised No 2,004,808 Disulfide Bond Formation: Mechanisms for Isomerization and Novel Pathways 93.859 5 R01 GM055090-12 REVISED No (20) Dithiolopyrrolone Antibiotics: Biosynthesis, Mode of Action and Cellular Function 93.859 1K99GM099904-01 No 24,258 Drosophila Transgenic RNAi Resource Project 93.859 5R01GM084947-04 No 617,762 Dynamics of Signaling Pathways: Mechanism and Function 93.859 5R01GM083303-05 No 259,788 Ecological triggers and transcriptional profiling to guide antibiotic discovery 93.859 1K99GM097096-01 REVISED No 68,317 Enantioselective Synthesis of N-Heterocyclic Rings Using Thiourea-Based Catalysts 93.859 5F32GM096715-02 No 47,759 55
Enantioselective Thiourea-Catalyzed C-H Functionalization via Hydride Transfer 93.859 1F32GM099249-01 No 34,722 Enantioselective Thiourea-Catalyzed Syntheses of beta-lactones and beta-lactams 93.859 1F32GM097831-01 REVISED No 27,006 Enzyme secretion as a cooperative behavior 93.859 5K25GM085806-03 No 8,150 Epithelial Stem Cell Programs 93.859 5R01GM083348-04 No 309,404 Evolution of Biological Hydrogen Production 93.859 5F32GM089028-03 No 48,219 Evolution of Genome Incompatibilities 93.859 5R01GM065169-08 No 299,228 Evolutionary Graph Theory and its Applications 93.859 5R01GM078986-04 No 20,835 Exogenous Gene Control via Modulation of RNA Self-Cleavage 93.859 5 R01 GM075127-04 No (2) Expanding the Scope of Protein Evolution 93.859 5 R01 GM065400-09 No (9) Experimental Evolution of Anticipation 93.859 5F32GM085920-03 No 8,692 Factors Controlling Transcription and Chromatin in Yeast 93.859 5R37GM032967-29 REVISED No 716,003 Feedback Control of the Cell Cycle 93.859 5R01GM043987-23 No 476,167 Feedback Control of the Cell Cycle 93.859 5R37GM043987-20rev No 104 Force generation and detection in the spindle: the case of the kinetochore 93.859 5K99GM094335-02 No 61,231 Function and Regulation of Intercellular Communication 93.859 5R01GM037751-24 No 83,941 Functional Analysis of a Potassium Sensing Kinase in Bacillus Subtillis 93.859 5F32GM087941-03 No 50,676 Functional Analysis of the Proteasome Base 93.859 5R37GM043601-22 No 615,541 Functional Coupling of Steps in Genes Expression 93.859 5R01GM043375-21 REVISED No 1,103,995 Functional Genomic Analysis by RNAi Screening in Drosophila Cells 93.859 2R01GM067761-09A1 REVISED No 265,925 Functional Genomic analysis using RNAi screen in Drosophila 93.859 5R01GM067761-08 REVISED No 264,026 Functionally Tethered Oligonucleotides 93.859 3R01GM044853-20S1 No 360,534 Genetic Mechanisms of Axis Formation in Vertebrates 93.859 2R01GM056211-14A1 No 340,080 Genetic Mechanisms of Axis Formation in Vertebrates 93.859 3R01GM056211-13S1 REVISED No 124,421 Genetics and Genomics PhD Training Grant 93.859 5T32GM096911-02 No 158,512 Genetics of Sleep in Zebrafish 93.859 5R01GM085357-03 No (13,630) Genome mining of newly sequenced streptomycetes for novel natural products 93.859 5F32GM089044-03 No 51,349 Genome wide views of chromatin occupancy in the control of Aquilegia development 93.859 5F32GM096699-02 No 44,365 Harvard Chemical Biology Graduate Program 93.859 5T32GM095450-02 No 213,434 Harvard Systems Biology Graduate Program 93.859 5T32GM080177-03 No 254,633 Histone Variants and Transcription-Linked Deposition 93.859 5 R01 GM068696-05 No (47) Hormonal Modulation of Aggression in Drosophila 93.859 2R01GM074675-05A1 REVISED No 267,581 Identification and Characterization of Small Molecule-RNA Conjugates in Yeast 93.859 5F32GM095028-02 REVISED No 48,720 Illegitimate Recombination by Drug Resistance Elements 93.859 5R01GM025326-31 No (121) Illegitimate Recombination by Drug Resistance Elements 93.859 5R01GM025326-34 No 871,520 Improving the Safety Profile of Lentiviral Vectors 93.859 5R01GM079187-04 REVISED No 99,791 Integrative Analysis of Multiple Genomic Data Sets 93.859 5R01GM082798-06 No 400,527 Interrogation of Functional Aspects of Transcription at Heterochromatic LOCL 93.859 1F32GM101794-01 No 14,325 Interspecific divergence of Y chromosome effects on gene expression in Drosophila 93.859 5F32GM086950-03 REVISED No 25,663 Investigating the shikimate pathway in Plasmodium falciparum 93.859 3F32GM093510-03S1 No 52,519 Joint Interdisciplinary Training Program in Biostatics and Computational Biology 93.859 5T32GM074897-08 No 321,799 Joint Training Program in Molecules, Cells and Organisms 93.859 5T32GM007598-35 No 958,049 Limits and trade-offs of feedback control 93.859 5R01GM081563-05 No 361,827 Mass Spectrometry-Based Approaches to Study Protein Ubiquitination 93.859 5R01GM067945-09 REVISED No 588,164 MBRS IMSD Program at the Harvard School of Public Health 93.859 5R25GM055353-15 No 360,053 Measuring and Predicting PDZ Domain-Peptide Interactions on a Genome-wide Scale 93.859 5R01GM072872-07 No 315,510 Mechanism and Inhibition of Bacterial Transglycosylases 93.859 5R01GM076710-04 REVISED No (1) Mechanism and Inhibition of Bacterial Transglycosylases and Transpeptidases 93.859 5R01GM076710-06 No 444,634 Mechanism of Action of Halofuginone as a Novel Therapeutic 93.859 5R01GM089885-03 No 302,371 Mechanism of Action of Yeast Silencing Complexes 93.859 5R01GM061641-09 REVISED No 597 Mechanism of Action of Yeast Silencing Complexes 93.859 5R01GM061641-11 No 245,151 Mechanism of CRL4-Cdt2, an S phase-specific ubiquitin ligase 93.859 2R01GM080676-05 No 81,282 Mechanism of the eukaryotic replicative DNA helicase 93.859 5R01GM062267-11 No 308,518 Mechanisms and regulation of nucleation and stabilization in clathrin-mediated endocytosis 93.859 5F31GM095295-02 REVISED No 25,523 Mechanisms of Vertebrate Hedgehog Signaling 93.859 5R01GM092924-02 No 296,293 Mechanisms of yeast transcriptional initiation 93.859 5R01GM030186-31 No 713,783 Mechanistic analysis of post-translational membrane protein insertion into the ER 93.859 1R01GM099943-01 No 118,815 Medical Scientists Training Program 93.859 3T32GM007753-33S2 No 2,445,749 Medical Scientists Training Program 93.859 3T32GM007753-34S1 No 8,666 Meiotic Chromosome Synapsis and Recombination in Yeast 93.859 5R01GM044794-21 REVISED No (60,967) Meiotic Chromosome Synapsis and Recombination in Yeast 93.859 5R01GM044794-23 No 789,598 56
Membrane Protein Structures by Solution NMR 93.859 5U54GM094608-03 No 2,582,817 Membrane Remodeling and Protein Trafficking in Bacteria 93.859 5R01GM073831-07 REVISED No 328,357 Metabolic Adaptability of E. Coli: Engineering Autotrophic CO2 fixation 93.859 1F32GM101767-01 No 10,183 Methods for Analysis with Missing and/or Censored Data 93.859 5R01GM048704-15rev No 143,037 Microbial Community Dynamics: A Systems Biology and Evolutionary Approach 93.859 5F32GM090760-03 No 50,220 Microbial Diversity in Mechanisms of Disulfide Bond Formation and Reduction 93.859 5R01GM041883-23 No 709,541 Microtubule Dynamics and Mitotic Mechanism 93.859 5R01GM039565-23 No (13,539) Microtubule Dynamics and Mitotic Mechanism 93.859 5R01GM039565-25 No 504,796 MIDAS Center for Communicable Disease Dynamics 93.859 5U54GM088558-03rev No 3,885,111 Minority Physicians and Research Careers: Applying the Theory of Planned Behavior 93.859 5R01GM098549-02 No 343,309 Mixed Hydrogen-Bonding Flavin Catalysis for Asymmetric Transformations 93.859 5F32GM089036-03 No 46,840 Modular Enzymatic Assembly Lines for Antibiotics 93.859 2R01GM020011-41 REVISED No 206,114 Modular Enzymatic Assembly Lines for Antibiotics 93.859 5R01GM020011-40 REVISED No 265,154 Molecular Analysis of Metabolites and Signaling Networks in Microbial Symbioses 93.859 5K99GM098299-02 No 85,438 Molecular Biophysics Training Grant 93.859 5T32GM008313-24 No 619,712 Molecular Chaperones and Protein Degradation 93.859 5R01GM051923-16 REVISED No 380,169 Molecular Genetic Analysis of Extracellular RNAs in C. elegans 93.859 5R01GM089795-04 No 457,856 Molecular Genetics of Biofilm Formation 93.859 5R01GM058213-12 REVISED No (4,502) Molecular Genetics of Biofilm Formation 93.859 5R01GM058213-15 No 334,769 Molecular Genetics of the Bithorax Complex 93.859 5R01GM28630-27 No 295,832 Molecular Mechanisms Underlying Parallel Agouti Adaptation in Peromyscus 93.859 5F32GM083073-03 No (29) mrna Capping Enzyme 93.859 5R01GM056663-12 No 1,298 mrna Capping Enzyme 93.859 5R01GM056663-14 No 371,425 Multivalency: Mechanisms and Applications 93.859 5R01GM030367-27 No 301,173 Mutant Studies of Aggression in Drosophila 93.859 5R01GM067645-08 REVISED No 216,229 Myosin VI Steps Backwards: A Computational Study to Elucidate the Mechanism 93.859 F32GM083422-03 No (1,031) Network organization of the human autophagy system 93.859 5R01GM095567-02 No 307,719 New Approaches for the Delivery of Proteins and Nucleic Acids Into Cells 93.859 5R01GM095501-02 REVISED No 217,264 NMR and Computational Studies of Biomolecules 93.859 5P01GM047467-20 REVISED No 1,731,675 Novel genomic effects of Y-linked polymorphisms 93.859 5R01GM084236-04 REVISED No 379,346 Octopamine Neuroanatomy and Functioning in Fruit Fly Social Behavior 93.859 5F32GM096591-02 No 46,441 Organogenesis of the Pharynx in C Elegans 93.859 5R37GM056264-16 No 338,420 Organogenesis of the Pharynx in C. elegans 93.859 3R01GM056264-14 No (95,772) Organometallic Chemistry for Applications in Biomedical Sciences 93.859 5R01GM088237-03 REVISED No 188,107 Phages and Genomic Variation in Vibrio Cholerae Evolution 93.859 3R01GM068851-08S1 No 97,695 Pharmacological Sciences 93.859 5T32GM007306-35 No 11,123 Pharmacological Sciences 93.859 5T32GM007306-37 No 342,463 Polo-like Kinase Functions in Normal and Tumor Cells 93.859 5 R01 GM059172-08 No 5 Polynuclear iron complexes as functional mimics of the nitrogenase FeMo-cofactor 93.859 5R01GM098395-02 No 191,359 Population mixture in evolutionary and medical genetics 93.859 1R01GM100233-01 No 90,228 Preparation of a Solid-Phase Polyketide Synthase Mimic 93.859 1F32GM099233-01 No 38,622 Primer Synthesis and Handoff by Bacteriophage T7 DNA Primase 93.859 1F32GM101761-01 No 8,022 Properties of the eukaryotic replicative DNA helicase 93.859 5 R01 GM062267-09 No (1,579) Protein Transport Across Membranes 93.859 5R01GM052586-18 No 573,979 Protein/Protein Interactions in Prokaryotic Gene Control 93.859 2R01GM044025-22A1 No 40,507 Protein/Protein Interactions in Prokaryotic Gene Control 93.859 5R01GM044025-21 No 76,912 Quantitative Fluorescent Speckle Microscopy 93.859 5U01GM067230-09 REVISED No 498,095 Quantitative methods for systems-level analyses of regulation and signaling dynamics 93.859 5R01GM096193-03 No 353,076 Regulation of Proteasome Activity by Ubp6 and Hul5 93.859 3R01GM065592-08S1 No 63,120 Regulation of rrna Genes by Silencing Mechanisms 93.859 5R01GM079535-04 No 24,417 Regulation of Yeast PHO5 Gene 93.859 5R01GM051377-18 REVISED No 163,739 Replication Initiation in Bacteria and Eukaryotes 93.859 5R01GM084162-03 REVISED No 248,443 Reprogramming using small molecules 93.859 1R01GM096067-01A1 No 42,941 RNAi-Mediated Heterochromatin Assembly 93.859 5R01GM072805-08 REVISED No 323,564 Robust Approaches to the Development and Evaluation of Prognostic Classifiers 93.859 5R01GM079330-05 No 90,798 Role of RNA polymerase in bacterial differentiation 93.859 2R01GM018568-40 No 319,010 57
Role of RNA Polymerase in Bacterial Differention 93.859 5R01GM018568-39 REVISED No 720,794 Scope and Mechanism of Peptide Translation from Short Open Reading Frames in the Human Genome 93.859 5F32GM099408-02 REVISED No 44,365 Signal Transduction to P70 S6 Kinase 1 93.859 2R01GM051405-17 No 206,662 Signal Transduction to P70 S6 Kinase 1 93.859 5R01GM051405-16 REVISED No 230,513 Signatures of Immunity on the Antigenic Diversity of Pathogens 93.859 1F32GM097997-01rev No 39,678 Spatiotemporal Coordination of Formin and Arp2/3 in Epithelial Cell Migration 93.859 1F32GM100695-01 REVISED No 21,665 Statistical Models and Inference in the Single-Molecule Approach to Biology 93.859 5R01GM090202-04 No 410,572 Stereoselective Synthesis of Ketals using Thiourea-Based Catalysts 93.859 1F32GM095030-01 REVISED No 4,070 Stochastic Partitioning and Degradation of Macromolecules 93.859 5R01GM095784-02 No 311,407 Structural and functional studies of urea channels 93.859 5R01GM082927-04 REVISED No 144,027 Structural details of CcdA, a membrane transporter of thiol-reducing potential 93.859 5R01GM079388-04 No 125,391 Structure and Function of TRPV Ion Channels 93.859 5R01GM081340-05 No 356,539 Structure and interactions of the Voltage-Dependent Anion Channel(VDAC) 93.859 5R01GM075879-08 No 286,631 Structure and Synthesis of DNA 93.859 5R01GM054397-48 No 366,419 Structure, Function and Inhibition of Human O-GlcNAc Transferase 93.859 1R01GM094263-01A1 No 194,983 Studies on the Biological Mechanisms of Antibiotics 93.859 5R01GM066174-11 No 508,600 Study of biological evolution of structure and function in proteins 93.859 2R01GM068670-09A1 No 202,259 Study of biological evolution of structure and function in proteins 93.859 5R01GM068670-08 Revised No 92,181 Super-resolution studies of the entry and assembly mechanisms of influenza viruses 93.859 5R01GM068518-07 REVISED No 358,083 Synaptonemal Complex Assembly and Function in Meiosis 93.859 5R01GM072551-07 No 408,481 Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates 93.859 2R01GM065865-09 No 73,626 Synthesis and Discovery Enabled by Small Molecule-Nucleic Acid Conjugates 93.859 5R01GM065865-08 No 285,440 Synthesis of Bioactive Alkaloids and Peptides 93.859 5R01GM033328-26 No 409,470 Synthesis of Polyketides and Terpenes 93.859 5R01GM081546-04 REVISED No 232,869 Systematic analysis of proteolysis pathways for cullin targets 93.859 5R01GM070565-08 No 340,281 Systematic Analysis of the Dub Proteome 93.859 5R01GM054137-17 No 252,751 Systems Biology of Sporulation in Bacillus Subtilis 93.859 5R01GM078990-04 No 83,269 Systems-Level Physiological Basis of Selection and Epistasis in Adaptation 93.859 5R01GM078209-05 No 206,415 The Evolution of Malarial Antifolate Resistance 93.859 5R01GM079536-04 REVISED No 107,754 The Mechanics of Actin-mediated Cell Protrusion 93.859 5R01GM071868-06 REVISED No 212,278 The Mechanism of Pericentriolar Material Assembly During Centrosome Biogenesis 93.859 3R01GM098394-01A1S1 No 181,822 The population genetics of antibiotic resistance in multi-drug environments 93.859 2R01GM081617-06 No 21,761 The population genetics of antibiotic resistance in multi-drug environments 93.859 5R01GM081617-05 REVISED No 275,186 The RNA polymerase II transcription complex 93.859 5R01GM046498-21 REVISED No 370,415 The Role of Peptidoglycan-binding Factors in Cytokinetic Ring Stabilization 93.859 1F32GM100609-01 REVISED No 21,041 Thiazolyl peptide analogs that provide insight into antibiotic targeting 93.859 5F32GM098051-02 No 49,427 Total Synthesis of Spiro-prorocentrimine 93.859 5F32GM087876-02 No 7,934 Tracking the fate of microrna - regulated mrna 93.859 5F32GM089102-03 No 153 Transcriptional dynamics and cellular function of p53 pulses 93.859 5F32GM095168-03 REVISED No 50,168 Transport of gene silencing between cells during RNA interference 93.859 5K99GM085200-02 REVISED No 12,214 Transport of Proteins In and Out of the Nucleus 93.859 5R37GM036373-28 No 307,395 Transvection and somatic homolog pairings in Drosophila 93.859 5R01GM085169-04 No 564,829 Ubiquitin chain editing by the mammalian proteasome 93.859 5R01GM095526-02 No 458,981 Uncovering the mechanism of OGT substrate recognition and membrane localization 93.859 1F32GM100539-01 REVISED No 25,116 Understanding the Evolution of Halogenation in Biological Systems 93.859 5F32GM084625-03 No (1) Wall Teichoic Acid Biosynthesis: A New Target for Therapeutic Intervention 93.859 5R01GM078477-04 No 168,684 Subtotal of 93.859 93.859 60,062,161 58
A Process Model of Adolescent Risk Taking Behavior 93.865 5F32HD061195-02 No 51,222 A Trial of Zinc and Micronutrients in Tanzanian Children 93.865 5R01HD048969-05 No 64,558 Boston Re-entry Survey 93.865 1R21HD073761-01 No 3,299 Bounds for Direct and Indirect Effects with Applications to Perinatal Epidemiology 93.865 5R03HD060696-02 No 96,741 Brainstem GABAergic Neuron Development and Function 93.865 5F32HD063257-03 No 54,021 Cadherin-independent epithelium formation 93.865 5R21HD066263-02 No 196,341 Childhood Abuse and PTSD: Association with Select Reproductive Outcomes 93.865 5F31HD063279-02 No 27,726 Children's Acquisition of Counterintuitive Concepts 93.865 1 F32 HD069099-01A1 No 13,088 Cognition in Infancy 93.865 5R01HD023103-29 No 501,261 Community Level Prevention of Child Abuse and Neglect 93.865 5K01HD053172-05 No 130,520 Cotrimoxazole Prophylaxis to Improve Survival among HIV-Exposed Infants in Botswana 93.865 5R01HD061265-03 No 986,932 Developmental Reprogramming after Nuclear Transfer 93.865 5R01HD046732-08 No 373,560 Early Determinants of Childhood Obesity: Etiology, Disparities and Policy Analysis 93.865 1K99HD068506-01 No 95,462 Exploring Trends in US Health Inequities in Context: NHES to NHANES, 1959-2006 93.865 521HD060828-02rev No 188,262 Genetic and chemical screening in zebrafish to study tendon development 93.865 5K99HD069533-02 No 67,360 Hedgehog Signaling and Organogenesis of the Limb 93.865 5R37HD032443-18 No 472,969 Histone Modification During Embryogenesis 93.865 1R21HD072733-01 REVISED No 9,941 Identification and Function of Receptors and Ligands 93.865 5R37HD029417-20 No 224,232 Lineage and cell migration in patterning the limb primordium 93.865 5R01HD045499-08 No 639,897 Long-term Follow-Up of Infertility Patients: A Pilot Study 93.865 5R21HD059955-02rev No 148,069 Lopinavir/ritonavir + zidovudine to prevent perinatal HIV in Thailand 93.865 5R01HD056953-04rev No 485,576 Malaria in Pregnancy: Nutrition and Immunologic Effects 93.865 5R01HD057941-03 No 716,670 Mechanical and molecular factors underlying morphogenesis of the intestinal villi 93.865 5F32HD069074-02 No 50,532 Monitoring HAART in HIV-Infected Parents in Thailand 93.865 5R01HD042964-05rev No 2,075 Multi-vitamins, HAART and HIV/AIDS in Uganda 93.865 5R01HD060333-05 No 326,116 Multicolor Fluorescent Analysis in Zebrafish 93.865 5R01HD067140-03 No 253,319 Multiethnic Study of Family Involvement in Middle School 93.865 7R03HD050297-03 No (237) Novel Regulators of Bone Formation 93.865 5R01HD055601-04 No 312,830 Origins of Knowledge: Conceptual Continuity and Change 93.865 5R01HD038338-10 No 150,416 Patterning and Morphogenesis of the Vertebrate Gut 93.865 5R01HD047360-08 No 376,157 Patterning of Late-acting Germinal Zones in the Vertebrate CNS 93.865 5R01HD051936-05 No 592,524 PHACS - Data and Operations Center 93.865 5U01HD052102-08revised No 14,087,351 Phthalates in Drugs and Male Genital Malformation 93.865 5R01HD059861-04 No 494,829 Predoctoral Training Program in Reproductive Epidemiology, Perinatal and Pediatric Epidemiology 93.865 5T32HD060454-03 No 174,839 Prenatal Iron Supplements: Safety and Efficacy in Tanzania 93.865 5U01HD061232-04 No 418,492 Programmable metafluorophores for quantitative multiplex in situ imaging of mrna 93.865 1R21HD072481-01 No 10,327 Randomized trial of vitamin B12 in pregnant Indian women 93.865 5 R03 HD052143-02 No (2,442) Regulation of Xenopus Embryonic Development by TGFbeta Superfamily Ligands and SM 93.865 5R01HD029468-17 REVISED No 3,854 Response of Genital Tract HIV-1 to HAART: Role of HSV-2 93.865 5K23HD049292-05Rev No (2,255) School Reform and Beyond: Pre-K to 1st grade 93.865 5R21HD061718-02 No 135,376 Standard zidovudine plus infant nevirapine to prevent perinatal HIV in Thailand 93.865 5R01HD052461-05revised No 827,427 The Role of Chromatin in Pluripotency and Cell Fate Specification 93.865 5K99HD067220-02 No 74,502 Training Program in Nutrition and Metabolism 93.865 5 T32 HD052961-04 REVISED No (180) Trial of Vitamins in HIV Progression and Transmission 93.865 5 R01 HD032257-14 No 36,955 Subtotal of 93.865 93.865 23,870,514 Aging Memory 93.866 5 R37 AG008441-20 REVISED No 21,701 AP1-Dependent Regulation of Bone Mass and Energy Expenditure in the Hypothalamus 93.866 5R01AG040222-02 No 488,369 Associative learning and brain structure in individuals at risk for dementia 93.866 5K23AG034258-03 No 138,583 Automated Acquisition of C. elegans Survival Curves with a Flatbed Scanner 93.866 1 R03 AG032481-02 No 9 Cellular and Molecular Analysis of Defects at Aging Neuromuscular Synapses 93.866 5R01AG032322-05 No 394,332 Cognitive and fmri studies of socio-emotinoal processing in normal aging 93.866 5R01AG032780-04 No 212,071 Comparability of self-reports on functional health 93.866 5R03AG034316-02 No 2,305 Correcting Cognitive Deficits by Gene Therapy 93.866 5K01AG025894-05 No 18,534 DNA Damage and Neurodegeneration in the Aging Brain 93.866 5P01AG027916-05 No 571,745 EDD as a Target of RIP1 in Mediating a Cellular Necrotic Death Pathway 93.866 5F31AG034747-02 REVISED No 6,910 59
Effects of Aging on the Neural Correlates of Successful Retrieval 93.866 5F32AG034699-03 No 48,436 Environmental Determinants of Cognitive Function and Decline in Older Adults 93.866 5F31AG038233-02 No 35,071 Episodic Simulation in Healthy Aging and Alzheimer's Disease 93.866 5F32AG038079-03 No 47,556 Estimating the Potential Medicare Savings from Comparative Effectiveness 93.866 1R37AG036791-1A1 No 969 Evaluating the Health Benefits of Workplace Policies and Practices - Phase II 93.866 5U01AG027669-07rev No 1,699,650 Financial Incentives and Variations in the Care of Medicare Beneficiaries 93.866 5R01AG027312-04 No 287,358 Functional impairment from stroke: an exploratory study of disparities 93.866 5R21AG034385-02rev No 129,271 Gene Regulation and DNA Damage in the Aging Brain 93.866 5R01AG026651-05 REVISED No 107,822 Health and Retirement Survey for India 93.866 5R21AG032572-02rev No 43,437 Income Effects and Current Law Forecasts of Health Care Spending Growth 93.866 5R01AG034417-04 No 377,124 Leveraging Medicare Payment and Reporting Policies to Improve Nursing Home Quality 93.866 5R01AG030079-03 No 159,815 Longitudinal Aging Biomarker Study in India (LASI-Biomarkers) 93.866 1R21AG034443-01A2 No 23,570 Mechanism and Regulation of Caspase-11 93.866 5R37AG012859-18 No 108,241 Medicare Part D Plan Generosity and Dual-Eligible Nursing Home Residents 93.866 5R01AG034085-03 No 432,448 Networks and Neighborhoods 93.866 5P01AG031093-05 No 2,016,864 Novel GABA-A Modulators as Cognitive Enhancers 93.866 5R01AG035361-03 No 558,659 Organizational Factors and the Delivery of Nursing Home Care 93.866 5K01AG038481-02 No 115,742 Protection against renal ischemic injury by short term dietary restriction 93.866 5R01AG036712-03 No 324,509 Provider Payment Reform and Implications for Health Care Costs 93.866 5F30AG039175-02 REVISED No 39,226 Public Policy and the Demand for Long-Term Care Insurance 93.866 1R01AG041109-01 REVISED No 165,178 Racial Discrimination and Risk of Chronic Disease 93.866 5R01AG027122-04rev No 277,737 Reforming Medicare: Beneficiary Choice, Plan Payment, and Accountable Care 93.866 5K08AG038354-03 No 145,696 Regulation of Cell Survival by Post-Translational Modiciation of MCL-1 93.866 5F31AG040895-02 No 32,791 Regulation of mitochondrial metabolism by SIRT4 93.866 5R01AG032375-04 No 367,531 Reversing age-related dysfunction of skeletal muscle stem cells 93.866 5F32AG034703-03 No 875 Reversing age-related dysfunction of skeletal muscle stem cells 93.866 5R01AG033053-05 No 480,593 Role of Chromatin in Genomic Maintenance 93.866 5R01AG019719-10 No 323,285 Roybal Center on Translational Research in Aging 93.866 5P30AG034420-03 REVISED No 355,761 SIRT1 as a regulator of health and lifespan of mammals 93.866 5R01AG028730-05 REVISED No 161,674 Social protection, work and family strain: cumulative disadvantage effects in the US and Europe 93.866 5R01AG040248-02 No 172,361 Tau causes neurodegeneration in vivo through mitochondrial disruption 93.866 5F31AG032839-03 No 3,530 The Biology of Resilience: Oxytocin, Social Relationships and Health 93.866 5R21AG030632-02 No 36,968 The Center for the Global Demography of Aging 93.866 5P30AG024409-07 No 295,201 The Physiologic Response to Weather Changes and Extremes in an Elderly Cohort 93.866 1R21AG040027-01 No 116,755 The role of p97 in protein degradation during aging and disease 93.866 5F31AG041582-02 No 12,600 The Role of Private Plans in Medicare 93.866 5P01AG032952-04 No 2,039,051 The Role of the NALP3 Inflammasome in Age-Related Macular Degeneration 93.866 5F31AG039245-02 No 25,542 The variability of the lifespan phenotype in C. elegans 93.866 5R01AG034994-03 No 284,442 Training and research application for c-spine ultrasound of an aging population. 93.866 5F30AG040931-02 No 41,562 Training in the Molecular Biology of Neurodegeneration 93.866 5T32AG000222-20 REVISED No 726,287 Ubiquitin-mediated proteolysis and cell cycle control 93.866 5R01AG011085-19 No 522,369 Widowhood and Mortality: Modifying Role of Individual and Community Context 93.866 5R21AG037889-02 No 147,647 Subtotal of 93.866 93.866 15,145,763 Anatomical and Biochemical Organization of the Retina 93.867 5R01EY000811-39 No 49,890 Application of formal modeling to understand limitations in visual working memory 93.867 5F32EY020706-03 No 49,544 Cell surface molecules that require arrangement of retinal neurons and arbors 93.867 1R01EY022073-01 No 136,625 Cell-Cell Signaling in Development and Regeneration of Visual Connections 93.867 2R01EY011559-20A1 No 42,475 Cell-Cell Signaling in Visual Development 93.867 5R01EY011559-19 REVISED No 17,682 Connexin Molecular Biology in the Lens and Ciliary Epithelium 93.867 5R01EY002430-33 REVISED No 246,901 Connexins and Electrical Synapses in the Retina 93.867 2R01EY014127-05A1 No 320,093 Core Grant for Vision Research 93.867 5P30EY012196-15 No 843,421 Cortico-Cortical Feedback 93.867 5R01EY011379-15 No 367,502 Defining the neural correlates of ensemble representation 93.867 1F32EY022292-01 No 20,506 Determination of Retinal Cell Fate 93.867 2R01EY009676-16 REVISED No 197,726 Dynamic Regulation of Feedforward Inhibition in the Visual Thalamus 93.867 5F32EY020718-03 No 55,605 Functional connectivity of mouse visual cortex 93.867 5R01EY010115-20 No 403,244 Internal Signals in the Parietal Visual Pathway 93.867 5R01EY012106-12 No 274,615 Molecular Biology of Retinal Development 93.867 5R01EY008064-22 REVISED No 529,294 60
Neural Computation from Retina to Visual Cortex 93.867 5R01EY014737-07 No 301,910 Neuronal ensembles in the rodent visual cortex 93.867 2R01EY018742-05 No 299,876 Neuronal ensembles in the rodent visual cortex 93.867 5R01EY018742-04 REVISED No 130,388 Neuronal Measures of the State of Visual Attention 93.867 5R01EY021550-02 No 399,297 Predictive Representation of Motion in Visual Cortex 93.867 5 R01 EY012106-10 No (12,390) Processing Streams in Early Vision 93.867 5R01EY009258-19 REVISED No 159,023 Research Training Visual Neuroscience 93.867 5T32EY007110-24 No 181,469 Reverse Correlation Mapping in Face Patches 93.867 3R01EY016187-07S1 No 502,936 Reverse Correlation Mapping in Face Patches 93.867 5R01EY016187-05 REVISED No 36,759 Structure and Function of Lens Membrane Proteins 93.867 5R01EY015107-08 REVISED No 245,059 Transgenic Studies of Vertebrate Retinal Development 93.867 5R01EY015163-05 REVISED No (72) Using Attention to Understand Cortical Population Codes 93.867 1K99EY020844-01 REVISED No 23,766 Visual Processing in the Cerebral Cortex 93.867 5R01EY005911-27 No 169,334 Visual Psychophysics of Human Face Processing 93.867 5R01EY013602-10 No 332,612 Subtotal of 93.867 93.867 6,325,090 Boston-Area Research Training Program in Biomedical Informatics 93.879 5T15LM007092-20 REVISED No 1,608,011 Evolving Clinical Information Libraries: Contextualizing Evidence Based Medicine 93.879 5G08LM009778-02 REVISED No 104,224 Repurposing Electronic Health Data for Serendipitous Therapy Discovery 93.879 5K99LM011020-02 No 95,959 Subtotal of 93.879 93.879 1,808,194 Building Research Capacity to Improve Mental Health in China across the Lifespan 93.989 1D43TW009081-01 REVISED No 149,183 Fostering Opportunities for Nutrition and Global Health 93.989 5R25TW007505-03 No 112,930 Genetic Polymorphism and Diversity of Plasmodium Vivax Malaria 93.989 5R03TW007966-03rev No 10,668 International Training in AIDS-Related Epidemiology 93.989 5D43TW000004-25 No 728,869 Molecular Analysis of Erthrocyte Invasion in Malaria Isolates from Senegal 93.989 5R03TW008053-03rev No 6,533 Substituting Brown Rice for White Rice: Effect on Diabetes Risk Factors in India 93.989 5R03TW008726-03 No 72,886 Tanzania AIDS and TB ICOHRTA 93.989 5U2RTW008254-04 No 241,786 Tanzania Infectious Disease Research Training Program 93.989 3D43TW007886-05S1 No 207,393 The economic impacts of community-based integrated health care systems in rural Rwanda 93.989 5K01TW008773-04 No 206,057 Training in Malaria Pathogenesis and Diversity in Africa 93.989 5 D43 TW001503-10rev No 63,286 Training Program in International Mental Health 93.989 5D43TW005809-10 REVISED No 78,993 Subtotal of 93.989 93.989 1,878,584 Maternal and Infant Health and HAART Outcomes in the Mashi PMTCT Study, Botswana 93.unknown 2R01HD044391-06rev No 232,255 Subtotal of 93.unknown 93.unknown No 232,255 Diabetes Risk Across Womens Lifespan: A Study of Long-Term Health Implications of Glucose Intolerance in Pregnancy Contract HHSN275201000020C No 1,703,127 Innovative Methods for Evidence Synthesis for Medical Devices Contract HHSF223201000098C No 218,468 Mongolian Study of Pregnant Mothers Contract HHSN261201000660 No 48,653 Refactoring the ITK Level Set and Mesh Frameworks to Enable the High Performance Demands of Imaging Based Systems Biology Contract HHSN276201000489P Yes 63,577 Subtotal of Contract 2,033,825 Total Department of Health and Human Services Direct Awards 412,992,921 EPA Are diabetics and the neurologically impaired at increased risk from air pollutant exposures - A National analysis 66.unknown RD-83490001-0 No 82,894 Statistical Models for Estimating the Health Impact of Air Quality Regulations 66.unknown RD-83362202-0 No 14,389 The SolSource 3-in-1: A comprehensive Platform for Rural Energy Optimization in the Himalaya 66.unknown SU-83474601 No 54,216 Subtotal of 66.unknown 66.unknown 151,499 Air Pollution Mixtures: Health Effects Across Life Stages 66.509 RD-83479801-1 No 1,556,140 Effects of Changing Climate on Fires and Air Quality 66.509 RD-83428201-1 No 217,590 Metal Mixtures and Children's Health 66.509 RD-83172501-5 No (384) Novel Exposure Scenarios to Define the Health Effects of Particle Sources 66.509 RD-83241601-5 No 115,129 Predicting Regional Allergy Hotspots in Future Climate Scenarios 66.509 RD-83435901-0 No 189,602 The effect of air pollution control on life expectancy in the United States: national population-based analysis 66.509 83489401-0 No 74,291 Uncertainty Analysis in Integrated Assessments 66.509 RD-83366701-4 No 40,661 Subtotal of 66.509 66.509 2,193,029 61
Constraints on California and Arctic Methane Emissions using a Regional Lagrangian Model and Aircraft-based Measurements during the CalNex and HIPPO Campaigns 66.514 No Award Number No 6,931 Subtotal of 66.514 66.514 6,931 Analysis and Reports of CATHGEN Database Contract EP-12-D-000018 No 30,262 Global Mercury Emissions and U.S. Population Exposures Contract EP-11-H-001346 No 88,383 Subtotal of Contract Contract 118,645 Total EPA Direct Awards 2,470,104 Institute of Museum and Library Services Peabody Museum Archaeological Collections Digital Imaging and Cataloguing Project 45.301 MA-05-11-0312-11 No 75,536 Subtotal of 45.301 45.301 75,536 Total Institute of Museum and Library Services Direct Award 75,536 NASA A Tropospheric Chemistry Module for Earth System Models and Data Assimilation Systems: Application to Chemical Data Assimilation of Satellite Observations in the GEOS DAS 43.unknown NNX11AN17G No 130,408 ATTREX: A Venture Class Mission to Understand the Role of the Tropical Tropopause Layer in Earth's Climate 43.unknown NNX10AO82A No 276,326 Budgets for Carbon Cycle Gases (CO2, CH4, and CO) in the Amazon Basin from Aircraft and Remote Sensing Data 43.unknown NNX10AR75G No 138,996 Catastrophic Disruption of Small Bodies in the Outer Solar System 43.unknown NNX09AP27G No 59,090 CO2 Laser Sounder for ASCENDS Mission Technology Development and Airborne Demonstration 43.unknown NNX09AE56G No 30,029 Dark Matter and Galactic Paleontology 43.unknown HST-HF-51283.01-A No 103,818 Data-model fusion and forecasting 21st-Century environmental change in northeastern North America 43.unknown NNX10AT52A No 117,508 Dynamic Studies of Exoplanet Atmospheres: From Global Properties to Local 43.unknown 1368708 No 175,339 Experimental Investigatio of Planetary Impact Processes: Porosity and Post-Shock Temperatures 43.unknown NNX06AC13G No (2,339) Experimental investigation of isoprene oxidation for different limiting chemical regimes: updating the oxidation mechanism No to evaluate and improve satellite retrievals of formaldehyde and glyoxal 43.unknown NNX11AL51H No 24,145 Exploring the ISM with MAP: the microwave emission from spinning dust (LTSA Junior Researcher) 43.unknown NNX07AH86G No (28) In Situ Total Water Measurements Using Photofragment Fluorescence and UV Absorption Detection in Support of MACPEX 43.unknown NNX10AO28G No 604 In Situ Water Vapor Measurements Using Photofragment Fluorescence, Multipass Laser IR and UV Absorption Detection in Support of MACPEX 43.unknown NNX10AO36G No (985) Interaction between Convection, Disturbance and Deforestation in the Amazon: A Remote Sensing and Modeling Study 43.unknown NNX08AU95H No 19,098 Isotopic Studies of the Formation of Planets and Planetesimals 43.unknown NNX10AI43G No (850) Measurement requirements for geostationary satellite instruments to observe 43.unknown NNX10AN74H No 24,349 Quantifying Methane Sources in the United States Using Satellite and Aircraft Observations 43.unknown NNX10AP13H No 24,415 Quantifying the Chemistry-Climate Impact of Lightning NOx Emissions as Constrained from Satellite Observations and Inverse Modeling Techniques 43.unknown NNX09AO23H No 6,620 Radiative Transfer in CO-2 Rich Paleoatmospheres and the Early Climates of Earth and Mars 43.unknown NNX09AQ98 No 4,573 The Atmospheric Structure of Giant Hot Exoplanets 43.unknown HST-GO-12181.06-A No 42,051 The First Characterization of a Super-Earth Atmosphere 43.unknown HST-GO-12251.01-A No 36,183 The Herschel view on supergiant High Mass X-ray Binaries: revealing the most obscured high-energy sources of our Galaxy 43.unknown 1433006 No 24,425 The Ultraviolet and Optical Counterparts of the Intermediate Mass Black Hole Candidate ESO 243-49 HLX-1 43.unknown HST-GO-12256.01-A No 30,984 Understanding the co-evolution of galaxies and their central black holes 43.unknown HST-HF-51282.01-A No 101,445 Understanding the IGM Absorbers with Numerical simulations of the WHIM 43.unknown HST-AR-12131.01-A No 4,195 Subtotal of 43.unknown 43.unknown 1,370,399 A higher resolution Galactic dust map: Mapping Galactic dust with the Wide field infrared Survey Explorer (WISE) 43.001 NNX12AE08G No 19,233 A Model Analysis of NOx Sources and Tropospheric Ozone in the Northern Extratropics Constrained by Aura and In-Situ Data 43.001 NNX09AC51G No 137,278 A New Analysis Method of Fermi Data, and Study Sub-Photospheric Dissipation 43.001 NNX11AP98G No 64,215 A New Galactic Dust Map: Improving the Calibration, Dust Temperature Correction, and Point Source Subtraction of the SFD Dust Map for Cosmological Applications 43.001 NNX10AD69G No 77,831 A Renaissance of GRB Radio Studies with the Expanded VLA 43.001 NNX12AD69G No 9,626 A Search for Water on A Neptune-Mass Transiting Planet 43.001 1343259 No 2,318 Activities in Support of CLAREEO Post-MCR: Radio Occultation Science and Testing Climate Models 43.001 NNX11AD01G No (7,576) Advising GNSS Radio Occultation and Climate Modeling Studies for the CLARREO Science Definition Team 43.001 NNX11AE74G No 322,824 Air Quality Applied Sciences Team Membership 43.001 NNX11AI40G No 165,725 High Resolution Meteorological and Remote Sensing Data 43.001 NNX08AV12H No 4,122 Analysis of Aura satellite data for the tropics using the GEOS-Chem model 43.001 NNX10AG59G No 204,479 Analysis of OMI observations to constrain the budget of tropospheric ozone and VOC emissions 43.001 NNXllAH23G No 163,890 Application of the Global Modeling Initiative (GMI) Combo Model to Hindcasts of Tropospheric Ozone and Related Species 43.001 NNX09AJ41G No 254,506 ARCTAS Mission Support and Data Analysis 43.001 NNX08AH66G No 131,538 Astro-comb Optical Wavelength Calibrator for Exoplanet Research 43.001 NNX09AC92G No 89,471 Astrophysical Consequences of a New Force in the Dark Sector 43.001 NNX10AD85G No 77,724 BrO/ ClO/ ClONO2/ ClOOCl Instrument in Support of In Situ Studies of Ozone Catalytic Loss in the Stratosphere 43.001 NNX09AG84G No 424,572 62
Combined In Situ Water Vapor and Total Water Instrument for high Accuracy in situ Airbourne Observations in the Troposphere and Stratosphere 43.001 NNX09AF39G No 759,565 Cosmological Hydrodynamics on a Moving Mesh 43.001 NNX12AC67G No 50,828 Data Assimilation, Validation and Analysis of Aura Observations to Improve Understanding of Tropospheric Ozone 43.001 NNX08AN70G No 19,478 Detector-Telescope Development for ProtoEXIST: 2nd and 3rd Generation 43.001 NNX09AD76G No 58,303 Direct Laboratory Determination of the Product of the C1 Atom Quantum Yield and Photolysis Cross Section of C1OOC1 43.001 NNX09AE29G No 103,220 Direct Study of the Atmospheres of Exoplanets Detected by NASA Kepler Mission 43.001 NNX09AB53G No 74,856 Exploring Cryogenian biological and environmental change in Mongolia 43.001 NNX12AD72G No 10,675 Fermi Bubbles: Improved Spectral and Morphological Measurements 43.001 NNX11AP92G No 61,098 Giant impacts on terrestrial planets: a high-resolution 3D study of magma ocean formation and atmospheric blowoff 43.001 NNX11AK93G No 59,949 High accuracy measurements of CO2, CH4, N2O, and CO from suborbital platforms 43.001 NNX09AJ94G No 158,849 High Power Mid-IR Laser Development 2.8 to 3.5 Microns 43.001 NNX12AB13G No 216,944 Improved Quantification of Regional Carbon Budgets Using High Density CO2 and CO Data from Satellite and Aircraft 43.001 NNX08AC26G No 50,025 In Situ Measurement of HOx (OH and HO2) Radicals and Total H2O Isotopes (HDO and H2O) in the Troposphere, Tropical Tropopause Layer (TTL), and Lower Stratosphere 43.001 NNX09AJ27G No 422,681 Integrated Cavity Output Spectroscopy (ICOS): A Key Approach to HDO, H218O, and H2O Observations 43.001 NNX09AJ90G No 467,529 Isotopic Studies of Solar System Origins 43.001 NNX11AK82G No 85,031 Life in Extreme Environments: Deep Sampling of Microbial Diversity 43.001 NNX09AM11H S01 No 27,250 Management of the GEOS-Chem Chemical Transport Model and Application to Improve Understanding of Tropospheric Ozone 43.001 NNX11AH93G No 62,430 Masses of Terrestrial Planets Discovered by the Kepler Mission 43.001 NNX09AJ50A No 33,064 Mobilization of water during planetary collisions: Schock thermodynamics experiments on icy mixtures and hydrated minerals 43.001 NNX11AQ24G No 77,527 Neoproterozoic Evolution and Environmental Change: Integrated Experimental and Geological Approaches 43.001 NNX07AV51G No 54,261 Numerical Simulations of Accretion Flows, Jets and Winds Around Black Holes 43.001 NNX11AE16G No 198,698 Physics of Colloids in Space 43.001 NNX08AE09G No 112,060 ProtoEXIST2-3 Development and Balloon Flight Demonstration 43.001 NNX11AF35G No 587,478 Providing Advice on Issues of Infrared SI Traceability to the Science Definition Team for the CLARREO Mission 43.001 NNX11AF94G No 94,653 Rapid Optical And Near-Infrared Spectroscopy of Swift GRBS: Cosmic Reionization, Metal Enrichment, And High-Z Hosts 43.001 NNX12AE68G No 9,780 Rapid Spectroscopy of Swift GRBs: Metal Enrichment, Cosmic Re-ionization, and Short Bursts 43.001 NNX10AI24G No 2,188 Redox Evolution of the Terrestrial and Martian Surfaces 43.001 NNX11AP89H No 20,000 Regolith X-ray Imaging Spectrometer (REXIS) 43.001 NNX12AG65G No 21,831 Revealing The Outer Solar System Using Occultations Of Stars 43.001 NNX10AH40G No 76,861 SEAC4RS mission support using the nested GEOS-Chem chemical transport model 43.001 NNX12AC05G No 28,761 Source attribution, emission monitoring and treaty verification by combining remote sensing and suborbital data 43.001 NNX11AG47G No 245,634 Spatial and Temporal Distributions of Sources for non-co2 Greenhouse Gases (CH4, CO, N2O) and aerosols over Amazonia 43.001 NNX09AU40G No 205,443 Spatial and Temporal Distributions of Sources for non-co2 Greenhouse Gases (CH4, CO, N2O) over North America 43.001 NNX08AR47G No (1) Testing the Borealis Impact Hypothesis: An investigation of mantle and crustal signatures from a giant impact 43.001 NNX11AE96G No 69,428 The ADS All Sky Survey 43.001 NNX12AE11G No 55,936 Understanding the Stormy Life of our Galactic Center 43.001 NNX08AX04H No 2,389 Using Thermal Emission to Study Properties of GRB Prompt Emission 43.001 NNX11AK98G No 26,704 Validating Kepler's Habitable-Zone Super-Earths with the Spitzer Space Telescope 43.001 NNX12AC77G No 60,623 Wavelength-Dependent Complex Indices of Refraction of Different Types of Secondary Organic Materials 43.001 NNX12AG95G No 4,257 Subtotal of 43.001 43.001 6,818,062 Metallic Hydrogen: A Game Changing Rocket Propellant 43.007 NNX11AR38G No 8,084 Subtotal of 43.007 43.007 8,084 CLARREO Infrared Instrument Integrated Product Team Support Contract NNL10AC84T No 22,725 NASA Algorythm Institute Contract NNH10CD71C No 815,169 Subtotal of Contract Contract 837,894 Total NASA Direct Awards 9,034,439 63
National Endowment for the Arts Causation Links Influencing Birth and Mortality rates of Arts and Cultural Institutions 45.024 12-3800-7002 No 2,910 Subtotal of 45.024 45.024 2,910 Total National Endowment for the Arts Direct Award 2,910 National Endowment for the Humanities Interpreting the Colonial Experience at Magdalena de Cao Viejo, Chicama Valley, Peru, 1578-1770 45.161 RZ-51150-10 No 23,429 Subtotal of 45.161 45.161 23,429 Total National Endowment for the Humanities Direct Awards 23,429 National Science Foundation Progenitors to Probes: New Insights on Gamma-Ray Bursts with the EVLA 47.unknown SOSPI2A-003 No 12,595 Subtotal of 47.unknown 47.unknown 12,595 CAREER: Bio-inspired Automatic Control of a Flying Robotic Insect 47.041 CMMI-0746638 No 14,466 CAREER: BuckliOrigami: Soft, Active and Foldable Structures Through Instabilities and Large Deformation 47.041 CMMI -1149456 No 1,087 CAREER: High-Speed 3D Imaging of Colloidal Self-Assembly with Digital Holographic Microscopy 47.041 CBET-0747625 No 75,432 CAREER: Nanoscale Opto-Mechanical Systems 47.041 ECCS-0846684 No 88,964 CAREER: Near-Field Optical Forces 47.041 ECCS-0747560 No 108,482 Collaborative Research: Planning Grant: I/UCRC Spatiotemporal Thinking and Computing 47.041 IIP-1160990 No 2,537 COLLABORATIVE RESEARCH: Nanobeam Lasers 47.041 ECCS-1028519 No 177,717 Collaborative Research: Nanostructure Growth Process Modelling and Optimal Experimental Strategies for Repeatable Fabrication of Nanostructures for Application in Photovoltaics 47.041 CMMI-1000720 No 66,084 Developing Computational Models to Guide the Design of Chemomechanically Responsive, Reconfigurable Surfaces 47.041 1124839 No 61,677 Femtosecond Laser Doping of Silicon: a Novel Fabrication Method for Photovoltaics 47.041 CBET-0754227 No 20,564 Large deformation and instability in soft active materials 47.041 CMMI-0800161 No 58 Novel Ti02-based microphotonic devices 47.041 ECCS-0901469 No 103,388 Solar Cells From Earth-Abundant Materials 47.041 CBET-1032955 No 229,246 Stress and Deformation caused by Insertion in Li Ion Batteries 47.041 CMMI-1031161 No 191,646 TiO2 ultrafast all-optical devices 47.041 ECCS-1201976 No 28,803 Using two-photon polymerization for the fabrication of 3D matrices for cell migration studies 47.041 CBET-0854288 No 169,647 Subtotal of 47.041 47.041 1,339,798 Collaborative Research: A field-experimental test for evolutionary trait-mediated indirect effects in food webs 47.047 DEB-0949531 No 23,758 Subtotal of 47.047 47.047 23,758 2009 Waterman Award 47.049 AST-1004488 No 348,783 A biophysical analysis of C. elegans thermotactic behavior in diverse environments 47.049 PHY-0957185 No 140,625 A New MCMC Framework with Applications to Protein Bioinformatics 47.049 DMS-0706989 No 161,853 Algebraic Geometric Approaches to Biological Complexity 47.049 DMS-0856285 No 362,583 An experimental study of the work hardening behavior of metallic thin films 47.049 DMR-0906892 No 86,493 Arithmetic Gross-Prasad conjecture for unitary Shimura varieties. 47.049 DMS-1001631 No 30,919 Bayesian Partition Models for Detecting Influential and Interactive Variables 47.049 DMS-1007762 No 18,138 Biomimetic Chemistry of Molybdenum and Tungsten: Analogue Reaction Systems of Oxotransferases and Hydroxylases 47.049 CHE-0846397 No 112,644 CAREER: Bimetallic Pd and Ag Catalysts for Electrophilic Trifluoromethylation 47.049 CHE-0952753 No 80,377 CAREER: Dynamics of neural circuits governing locomotory decisions in C. elegans 47.049 PHY-0952766 No 165,704 CAREER: Fluctuations and fitness- fundamental limits and selection conflicts 47.049 DMS-0748760 No 85,811 CAREER: Iron mediated catalytic C-H bond functionalization 47.049 CHE-0955885 No 81,279 CAREER: Molecular Diversity in Drug Delivery Design: An Intergrated Approach to Research and Education 47.049 DMR-1055412 No 172,269 CAREER: Spin Resolved Imaging of Correlated Electron Systems Including Cuprates and Pnictides 47.049 DMR-0847433 No 142,159 CAREER: Structure-Property Relation Studies in Functional Metal-Oxide Thin Films Photon Effects 47.049 DMR-0952794 No 125,397 Causal Inference From Two-Level Factorial Designs 47.049 DMS-1107004 No 40,579 CDI Type II: Scientific Computation for Astronomy Neurobiology and Chemistry using Graphics Processing Units and Solid-State Storage 47.049 PHY-0835713 No 508,055 Classical and Quantum Geometric Langlands Correspondence 47.049 DMS-1063470 No 86,162 64
CMG Collaborative Research: Statistical Evaluation of Model-Based Uncertainties Leading to Improved Climate Change Projections at Regional to Local Scales 47.049 DMS-0724522 No 18,756 CMP: Charge Fractionalization and Spin Charge Separation in One Dimensional Conductors 47.049 DMR-0707484 No 83 Collaborative Proposal: Statistical Methods for Analyzing Complexity and Growth of Large Biological and Information Networks 47.049 DMS-1106980 No 19,135 Collaborative Research: Carbon-Based Long-Coherence Quantum Bit 47.049 PHY-1104528 No 34,167 Collaborative Research: Development of a Green-Orange Astro-comb for Exoplanet and Cosmology Research 47.049 AST-1006503 No 106,286 Collaborative Research: Homotopy Theory: Applications and New Dimensions 47.049 DMS-0906194 No 156,057 Collaborative Research: Large-Aperture Experiment to Detect the Dark Age (LEDA) 47.049 AST-1106059 No 4,312 Collaborative Research: Models for Network Evolution: A Study of Growth and Structure in the Wikipedia 47.049 DMS-0907009 No 2,653 Collaborative Research: Optical Confirmation, Redshifts, and Richness for Galaxy Clusters Discovered with the South Pole Telescope 47.049 AST-1009012 No 240,904 Complex Dynamics and Moduli Spaces 47.049 DMS-0755765 No 198,762 Complex Manifold Theory and Kaehler Geometry 47.049 DMS-1001416 No 82,383 Differential Equations in Geometry 47.049 DMS-0804454 No 151,704 Double Loop Groups and Algebras, Central extensions and their Representations 47.049 DMS-1001280 No 41,352 Electron Magnetic Moment, Fine Structure Constant, Mass Ratios, Laser Spectroscopy and QED 47.049 PHY-0555508 No 8,209 Electron Magnetic Moment, Fine Structure Constant, Mass Ratios, Laser Spectroscopy and QED 47.049 PHY-1068219 No 233,414 FRG: Collaborative Research: High-Dimensional Statistical Inference: Theory, Methodology, and Applications 47.049 DMS-0854970 No 60,407 FRG: Collaborative Research: How the Algebraic Topology of Closed Manifold Relates to Strings and 2D Quantum Field Theory 47.049 DMS-0757293 No 13,141 FRG: Collaborative Research: Overcomplete Representations with Incomplete Data: Thoery, Algorithms, and Signal Processing Applications 47.049 DMS-0652743 No (33,841) FRG: Collaborative Research: Periods of automorphic forms and applications to L-functions 47.049 DMS-1065527 No 1,200 FRG: Collaborative Research: Quantum Spin Systems. Theory and Applications in Quantum Computation 47.049 DMS-0757425 No 91,881 Galois Representations and Modular Forms 47.049 DMS-0600716 No 32,308 Galois Representations and Modular Forms 47.049 DMS-1062759 No 108,859 Gamma-ray BursGamma-ray Bursts: From Progenitors to Probes 47.049 AST-1107973 No 170,549 Gauge Theory and Geometry in Dimensions Three and Four 47.049 DMS-0904589 No 182,904 Geometry of Linear Systems on Curves: Birational Geometry of Moduli Spaces 47.049 DMS-1001926 No 106,416 Geometry of Strings and Gravity 47.049 PHY-0937443 No 107,878 High-Fidelity, Long-Term Coherent Memory with Bose-Einstein Condensates for Implementation of Quantum Repeater Architectures 47.049 PHY-1104347 No 107,076 Hydration Induced Changes in the Structure and Dynamics of Biomolecular Conformations 47.049 CHE-0962680 No 111,970 Hydrogen at Ultra-High Pressure 47.049 DMR-0804378 No 59,380 Imaging Electron States in Nanostructures 47.049 DMR-1105341 No 60,888 Institute for Theoretical, Atomic, Molecular, and Optical Physics 47.049 PHY-0653575 No 480,101 Interactions of Particles, Fields and Strings 47.049 PHY-0804450 No 306,189 Interactions of Particles, Fields and Strings 47.049 PHY-1067976 No 27,078 Investigating Dark Energy and Neutrino Mass with Pan-STARS and LSST- Institutional Allowance 47.049 AST-0901965 No 7,453 IPA Agreement 47.049 DEB-1127908 No 140,210 Many-Body Quantum Dynamics and Quantum Disorder Systems 47.049 DMS-0804279 No 106,614 Many-body System 47.049 DMS-1001655 No 33,129 Material Worlds Network: Control of the Electron Nuclear Interaction in Nano-Electronic Devices 47.049 DMR-0908070 No 252,206 Materials Research Science and Engineering Center 47.049 DMR-0213805 No (22,374) Materials Research Science and Engineering Center 47.049 DMR-0820484 No 1,916,649 Materials World Network for the Rapid Discovery of Low Thermal Conductivity Ceramics by Integrated Simulation 47.049 DMR-1032564 No 21,181 Materials World Network to Optimize the Growth of InGaN Quantum Dots within High Quality Optical Micro-Cavities 47.049 DMR-1008480 No 268,422 Mathematical Sciences Postdoctoral Research Fellowship 47.049 DMS 0902820 No 1,757 Mathematical Sciences Postdoctoral Research Fellowship 47.049 DMS 1103795 No 2,712 Mathematical Sciences Postdoctoral Research Fellowship 47.049 DMS 1103831 No 2,500 Measuring Black Hole Spin: Physics of the Inner Region of an Accretion Disk 47.049 AST-0805832 No 6,730 MPS: Particle Physics and Cosmology in the Experimental Age 47.049 PHY-0855591 No 181,197 Nanoscale Studies of Topological Insulators 47.049 DMR-1106023 No 116,504 New Reactions and Strategies in Synthesis 47.049 CHE-0749566 No (4,109) New Reactions and Strategies in Synthesis 47.049 CHE-1152205 No 52,418 Novel Methods for High Resolution NMR Spectroscopy in Inhomogeneous Fields 47.049 CHE-0724057 No 52,445 Novel Phases of Quantum Matter 47.049 DMR-1103860 No 99,187 Novel routes for nitrogen functionalization of organics with metallic Ag, Au and Cu: Fundamental principles on a molecular level 47.049 CHE-0952790 No 138,872 Number Theory and Geometry 47.049 DMS-0501029 No 45,727 Number Theory and Geometry 47.049 DMS-1100511 No 51,663 Number Theory and Related Fields 47.049 DMS-0968831 No 62,110 Optical Information Processing with Ultraslow Light in Bose-Einstein Condensates 47.049 PHY-0757427 No (2,978) p-adic Hodge Theory and Applications 47.049 DMS-1001139 No 81,589 Physics with New Atomic Systems: Quantum Interactions, Cooling and Applications 47.049 PHY-0757157 No (116,279) 65
Physics with New Atomic Systems: Quantum Interactions, Cooling and Applications 47.049 PHY-1067990 No 303,010 Post-Doctoral Research Fellowship 47.049 DMS 0902665 No 2,337 Quantum Optical Physics with Nanaophotonics Systems 47.049 PHY-0969816 No 509,047 Quantum Optical Techniques for Solid-state Quantum Information Processing 47.049 PHY-0653555 No 82,404 Quantum Phase Transitions of Correlated Electrons and Atoms 47.049 DMR-0757145 No 39,649 Representations of Affine Kac-Moody Algebras and Representations of Groups Over a 2-dimensional Local Field 47.049 DMS-0600903 No 131 Research and Education in Physical Mathematics 47.049 DMS-0605031 No (9) REU Site: Biomaterials Research Initiative Dedicated to Gateway Experiences (BRIDGE) 47.049 DMR-1005022 No 146,832 Science of Nanoscale Systems and their Device Applications 47.049 PHY-0117795 No (111) Science of Nanoscale Systems and their Device Applications 47.049 PHY-0646094 No 714,330 SOLAR Optical Hyperdoping: Transforming Semiconductor Band Structure for Solar Energy Harvesting 47.049 DMR-0934480 No 606,747 Statistical Inference for Stochastic Processes, Analysis of MCMC Algorithms and Applications to Climate Science 47.049 DMS-1107070 No 46,435 Strongly Correlated Quantum Gas with Single Site Addressability 47.049 PHY-0969772 No 182,908 Strongly Correlated Quantum Systems: From Electronic Materials to Cold Atoms to Photons 47.049 DMR-0705472 No 131,296 Studies in Representation Theory 47.049 DMS-1001405 No 71,730 Supernovae and Supernova Cosmology 47.049 AST-0907903 No 278,634 Synthesis and Properties of Deformable Biomaterials and Soft Matter Systems 47.049 DMR-1006546 No 166,640 Testing Accretion Physics and Strong-Field Gravity by Imaging Accreting Black Holes 47.049 AST-0907890 No 181,304 The MEarth Project: A Transit Search for Rocky Planets in the Habitable Zone of Low Mass Stars 47.049 AST-1109468 No 166,972 The Natal Environments of Dense Cores: Constraints on Dense Core Evolution 47.049 AST-0908159 No 211,004 The Origin and Properties of Magnetic Dynamos Across the Sub-Stellar Boundary 47.049 AST-1008361 No 196,853 The Production and Study of Cold Antihydrogen 47.049 PHY-0757924 No 456,494 Theoretical Problems in Condensed Matter and Statistical Physics 47.049 DMR-0906475 No 93,714 Theoretical Problems in Soft Matter and Biological Materials 47.049 DMR-0654191 No 11,819 Theoretical Problems in Soft Matter and Quantitative Biology 47.049 DMR-1005289 No 158,165 Understanding Supernovae for Cosmology and for Themselves 47.049 AST-0606772 No (35) Unraveling Reactions Mechanisms on Au-titania Nanostructures: Probing Interface Effects 47.049 CHE-0956653 No 162,658 Visualizing flagella while tracking bacteria 47.049 PHY-1057408 No 33,721 Catalytic Chemistry Workshop: Defining Critical Directions for the Future 47.049 CHE-1125137 No 50,098 CDI Type II: Collaborative Research: Bibliographic Knowledge Network 47.049 DMS-0835500 No (504) Current Developments in Mathematics Conference 47.049 DMS-1001688 No 4,590 Mathematical Science Postdoctoral Research Fellowship (MSPRF) 47.049 DMS-1004464 No 3,333 MRI: Acquisition of a 3D Tomographic Atom-Probe Microscope 47.049 DMR-1040243 No 210,000 Subtotal of 47.049 47.049 14,760,122 A Test for the Younger Dryas Impact Hypothesis 47.050 AGS-1007367 No 6,876 Advances in Seismology and Implications for Interdisciplinary Research Adam M. Dziewonski Symposium 47.050 EAR-1132277 No 28,935 Ca Isotope Variations in Oceanic Basalts 47.050 EAR-1144727 No 85,728 CAREER: Career Development in the Emerging Field of Geomycology: Research and Education in Metal Biomineralization by Fungi 47.050 EAR-0846715 No 83,003 Collaborative Proposal: Testing Climate Models by Feedback Analysis Using AIRS and GPS Radio Occulation Data 47.050 ATM-0755099 No 105,335 Collaborative Research: Biological controls on reactive oxygen species in the oligotrophic ocean 47.050 OCE-1129594 No 4,544 Collaborative Research: The ENSO-Mediterranean Teleconnection: Observations 47.050 ATM-0917468 No 20,183 Collaborative Research: Beyond the Instrumental Record: The Ocean Circulation at the Last Glacial Maximum and the Deglacial Sequence 47.050 OCE-1060454 No 5,806 Collaborative Research: Biological Production Production of Reactive Oxygen Species in Freshwaters 47.050 EAR-1024817 No 63,646 Collaborative Research: Characterization of Microbial Transformations in Basement Fluids, from Genes to Geochemical Cycling 47.050 OCE-1061934 No 118,241 Collaborative Research: Climatic and Biotic Transformations of Neogene Mammalian Faunas of Pakistan 47.050 EAR-0958178 No 32,299 Collaborative Research: Combined Seismological and Geodetic Constraints on 3-D Mantle Structure 47.050 EAR-0809658 No 116,529 Collaborative Research: Constraining Arc Processes through Comprehensive Geochemical Study of the Chilean Southern Volcanic Zone 47.050 EAR-0948511 No 77,011 Collaborative Research: Determination of HONO and NO2 flux and concentration over forest canopies using quantum cascade laser absorption spectroscopy 47.050 ATM-0814202 No 13,826 Collaborative Research: Do symmetric and asymmetric segments on the Mid-Atlantic Ridge have distinct geochemical signatures 47.050 OCE-1061264 No 201,047 Collaborative Research: Global 3-D Modeling of Atmospheric Mercury and its Coupling to the Ocean and Land: Impacts of Past and Future Anthropogenic Emissions 47.050 AGS-0961357 No 146,061 Collaborative Research: HIAPER Pole-to-Pole Observations (HIPPO) of Carbon Cycle and Greenhouse Gases 47.050 AGS-0628575 No 315,210 Collaborative Research: Improving Estimated Fluxes of Greenhouse Gases over North America Using a Receptor-Oriented Modeling Framework and In-situ Atmospheric Measurements 47.050 ASG-0830916 No 89,335 Collaborative Research: Interwoven biogeochemical cycles and biological transformations of mercury and selenium in the upper ocean 47.050 1130549 No 48,223 66
Collaborative Research: P2C2--ICE age Chemistry And Proxies (ICECAP) Phase 2 47.050 AGS-1102880 No 44,598 Collaborative Research: Processes and Patterns in Back Arc Basin Hydrothermal Vent Communities 47.050 OCE-0732369 No 9,859 Collaborative Research: Seeing the forest with the leaves: inferring plant habit and ecophysiology from leaf fossils 47.050 EAR-1023994 No 3,031 Collaborative Research: Spatial and Temporal Evolution of an Active Blind-Thrust Fault from Inception to the Most Recent Earthquake 47.050 EAR-0711220 No 2,867 Collaborative Research: Stratosphere-Troposphere Analyses of Regional Transport (START) Experiment (2008) 47.050 ATM-0723327 No (3,622) Collaborative Research: The Physics and Statistics of Global Sea Level Change 47.050 OCE-0960787 No 58,951 Collaborative Research: Understanding MJO initiation with DYNAMO observations and a hierachy of models 47.050 AGS-1062016 No 138,365 Collaborative Research: Westerly wind burst modulation by the SST: from understanding to ENSO prediction 47.050 AGS-0754332 No 41,669 Comparative Studies of Circum-Arctic Neoproterozoic-Paleozoic Terranes 47.050 EAR-1049463 No 86,291 Coral-based reconstruction of dust emission and precipitation patterns from the Sahara-Sahel region 47.050 OCE-0823486 No 27,936 Development and Deployment of a Modular, Autonomous In Situ Underwater Stable Isotope Analyzer 47.050 OCE-0838107 No 114,566 Hopanoid Physiology: Implications for Microbial Life on the Early Earth 47.050 EAR-1024723 No 226,544 Hygroscopic Phase Transitions of Atmospheric Particles 47.050 AGS-0925467 No 229,106 Magnesium Isotope Geochemistry of Carbonate Sediments 47.050 OCE-0961372 No 90,107 Microbial Genome Sequencing: Comparative Genomics of Chemosynthetic Symbionts 47.050 EF-0412205-004 No 1,676 New Methods in Storm Track Dynamics Theory 47.050 AGS-0736022 No 77,491 Pure standards of archael and bacterial GDGTs for the oceanographic community 47.050 OCE-1129343 No 224,817 Rupture Propagation and Arrest in Geometrically Complex Fault Systems: Bends, Stepovers, and Damaged Border Zones 47.050 EAR-0809610 No 121,910 Selected Studies of the Atmosphere with an Emphasis on Air Quality in China and on Prospects for Wind and Solar Energy as Potential Future Substitutes for Fossil Fuel 47.050 AGS-1019134 No 95,244 Studies of Mantle Flow and Evolution 47.050 EAR-1015353 No 73,007 Testing the Significance of Melt Inclusions for Ocean Ridge Petrogenesis 47.050 OCE-0850442 No 52,150 The acquisition of a specialized sulfur isotope mass-spectrometer, construction of a custom designed, semi-automated sample preparation-fluorination system and support for early career investigators 47.050 EAR-0949227 No 73,799 Subtotal of 47.050 47.050 3,352,200 AF: Medium: New Directions in Computational Complexity 47.070 CCF-0964401 No 74,811 AF: Small: The Theory and Practice of Hash-Based Algorithms and Data 47.070 CCF-0915922 No 71,679 AF:Small:Computational Entropy 47.070 CCF-1116616 No 117,744 Career: CodeBlue: A Wireless Sensor Network Infrastructure for Medical Applications 47.070 CNS-0546338 No 2,711 Career: Foundations for Ubiquitous Image-Based Appearance Capture 47.070 IIS-0546408 No 146,325 Career: Foundations of Markets as Information Aggregation Mechanisms 47.070 CCF-0953516 No 82,847 Career: Practical, expressive, language-based information security 47.070 CCF-1054172 No 30,317 Career: Programming Nucleic Acids Self-Assembly 47.070 CCF-1054898 No 80,150 Career: Quantifying diffusion and dynamics on healthcare, innovation and communication networks 47.070 IIS-1149662 No 25,000 Career: Self-Organizing Systems: Engineering and Understanding Robust Collective Behavior 47.070 CCF-0643898 No 143,421 CGV: Large: Collaborative Research: Analyzing images through time 47.070 IIS-1110955 No 49,713 CGV:Small:Collaborative Research:From Virtual to Real 47.070 IIS-1116619 No 26,434 Collaborative Research -- CSR-EHS: Integrated Power Delivery - Hardware - Software Techniques to Eliminate Off-Chip Regulation -- Embedded Systems 47.070 CNS-0720566 No 266,827 Collaborative Research: CRI: Large-Scale Open Sensor Network Testbed for Urban Monitoring 47.070 CNS-0551417 No 8,262 Collaborative Research: II-New: Prototyping Platform to Enable Power-Centric Multicore Research 47.070 CNS-1059264 No 2,149 Collaborative Research: Scalable Data Management Using Metadata and Provenance 47.070 CCF-0937914 No 97,634 Collaborative Research: SEI: Discovering Unexpected Planets and Other Astronomical Oddities 47.070 IIS-0713273 No 1,118 Collaborative Research: Technological and Educational Foundations for Understanding and Improving Large-classroom Learning 47.070 IIS-0835338 No 143,541 CRI: CRD: Public Web-based Photo-Collections as a Research Testbed 47.070 CNS-0708895 No 223,819 CT-ISG: The Assumptions for Cryptography 47.070 CNS-0831289 No 8,061 DIP: Collaborative Research: Social Robots as Mechanism for Language Instruction, Interaction, and Evaluation in Pre-School Children 47.070 IIS-1123085 No 44,902 EMT/BSSE Programmable Self-Adaptation: A Bio-inspired Approach to Multi-agent Robotic Systems 47.070 CCF-0829745 No 25,078 Flexible voltage stacking for chip multiprocessors 47.070 CCF-0903437 No 4,647 HCC: Collaborative Research: Information Exchange and Social Factors in Human-Computer-Teamwork Decision Making 47.070 IIS-0705406 No 30,685 HCC: Small: Incentive-Compatible Machine Learning 47.070 CCF-0915016 No 95,008 HCC:Large:Collaborative Research: Beyond Flat Images: Acquiring, Processing, and Fabricating Visually Rich Material Appearance 47.070 IIS-1012454 No 111,472 ICES: Small: Heuristic Mechanism Design 47.070 CCF-1101570 No 56,987 III:Small:Representation, modeling and inference for large biological and information networks 47.070 IIS-1017967 No 197,399 ITR- (EVS+NHS) - (dmc+int) : Knowledge Infusion 47.070 CCF-0427129 No 78,107 NeTS-FIND: A Network-Wide Hashing Infrastructure for Monitoring and Measurement 47.070 CNS-0721491 No 75,176 NSF CCF-CPA: Reliability in the Face of Variability under Nanoscale Technology Scaling 47.070 CCF-0702344 No 72,273 RI-Small: Autonomous Microrobotic Swarms 47.070 IIS-0811571 No 62,100 RI: Medium: Collaborative Research: Unlocking Biologically-Inspired Computer Vision: A High-Throughput Approach 47.070 IIS-0963668 No 222,956 RI: Toward Shape from Specular Reflections Under Real-World Illumination 47.070 IIS-0712956 No 46,448 Towards a Basic Understanding of Channels with Synchronizations Errors 47.070 CCF-0634923 No (4) Subtotal of 47.070 47.070 2,725,797 67
A Novel Rodent Model for the Neurophysiology of Visual Object Recognition 47.074 IOS-0947777 No (1,226) ABI Innovation: Building and sharing molecular visualizations with Molecular ViewBook 47.074 DBI-1062164 No 321,192 Biogeographic and ecological diversification of trees across the Indonesian archipelago: developing indigenous leadership in biodiversity informatics 47.074 DEB-1020868 No 28,528 Bioluminescence: Molecular Mechanisms and Biochemical Control 47.074 MCB-0343407 No (6) Career: Scalable Computational Models for Mulicellular Systems Biology 47.074 DBI-1053486 No 210,225 Centriole Inheritance During Sexual Reproduction 47.074 MCB-1121176 No 178,243 Collaborative Proposal: Instrumental Development of Microfluidics-based Fluorescence Acrivated Cell Sorting Device for Research and Education 47.074 DBI-0649865 No (16,437) Collaborative Research (MIP): Microbial Interactions at Cold Seeps: Characterizing C2-C4 anaerobic hydrocarbon degradation and its influence on AMO and sulfate reduction 47.074 MCB-0702504 No 15,307 Collaborative Research and NEON: PalEON - A PaleoEcological Observatory Network to Assess Terrestrial Ecosystem Models 47.074 EF-1065646 No 13,901 Collaborative Research, LiT, MSB: The Changing Diversity and the Evolution of Decomposer Fungi in Response to Soil Warming and Nitrogen Additions 47.074 DEB-1021079 No 141,566 Collaborative Research: ARTS: Taxonomy and systematics of selected Neotropical clades of arachnids 47.074 DEB-1144417 No 48,031 Collaborative Research: AToL: Phylogeny on the Half-shell--Assembling the Bivalve Tree of Life 47.074 DEB-0732903 No 284,670 Collaborative Research: Continental-scale Monitoring, Modeling and Forecasting of Phenological Responses to Climate Change 47.074 EF-1065029 No 90,122 Collaborative Research: Ecosystem Responses to Progressive and Rapid Climate Change During the Holocene in New England 47.074 DEB-0815036 No 31,220 Collaborative Research: Estimating Species Trees from Multilocus DNA Sequence Data 47.074 DEB-0743616 No 38,801 Collaborative Research: Evolution of Sex Chromosomes in Turtles 47.074 MCB-0817687 No 7,994 Collaborative Research: Evolutionary Genetics and Genomics of Cave Adaptation in the Mexican tetra 47.074 IOS-0821982 No 21,273 Collaborative Research: Gymnosperms on the Tree of Life: Resolving the Phylogeny of Seed Plants 47.074 IOS-0629890 No 45,793 Collaborative Research: Mechanisms of Scent Mediated Self/Non-Self Recognition in a Pelagic Seabird 47.074 IOS-0923117 No 135,896 Collaborative Research: Metabolism in Boston 47.074 DEB-0948580 No 18,308 Collaborative Research: Microparasite-Macroparasite Interactions: Dynamics of Co-Infections and Implications for Disease Control 47.074 EF-0904359 No 10,302 Collaborative Research: Molecular Genetic Studies of Bdelloid Rotifers 47.074 MCB-0923628 No 152,525 Collaborative Research: Moths, Ants, and Carnivorous Plants: the Spatial Dimension of Species Interactions 47.074 DEB-0541680 No 8,251 Collaborative Research: Multilocus Comparative Phylogeography of Pine-Oak Woodland Birds in North America 47.074 DEB-0815705 No 34 Collaborative Research: Plumage Redness and Good Genes in the House Finch 47.074 IOS-0923088 No 84,834 Collaborative Research: Resolving old questions in Mollusc phylogenetics with new EST data and developing general phylogenomic tools 47.074 DEB-0844881 No 4,958 Collaborative Research: Species Diversity and Abundance in Insular Systems 47.074 DEB-0722471 No (4) Collaborative Research: Testing the Munch Hypothesis: Hydraulics of Phloem Transport in Vines and Trees 47.074 IOS-1021779 No 47,982 Collaborative Research: The Comparative Genetics of Mimicry in Butterflies 47.074 DEB-1020355 No 231,495 Collaborative Research: The Genetics of Convergence at Multiple Levels: Evolution of Colorful Dewlaps in Anolis 47.074 DEB-1119731 No 131,966 Damage Sensing and Processing by the Bacterial Nucleotide Excision Repair Pathway 47.074 MCB-0918161 No 134,274 DIMENSIONS: Collab. Res:The climate cascade: functional and evolutionary consequences of climatic change on species, trait, and genetic diversity in a temperate ant community 47.074 DEB-1136646 No 20,996 Dimensions: Collaborative Research: Functional Diversity of Microbial Trophic Guilds Defined Using Stable Isotope Ratios of Proteins 47.074 DEB-1136484 No 177,480 Dissecting the Molecular Mechanisms Underlying Organization of the Bacterial Chromosome 47.074 MCB-1148818 No 11,164 Dissertation Research: Behavioral and genomic evidence for sexual isolation between two sister species of Peromyscus 47.074 DEB-1110450 No 8,993 Dissertation Research: Determining the drought sensitivity of the Amazon forest 47.074 DEB-1110540 No 8,729 Dissertation Research: Establishing phylogenomic resources to trace the global diversification of prorhynchid flatworms (Platyhelminthes: Lecithoepitheliata) 47.074 DEB-1210328 No 1,216 Dissertation Research: Function and Evolution of Sweet Taste Receptors in Birds 47.074 IOS-1110478 No 8,814 Dissertation Research: Ornament evolution in Anolis lizards: the interaction between survival and sexual selection in a manipulative field experiment with replication 47.074 DEB-1210320 No 57 Dissertation Research: Phenological Interactions in Arabidopsis Thaliana--Natural Variation and Natural Selection 47.074 DEB-0807973 No 872 Dissertation Research: Pitcher Plants: a Window into Metacommunity Process 47.074 DEB-0909694 No 4,731 68
Dissertation Research: Rapid evolution and the character displacement hypothesis: a unique test using a replicated natural colonization experiement 47.074 DEB-1110521 No 12,371 Dissertation Research: Systematics and Evolution of Neotropical Bell-Flowers (Lobelioideae) 47.074 DEB-1210401 No 1,117 Dissertation Research: The deep evolution and development of Archosaurian head and the origin of the face of birds 47.074 DEB-1110564 No 2,422 Dissertation Research: Functional ecology and evolution of an ant gut 47.074 DEB-1110515 No 6,979 Dynamics, Plasticity and Evolvability of bacterial small regulatory RNAs 47.074 MCB-1121057 No 170,230 Evolution, Genetics and Development: The Origin of Adaptive Pigment Alleles in Beach Mice 47.074 DEB-0919190 No (19,964) Filtered Push: Continuous Quality Control for Distributed Collections and Other Species-Occurrence Data 47.074 DBI-0960535 No 362,561 Floral development, conservation genetics, and horizontal gene transfer in the world's largest flowers, Rafflesiaceae 47.074 DEB-1120243 No 48,391 Fluctuation Theories for Complex Biological Systems 47.074 EF-1137676 No 100,477 FSML: Infrastructure for molecular and microbial ecology at the Harvard Forest 47.074 DBI-0930516 No 55,640 How Important Is 'Colored' Stochastiticy for Plant Population Dynamics 47.074 DEB-1020889 No 203,372 Investigation of Inductive Mechanisms in Arthropod Germ Line Specification: Analysing The Role of Dpp Signaling 47.074 IOS-0817678 No 37,196 Landscape Vulnerability and Resilience to Global Change 47.074 DEB-1057617 No 28,714 LTER IV: Integrated Studies of the Drivers, Dynamics, and Consequences of Landscape Change in New England 47.074 DEB-0620443 No 907,146 Maximizing the Utility of Orthologs and Phylogenetic Profiles for Systems-Scale Comparative Genomics 47.074 DBI-0640809 No 50,255 Modification of the ABC Program and the Evolution of Floral Novelty 47.074 IOS-0720240 No 1,185 Modification of the ABC Program and the Evolution of Floral Novelty 47.074 IOS-1121005 No 220,896 Molecular basis of developmental variation in Arabidopsis arenosa 47.074 IOS-1146465 No 65,982 Molecular Genetics of Systemic RNAi 47.074 MCB-0744029 No 33,944 Neuromuscular and Kinematic Mechanisms of Avian Maneuvering Flight 47.074 IOS-0744056 No 162,312 NSF Postdoctoral Fellowship in Biology FY 2010 47.074 DBI-1103761 No 4,937 NSF Postdoctoral Fellowship in Biology FY2010 47.074 DBI-1003227 No 3,292 RAPID: Regional and Landscape Initiatives at Harvard Forest LTER 47.074 DEB-0952792 No 34,667 REU Site: Cellular and Molecular Biology 47.074 DBI-1004542 No 73,304 REU Site: Harvard Forest Summer Research Program in Forest Ecology 2010-2014: Ecological data-model fusion and environmental forecasting for the 21st Century 47.074 DBI-1003938 No 111,882 Testing Structure/Function Relationships in an Ecological Context: Integration of Biomechanics, Behavior, and Performance During Aerial Predation in Dragonflies 47.074 IOS-0952471 No 87,231 The Single Origin of Mycorrhizas Among the Amanita: A Model for Elucidating the Genetic Architecture of Symbiosis 47.074 IOS-1021606 No 197,559 Undergraduate Diversity at the Society for the Study of Evolution and the Society of Systematic Biologists 47.074 DEB-0826811 No 582 Understanding Xylem Refilling: Molecular and Biophysical Perspectives 47.074 IOS-0919729 No 101,402 Workshop on the Future of Evolutionary Biology 47.074 DEB-1137385 No 13,042 Dimensions IRCN: Diversity and Forest Change: Characterizing functional, phylogenetic and genetic contributions to diversity gradients and dynamics in tree communities 47.074 DEB-1046113 No 111,047 RCN: Coordinated Computing in Structural Biology 47.074 MCB-0639193 No 92,401 RCN: EDEN (Evo-Devo-Eco Network): A research coordination network to promote technique and community development across the Evo-Devo-Eco field 47.074 IOS-0955517 No 64,623 Subtotal of 47.074 47.074 6,010,265 A new history and geography of human genes informed by ancient DNA 47.075 BCS-1032255 No 564,117 Career: Flexible Resource Allocation and Efficient Coding in Human Vision 47.075 BCS-0953730 No 133,071 Career: New Methods for Understanding Race, Inequality, and Spatial Separation 47.075 SES-0748734 No 62,288 Career:Teaching Mixed Methods, International Research, and Comparative Perspectives through a Study of Childbearing and Childrearing under China's Fertility Limitation Policies 47.075 BCS-0845748 No 130,337 Cognitive and Affective Neuroscience of Moral Judgement 47.075 SES-0821978 No 53,762 Collaborative Proposal: Designing Taxes that Improve Insurance to Earnings Uncertainty over the Life Cycle 47.075 SES-1062009 No 53,592 Collaborative Research: DAT: From grant to commercialization: an integrated database which can trace, asses, and measure the impact of scientific funding 47.075 SBE-0965279 No 30,520 69
Collaborative Research: Dual Standards in Affective Forecasting and Experience 47.075 BCS-0722132 No 8,997 Collaborative Research: Evolutionary, Developmental and Neurobiological Sources of Moral Judgements 47.075 BCS-0725125 No (2,470) Collaborative Research: Improving the Accuracy of Affective Forecasting 47.075 SES-0951695 No 104,582 Collaborative Research: Market Design in Public Procurement: Theory and Evidence 47.075 SES-0924371 No 91,711 Collaborative Research: Transformation in Political Party Organizations and the Rise of Candidate-Centered Elections in the US 1878-2008 47.075 SES-1067448 No 136,894 Collaborative research: Understanding the Economic Crisis and its Social Impacts through Postdoctoral Fellowships 47.075 SES-0957923 No 54,469 Collaborative Research: Workforce Diversity and Corporate Performance 47.075 SES-1023279 No 32,879 Comparative Vision and Attention 47.075 BCS-1026256 No 25,398 Cooperation and Self Control 47.075 SES-0951462 No 110,867 Cooperation in Mutualisms: Contracts, Markets, Space, and Dispersal (BIOCONTRACT) 47.075 SES-0750480 No (1,755) Correlation and heterogeneity robust inference using conservativeness of test statistics 47.075 SES-0820124 No (10,036) DAT: Creating a Patent Collaboration Network Database to Examine the Social Production of Knowledge 47.075 SBE-0830287 No 8,326 DDR: A Multilevel Study of Symbolic Boundries towards Muslims, 2001-2007 47.075 SES-0927031 No 3,150 Doctoral Dissertation Improvement Grant: Ritualized Animals, Understanding Human-Animal Interactions at Teotihuacan 47.075 BCS-1028851 No 1,532 Doctoral Dissertation Improvement Grant: The effects of forelimb anatomy on throwing performance: a biomechanical analysis 47.075 BCS-0961943 No 5,603 Doctoral Dissertation Improvement: C-Peptide of Insulin as an Index of Energy Expenditure in Wild Chimpanzees 47.075 BCS-0925697 No 3,543 Doctoral Dissertation Improvement: Impacts of Food Processing on Diet-Induced Thermogenesis 47.075 BCS-0962038 No 2,602 Doctoral Dissertation Improvement: Moche Sociopolitical Organization form a Mid-Sized Center in the Chicana Valley, Peru 47.075 BCS-1032294 No 11,570 Doctoral Dissertation Improvement: The Effects of Food Processing on Mechanical Properties and Masticatory (Chewing) Performance 47.075 BCS-0925688 No 1,734 Doctoral Dissertation in Political Science: Inside Autocracy 47.075 SES-1065650 No 6,563 Doctoral Dissertation Research in Economics: Peer Effects in Prison 47.075 SES-1124225 No 5,500 Doctoral Dissertation Research in Economics: Reference-Dependent Preferences, Expectations, and Dynamic Choice 47.075 SES-1024063 No 1,574 Doctoral Dissertation Research in Political Science: Secret Police and State Violence under Authoritarianism 47.075 SES-1159259 No 1,435 Doctoral Dissertation Research in Political Science: Sources of Extremism and Moderation in the Living Shariah 47.075 SES-1159298 No 1,600 Doctoral Dissertation Research in Political Studies: The Mobilization and De-mobilization of Latino Identities in Reaction to Explicit and Implicit Cues in Immigrant Political Rhetoric 47.075 SES-1065666 No 8,786 Doctoral Dissertation Research: A Social Scientific Analysis of Architectural Design, Access, and Disability 47.075 SES-1127257 No 9,826 Doctoral Dissertation Research: Aftermath; Negotiating with Computers in the Work of Mathematical Proof 47.075 SES-1154889 No 1,580 Doctoral Dissertation Research: Articulating the Past, The Value of Dinosaurs in America, 1870-1930 47.075 SES-1027186 No 3,138 Doctoral Dissertation Research: Low Income Youth and Perceptions of Mortality 47.075 SES-1031612 No 273 Doctoral Dissertation Research: Teaching Transformations, South Africa's Post-Apartheid Generation and Apartheid History Education 47.075 SES-1029273 No 2,559 Doctoral Dissertation Research: The Social Consequences of Neighborhood Economic Diversity 47.075 SES-0928252 No 910 Doctorial Dissertation Research: Beyond the Religious Persuit of Race: Re-examining Secularization within Scientific Theories of Human Difference 47.075 SES-1027045 No (767) Equal Opportunity Innovations at Work: Mechanisms for Reducing Job Segregation 47.075 SES-0620534 No (14) Estimating the Policy Preferences of United States Courts of Appeals Judges Across Circuits and American Political Institutions 47.075 SES-0924236 No 13,662 Evaluating the Returns to Rural Banking: Village and Household Evidence from Southern India 47.075 SES-1123899 No 40,748 Evidence Observed: Daubert's Impact on Science and Justice 47.075 SES-0850962 No 55,733 Explaining Low Fertility in Postindustrial Societies 47.075 SES-1123885 No 63,306 Fertility Transition and Emerging Differences in Parental Investment and Children's Economic Roles 47.075 BCS-0964031 No 55,827 From Words to Inferences: The Development of Incremental Language Comprehension 47.075 BCS-0921012 No 186,712 Leadership Decision Making 47.075 SES-0820441 No 122,008 Life in the Gray Zone: Governance of New Biology in Europe, South Korea, and the United States 47.075 SES-1058762 No 87,874 Mark(er)ing Race: An Ethnographic Study of Human Difference in Contemporary Genetics 47.075 SES-0849109 No 32,761 Models of Dynamic Choice 47.075 SES-1123729 No 60,182 New Evidence on Tax and Transfer Policies from the Universe of U.S. Tax Records 47.075 SES-1025490 No 119,465 NSEC: Nanotechnology in Society Project Nano Connection to Society 47.075 SES-0531146 No 271,823 Phylogenetic Comparative Methods in Biological Anthropology 47.075 BCS-0923791 No 103,086 70
Resolving Pliocene and Pleistocene Hominin Ontogeny With Synchrotron Virtual Histology 47.075 BCS-1126470 No 10,446 Sciences of the Similar: Generic Pharmaceuticals and the Limits of Equivalence 47.075 SES-1126132 No 20,010 Self Control at Work: A Field Experiment 47.075 SES-0961857 No 46,854 SoCS: Enhancing Immersive Social Perspective Taking and Perceived Virtual Similarity to Enable Intelligent Social Relationships 47.075 SES-0966838 No 153,513 STS Post Doctoral Fellowship: From Morphology to DNA: Metagenomics and its Impacts on Species-Based Conservation Science and Policy 47.075 SES-1127269 No 49,515 Subject Preference and Ergativity 47.075 BCS-1144223 No 4,785 The Investigation of a Semasiographic Recording System: The Search for Pattern and Meaning in the Inka Khipus 47.075 BCS-1111489 No 41,998 The Material Basis of Function in the Brain: Connections to Philosophy of Biology and Phenomenology 47.075 SES-1026632 No 51,021 Topics in Dynamics and Political Economy 47.075 SES-1238467 No 48,093 Understanding Educational Markets: Experimental and Observational Evidence from Pakistan 47.075 SES-0962504 No 214,470 Understanding the Role of the Parietal Cortex in visual obejct grouping and feature binding 47.075 BCS-0855112 No 17,864 Acquisition of An Endangered Mayan Language 47.075 FN-50094-11 No 44,881 Subtotal of 47.075 47.075 No 3,576,883 Career: Learning About Complex Causality in the Classroom 47.076 DRL-0845632 No 100,663 Collaborative Research: Mental Abacus Education and Spatial Representations 47.076 DRL-0910070 No 19,700 Creation and Dissemination of Upper-elementary Mathematics Assesment Modules 47.076 DUE-0831450 No 438,751 EcoMOBILE: Blended real and virtual immersive experiences for learning complex causality and ecosystems science 47.076 DRL-1118530 No 151,094 FICSMath 2008 (Factors Influencing College Success in Mathematics) 47.076 DRL-0813702 No 328,661 From 'cook book' to exploration: Optimizing learning gains in introductory physics laboratory instruction 47.076 DUE-0942044 No 161,064 Graduate Research Fellowship Program 47.076 DGE-0644491 No 790,293 Graduate Research Fellowship Program 47.076 DGE-1144152 No 8,644,646 Helping Teachers to Use and Students to Learn from Contrasting Examples: A Scale-up Study in Algebra I 47.076 DRL-0814571 No 416,634 IGERT: Integrated Training Program in Biomechanics 47.076 DGE-0221682 No (5,516) IGERT: Multidisciplinary and Comparative Program in Inequality and Social Policy 47.076 DGE-0333403 No 355,912 Investigating the Effect of Professional Development, Mathematical Knowledge for Teaching, and Instruction on Student Outcomes 47.076 DRL-0918383 No 795,778 ITEST Strategies 47.076 DRL-0833378 No 361,830 Learning to RECAST Students' Causal Assumptions in Science Through Interactive Multimedia Professional Development Tools 47.076 DRL-0455664 No 54,012 Life on Earth 47.076 DRL-1010889 No 743,392 MOSART II 47.076 DUE-0926272 No 479,027 MOSART-LS: Misconceptions Oriented, Standards-based Assessment Resource for Teachers in the Life Sciences 47.076 DUE-0830922 No 453,821 Recruiting, Training, and Retaining Boston's Next Generation of Math and Science Teachers 47.076 DUE-0531970 No 97,950 Sources of Mathematical Thinking 47.076 DRL-0633955 No 209,480 Studying Technology-based Strategies for Enhancing Student Interest in STEM Careers through Algebra Curricula in Grades 5-9 47.076 DRL-0929575 No 451,574 Investigating a Framework for STEM-Reading to Support Secondary School Students with Reading Disabilities 47.076 SV2-82008 No 1,872 Subtotal of 47.076 47.076 15,050,638 Collaborative Research: BICEP2 and SPUD - A Search for Inflation with Degree-Scale Polarimetry from the South Pole 47.078 ANT-1044978 No 1,085,928 Collaborative Research: Impacts of Recent Climate and Emissions Changes on Mercury Bioaccumulation in Arctic Marine Food-Webs 47.078 ARC-1023213 No 117,648 Collaborative Research: The Impacts of Arctic and Alpine Refugia on Genetic Divergence in Tundra Flora 47.078 ARC-0714212 No 19,089 Collaborative Research: Type 1: LOI: L02170303: Arctic Climate Response to Decadal Changes in Radiative Forcing from Aerosols and Ozone 47.078 ARC-1049021 No 120,206 Long Term Human Ecodynamics in Coastal Peru: A Case Study of Polar Tropical Teleconnections 47.078 ARC-1152156 No 23,064 The Search for the Imprint of Inflation on the Cosmic Microwave Background from the South Pole 47.078 No Award Number No 1,295 Transient and Rapid Glacial Motions, Including Glacial Earthquakes 47.078 ANT-0739444 No 74,576 Subtotal of 47.078 47.078 1,441,806 International: The Clusioid Clade (Malpighiales): Systematics, Biogeography, and Horizontal gene transfer 47.079 OISE-0936076 No 3,203 Subtotal of 47.079 47.079 3,203 71
CDI Type II: Bridging the Computational Semantic Gap: A Demand-Driven Framework for Portal-Based Chemistry, Astronomy and Neurobiology 47.080 OIA-1125087 No 72,588 CDI-Type II: Collaborative Research: Preparing the Next Generation of Computational Thinkers: Transforming Learning and Education Through Cooperation in Decentralized Networks 47.080 OCI-1026473 No 47,161 Collaborative Proposal: CI-TEAM DIFFUSION: PORTAL, Pedagogical Open-access Research-based Tools for Advancing Learning in Science and Engineering 47.080 OCI-1135469 No 36,278 Collaborative Research: S12-SSI: Scalable Hierarchical Algorithums for Extreme Computing (SHARE) 47.080 OCI-1060067 No 27,671 CRCNS Data Sharing: An open data repository for cognitive neuroscience: The Open fmri Project 47.080 OCI-1131338 No 12,294 Subtotal of 47.080 47.080 195,992 Building the Pipeline to DASCH for Temporal Surveys 47.082 AST-0909073 Yes 230,105 Carbon Isotopic Heterogeneity in Modern Bacterioplankton: Model Systems for Understanding Paleoenvironmental Signatures 47.082 OCE-0927290 Yes 138,184 Career: Distribution of Fitness Effects, Identity and Interaction of Beneficial Mutations Available for Adaptation 47.082 DEB-0845893 Yes 275,742 Career: Exploring Models of Quantum Gravity 47.082 PHY-0847457 Yes 81,158 Career: Physical Aspects of Spindle Self-Organization 47.082 PHY-0847188 Yes 243,575 Collaborative Research: An Ultrastable Blue Astro Comb for Exoplanet and Cosmology Research 47.082 AST-0905214 Yes 14,972 Collaborative Research: Layers of Adaptive Radiation in Anolis Lizards: Investigation of Previously Unexplored Ecological and Taxonomic Diversity 47.082 DEB-0918975 Yes 240,661 Collaborative Research: New MCMC-enabled Bayesian Methods for Complex Data and Computer Models Applied in Astronomy 47.082 DMS-0907185 Yes 159,665 Collaborative Research: P2C2 Understanding the Role of a High-Latitude Convective Cloud Feedback in Equable and Future Climate Dynamics 47.082 ATM-0902844 Yes 282,150 Collaborative Research: RoboBees: A Convergence of Body, Brain and Colony 47.082 CCF-0926148 Yes 1,946,921 Collaborative Research: Studies of the Structure of the Earth's Interior 47.082 EAR-0838304 Yes 32,558 Dimensions of Mind Perception 47.082 BCS-0841746 Yes 23,653 EAGER: Stress resistance pathways in C. elegans 47.082 MCB-0944253 Yes 56,522 Energetic, Development, and Ovarian Function in Adolescent Gambian Women 47.082 BCS-0921237 Yes 15,998 FRG: Collaborative research: Generalized Geometries in String Theory 47.082 DMS-0854971 Yes 84,484 Geometric Representation Growth 47.082 DMS-0901638 Yes 43,670 Geometry and PDE Analysis in General Relativity 47.082 DMS-0904583 Yes 30,862 Graduate Research Fellowship Program 47.082 DGE-0946799 Yes 1,000,000 HCC: Medium: Collaborative Research: Computer Vision and Online Communities: A Symbiosis 47.082 IIS-0905243 Yes 143,738 Minority Postdoctoral Research Fellowship 47.082 DBI-0905948 Yes 5,590 Modular Compactification of Mg, N 47.082 DMS-0901095 Yes 37,976 MRI-R2: Development of a System for Dynamic, Multipoint, Dual-Color Fluorescence Fluctuation Spectroscopy 47.082 DBI-0959721 Yes 32,464 MRI: Development of a New Instrument to Observe Isotopic Fluxes of CH4 and CO2 from Arctic Melt Regions, to Link Carbon Fluxes, Climate Feedbacks and Sea Level Rise 47.082 ATM-0922596 Yes (13,293) Noble gas studies along ultraslow spreading Southwest Indian Ridge: Constraining magmatic degassing processes and the origin and lengthscale of mantle heterogeneities 47.082 OCE-0929193 Yes 149,556 Optical and Dynamic Nuclear Polarization Approaches to Hyperpolarization of Nanoparticles for Molecular Imaging 47.082 CBET-0933015 Yes 101,341 P2C2: A Bayesian approach to estimating temperature and precipitation and their inter-relationship over the last millennium 47.082 ATM-0902374 Yes 189,252 Postdoctoral Research Fellowships in Biology for FY 2009 47.082 DBI-0905714 Yes 2,886 Research and Education in Physical Mathematics 47.082 DMS-0907985 Yes 111,150 RI: Medium: Collaborative Research: Robotic Hands: Understanding and Implementing Adaptive Grasping 47.082 IIS-0905180 Yes 150,813 TC: Large: Collaborative Research: Combining Foundational and Lightweight Formal Methods to Build Certifiably Dependable Software 47.082 CNS-0910660 Yes 124,179 The 2010 Cooperative Congressional Election Study 47.082 SES-0924191 Yes 37,984 The Formation of Stars: From Clouds to Protostars- Institutional Allowance 47.082 AST-0901055 Yes 2,986 Topics in representation theory and number theory 47.082 DMS-0901102 Yes 172,023 Topology, Geometry and Physics 47.082 DMS-0903186 Yes 94,666 Total Positivity: Connections with Algebra, Topology, and Statistical Physics 47.082 DMS-0854432 Yes 53,366 Trapping single small molecules in solution 47.082 CHE-0910824 Yes 129,683 Using Inuit Qaujimajatuqangit, Traditional Knowledge, to Guide the Development of Hypotheses on Narwhal Tusk Function 47.082 ARC-0756708 Yes 27,278 Xenon Isotopes in Mid Ocean Ridge and Ocean Island Basalts: implications for the volatile evolution of the Earth 47.082 EAR-0911363 Yes 57,831 Subtotal of 47.082 47.082 6,512,349 Total National Science Foundation Direct Awards 55,005,407 72
U.S. Institute of Peace A Group-Based Psychosocial Intervention for War-Affected Youth in Sierra Leone 91.unknown USIP-008-10F No 81,063 Subtotal of 91.unknown 91.unknown 81,063 Total U.S. Institute of Peace Direct Award 81,063 Total Research and Development and Research Training Cluster Direct Awards 533,279,946 Research and Development and Research Training Cluster Subawards Received Agency for International Development Brigham and Women's Hospital - Health and Rehabilitative Support for Earthquake-affected Populations in the Haitian Border Region 98.unknown 106376 No 1,995 University Research Co., LLC - Translating Research into Action (TRAction) 98.unknown FY10-S01-6990 No 24,223 Subtotal of 98.unknown 98.unknown 26,218 Tufts University - Nutrition Collaborative Research Support Programs (CRSP), Focus on Africa 98.001 AID-OAA-L-10-00006 No 89,091 International Medical Corps - Building a Better Response: Strengthening Non-Governmental Organization (NGO) Capacity and Engagement in the International Humanitarian Architecture 98.001 No Award Number No 27,446 Public Health Institute - Global Health Fellows Program 98.001 1012327 No 29,844 Tufts University - Nutrition Collaborative Research Support Programs (CRSP), Focus on Asia 98.001 No Award Number No 48,643 Subtotal of 98.001 98.001 195,024 PACT - Developing, Implementing and testing Peer Education Strategies for OVCs in South Africa Contract X3-P-505 No (7,428) University Research Co., LLC - Support to Nicaragua and Honduras Research and Evaluation Studies for the Health Care Improvement Project Contract FY11-P08-8700 No 40,414 John Snow International - Sustaining Family Planning and Maternal and Child Health Services Project in Georgia Contract 13144-01 No 87,606 Subtotal of Contract Contract 120,592 Total Agency for International Development Subawards Received 341,834 Central Intelligence Agency Scitor Corporation - Evaluation of China's Renewable Energy Contract G1073-011 No 138,350 Subtotal of Contract Contract 138,350 Total Central Intelligence Agency Subaward Received 138,350 Department of Agriculture Commonwealth of Massachusetts/Department of Public Health - Getting to the Heart of the Matter: Using Emotion-Based Techniques to Implement VENA (GHM) - Phase II 10.unknown RESEARCHSERVEHH20000-HH2 No 9,636 United States Department of Agriculture (USDA) Forest Service - Supporting Carbon Cycle and Earth Systems Modeling with Measurements and Analysis from the Howland AmeriFlux Site 10.unknown 12-JV-11242306-015 No 7,489 Subtotal of 10.unknown 10.unknown 17,125 University of Rhode Island - A Foodweb Approach to Native Plant Protection in a Forest Ecosystem 10.310 51411 No 12,338 Subtotal of 10.310 10.310 12,338 University of New Hampshire - Synthesis of Data from the Phenocam Network: Phenological Controls on Forest Productivity 10.652 PZ10-0007 No 42,129 Subtotal of 10.652 10.652 42,129 Total of Department of Agriculture Subawards Received 71,592 Department of Commerce University of Alaska Fairbanks - Development and Deployment of In Situ Osmotic Sampling Systems for Capturing Temporal and Spatial Changes in Microbial Community Composition and Function 11.430 UAF 10-0080 No 53,303 Subtotal of 11.430 11.430 53,303 Columbia University - Atlantic Multidecadal Variability: Mechanisms, Impact, and Predictability: A study using observations and IPCC AR4 Model Simulations 11.431 1 Acct 5-62180 No 31,994 Subtotal of 11.431 11.431 31,994 Total of Department of Commerce Subawards Received 85,297 73
Department of Defense Dana Farber Cancer Institute - A systems Biology Approach to Link Nuclear Factor kappa B Activation with Lethal Prostate Cancer 12.unknown 3075901 No 26,496 Lincoln Laboratory - Anticipatory Techniques for Evaluation of Medical Distress 12.unknown 7000136763 No 31,575 irobot - Development of a Low-Cost Dexterous Robotic Hand 12.unknown 66043 No 144,896 HRL Laboratories, LLC - Development of Multiple Quantum Dot Devices 12.unknown 702082-BS No 188,116 MITRE Corporation - Development of Nanowire-Based Processing Technologies on Non-Silicon Substrates 12.unknown 92007 No 119,100 BAE Systems - MAST-CTA: Smart Composite-Based Rapid Prototyping of Micro-Systems 12.unknown 6215 No (463) Carnegie Mellon University - Mechanism Design for Distributed Resource Allocation 12.unknown 11-00919-EXP-000 No 37,174 Massachusetts Institute of Technology - Network Analysis for PACE (Processing Algorithms Co-Designed with Electronics) 3-D Graph Processor Program 12.unknown PO 7000075411 No 12,022 University of Illinois at Urbana - Champaign - Secure Virtual Architecture: A foundation for Integrating Analysis, Confinement, and Diversification 12.unknown 2010-02387-03 No 240,498 MITRE Corp - Development of Functional Nanowire-Based Nanoprocessors 12.unknown 90029 No 389,022 Subtotal of 12.unknown 12.unknown 1,188,436 University of Virginia - An Integrated Cellular Materials Approach to Force Protection 12.300 GG10931-128297 No 59,349 University of Tennessee - Assessing the Potential Consequences of Subsurface Bioremediation: Fe-Oxide Bioreductive Processes and the Propensity for Contaminant-Colloid Co-Transport and Media Structural 12.300 8500021880 No 121,952 Regents of the University of California - Santa Barbara - Dielectric Enhancements For Innovative Electronics 12.300 KK1132 No 194,620 Florida Atlantic University - Discrete Ricci Flow in Higher Dimensions 12.300 130106 No 65,771 Massachusetts Institute of Technology - Explorations in Cyber International Relations 12.300 5710002616 No 493,909 Drexel University - Fish fins as multifunctional sensory and propulsive systems for autonomous operations in the complex underwater environment 12.300 N00014-Harvard No 25,060 Massachusetts Institute of Technology - GATE: Grapheme Approaches to Terahertz Electronics 12.300 5710002633 No 188,998 Massachusetts General Hospital - Individual Differences in Imagery in 3D Virtual Environments 12.300 216622 No 25,026 University of Pennsylvania - Large Area 3D Optical Metamaterials with Turnability and Low Loss 12.300 555991 No 167,227 University of Pennsylvania - Networks Opposing Botnets (NoBot) 12.300 552404 No 90,125 Drexel University - Neuromechanics of Fish Pectoral Fin Sensory and Motor Control Systems as a Model for Controlling Agile, Autonomous Undersea Vehicles 12.300 204087-3667-H No 130,151 University of Pittsburgh - Novel Materials Approaches for Prevention of Marine Biofouling 12.300 0025570 (407408-1) No 131,961 Massachusetts Institute of Technology - Provably-Stable Vision-Based Control of High-Speed Flight through Forest and Urban Environments 12.300 5710002910 No 48,936 Oregon State University - Sensors Powered by Benthic Microbial Fuel Cells at the MARS Observatory 12.300 N0271A-A No 63,670 Boston University - Utilizing Synthetic Biology to Create Programmable Micro-Bio-Robots 12.300 4500000551 No 207,145 Subtotal of 12.300 12.300 2,013,900 Children's Hospital Corporation - Breast Cancer Reversal by Engineering the Tumor Microenvironment 12.420 71234 No 903,041 Center for Integration of Medicine and Innovative Technology (CIMIT) - Microfluidic Blood Cleansing Device for Sepsis Therapy 12.420 218257 No 239,543 Center for Integration of Medicine and Innovative Technology (CIMIT) - SEAS - CIMIT Medical Devices Graduate Design Course 12.420 No Award Number No 11,572 Brigham and Women's Hospital - The Role of BRCA1 in Lethal Prostate Cancer 12.420 106159 No 111,765 Subtotal of 12.420 12.420 1,265,921 74
Massachusetts Institute of Technology - Atom Interferometry on Atom Chips - A Novel Approach Towards Precision Inertial Navigation Systems (PINS) 12.431 5710002242 No (481) University of Texas Health Science Center at Houston - Bionanoscaffolds for Post-Trauma Osteoregeneration 12.431 0007044 (D) No (30,632) Pennsylvania State University - Control of Communication Networks 12.431 SA08-02 No 275,894 Regents of the University of California - Santa Barbara - Emergent Phenomena at Mott Interfaces 12.431 KK1007 No 53,244 Princeton University - Innovative Design and Processing for Multi-Functional Adaptive Structural Materials 12.431 1812 No 556,117 Massachusetts Institute of Technology - Milli-Biology: Programmed Assembly of Engineered Materials 12.431 5710002407 No (135,224) University of Maryland, College Park - MURI:Atomtronics: Material and Device Physics of Quantum Gases 12.431 Z841802 No 21,653 The University of Sydney - Precision Quantum Control and Error Suppressing Quantum Firmware for Robust Quantum Computing 12.431 LEX 7367 No 136,676 Regents of the University of California - Santa Barbara - Quantum BioImaging with Diamond Spins (QuBIDS) 12.431 KK1201 No 108,084 Massachusetts Institute of Technology - Quantum Emulation of New Materials using Ultracold Atoms 12.431 5710002237 No 401,935 Boston University - Synthetic Mammalian Gene Regulatory Circuits for In Vivo Biomedical Applications 12.431 4500000572 No 175,010 University of Illinois at Urbana - Champaign - Transient Electronics: Resorbable Radios and RF Energy Scavenging Systems 12.431 2011-05087-01 No 90,250 Subtotal of 12.431 12.431 1,652,526 BBN Technologies Corporation - CCRI: Economic (Market-Oriented) Approach to Cross-Network Analysis 12.630 W911NF-09-2-0053 No 92,732 California Institute of Technology - Novel Devices for Plasmonic and Nanophotonic Networks: Exploiting X-Ray Wavelengths at Optical Frequencies 12.630 67N-1069926 No (1,107) Subtotal of 12.630 12.630 91,625 Regents of the University of California - Berkeley - Hardware, Languages, and Architectures for Defense Against Hostile Operating Systems 12.800 6768 No 55,279 Stanford University - Integrated Hybrid Nanophotonic Circuits 12.800 29017980-51649-A No 43,317 Stanford University - Large Scale Integrated Nanophotonics 12.800 29676680-51649-E No 157,503 Georgia Institute of Technology/Georgia Tech Research Corpor - Multi-functional Light-Matter Interfaces based on Neutral Atoms and Solids 12.800 RC413-G4 No 160,491 Cornell University - Passive Heat Transfer in Environments with Large Inertial and Gravitational Stresses 12.800 56557-8926 No 93,564 University of Connecticut - Production, Manipulation and Applications of Ultracold Polar Molecules 12.800 6769 No 151,914 Regents of the University of California - Santa Barbara - Quantum Memories in Photon - Atomic - Solid - State Systems 12.800 KK1225 No 147,548 University of Pennsylvania - Topological and Geometric Tools for Analysis of Complex Networks 12.800 552082 No 169,658 Subtotal of 12.800 12.800 979,274 University of Virginia - A Micro-Cellular Solids Approach to Thermo-Structural Materials with Controlled Architectures 12.910 GG11379-136859 No 44,676 Massachusetts Institute of Technology - Coherent Quantum Sensors 12.910 5710002919 No 158,106 Space and Naval Warfare Systems Center Pacific - Colloid Morphogenesis 12.910 N66001-09-1-2110-DOD35CAP No 4,927 Space and Naval Warfare Systems Center Pacific - Control and Manipulation of Casimir Forces by Nanomechanical Design 12.910 N66001-09-1-2070-DOD35CAP No 519,670 Stanford University - Geometric Approach to Hodge Conjecture and Polynomial Optimization 12.910 22196330-42574-A No 126,343 Princeton University - Harnessing Quantum Entanglement in Semiconductor Circuits 12.910 1622 No 317,019 Princeton University - Harnessing Quantum Entanglement in Semiconductor Circuits 12.910 1623 No 44,996 Regents of the University of California - Irvine - Millimeter-Scale Synthetic DNA Arraya Made out of Paper and Tape 12.910 2010-2492 No 23,656 Regents of the University of California - Santa Barbara - Quantum Information Processing with Spins in Diamond 12.910 KK9135 No 288,169 University of Chicago - Room Temperature Coherent Energy Transfer: New routes to Biomimetic Devices 12.910 45634-A No 85,401 Subtotal of 12.910 12.910 1,612,963 General Dynamics Information Technology - Algorithms for Decision Making In High-Complexity Situations Contract contract F33601-03F-0203 No (4,819) SiOnyx Inc. - Black Silicon Solar Cells: High Efficiency Thin Film Photovoltaics Contract A13093 No 2,176 UES, Inc. - Development of Micro-Heater for The Mechanical Characterization of Thin Films Contract S-901-139-0002 No 10,045 Weidlinger Associates Inc. - Fracture Evaluation and Design Tools for Welded Aluminum Ship Structures Subjected to Impulsive Dynamic Loading Contract 21112032-02 No 9,641 Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. - Herpes-specific Antibodies in RV135 Trial Contract 716602 No 48,552 Tiax, LLC - In-Vivo Measurement of Gas Bubble Formation Contract 521776-02S No 17,019 Electric Power Research Institute - Investigation of Sources and Composition of Particulate Exposures (SCOPE) - Atlanta Contract EP-P15913/C7935 No 63,458 BAE Systems - MAST-CTA: Smart Composite-Based Rapid Prototyping of Micro-Systems Contract 740369 No 99,316 Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. - Measurement of ADCC Titers in Samples from the RV144 Trial Contract 689633 No 255,380 CFD Research Corporation - Mechanobiology of Diffuse Axonal Injury: Mechanisms and Opportunities for Early Neuroprotection Contract 1459 No 333,279 Physical Sciences Inc. - Monolithic Integrated-Optic TDLAS Sensors and Networks Contract SC57520-1779 No 59,971 Lincoln Laboratory - Photonic Device Development at Harvard University Contract 7000136946 No 112,255 EOS Photonics, Inc. - Plasmonic Beamsteering Contract A15856 No 25,354 Lincoln Laboratory - Quantum Cascade Photonic Crystal Microlasers with Integrated Microfluidic Delivery for Intra-Cavity IR Spectroscopy on a Chip Contract 7000031015 No (4,325) BAE Systems - SAFE: A Semantically Aware Foundation Environment for CRASH Contract 739625 No 248,379 MetroLaser, Inc. - SBIR Phase II: A Glass-Ceramic Optical Thermal History for Extreme Environments Contract A12904 No 1,014 Physical Sciences Inc. - STTR phase 2: Robust MAV Control Contract SC47539-1704 No 100,122 Subtotal of Contract Contract 1,376,817 Total of Department of Defense Subawards Received 10,181,462 75
Department of Education University of Houston - National Research and Development Center for English Language Learners 84.305A R-06-0031 No 15,883 Regents of the University of Michigan - NCER-SoBeh G2 - SECURe: Developing an Integrated Socioemotional and Cognitive Regulation 84.305A 3001243177 No 183,890 Subtotal of 84.305A 84.305A 199,773 Stanford University - Addressing Practical Problems in Achievement Gap Estimation: Nonparametric Methods for Censored Data 84.305D 27788150-50132-A No 63,461 Subtotal of 84.305D 84.305D 63,461 Strategic Education Research Partnership - Catalyzing comprehension through discussion and debate 84.305F No Award Number No 1,052,853 Subtotal of 84.305F 84.305F 1,052,853 Regents of the University of Minnesota - Enhancing the Mathematical Problem Solving Performance of Sixth Grade Students Using Schema-based Instruction 84.305K 3019189101 No 32,590 Subtotal of 84.305K 84.305K 32,590 Regents of the University of Minnesota - Learning of Ratio and Proportion Problem-Solving Using Schema-Based Instruction: Efficacy and Sustainability 84.324 A002020901 No 31,801 Subtotal of 84.324 84.324 31,801 The Achievement Network - Increasing Student Achievement Through the Use of Interim Assessment Data: Expanding the Achievement Network Model 84.396C No Award Number Yes 376,760 Subtotal of 84.396C 84.396C 376,760 Council of the Great City Schools - Classroom Talk in Urban Middle Schools Contract No Award Number No 353 University of Houston - Diagnostic Assessment of Reading Comprehension: Development and Validation Contract R06-0054 No (2,757) Subtotal of Contract Contract (2,404) Total of Department of Education Subawards Received 1,754,834 Department of Energy Aerodyne Research, Inc. - An Absolute CO2 Monitor with Extremely High Accuracy 81.unknown ARI-10607-2 No 74,027 Marine Biological Laboratory - Effects of warming on tree species' recruitment in deciduous forests of the eastern United States 81.unknown 35495 No 89,971 Aerodyne Research, Inc. - High Precision, Airborne COS Monitor to Constrain the Partitioning of CO2 Fluxes 81.unknown ARI-10608-2 No 223,713 Stanford Linear Accelerator Center - Management Effort on Science Raft Electronics for the large Synoptic Survey 81.unknown 88903 No 31,655 Lawrence Livermore Laboratory - Recovering Large Volumes of Homogeneously Shocked Samples 81.unknown B598243 No 14,019 Subtotal of 81.unknown 81.unknown 433,385 Boston University - An Open Source Platform for Multi-Scale Spatial Distributed Simulations of Microbial Ecosystems 81.049 GC208288NGD No 19,103 Pennsylvania State University - Analysis of Long-Term Trends and Anomalies in CO2 and H20 Exchange at a NE US Mixed Deciduous Forest in Response to Climate Variability 81.049 3452-HU-DOE-4157 No 672 Massachusetts Institute of Technology - Center for Excitonics 81.049 5710002745 Yes 557,846 Regents of the University of California - Santa Barbara - Center on Materials for Energy Efficiency Applications 81.049 KK1006 Yes 9,458 Northwestern University - CITFAM: Center for Integrated Training in Far-from-equilibrium and Adaptive Materials. 81.049 611828930060024673 PROJ0001549 Yes 152,131 Aerodyne Research, Inc. - Compact High Precision Field Instrument For All Major Greenhouse Gases 81.049 ARI 10808-1 No 17,632 Pennsylvania State University - Impacts of Climate Variability and Change on Forest Structure, Composition and Function in the Northeastern United States 81.049 3593-HU-USDOE-4157 No 73,430 Pennsylvania State University - Improving forecasts of species' responses to climatic change: Hierarchical Bayesian analysis of tree distributions and abundance across space and time 81.049 3892-HU-DOE-4157 No 18,791 Pennsylvania State University - Reducing Uncertainty about the Effects of Climatic Variation on Forest Ecosystems by Measuring, Modeling, and Analyzing Intermediate-Turnover Carbon Pools 81.049 4002-HU-DOE-4157 No (16,841) Massachusetts Institute of Technology - Study and Control of Excitons Using Optical Nanostructures 81.049 5710003011 No 116,119 Subtotal of 81.049 81.049 948,341 Massachusetts Institute of Technology - Next Generation Sulfide Materials; Optimizing CZTS and Developing SnS by Systematic Defect Engineering 81.087 5710003414 No 80,715 Subtotal of 81.087 81.087 80,715 Massachusetts Institute of Technology - Bioprocess and Microbe Engineering for Total Carbon Utilization in Biofuel Production 81.135 5710002810 Yes 218,866 Subtotal of 81.135 81.135 218,866 North Carolina State University - Impacts of elevated temperature on ant species, communities and ecological roles at two temperate forests in eastern North America 81.502 2007-1694-01 No 375,704 Subtotal of 81.502 81.502 375,704 Total of Department of Energy Subawards Received 2,057,011 76
Department of Homeland Security EOS Photonics, Inc. - Broadly Tunable Sampled Grating Quantum Cascade Lasers Contract A15855 No 17,710 Subtotal of Contract Contract 17,710 Total of Department of Homeland Security Subaward Received 17,710 Department of Housing & Urban Development Boston Public Health Commission - IPM Intensity Impact Study 14.unknown 510301 No 30,016 Neighborhood Reinvestment Corp - Achieving Excellence in Community Development 14.unknown 250-09-0009AE No 180,399 Neighborhood Reinvestment Corp - The Edward M. Gramlich Fellows Alumni Event 14.unknown No Award Number No 45,499 Neighborhood Reinvestment Corp - The Edward M. Gramlich Fellowship in Community and Economic Development Summer Fellowship Program 2011 14.unknown No Award Number No 10,265 Neighborhood Reinvestment Corp - The Edward M. Gramlich Fellowship in Community and Economic Development Summer Fellowship Program 2012 14.unknown No Award Number No 12,000 Subtotal of 14.unknown 14.unknown 278,179 Total of Department of Housing & Urban Development Subaward Received 278,179 Department of State Social Science Research Council - Summer Institutes for Non-Russian Languages 19.unknown 18911 No (22,864) Subtotal of 19.unknown 19.unknown (22,864) Total of Department of State Subaward Received (22,864) Department of the Interior Pennsylvania State University - Improving Passive Mine Treatment for Manganese Removal - Phase II 15.255 4308-HU-USDI-6005 No 10,182 Subtotal of 15.255 15.255 10,182 Total of Department of the Interior Subaward Received 10,182 Department of Transportation The University of New Orleans - University Transportation Center 20.unknown 138 No 10,761 Subtotal of 20.unknown 20.unknown 10,761 Massachusetts Institute of Technology - Crisis Management in Transportation: Building Capacity through Exercises 20.701 5710002722 No 61,870 Massachusetts Institute of Technology - Hazardous Material Transportation and the Security Externality: What Should Be Done 20.701 5710002482 No 451 Massachusetts Institute of Technology - Improving Emergency Evacuation Preparedness: Policy and Organizational Implications for Transportation Agencies 20.701 5710002956 No 61,391 Massachusetts Institute of Technology - Improving Emergency Preparedness and Crisis Management Capabilities in Transportation - Year II 20.701 5710002481 No 4,526 Massachusetts Institute of Technology - Managing Big City Transit Systems: Case Studies of Jay Walder at the MTA 20.701 5710002957 No 2,051 Massachusetts Institute of Technology - Teaching Case Studies on Earthquake Preparedness in the Transportation Sector, Los Angeles Metropolitan Area 20.701 5710002595 No 1,178 Massachusetts Institute of Technology - Teaching Cases on Transportation and Global Warming 20.701 5710002723 No 4,468 Massachusetts Institute of Technology - Transparency in Transportation: User Power and Public Accountability 20.701 5710002721 No 33,955 Massachusetts Institute of Technology - University Transportation Center Graduate Fellowships 20.701 5710002958 No 31,460 Massachusetts Institute of Technology - Medium-Scale Quantum Simulators 20.701 7000182729 No 38,139 Subtotal of 20.701 20.701 239,489 Total of Department of Transportation Subawards Received 250,250 Department of Veterans Affairs Abt Associates, Inc. - A Program Evaluation of VA's Medical Research Contract 27349-1 No 156,497 Subtotal of Contract Contract 156,497 Total of Department of Veterans Affairs Subaward Received 156,497 77
Department of Health and Human Services Social + Scientific Systems, Inc. - A5260: Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r, DRV/r or RAL Metabolic Study of A5257 93.unknown CRB-SSS-S-11-001863 No 46,085 Immune Disease Institute, Inc - Adhesion Molecules in Transfusion Biology (Project 3 and Core C) 93.unknown PO S-411969 No 4,676 Social + Scientific Systems, Inc. - Anti-Viral and Immune Plasma Infrastructure Development IRC003/IRC004 93.unknown CRB-DRC01-S-10-00227 No 44,561 Beth Israel Deaconess Medical Center - Atrogin-1 and Muscle Protein Balance 93.unknown No Award Number No (1,318) Sanaria, Inc. - Automated Salivary Gland Dissection for Manufacture of Malaria PfSPZ Vaccine 93.unknown A14293 No 24,383 Dana Farber Cancer Institute - Cantor T32 CA70083-13 93.unknown 1008113 No 44,774 Healthy Housing Solutions Inc. - CDC Green Housing Study 93.unknown HHSI-11-S-1001 No 38,329 University of Virginia - Cell Migration Consortium 93.unknown GC12015.136199 No 21,437 The Forsyth Institute - Childhood Obesity Prevention: a Model for a School-Based Dental Program 93.unknown No Award Number No 1,052 Judge Baker Children's Center - Clinical Research Training Program 93.unknown 10032 No 42,493 Brigham and Women's Hospital - Comparing the long-term and real-world effectiveness of initial management strategies for DCIS 93.unknown 106114-HSPH No 47,377 Massachusetts General Hospital - Detection of Lung for Cancer Risks for Serum Metabolomics 93.unknown 215800 No 14,184 National Public Health Information Coalition - Developing Science-Based Communication Plans and Activities for Use in Public Health Crises 93.unknown No Award Number No 1,038,055 Beth Israel Deaconess Medical Center - Doctoral Dissertation Research: A Taste for Tastes: The Spread of Food Choices and Healthy Behaviours in Social Networks 93.unknown 5T32AG023480-05 No 415 Brigham and Women's Hospital - Electronic records for comparative effectiveness: emulating a randomized trial 93.unknown 106073 No 31,448 Dana Farber Cancer Institute - Functional Study of Histone Demethylase JARID1B in Cancer 93.unknown No Award Number No (1,707) Massachusetts Institute of Technology - Genetics in Immune-Mediated Diseases-Lupus 93.unknown No Award Number No (1) Sanaria, Inc. - High Throughout Mosquito Decapitation and Salivary Gland Extraction 93.unknown A14292 No 47,463 Medical Technology and Practice Patterns Institute, Inc. - Individualized Treatment Strategies and Optimal Hematocrit Target for Complex Dialysis Patients 93.unknown R21HS019513-02 No 22,448 University of Ibadan - Medical Education Partnership Initiative in Nigeria 93.unknown 7/225/27/HSPH-02 No 243,597 Aerodyne Research, Inc. - Nitrogen Dioxide and Light-Absorbing Carbon Sensors for Personal Exposure Assessment 93.unknown 10612-1 No 58,813 McLean Hospital - Novel Therapeutic Approaches for Parkinson's Disease, Subproject 2 93.unknown No Award Number No (7,245) Brigham and Women's Hospital - Role of Fatty Acid Metabolism for the Prevention of Sudden Cardiac Death 93.unknown 106287 No 2,596 The Queen's Medical Center - TAI CHI for Obesity: A Randomized Controlled Pilot Trial 93.unknown No Award Number No (634) Brigham and Women's Hospital - The Long-term Oxygen Treatment Trial 93.unknown 101949 No 24,189 Cambridge Health Alliance - Understanding Mechanisms Underlying Disparities in Mental Health Care Episodes 93.unknown No Award Number No 45,948 Subtotal of 93.unknown 93.unknown 1,833,418 Brigham and Women's Hospital - AMSA: ALXR/FPR Mediate Signaling in Severe Asthma 93.038 107194 No 12,490 Subtotal of 93.038 93.038 12,490 Regents of the University of Michigan - Reducing Social Disparities of Heatwave Impacts in a Changing Climate 93.061 3001107791 No 7,094 Subtotal of 93.061 93.061 7,094 Boston University - A Discrete Event Simulation Model of Environmental Exposures and Pediatric Asthma 93.113 RA208305NGN No (4,805) Brown University - Air Pollution and Pregnancy Outcomes in New York City 93.113 458 No 25,540 Brigham and Women's Hospital - Biomarkers of Exposure and Effect in a Traffic-Exposed Population 93.113 103830 No 194,091 Regents of the University of Michigan - Bisphenol A and Phthalate Exposure in relation to Fetal Growth and Preterm Birth 93.113 3001656278 No 40,211 Tufts University - Community Assessment of Freeway Pollution and Health (CAFEH) 93.113 No Award Number No 12,889 Brigham and Women's Hospital - Diet, Physical Activity, and the Relationship Between Air Pollution and CVD 93.113 104628 No 161,849 Yale University - Effect of Air Pollution and Traffic on Birth Outcomes 93.113 A07290(M09A10133) No 165,513 Brigham and Women's Hospital - Environment, Fetal Tissue DNA Methylation and Birthweight 93.113 107367 No 230,888 George Washington University - Environmental Endocrine Disruptors and Human Sperm Chromosomal Abnormalities 93.113 11-M06 No 24,734 Fred Hutchinson Cancer Research Center - Epigenomic profiling of histone turnover kinetics in mammalian cells 93.113 744658 No 246,395 Silent Spring Institute - Ethical and Legal Challenges in Communicating Individual Biomonitoring and Personal Exposure Results to Study Participants: Guidance for Researchers and Institutional Review Boards 93.113 7476-SEAS No 32,171 Johns Hopkins University - Extreme Heat and Human Health: Characterizing Vulnerability in a Changing Climate 93.113 5891 No 34,853 Regents of the University of Michigan - Fetal Lead Exposure, Genes, and Neurodevelopment 93.113 3000831952 No 1,525 Giner, Inc. - Field-Deployable Monitor to Assess Personal Exposure to Multiple Heavy Metals 93.113 GIC09-17 No 164,130 Brigham and Women's Hospital - Metal and Organochlorines Exposure: Impact of Adolescent Behavior and Cognition 93.113 101897 No 158,522 Children's Hospital Corporation - Metal Exposure and Children's Preschool Neurodevelopment 93.113 PO0000465780 No 133,860 Northwestern University - Micro-RNA Profiling and Cardiovascular Effects of Traffic Particle Exposure 93.113 60029990 HC No 7,014 Yale University - National Assessment of the Mortality and Morbidity Effects of Tropospheric Ozone 93.113 C10A10658 No 999 Regents of the University of California - Santa Cruz - Neurologic Function in children Exposed to Ambient Manganese 93.113 S0183200 No 62,960 Massachusetts Institute of Technology - Production sequencing of reference human epigenomes 93.113 7210024-5500000383 No 514,915 Johns Hopkins University - Statistical Methods for Complex Environmental Health Data 93.113 2001196559 No 18,252 Brigham and Women's Hospital - Stress, Lead, Iron Deficiency and Neurodevelopment 93.113 102614 No 27,668 Subtotal of 93.113 93.113 2,254,174 78
Yale University - Asthma Severity in Children and Fine Particle Composition 93.115 A06348 (M06A00111) No (486) Brigham and Women's Hospital - Metal Mixtures and Neurodevelopment 93.115 101834 No 36,253 Subtotal of 93.115 93.115 35,767 University of Maryland, Baltimore - Injectable and Strong Nano-Apatite / Stem Cell Scaffolds for Bone Regeneration 93.121 SR00001044 No 65,986 Children's Hospital Corporation - Micromechanical Determinants of Organ Design and Engineering 93.121 Purchase Order 0000411759 No 189,985 University of Medicine and Dentistry of New Jersey - Oral Colonization of Aggegatibacter in Primates 93.121 No Award Number No 54,649 Children's Hospital Corporation - Oral vaccination for AIDS prevention in rhesus monkeys 93.121 83586 No 252,968 University of Puerto Rico - Periodontitis, Biomarkers and Cardiovascular Disease 93.121 2011-000694 No 41,038 Brigham and Women's Hospital - Proteomics Approaches to Organogenesis Under Mass Spectrometry of Proteins Involved in Organogenesis 93.121 BWH PS 103132 No 191,011 Brigham and Women's Hospital - SysCODE: Systems-based Consortium for Organ Design and Engineering 93.121 103064 No 29,749 The Forsyth Institute - T- Regulatory cells in Periodontitis 93.121 No Award Number No 10,436 Subtotal of 93.121 93.121 835,822 Colorado School of Mines - Remediation Effectiveness for Mining Sites: Hysteresis and Metal Mixtures Effects 93.143 400354 No 51,146 Subtotal of 93.143 93.143 51,146 University of Botswana - Programmatic: Enhancing Medical Education and Health Research in Botswana 93.145 No Award Number No 312,976 Subtotal of 93.145 93.145 312,976 Beth Israel Deaconess Medical Center - Geriatric Training Program for Physicians, Dentists and Behavioral and Mental Health Professionals 93.156 No Award Number No 103,843 Subtotal of 93.156 93.156 103,843 Massachusetts Institute of Technology - A Data Analysis Center for Integration of Fly and Worm modencode Datasets 93.172 5710003103 No 167,107 California Institute of Technology - Center for In Toto Genomic Analysis of Vertebrate Development 93.172 19-1090880 No (573,539) Lawrence Berkeley National Lab - Comprehensive Characterization of the Drosophila Transcriptome 93.172 6823741 No 95,511 Arizona State University - Computational Analysis of Gene Expression Pattern Images 93.172 12-697 No 43,590 Fred Hutchinson Cancer Research Center - Genome-wide Profiling of Histone Variants in Drosophila and Ceanorhabditis 93.172 710401 No 99,001 Dana Farber Cancer Institute - Mapping the human binary interactome network 93.172 1016311 No 4,941 Stanford University - Production Center for Global Mapping of Regulatory Elements 93.172 26555590-49487-C No 222,730 The Broad Institute - Reconstruction of the Protein and Non-coding RNA circuits that control and maintain ES cell chromatin 93.172 16820130-5500000400 No 136,679 The Broad Institute - Center for Cell Circuits 93.172 6820132-5500000480 No 247,591 Subtotal of 93.172 93.172 443,611 Brigham and Women's Hospital - Risk Factors for Hearing Loss 93.173 107066 No 40,017 Subtotal of 93.173 93.173 40,017 Harvard Pilgrim Health Care, Inc - Economics Risk Decision Analyses of Post-Certification Immunization Policies for Polio 93.185 No Award Number No (229) Subtotal of 93.185 93.185 (229) Beth Israel Deaconess Medical Center - Clinical and Autonomic Effects of Mind-Body Exercise in COPD 93.213 1024577 No 125,721 Beth Israel Deaconess Medical Center - Remedying Dysfunctional Angiogenesis and Tissue Ischemia with Barleria Lupulina 93.213 1025584 No 18,106 The Queen's Medical Center - Tai Chi for Obesity: A Randomized Controlled Pilot Trial 93.213 No Award Number No (17) Brigham and Women's Hospital - Use and Effectiveness of a Model Integrative Care Clinic in an Academic Hospital 93.213 106515 No 13,871 Subtotal of 93.213 93.213 157,681 University of Chicago - Assessing the Effect of FDA Advisories on Provider, Patient, and Firm Behavior 93.226 44031 No 63,437 Children's Hospital Boston - Children's Hospital Boston Center for Quality Measure 93.226 80563 No 40,909 Children's Hospital Boston - Children's Hospital Boston Center of Excellence for Quality Measurement 93.226 80563 No 10,328 University of Washington - Communication to Prevent and Respond to Medical Injuries: WA State Collaborative 93.226 700345 No 65,908 Yale University - Consumer Assessment of Healthcare Providers and Systems 93.226 A08572 (M08A00778) No 60,025 Harvard Pilgrim Health Care Foundation - Drug Cost Containment Changes and Quality of Care for Mentally Ill Dual Enrollees 93.226 No Award Number No 51,888 Harvard Pilgrim Health Care, Inc - Intended and Unintended Consequences of Nonpayment for Preventable Complications 93.226 No Award Number No 79,386 Health Research, Inc. - New York State Medical Liability Reform and Patient Safety Demonstration Project 93.226 4075-02 No 121,851 Dartmouth College - Technology Evaluation of Emerging Spine Surgery Interventions in the Elderly 93.226 662 No 22,200 Subtotal of 93.226 93.226 515,932 Brigham and Women's Hospital - Evaluating cardiometabolic and sleep health benefits of a workplace intervention 93.233 106694 No 24,997 Beth Israel Deaconess Medical Center - Neuronal Control Mechanisms of the Ascending Sleep Arousal Pathway 93.233 1024773 No 276,624 Brigham and Women's Hospital - The Role of Circadian Periodicity in Human Cardiovascular Disease and Diabetes 93.233 106799 No 33,361 Subtotal of 93.233 93.233 334,982 79
University of Illinois at Chicago - A Services Approach to Preventative Mental Health for Adolescent Refugees 93.242 2006-07177-01-03 No (708) Rand Corporation - An In-Depth Investigation of Racial and Ethnic Disparities in Schizophrenia Care 93.242 9920110012 No 169,861 Group Health Cooperative/Center for Health Studies - ANTIDEPRESSANT TREATMENT AND RISK OF OBESITY 93.242 2011113096 No 51,333 Brigham and Women's Hospital - Community-based accompaniment with supervised antiretrovirals in Lima, Peru 93.242 104741 No 36,019 University of Chicago - Conte Center for Computational System Genomics of Neuropsychiatric Phenotypes (Projects 2 and 4) 93.242 FP046983-D No 133,692 Social + Scientific Systems, Inc. - Cost-Effectiveness Substudy for Promoting Maternal and Infant Survival Everywhere 93.242 BRS-IMPCT-S-12-000325-002532 No 41,417 Internet Solutions for Kids, Inc. - CyberSenga: Harnessing the Power of the Internet to Prevent HIV in Ugandan Youth 93.242 No Award Number No (707) Yale University - Evaluating the Link Between HIV Prevention and Treatment 93.242 A07383 (M09A10162) No 87,799 Regents of the University of California - San Diego - Expanding rapid ascertainment networks of schizophrenia families in Taiwan 93.242 10294558-003 No 21,003 New England Research Institutes, Inc. - Health Effects of Dental Composites in Children 93.242 No Award Number No 12,863 Fordham University - Health Risk Behavior in Late Childhood: Impact of Longitudinal Randomized Trial 93.242 No Award Number No 48,193 Johns Hopkins University - Implementation of Federal Mental Health Parity 93.242 No Award Number No 47,822 Regents of the University of Michigan - Implementing Chronic Care Management for Bipolar Disorder 93.242 3001086768 No 12,997 Regents of the University of California - San Francisco - Long-term CNS consequences of treatment during acute HIV infection 93.242 6878sc No 4,334 Kaiser Foundation Research Institute - Medicare Drug Benefits and High Cost Medications: Antipsychotics Under Part D 93.242 9595/KR020584-001 No 61,664 Regents of the University of California - San Diego - Memory Functioning in children and Adolescents with Perinatal HIV Infection 93.242 10306765-002 No 61,463 Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. - Modifiable Risk and Protective Factors for Suicidal Behaviors in the US Army 93.242 2192 No 1,788,195 National Bureau of Economic Research - Neighborhood Poverty and Mental Health of Low-Income Mothers- An Experimental Study 93.242 40-4108-HMS No 75,661 Children's Hospital Corporation - Network Science Methodology for Assessing PTSD Risk 93.242 79795 No 6,623 New York University School of Medicine - Networking Science Methodology of Assessing PTSD Risk 93.242 11-00293 No 16,786 Johns Hopkins University - OCD Collaborative Genetics Association Study 93.242 2000924094 No 17,733 Northern California Institute for Research and Education - Optimizing Cognitive Remediation Outcome in Schizophrenia 93.242 VIN1399 No 15,360 University of Massachusetts Medical School - Preclinical Development of HIV-1 Vif Antagonists 93.242 PO M169052 No 9,067 Beth Israel Deaconess Medical Center - Predictors and Mechanisms of Conversion to Psychosis 93.242 1024853 No 43,206 Yale University - Reducing Violence and HIV Risk Among War-Exposed Liberian Youth 93.242 M12A11193(A08464) No 2,807 Social + Scientific Systems, Inc. - Statistical and Data Management Center - Pediatric AIDS CTG 93.242 BRS-IMPCT-S-11-000325-001852 No 539,735 Brigham and Women's Hospital - Statistical Methods for the Design and Interpretation of Deep Resequencing Studies 93.242 107498 No 66,011 University of North Carolina - Chapel Hill - Stress Response as Prospective Predictors of Girls' Suicidality and Self-Injury 93.242 5-30447 No 61,866 Columbia University - The Cross-National Epidemiology of Trauma Exposure and PTSD 93.242 1 (Acct. 5-30127) No 223,921 Beth Israel Deaconess Medical Center - Vulnerability to Progression in Schizophrenia (Administrative Core) 93.242 5 P50 MH080272-05 No 98,896 Beth Israel Deaconess Medical Center - Vulnerability to Progression Schizophrenia (Project 3) 93.242 5P50MH080272-05 No 148,117 Subtotal of 93.242 93.242 3,903,029 The Center to Protect Workers' Rights (CPWR) - Effectiveness of employee safety incentive programs in construction 93.262 3002-007-01 No 16,969 The Center to Protect Workers' Rights (CPWR) - Effectiveness of employee safety incentive programs in construction 93.262 3003-007-01 No 139,327 New York Center for Agricultural and Medical Health - Northeast Fisheries Winch Safety Improvement Project 93.262 No Award Number No 63,595 Board of Trustees of the University of Illinois - Translocations in Dioxin Exposed Workers from Ufa 93.262 2007-04528-09-00 (489986) No 16,373 Subtotal of 93.262 93.262 236,264 The Center to Protect Workers' Rights (CPWR) - Adoption of Innovations to Minimize (AIM) Exposure to Dust and Fumes in Construction 93.269 3003-005-01 No 32,139 The Center to Protect Workers' Rights (CPWR) - Validating Safety Climate in a Contractor Safety Assessment Program (CSAP) 93.269 11-1-PS No 21,939 Subtotal of 93.269 93.269 54,077 San Diego State University Research Foundation - Administrative Core of the CIFASD (U24) 93.273 53253H P1660 7802 211 No 13,739 Subtotal of 93.273 93.273 13,739 McLean Hospital - Alpha Adrenergic Pharmacotherapy for Polydrug (Stimulant/Opiate) Abuse 93.279 400658 No 127,070 Regents of the University of Michigan - Ecologic Stressors, PTSD and Drug Use in Detroit 93.279 3001275539 No 32,551 Weill Medical College of Cornell University - Quality of life outcomes in prescription and injection opioid dependence 93.279 11111987-3 No 14,253 Brandeis University - Research Center on Managed Care and Drug Abuse Treatment 93.279 4-01394, 4-01044 No 38,141 Johns Hopkins University - Statistical Designs and Methods for Partially Controlled HIV/AIDS Studies 93.279 2000246062 No 69,170 Boston University - Strategies for Enhancing Extinction of Drug-Seeking Behavior 93.279 4500000293 No 186,115 Subtotal of 93.279 93.279 467,299 Boston University - Evaluating the roles of schools in adolescent mental health service provision 93.281 4500000279 No 15,458 Subtotal of 93.281 93.281 15,458 National Public Health Information Coalition - Planning and Management of a Public Health Comm and Community Engagement Project 93.283 1349-01 No 926 Subtotal of 93.283 93.283 926 80
Beth Israel Deaconess Medical Center - An XFM Interventional Guidance System for Cardiac Resynchronization Therapy 93.286 R01ED008743 No (8,528) University of Maryland, College Park - Depth-Resolved Quantitative Multi-Model Imaging for GI Cancer Detection 93.286 Z032801 No 23,369 Numerica Technology - Numerical Tools for Analyzing Cell Signaling Circuits in Normal and Tumor Cells 93.286 100907 No 4,681 Subtotal of 93.286 93.286 19,522 Northeastern University - Culturing Uncultivatable Gut Microorganisms 93.301 50017178050 No 203,611 Subtotal of 93.301 93.301 203,611 Brigham and Women's Hospital - Air Pollution, Stress and Urban Child Development 93.307 106478 No 25,350 The Forsyth Institute - EFFECTIVENESS AND IMPROVEMENT OF RURAL, SCHOOL-BASED, CARIES PREVENTION PROGRAMS 93.307 006964-HSPH2390 No 15,618 Northeastern University - Effects of a housing policy experiment on youth behavioral problems 93.307 500181 No 102,794 University of Massachusetts - Boston - Establishing Exploratory NCMHD Research Centers of Excellence (P20) 93.307 No Award Number No (180) University of Puerto Rico - UPR-CHA Research Center of Excellence: Making a Difference for Latino Health 93.307 No Award Number No 40,886 Subtotal of 93.307 93.307 184,468 Massachusetts General Hospital - Molecular prostheses for mitochondrial disorders 93.310 219702 No 125,056 Dana Farber Cancer Institute - NMR Structure Determination of Membrane Proteins Enabled by DNA Nanotubes 93.310 1149304 No 46,701 Brigham and Women's Hospital - Prevalence, risk factors and consequences of complex M. Tuberculosis infections 93.310 105405 No 5,126 Subtotal of 93.310 93.310 176,883 University of Rochester - End-of-Life Quality of Care in Nursing Homes 93.361 415084-G No 102,462 University of Miami - Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children 93.361 5R01NR012885 No 35,195 Subtotal of 93.361 93.361 137,656 Brigham and Women's Hospital - Perinatal Programming of Infant Stress Reactivity and the Atopic Phenotype 93.388 106021 No 93,292 Subtotal of 93.388 93.388 93,292 Regents of the University of Michigan - CHARMM Modernization, Performance and Continued development 93.389 3001052298 No 74,197 University of Texas Health Science Center at San Antonio - Development of a barrier colony of common marmosets 93.389 130447/130446 No 32,385 Brigham and Women's Hospital - Functional Biomedical Informatics Research Network 93.389 100996 No 25,909 Dana Farber Cancer Institute - Small Molecule Screening and Cell-Based Assay Core 93.389 4474803 No 155,711 Subtotal of 93.389 93.389 288,202 Columbia University - National Center for Multi-Scale Study of Cellular Networks 93.390 5-76089 No 551 Columbia University - National Center: Multi-Scale Study of Cellular Networks 93.390 5-76638 No 162,489 Subtotal of 93.390 93.390 163,040 University of Southern California - A Genome-wide Association Study of Prostate Cancer in African Americans 93.393 H48688 No 899,706 University of Texas - A Genomewide Association of Study of Lung Cancer in Never Smokers 93.393 12052705/98510704 No 38,597 Brigham and Women's Hospital - A prospective analysis of peripheral blood cytokines and nonohodgkin lymphoma 93.393 107288 No 11,001 Dana Farber Cancer Institute - CanCORS: Cancer Statistical Coordinating Research Center 93.393 1156208 No 238,861 Dana Farber Cancer Institute - CanCORS: Statistical Coordinating Research Center 93.393 1156308 No 258,712 Dana Farber Cancer Institute - Cellular Targets of the Papillomavirus E6 Oncoproteins 93.393 No Award Number No 198 Brigham and Women's Hospital - Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 93.393 103467 No 269,928 Brigham and Women's Hospital - Cohort Study of Genetic Susceptibility to Breast Cancer 93.393 103187 No 31,273 Brigham and Women's Hospital - Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma 93.393 103920 No (6,740) Dana Farber Cancer Institute - Comparative Modeling: Informing Breast Cancer Control Practice and Policy 93.393 4481402 No 17,309 Brigham and Women's Hospital - Cysteine, Related Gene Variants and Breast Cancer Risk 93.393 103030 No 3,428 Brigham and Women's Hospital - Dietary and Hormonal Determinants of Cancer in Women (Core C) 93.393 105845 No 150,972 Columbia University - Dietary Factors and Risk of Pancreatic Center in a Pooled Analysis 93.393 5-38632 No 17,255 University of Southern California - Elucidating Loci involved in Prostate cancer Susceptibility 93.393 H46392 No 13,596 Dana Farber Cancer Institute - Epigenetic Events and Colorectal Cancer 93.393 1186702 No 24,508 Brigham and Women's Hospital - Genetic Susceptibility to Endometrial Cancer 93.393 152546 No (27) Brigham and Women's Hospital - Growth Factor's and Lethal Prostate Cancer Signature 93.393 105765 No 183,645 Boston University - Health Advocates as a Vehicle to Improve Treatment for Smokers in Public Housing 93.393 3840-5 No 41,184 Dana Farber Cancer Institute - Papillomavirus E2 Growth Suppression Mechanisms 93.393 1037924 No 332,922 Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. - Pesticide Exposure and DNA Methylation in Pesticide Applications 93.393 696310 No 40,022 University of Massachusetts - Worcester - RCT for Smoking Cessation in 10 Medical Schools 93.393 6114207/RFS900193 No 36,918 Roswell Park Cancer Institute - Roswell Park Subcontract, Testing Tobacco Products Promoted to Reduce Harm 93.393 No Award Number No 10,612 Brigham and Women's Hospital - Sex Steroid Hormones, Gene Variants and Colorectal Cancer 93.393 104045 No 10,146 Brown University - The Epidemiology of Molecular Alterations in Mesothelioma 93.393 180 No 10,427 Dana Farber Cancer Institute - The Function of Snf5, an Epigenetic Tumor Suppressor 93.393 1110008 No 38,514 Brigham and Women's Hospital - The Role of Prolactin in the Etiology of Postmenopausal Breast Cancer 93.393 101096 No (1,175) Harvard Pilgrim Health Care Foundation - Unified Approaches for Missing Data in Observational Studies 93.393 AH000434 No 6,245 Brigham and Women's Hospital - Whole Genome Association Study of Mammographic Density 93.393 104369 No 168,454 Subtotal of 93.393 93.393 2,846,492 81
Purdue University - Exploratory Study of Environmental Effects on Activity/ Overweight in Older Women 93.394 4102-21003 No 757 Brigham and Women's Hospital - Harvard Genome Characterization Center (U24) 93.394 105236 No 84,277 Beth Israel Deaconess Medical Center - Harvard/Michigan/Cornell Prostate Cancer Biomarker Clinical Validation Center 93.394 1024500 No 87,326 Dana Farber Cancer Institute - Molecular and Genetic Analysis of Neuroendocrine Tumor Risk and Survival 93.394 1194201 No 74,652 Massachusetts General Hospital - Quantitative Analysis of Pharmacological Mechanism by Intravital Imaging 93.394 219649 No 216,394 The Broad Institute - The Cancer Gemone Atlas Data Analysis Center 93.394 5420131-5500000437 No 275,154 Subtotal of 93.394 93.394 738,559 University of Utah - Anti-Cancer Agents From Unique Natural Product Sources 93.395 2405119-04 No 997 Dana Farber Cancer Institute - Black-White Differences in Advanced Cancer Communication, Acceptance and Care 93.395 1106507 No 11,426 Massachusetts General Hospital - Center for Molecular Imaging Research, Project 4 - CD8 Imaging 93.395 204785 No 67 Massachusetts Institute of Technology - Optical Biopsy Using Optical Coherence Tomography 93.395 5710002573 No 78,067 Subtotal of 93.395 93.395 90,556 The Methodist Hospital Research Institute - High-content Image Analysis and Modeling for RNAigenome-wide Screening 93.396 009-8515 No 153,897 Burnham Institute for Medical Research - Intravital Microscopy Core 93.396 54337-11063-HMS-04 No 145,241 Whitehead Institute for Biomedical Research - Mechanism of Breast Development and Carcinogenesis (Project 4) 93.396 11-1600-1304 (Project 4) No 271,425 Brigham and Women's Hospital - Molecular Pathogenesis of the Hamartoma Syndromes P01 Project 1: Tuberous Sclerosis-Pathway and Pathogenesis 93.396 102695 No 137,734 Brigham and Women's Hospital - Molecular Pathogenesis of the Hamartoma Syndromes- Project 3 93.396 102696 No 285,020 Drexel University - Role of Nutrient Sensor O-GlcNAc Transferase in Regulating Cancer 93.396 232487 No 15,053 Brigham and Women's Hospital - Sex Hormones and the TMPRSS2:ERG Fusion in Prostate Cancer Progression 93.396 104372 No 182,577 Subtotal of 93.396 93.396 1,190,947 Brigham and Women's Hospital - Behavioral and Biologic Factors Associated with Tanning Bed Use and Cessation 93.397 104003 No 2,011 Dana Farber Cancer Institute - Biguanides for the treatment of Prostate Cancer 93.397 1060110 No 55,037 Dana Farber Cancer Institute - Cancer Center Support Grant 93.397 46HSPH-S5 No 235,805 Dana Farber Cancer Institute - Cancer Center Support Grant 93.397 HMS-46S5 No 665,390 Dana Farber Cancer Institute - Cancer Center Support Grant 93.397 HSPH-47 No 31,919 Dana Farber Cancer Institute - Comprehensive Partnerships to Reduce Cancer Health Disparities 93.397 1190602 No 161,863 Dana Farber Cancer Institute - Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer 93.397 p1082608 No 83,029 Dana Farber Cancer Institute - DF/HCC SPORE IN GASTROINTESTINAL CANCER 93.397 1132305 No 31,381 Dana Farber Cancer Institute - In vivo analysis of signaling dynamics in the Notch interaction network 93.397 1190702 No 99,572 Massachusetts Institute of Technology - MIT Center for Single-Cell Dynamics in Cancer (SCDC) 93.397 5710003044 No 162,588 Regents of the University of New Mexico - Population-based Research Optimizing Screening 93.397 3RF82 No 158,202 Massachusetts Institute of Technology - Regulatory Networks in Cancer Initiation and Progression 93.397 5710003158 No 114,356 Univ of TX M.D. Anderson Cancer Ctr - Regulatory T Cell Compartment (Project 2) 93.397 12011577/98215380 No 98,203 Dana Farber Cancer Institute - SPORE in Lung Cancer (Project 1) 93.397 P1082009 No 211,587 Dana Farber Cancer Institute - Spore in Lung Cancer Project 1 93.397 No Award Number No (4,456) Dana Farber Cancer Institute - Understanding the role of histone methylation in transcription regulation 93.397 1124408 No 67,598 Subtotal of 93.397 93.397 2,174,086 Dana Farber Cancer Institute - DFCI Training Grant 93.398 No Award Number No 51,208 Dana Farber Cancer Institute - The regulation of the WAVE complex by phosphorylation 93.398 No Award Number No 42,938 Dana Farber Cancer Institute - Tumor Cell Biology Training Program 93.398 No Award Number No 103,739 Dana Farber Cancer Institute - Tumor Cell Biology Training Program 93.398 No Award Number No 10,913 Subtotal of 93.398 93.398 208,798 Brigham and Women's Hospital - Aspartame Intake and Risk of Cancer 93.399 103047 No 3,992 Massachusetts Institute of Technology - Center for Cancer Nanotechnology Excellence (Pilot Project 1) 93.399 5710002638 No (2,413) Subtotal of 93.399 93.399 1,579 Commonwealth of Massachusetts/Department of Public Health - Mass in Motion: Community-Clinical Partnerships to Reduce Childhood Obesity 93.535 RESEARCHSERVEHH20000 No 124,081 Subtotal of 93.535 93.535 124,081 82
Brigham and Women's Hospital - Air Disinfection Technology Innovation for Resources Limited Settings 93.701 106381 Yes 44,884 Brigham and Women's Hospital - Automated Integration of Biomedical Knowledge 93.701 105135 Yes 143,354 Duke University - CARRA: Accelerating Toward an Evidence-based Culture in Pediatric Rheumatology 93.701 203-9012 Yes (783) University of Maryland, College Park - Coinfection and resistance impact on influenza aerosol generation and control 93.701 Z020201 Yes 66,144 Children's Hospital Boston - Comparative Phenotypic, Functional, and Molecular Analysis of ESC and ipsc 93.701 323053 Yes 103,788 Children's Hospital Boston - Comparative Phenotypic, Functional, and Molecular Analysis of ESC and ipsc 93.701 393048 Yes 193,939 Children's Hospital Boston - Comparative phenotypic, functional, and molecular analysis of ESC and ipsc 93.701 323053 Yes (1,594) Hospital for Special Surgery - Defining Common Molecular Parameters for Onset and Progression of Osteoarthristis 93.701 No Award Number Yes 168,706 University of North Carolina - Chapel Hill - Development of a novel vaccine for protection against gammaherpesvirus infection 93.701 5-30357 Yes 59,051 University of Miami Miller School of Medicine - Dietary intakes and patterns, biomarkers, and material and infant outcomes in HIV 93.701 SiteNo3 Yes 78,206 Vanderbilt Medical Center - Differentiation of ips Cells from Type 1 Diabetes into Hematopoietic Stem Cells 93.701 VUMC36016 Yes 499,304 University of Wisconsin - Discovery of natural product-based drugs from symbionts of insects 93.701 271K961 Yes 273,678 Brown University - Effect of Prescription Drug Benefits on Cardiovascular Outcomes in the Elderly 93.701 270 Yes 22,592 University of Mississippi - Enabling imputation and CNV analysis in genetic studies of African Americans 93.701 67701-HMS02 Yes (84,149) Beth Israel Deaconess Medical Center - Endothelial Dysfunction, Oxidative Stress, and Risk of Peripheral Arterial Disease 93.701 1023686 Yes 101,361 Harvard Pilgrim Health Care, Inc - Epidemiology and Epigenetics: Maternal Diet, DNA Methylation and Offspring Adiposity 93.701 AR001003 Yes 16,373 Tufts University - Epigenetics behind long-term and transgenerational effects of adolescent behavior 93.701 HSZ052 Yes 88,921 Brigham and Women's Hospital - Epstein-Barr Virus: A persistent vaccine vector 93.701 105114 Yes 2,175 Cambridge Health Alliance - Ethnic and Racial Bias in Screening for Psychiatric Disorders in Adolescents 93.701 No Award Number Yes 182,817 Massachusetts Eye and Ear Infirmary - Evaluation of New Strategies and Compounds to Treat MRSA Infections 93.701 39969 Yes 128,024 Johns Hopkins University - Generation and Characterization of Amyotrophic Lateral Sclerosis IPS cells 93.701 2000817724 Yes 14,509 University of Washington - Genetic risks for ALl in ARDSnet and the ispaar Consortium 93.701 729234Z Yes 107,828 Brigham and Women's Hospital - Genome Wide Association Study of Endometrial Cancer 93.701 105130 Yes 7,892 Fred Hutchinson Cancer Research Center - Genome-wide Profiling of Histone Variants in Drosophila and Ceanorhabditis 93.701 686835 Yes 7,069 National Bureau of Economic Research - Hospital Integration and Medicare Reimbursement Policy 93.701 33-4101-00-0-80-233 Yes 4,361 Brigham and Women's Hospital - HSDRC (Harvard Skin Disease Research Center) - Leukocyte Migration Core 93.701 105832 Yes (1) Children's Hospital Corporation - Human autism genetics and activity dependent gene activation 93.701 No Award Number Yes 174,398 Brigham and Women's Hospital - Inflammation/Oxidation, Omega-3's, and Post-Op AFib and Cognitive Decline 93.701 105129 Yes 411,321 Children's Hospital Corporation - Metal Exposure and Children's Preschool Neurodevelopment 93.701 319844 Yes 53,334 Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. - Modifiable Risk and Protective Factors for Suicidal Behaviors in the US Army 93.701 2192 Yes 256,160 Johns Hopkins University - North American AIDS Cohorts Collaboration on Research and Design 93.701 2000784426 Yes 26,095 University of Washington - Novel Methods of Measuring Health Disparities 93.701 703730Z Yes 35,970 Brown University - Nudging Doctors to Collaborate with Pharmacists to Improve Medication Adherence 93.701 419 Yes 21,572 Brigham and Women's Hospital - Physical Activity and Diet in the Prevention of Obesity in Men and Women 93.701 104748 Yes 22,275 Children's Hospital Corporation - Primary care imet to reduce teen tobacco, alcohol and drug use 93.701 88843 Yes 2,320 University of Massachusetts Medical School - Project 3: Viral Regulation of TLR and Cytoplasmic Signaling 93.701 6124552/RFS2011073 Yes 85,209 University of Pennsylvania - Reducing Cardiovascular Risk Using Novel Incentive Approaches 93.701 555707 Yes 50,481 Mount Sinai School of Medicine - Role of IGF-1 Receptor Signaling Pathways in Cell Survival and Migration 93.701 0256-7581-4609 Yes 22,759 Brigham and Women's Hospital - Stopping Rules for Cumulative Drug Safety Monitoring Using Healthcare Databases 93.701 105118 Yes 11,791 University of Nebraska at Lincoln - Structural insights into redox homeostasis 93.701 24-6230-0114-002 Yes (5,083) Dana Farber Cancer Institute - T-Cell Antigen Recognition 93.701 2842927 Yes 6,973 Brigham and Women's Hospital - T. Vaginalis Viruses as Mucosal Immunity Modifiers with Impact on Women's Health 93.701 106261 Yes 57,670 Brigham and Women's Hospital - Targeted Blood-Brain Disruption using Focused Ultrasound in a Large Animal Model 93.701 105127 Yes 22,704 Children's Hospital Boston - Tetrahydrobiopterin and pain 93.701 350625 Yes 30,182 American Society for Cell Biology - The Cell: An Image Library 93.701 148618.376427.0201 Yes 21,406 National Bureau of Economic Research - The Effect of Health Insurance on Utilization and Outcomes: The Oregon Experiment 93.701 ARRA-HU-33-6702 Yes 101,967 National Bureau of Economic Research - The Effect of Health Insurance on Utilization and Outcomes: The Oregon Lottery 93.701 ARRA-HMS-33-6702 Yes 46,813 Brigham and Women's Hospital - The Epidemiology of Home Allergens and Asthma 93.701 104845 Yes 23,092 Univ of TX M.D. Anderson Cancer Ctr - The Role of Aberrant Splicing of EVII in Ovarian Cancer 93.701 28319/ 98113937 Yes (874) Univ of TX M.D. Anderson Cancer Ctr - Validation and extension of an existing risk model for lung cancer 93.701 32795 / 98013889 Yes 30,655 Subtotal of 93.701 93.701 3,737,638 Brigham and Women's Hospital - Informatics for Integrating Biology and the Bedside 93.704 106458 No 133,400 Brigham and Women's Hospital - Informatics for Integrating Biology and the Bedside 93.704 106463 No 82,111 Subtotal of 93.704 93.704 215,511 Brigham and Women's Hospital - Perinatal Stress and Programming of Childhood Wheeze and Lung Function 93.834 106613 No 153,174 Subtotal of 93.834 93.834 153,174 83
Brigham and Women's Hospital - A Planning Study: Sleep Apnea Intervention for Cardiovascular Disease Reduction 93.837 106313 No 17,297 Brigham and Women's Hospital - Adult Tissue Morphogenesis: Functional Regulation of Intussuceptive Angiogenesis 93.837 104774 No 95,737 Brigham and Women's Hospital - Calcium-phosphorus metabolism and the risk of cardiovascular disease 93.837 104626 No 24,936 New England Research Institutes, Inc. - Candidate Gene Evaluation Core Facility for the PCGC 93.837 No Award Number No 362,811 Brigham and Women's Hospital - Carbohydrate: Amount and Type Affecting Risk for CVD and Diabetes 93.837 101944 No 39,806 Massachusetts General Hospital - Determination of the role of endothelial and mesenchymal cells in regulating lung 93.837 218050 No 50,515 DRVision Technologies LLC - Efficient Patient-Specific Cell Generation by Image-Guidance 93.837 A15268 No 88,386 Brigham and Women's Hospital - Genetic Determinants of COPD in Diverse Ethnic Groups 93.837 103133 No 33,106 Brigham and Women's Hospital - Genetic Features of Gender Differences in COPD 93.837 103576 No 14,650 Regents of the University of Michigan - Genetic Modification of Triggers of Acute Myocardial Infarction 93.837 3001679109 No 27,365 Joslin Diabetes Center - Genetics of Coronary Artery Disease in Type 2 Diabetes 93.837 No Award Number No 46,095 University of Washington - Glycogen Metabolism and PRKAG2 cardiomyopathy 93.837 651962 No (39) University of Mississippi - Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study 93.837 66744-HMS No (25,167) Massachusetts General Hospital - Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases 93.837 215420 No 218,655 Massachusetts General Hospital - Human Pluripotent Stem Cells and Progenitor Models of Cardiac and Blood Diseases- Research Component 93.837 215420 No 133,608 Brigham and Women's Hospital - Identification of Molecular and Genetic Mechanisms of Atrial Fibrillation 93.837 105810 No 245,023 Children's Hospital Corporation - Image-guided Intracardiac Beating-Heart Surgery 93.837 01 HL073647-08 No 198,900 Massachusetts General Hospital - Integrating lipid genotypes and phenotypes in ips-derived hepatocyes/adipocytes 93.837 218179 No 64,161 Massachusetts General Hospital - Integrating Lipid Genotypes and Phenotypes inios-derived Hepatocyes / Adipocytes 93.837 218179 No 56,596 Massachusetts General Hospital - Microenvironmental Control of Progenitors in Organ Dysfunction and Repair 93.837 215520 No 192,455 Brigham and Women's Hospital - Modifiable Effectors of Renin System Activation: Treatment Evaluation 93.837 106589 No 25,127 Duke University - Novel Mechanisms and Therapies in Heart Failure 93.837 203-1048 No 53,767 Stanford University - Predicting patients outcomes with bio/genetic markers via empirical models 93.837 24730170-44738-A No 88,969 Brigham and Women's Hospital - Rick Factors for Ischemic Stroke in Women 93.837 103967 No 4,856 Brigham and Women's Hospital - Risk Factors for CVD in Women 93.837 103587 No 36,489 New England Research Institutes, Inc. - RNA Expression Core Facility for the B2B CvDC 93.837 No Award Number No 451,966 Carnegie Mellon University - Robotic Crawler for Epidcardial Interventions 93.837 1090228-258136 No 20,995 University of Hawaii - Statins and the Effect of HIV Induces Inflammation on Cardiovascular Complications 93.837 ZA02210 No 18,136 Brigham and Women's Hospital - Violence, Genes and Cardiovascular Events in Women 93.837 102708 No 16,139 Subtotal of 93.837 93.837 2,601,342 Brigham and Women's Hospital - Common Genetic Determinants of Asthma and COPD: Program Project Statistical Core 93.838 102198 No 91,721 Albert Einstein College of Medicine - Early Insulin Therapy and Development of ARDS 93.838 9-526-2485 No 112,106 Brigham and Women's Hospital - Genetic Epidemiology of COPD: Genome-Wide Analysis 93.838 103118 No 275,771 Brigham and Women's Hospital - Genetics and Gene Expression Profiling in Asthma 93.838 107599 No 3,967 University of Chicago - HLA-G-LILRB-SHP2 Axis in Airway Smooth Muscle 93.838 41418-B No 19,971 Brigham and Women's Hospital - Identifying Genetic Determinants of Severe Early Onset COPD 93.838 107872 No 1,330 Brigham and Women's Hospital - Intrauterine smoke exposure and asthma: Genomic Origins 93.838 104893 No 15,628 Brigham and Women's Hospital - Lung Vitamin D and Omega-3 Trial 93.838 105859 No 231,122 Regents of the University of Michigan - Mesenchymal Cell Fate Determination by Extracellular Matrix Stiffness 93.838 3001967823 No 40,693 University of Colorado - Pathobiology of HIV (SIV)-induced angioproliferative pulmonary hypertension 93.838 FY10.064.001 No 33,999 Brigham and Women's Hospital - Project 1: Genetics of COPD 93.838 107263 No 70,730 Brigham and Women's Hospital - Prospective Trial of Simvastatin in the Prevention of COPD Exacerbations 93.838 100200 No 2,733 Massachusetts General Hospital - Protective Role of the S1P-S1P1 Pathway in Pulmonary Fibrosis 93.838 218503 No 63,611 Brigham and Women's Hospital - The Genetic Epidemiology of Asthma in Costa Rica 93.838 106790 No 41,072 University of Chicago - Therapeutic Potentiation of Bronchial Dilatation 93.838 45908 No 179,362 Brigham and Women's Hospital - Weiss T32HL007427-31 CLINICAL EPIDEMIOLOGY OF LUNG DISEASES 93.838 2T32HL007427 No 50,000 Brigham and Women's Hospital - Weiss T32HL007427-31 CLINICAL EPIDEMIOLOGY OF LUNG DISEASES 93.838 No Award Number No 18,000 Subtotal of 93.838 93.838 1,251,815 Immune Disease Institute, Inc - Immune Receptor Recognition and Signaling in Cell Membrane 93.839 No Award Number No 286,048 Beth Israel Deaconess Medical Center - Program in Blood Coagulation and Vascular Biology 93.839 No Award Number No 44,336 Children's Hospital Boston - T32 at Children's: David Williams Program Director 93.839 No Award Number No 16,040 Subtotal of 93.839 93.839 346,424 Spaulding Rehabilitation Hospital - Adiposity and Bone Loss in Spinal Cord Injury 93.846 No Award Number No 132,523 Hebrew Rehabilitation Center for Aged - Building Interdisciplinary Research Teams 93.846 10.10.90052 No 48,189 Brigham and Women's Hospital - Clinical Orthopedic and Musculoskeletal Education and Training 93.846 107155 No 45,590 The Forsyth Institute - Role of NHA-oc/NHA2 in Osteoclast Differentiation and Function 93.846 HMSVA NIH2320 No 4,190 Memorial Sloan Kettering - The Framingham School Study of Nevi in Children: Sonic II 93.846 No Award Number No 98,752 Subtotal of 93.846 93.846 329,244 84
Brigham and Women's Hospital - Acid-base status and the development of hypertension and diabetes 93.847 104825 No 19,666 Brigham and Women's Hospital - Biochemical and Genetic Markers of Type 2 Diabetes 93.847 105640 No 372,612 Brigham and Women's Hospital - Biochemical and Genetic Markers of Type 2 Diabetes 93.847 156531 No (3,096) Brigham and Women's Hospital - Biochemical and Genetic Markers of Type 2 Diabetes Risk 93.847 105640 No 30,489 Boston Medical Center - Boston Obesity Nutrition Research Center 93.847 186908 No 273,400 Massachusetts General Hospital - Common Genetic Variation and Diabetes Traits in Framingham 93.847 207092-NCE No 48,684 Massachusetts General Hospital - Common Genetic Variation and Quantitative Diabetes Traits 93.847 218446 No 10,933 Children's Hospital Boston - Customized stem cells for clinical application in blood disorders 93.847 456983 No 109,173 Children's Hospital Corporation - Developing a novel mouse model to study the role of inflammation in driving IBD 93.847 74162 No 32,341 Children's Hospital Boston - Dietary modulation of drug metabolism in the distal gut 93.847 74162 No 18,750 Children's Hospital Boston - Food and Beverage Patterns that Predict Weight Gain Among Adolescents 93.847 354441 No 23,811 University of Utah - Functional Genomics of the Mitochondrial Proteome 93.847 10021486 No 31,386 Children's Hospital Boston - Interrogating the Role of ALPK1 and TIFA as Susceptibility Genes in Inflammatory Bowel Disease 93.847 74162 No 30,445 Children's Hospital Boston - Interrogating the Role of ALPK1 and TIFA as Susceptibility Genes in Inflammatory Bowel Disease 93.847 PO0000355082 No 3,182 Joslin Diabetes Center - Joslin Diabetes NIH T32 Training Granti 93.847 2-20-877-35 No 30,163 Massachusetts General Hospital - Linking Lifestyle to the Oral and Gut Microbiota in a Large Prospective Cohort 93.847 217657 No 15,995 Vanderbilt University - Modified RNA to Control Pancreatic Cell Fates 93.847 VUMC 37965 No 302,614 Brigham and Women's Hospital - Physiology of Thyroid Hormone-dependent Gene Expression 93.847 107227 No 20,773 Vanderbilt University - Rational maturation of beta cells based on in-depth profiling (RatMat) 93.847 VUMC 38572 No 194,493 Children's Hospital Boston - Regulation of Triglyceride Metabolism by the transcription factor CREB-H 93.847 355083 No 6,030 Boston Medical Center - Risk Factors for Barrett's Esophagus 93.847 2284 No 37,671 Subtotal of 93.847 93.847 1,609,515 Boston Medical Center - Boston Obesity Nutrition Research Center 93.848 186906 No (2,740) Children's Hospital Boston - The pervasive effects of citrobacter rodentium infections on the mouse gut microbiota 93.848 purchase order 0000355079 No 28,625 Subtotal of 93.848 93.848 25,885 Brigham and Women's Hospital - Risk Factors for Recurrent Nephrolithiasis 93.849 133133 No (2,085) Brigham and Women's Hospital - The Pathobiology of Nephrolithiasis - Project 3 93.849 103234 No 31,362 Brigham and Women's Hospital - The Pathobiology of Nephrolithiasis (Core A) 93.849 103275 No 46,700 Subtotal of 93.849 93.849 75,977 Brigham and Women's Hospital - Antigen Specific Therapy in CNS Autoimmune Diseases: Project 1 93.853 101491 No 26,882 Michigan State University - Clinicopathological Correlates of Cerebral Malaria 93.853 61-0805HA No 15,851 University of Hawaii - HIV and Global Drug therapies: Peripheral Neurophathy Complications and Mechanisms 93.853 ZA03067 No 33,801 Dana Farber Cancer Institute - Molecular Mechanisms of Fate Choice in Neural Stem Cells: Core B- Transcriptional Control of Inhibitory Synapse Development 93.853 1100408/Core B No 158,904 Dana Farber Cancer Institute - Molecular Mechanisms of Fate Choice in Neural Stem Cells: Project 3- Transcriptional Control of Inhibitory Synapse Development 93.853 1100208/Project 3 No 305,614 Washington University - Neurologic AIDS Research Consortium 93.853 WU-08-199 No 79,063 Regents of the University of California - San Francisco - Peripheral Reservoir of HIV DNA In Monocytes Pivitol to Cognition in HIV 93.853 5728sc No 15,158 Brigham and Women's Hospital - Prospective Study of Restless Legs Syndrome 93.853 105230 No 54,381 Columbia University - Protocadherin Gene Expression and Function 93.853 5-39386 No 109,310 Dana Farber Cancer Institute - Reprogramming neural energy metabolism for control of excitability and seizures 93.853 1196401 No 68,340 Brigham and Women's Hospital - Role of B7 costimulation in induction and regulation of EAE 93.853 103501 No 149,303 Brigham and Women's Hospital - Small Molecule Probes for Elucidating Necrotic Cell Death Mechanisms 93.853 105131 No 95,772 Children's Hospital Boston - TRP channels as drug portals to block calcium channels and synaptic transmission 93.853 71279 No 189,696 Subtotal of 93.853 93.853 1,302,075 85
Children's Hospital Corporation - A cellular receptor for New World arenaviruses 93.855 219816 No (253) Children's Hospital Corporation - A cellular receptor for New World arenaviruses 93.855 472910 No 2,082 Beth Israel Deaconess Medical Center - A SIV/rhesus monkey penile mucosal transmission model 93.855 1025131 No 12,206 Massachusetts General Hospital - Acute HIV Infection: Implications for vaccine design 93.855 208779 No 67,595 Brigham and Women's Hospital - Allergens in Inner-City Schools and Childhood Asthma 93.855 103304 No 20,491 Duke University - An in Vivo Cytolytic CD8+ T Lymphocyte Assay for Evaluating AIDS Vaccine Efficacy 93.855 2030886 No 198,308 Beth Israel Deaconess Medical Center - CAVR - Project 5: Immunoglobulins Delivered by AAV Vector for the Prevention of SIV Infection 93.855 1025089 No 388,035 Beth Israel Deaconess Medical Center - CAVR Administrative Core (A2): NEPRC 93.855 1025090 No 56,678 Beth Israel Deaconess Medical Center - CAVR Immunology Core (C1) 93.855 1025092 No 136,353 Brigham and Women's Hospital - Cellular and Molecular Effectors of Synovitis Core B: Arthritis Genomics and Bioinformatics Core 93.855 101537 No 61,283 Brigham and Women's Hospital - Cellular and Molecular Effectors of Synovitis- Project 1: CpG-mediated dampening of the effector phase of arthritis 93.855 101536 No 80,715 New York University Langone Medical Center - Characterization of Pupylation in Mycobacterium Tuberculosis 93.855 10-01259: Project 801788 No 25,217 Massachusetts Eye and Ear Infirmary - Compounds and Strategies for Treating MRSA and VRE 93.855 No Award Number No 261,321 Harvard Pilgrim Health Care, Inc - Conjugate vaccine impact of pneumococcal carriage, disease, and population (SPARC2) 93.855 PH000391A No 359,202 Massachusetts General Hospital - Cost Effectiveness of Preventing HIV Complications 93.855 216621 No 87,743 Yale University - Costimulatory Mechanisms of Autoimmunity (Composite) 93.855 A08022 (M11A10892) No 795,212 Regents of the University of California - San Diego - Determinants of HIV Transmission 93.855 10283851-005 No 47,386 Michigan State University - Determinants of Malaria Disease in Malawi 93.855 RC060860HSPH No 19,249 Microbiotix, Inc. - Developing small molecule therapeutics for Ebola hemorrhagic fever virus 93.855 HMS001 No 86,219 Massachusetts Eye and Ear Infirmary - Development of anti-biofilm agents that target staphylococcal biofilms 93.855 No Award Number No 133,627 Dana Farber Cancer Institute - Eliciting B Cells to Produce Anti-HIV gp41 MPER-specific Neutralizing Antibodies 93.855 1188402 No 201,559 Brigham and Women's Hospital - Epidemiology and Transmission Dynamics of MDR/XDR Tuberculosis 93.855 103082 No 187,436 University of Hawaii - Global HIV Drug Therapies and Mitochonrdrial Complications and Mechanisms 93.855 ZA16503 No 27,668 Massachusetts General Hospital - Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 Infection 93.855 207904 No 14,246 Johns Hopkins University - Impact of Nutritional Status on Early HIV Treatment Failure in Resource-limited settings 93.855 2000814676 No 66,781 Microbiotix, Inc. - Inhibitors of wall teichoic acid biosynthesis in Staphylococcus aurous 93.855 No Award Number No 7,919 Social + Scientific Systems, Inc. - International Neurological Study 93.855 BRS-ACURE-S-11-000063-002151 No 413,322 Beth Israel Deaconess Medical Center - Live Attenuated SlV-Mediated Protection Against Mucosal SIV Infection - Project 3 93.855 1025087 No 404,523 Florida State University - M Tuberculosis Membrane Protein Pharmaceutical Targets 93.855 R01237 No 242,944 Beth Israel Deaconess Medical Center - Mechanisms of SIV persistence 93.855 1025211 No 143,196 Massachusetts General Hospital - Multidisciplinary AIDS Training Grant 93.855 219427 No 47,939 Johns Hopkins University - North American AIDS Cohorts Collaboration on Research and Design 93.855 2000056545 No 10 Johns Hopkins University - North American AIDS Cohorts Collaboration on Research and Design 93.855 2001317193 No 48,262 Massachusetts General Hospital - Novel Methods to inform HIV/TB clinical trial development 93.855 219762 No 723 Microbiotix, Inc. - Novel Methylenecyclopropane Analogues as Anti-Human Herpesvirus 6 and 8 Agents 93.855 A17998 No 6,619 Dana Farber Cancer Institute - Novel vaginal microbicides based on stable AAV-neutralizing antibody gene transfer 93.855 1149603 No 300,693 Massachusetts General Hospital - Optimizing HIV Care in Less Developed Countries 93.855 208049 No 168,273 University of Pittsburgh - Pathogenesis of New SIVsm Lineages in Rhesus Macaques 93.855 117144-1 No (77,196) Emory University - PD-1 Reagent Core, Core B 93.855 S369228 No 125,668 Vanderbilt Medical Center - Pharmacogenomics of HIV Therapy 93.855 VUMC 34640 No 68,411 Boston University - Phase 2 Pharmacodynamic Study of High-dose Levofloxacin 93.855 No Award Number No 2,048 Tulane University - Population-based Approach to malaria Research and Control 93.855 TUL-HSC-303-11/12 No 184,851 Massachusetts General Hospital - Project 3 - Induced tolerogenic dendritic cell therapy of allergic diseases 93.855 219483 No 286,811 Beth Israel Deaconess Medical Center - Role of Fe Receptor Polymorph isms In Antibody-Mediated Protection 93.855 1025608 No 1,162 Duke University - Role of Mucosal NK Cells in Control and Pathogenesis of Lentivirus 93.855 2030887 No 266,533 86
Duke University - Role of natural killer cells in vaccine-elicited control of HIV/SIV Infections 93.855 3035435 No (37,129) Rockefeller University - Simianizing Hepatitis C virus: Defining the species-tropism of a hepatotropic virus 93.855 5R01AI090055-03 No 23,383 Beth Israel Deaconess Medical Center - SLAM gene family controlled pathways to SLE 93.855 No Award Number No 52,624 Fred Hutchinson Cancer Research Center - Standardizing the isolation and characterization of intestinal cells from NHP 93.855 718943 No 48,880 Dana Farber Cancer Institute - Structural Approaches to HIV-1 Immunogen Design for BNAb Generation 93.855 1158004 No 147,266 Dana Farber Cancer Institute - Structural Determinants of TCR Assembly and Signaling 93.855 1072809 No 30,128 Brigham and Women's Hospital - TIM Family of Genes: Role in T Cell Immunity and Tolerance (Core C) 93.855 104286 No 68,214 Microbiotix, Inc. - Type III secretion inhibitor for Anti-Infective Therapy 93.855 No Award Number No 40,258 Subtotal of 93.855 93.855 6,352,694 Regents of the University of Michigan - Redefining Cerebral Malaria 93.856 610496HSPH No 34,453 Subtotal of 93.856 93.856 34,453 Boston College - Viral Evolution in Peripheral Macrophages and Brain during Progression to AIDS 93.858 1593-1 No 28,454 Subtotal 93.858 93.858 28,454 Massachusetts Institute of Technology - An Integrated Approach to Diversity-Oriented Synthesis 93.859 5615423-5500000396 No 174,953 Massachusetts Institute of Technology - An Integrated Approach to Diversity-Oriented Synthesis 93.859 5615433-5500000395 No 568,020 Massachusetts Institute of Technology - An Integrated Approach to Diversity-Oriented Synthesis 93.859 5710002500 No (510) DRVision Technologies LLC - Analysis of Tracking Based Phenotypes in CNS 93.859 DRV001 No 73,100 Albert Einstein College of Medicine - Atoms-to-Animals: Structural Genomics of Immunity 93.859 9-526-2175 No 61,068 University of Virginia - Cell Migration Consortium 93.859 GC12015.136194 No (3,485) Boston University - Computational Methods for Transcriptional Mapping of Eukaryotic Genomes 93.859 GC 201076 NGC No 11,963 Massachusetts General Hospital - Core C: Protein Chemistry 93.859 215349 No 260,333 Brigham and Women's Hospital - Genetic Predictors of Response to Anti-TNF Therapy in Rheumatoid Arthritis 93.859 106085 No 104,149 Columbia University - Influenza Outbreak Prediction: Applying Data Assimilation Methodologies to Make Skillful Forecasts of an Inherently Chaotic, Nonlinear System 93.859 5-30268 No 10,728 University of Texas Southwestern Medical Center - Mechanisms Regulating Clathrin-Mediated Endocytosis 93.859 5-23863 No 174,157 Regents of the University of California - Berkeley - Molecular Regulation of Choanoflagellate-Bacteria Signaling Interactions 93.859 7893 No 21,180 Regents of the University of California - Santa Cruz - Pathways that Integrate Cell Growth with the Cell Cycle 93.859 S0183075 No 70,924 Massachusetts General Hospital - Project 1: Locating General Anesthetic Binding Sites in GABAa and Acetylcholine Receptors 93.859 215351 No 293,811 Northwestern University - Regulation and Function of Intermediate Filaments in Cell Mechanics 93.859 60029184HC No 268,237 Northwestern University - Regulation and Function of Intermediate Filaments in Cell Mechanics 93.859 60029185 HC No 246,681 Massachusetts Institute of Technology - Single-molecule imaging with super-resolution: probe development, cellular targeting, optics, and application to neuroscience 93.859 5710002578 No 177,599 Fred Hutchinson Cancer Research Center - Statistical Methods for Prospective Evaluation of Biomarkers 93.859 721707 No 33,707 Texas A&M Research Foundation - Structures of M. tuberculosis proteins conferring susceptibility to known M. tuberculosis inhibitors 93.859 S110011 No 314,565 Massachusetts Institute of Technology - Systems Biology of Cell Decision Processes 93.859 5710003061 No 1,557,043 University of Texas - Austin - The Biophysical Basis of Translational Selection 93.859 UTA09-000854 No 27,735 New York Structural Biology Center - Transcontinental EM Initiative for Membrane Protein Structure 93.859 Subcontract Agreement 1 No 94,895 Children's Hospital Boston - Transcription Cofactors in Differentiation 93.859 70654 No 249,278 Sanford Burnham Medical Research Institute - Ultrastructural Basis of Mechanotransduction In Matrix Adhesions 93.859 56344-11736-PFHC-01 No 118,797 Subtotal 93.859 93.859 4,908,928 Vanderbilt University - Structural Analyses of Fission Yeast Splicing Complexes 93.862 VUMC9994 No (99) Subtotal of 93.862 93.862 (99) Princeton University - Adversity and Resilience after Hurricane Katrina 93.864 1538 No 111,757 Brigham and Women's Hospital - Immunology, Inflammation and Endometriosis 93.864 104182 No 30,614 Subtotal of 93.864 93.864 142,371 87
Boston University - A Comparative Approach to Social Inequalities in Health 93.865 4500000284 No 19,628 Brigham and Women's Hospital - Causes and Impact of Minority Stress on Health and Development in Youth 93.865 105009 No 48,475 National Bureau of Economic Research - Children and Neighborhoods: A Randomized Study of Mobility 93.865 40-4076-HMS No 178,318 Tulane University - Coordinating Center for the Pediatrics HIV/AIDS Cohort Study II 93.865 TUL-HSC-323-11-12 No 9,014 Massachusetts Institute of Technology - Economic and Health Impacts of Hospitalization and Maternity Insurance in India 93.865 5710003192 No 25,306 Northeastern University - Effects of a neighborhood experiment on adolescent female psychological distress 93.865 500178-P1103515 No 44,776 San Diego State University Research Foundation - Health, Poverty and Place: Modeling Inequalities in Accra Using RS and GIS 93.865 54975E-P1109-7802-211 No 202,959 Harvard Pilgrim Health Care, Inc - Improving Primary Care to Prevent Childhood Obesity 93.865 No Award Number No 2,629 New York University - Parenting and Adolescents: A Pooled Data Analysis of Ethnically Diverse Families 93.865 F6802-03 No 13,520 Tulane University - Pediatric HIV/AIDS Cohort Study (PHACS) 93.865 TUL-HSC-263-11/12 No 1,371 Center for Applied Linguistics - Predicting Spanish-Speaking Children's Growth in Reading Pre-K Through Seventh Grade 93.865 NICH01-002-10 No 192,726 University of Puerto Rico - Pregnancy and Early Lifestyle improvement Study (PEARLS) 93.865 No Award No No 28,943 University of Illinois at Chicago - Racial Discrimination in Online Contexts: The Impact on Adolescent Adjustment Over Time 93.865 2009-01602-02 No 27,840 University of Illinois at Chicago - Racial Discrimination in Online Contexts: The Impact on Adolescent Adjustment Over Time 93.865 Y88628 No 4,579 Children's Hospital Corporation - Serotonin and GABA Neuron Subtypes- their Development and Function (Project 5) 93.865 No Award Number No 334,575 Brigham and Women's Hospital - Tailored Nutrition and Food Security Interventions in Comprehensive HIV Care 93.865 104599 No 11,043 Boston University - Teratogenicity of Drugs Most Commonly Used in Pregnancy 93.865 3546-5 No 144,796 New York University - Testing CSRP's impact on low-income children's outcomes in 3rd-5th Grade: A 5-Year follow-up 93.865 F6077-08 No 50,515 Massachusetts General Hospital - Understanding Social Status' Impact on Adolescent Health 93.865 216354 No 10,622 University of Massachusetts at Amherst - Properties of HIV-1 DNA/RNA assays for detecting HIV infection in infants 93.865 12-006886 B 00 No 58,862 Subtotal of 93.865 93.865 1,410,497 Emory University - A Metabolomic Model of Aging in the Common Marmoset 93.866 S499884 No 87,162 University of Alabama - Childhood SES Factors: Impact on Age-related Cognitive and Vascular Health 93.866 000410331-002 No 24,274 Brigham and Women's Hospital - Cumulative Stress and Cardiovascular Risk in Middle Aged and Older Women 93.866 107327 No 36,641 National Bureau of Economic Research - Economics of Health, Wealth and Well-being 93.866 33-4135-03-HMS No 19,922 National Bureau of Economic Research - Explaining the Reduction in Nursing Home Residence: Analysis Across the Age Spectrum 93.866 83-4029-S2-HMS No 39,369 Hebrew Rehabilitation Center for Aged - Health care expenditures for nursing home residents with advanced dementia 93.866 10.10.90051 No 42,923 The Methodist Hospital Research Institute - High-content Image Analysis and Modeling for Neuron Assay Based Screening 93.866 No Award Number No 47,901 University of Wisconsin - Integrative Pathways to Health and Illness Project 1 - Psychosocial Contributors 93.866 398K521 No 65,483 Hebrew Rehabilitation Center for Aged - Interdisciplinary Study of Delirium and its Relationship to Cognitive Decline 93.866 No Award Number No 3,754 Northwestern University - LITCOG II: Health Literacy and cognitive Function among Older Adults 93.866 60028515 No 23,375 Massachusetts General Hospital - Medcare Study on Cost-Sharing Ramifications for Prescription Drug Benefit (SCRIPT) 93.866 217007 No 22,882 Boston University - Neural Substrates of Cognitive Decline in Aging Monkeys 93.866 9500234992 No 89,800 Hebrew Rehabilitation Center for Aged - Nonlinear Dynamics of Frality in Aging 93.866 10.10.90043 No 956 Board of Regents of the University of Wisconsin - Madison - Project 1: Psychosocial Contributors to Health and Illness 93.866 398K495 No 10,484 Boston Medical Center - Skeletal Muscle Precursor Resource Core 93.866 2147 No 33,765 National Bureau of Economic Research - What Does Health Insurance Do Evidence from the Oregon Health Insurance Lottery 93.866 HSPH-33-4126 No 82,753 National Bureau of Economic Research - What Does Health Insurance Do: Evidence From the Oregon Health Insurance Lottery 93.866 HMS-33-4126 No 18,325 Subtotal of 93.866 93.866 649,769 Northwestern University - The Mechanical basis of Primary Open Angie Glaucoma 93.867 SP0004560/PROJ0001557 No 307,377 Subtotal of 93.867 93.867 307,377 Brigham and Women's Hospital - An Automated System to Monitor Medical Device Safety 93.879 101647 No 28,070 Brigham and Women's Hospital - Analyzing Complex Healthcare Data to Determine Causality of Observed Drug Effects 93.879 105139 No 39,474 University of Texas Health Science Center at Houston - Development of an Inter-University Oral Health Research Database 93.879 0007266C No 11,616 The Methodist Hospital Research Institute - Neuronal Spines Tracking and Analysis for Time-Lapse, 3D Optical Microscopy 93.879 No Award Number No 21,036 Subtotal of 93.879 93.879 100,196 88
Brigham and Women's Hospital - Laboratory Response Network - Level B (LRNB) 93.889 107689 No 53,594 Subtotal of 93.889 93.889 53,594 Spaulding Rehabilitation Hospital - Bone Density and Circulating Mediators of Bone Metabolism in Chronic SCI 93.929 500165 No 2,441 Subtotal of 93.929 93.929 2,441 The Center to Protect Workers' Rights (CPWR) - Tools and Programs for Improving Occupational Health Conditions in Construction (TAPS) 93.955 1030-01 No (9) Subtotal of 93.955 93.955 (9) Regents of the University of Michigan - Discovery of Natural Product-Based Drugs from Costa Rican Biota 93.989 3001330903 No 254,379 Vanderbilt University - Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMC 93.989 VUMC34719 No (1) Vanderbilt Medical Center - Fogarty International Clinical Research Scholars Support Center @Vanderbilt-AAMC 93.989 VUMC 34889 No 75,530 Vanderbilt University - Fogarty International Clinical Research Scholars Support Center at Vanderbilt-AAMC 93.989 VUMC34720 No 62,648 Subtotal of 93.989 93.989 392,556 Massachusetts General Hospital - Direct Visualization and Characterization of Hypoxia in the Bone Marrow 98.839 215186 No 261,192 Subtotal of 98.839 98.839 261,192 Dana Farber Cancer Institute - Accountability and the Role of the Principle Investigator in Multicenter Trails Contract 1189602 No 16,897 Social + Scientific Systems, Inc. - Anti-Viral and Immune Plasma Infrastructure Development Contract CRB-DCR01-S-09-00242 No 9,713 Rand Corporation - CAHPS Survey for the Medicare Shared Savings Program and Other Physician Quality Programs Contract 9920120022 No 18,106 Institute of Nutrition of Central America and Panama - Center of Excellence for Strengthening Research Capacity on Prevention and Control of Cardiovascular Diseases (CVD) for Central America, Dominican Republic, and Mexico: 2009-2014 Contract No Award Number No 5,279 Regents of the University of California - San Francisco - Changes in Alcohol Consumption in HIV Positives in Uganda Contract 6243SC No 45,480 Commonwealth of Massachusetts/Department of Public Health - Commonwealth of Massachusetts Department of Public Health Hospital Preparedness Program 2010 Exercise Series Contract 8214 No 412,834 Brigham and Women's Hospital - Community-based accompaniment with supervised antiretroviral in Lima, Peru Contract 104741 No 37,494 Rand Corporation - Design and Data Analysis of the Medicare Health Plan CAHPS Survey Contract 9920070047 No 353,592 Rand Corporation - Disenrollment Survey Contract 9920100014 No 19,132 PhysioGenix, Inc. - Efficacy of GABAA alpha 5 receptor inverse agonists in learning impaired rats Contract A14789 No 48,066 General Electric Company - Enhancing the Insight Toolkit for Research, Education, and Clinical Interoperability Contract 400064897 No 111,590 National Hispanic Medical Association - Enhancing Workforce Diversity in Science and Health Related Careers Contract 41040 No 124,537 L and M Policy Research, LLC - Evaluation of the Nursing Home Value Based Purchasing Demonstration Contract NHVBPD-2008-02 No 17,766 National Opinion Research Center - Evaluation of State Health Information Exchange Cooperative Agreements Program Contract No Award Number No 101,934 National Hispanic Medical Association - Explorations/Reflection in Action Contract No Award Number No 1,954 National Academy of Sciences - Geographic Variation in Value for Privately Insured Population Contract IOM-2000000528 No 865,815 National Association of County and City Health Officials - Health Departments Barriers to the Administration of Emergency Preparedness Federals Funds Contract 2012-010903 No 44,195 Council of State and Territorial Epidemiologists - Health Disparities Geocoded Data Analytic Method Project Contract No Award Number No 4,495 L and M Policy Research, LLC - Home Health Study and Report Contract HHSR-2010-01 No 31,716 The Broad Institute - Host Genetic Factors in Resistance to Lassa Hemorragic Fever Contract 6220072-5500000455 No 285,161 The Wistar Institute - Immune Function and Biodefense in Children, Elderly, and Immunocompromised Populations Contract 29901-04-307 No 2,427 Duke University - Immunology Quality Assessment Program Contract 145839-1 No 88,606 Science Applications International Corporation Frederick - Just-in-time Accession of Clinically Annotated Pathology Specimens for Molecular Marker Research Contract 28XS155 No 25,280 National Hispanic Medical Association - Leader, Faculty and Career Development Program Contract No Award Number No 8,872 Harvard Pilgrim Health Care, Inc - Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP) Contract HHSF223200510012C-C0A7 No (632) Avram Corporation - Modeling Maternal and Child Health Policy in Ethiopia Contract 20120229 No 6,746 University of Massachusetts - Worcester - National Children's Study: Worcester Center Contract 6089703/RFS800114 No 65,512 Rand Corporation - National Implementation of Medicare Advantage and Prescription Drug Plan CAHPS Survey Contract 9920120015 No 162,493 Association of State and Territorial Health Officials - National Preparedness Leadership Initiative Project Plan Contract Project-16012-Contract-129 No 531,652 ECRI - NGC and NQMC Contract HHSA29020071005 No 61,910 The Wistar Institute - Protective Immunity in Special Populations Contract 29902-06-307 No 256,982 Tulane University - Roles of Protective or Pathogenic B Cell Epitopes in Human Lassa Fever Contract TUL-HSC-193-09/10 No 145,433 Chickasaw Nation Industries, Inc - The Medical Device Epidemiology Network [MDEpiNET] Methodology Center Contract 717-00368-000-2 No 58,223 University of Notre Dame - VectorBase Contract 208000 No 116,402 Subtotal of Contract Contract 4,085,660 Total Department of Health and Human Services Subawards Received 50,649,965 89
EPA Health Effects Institute - Causal Inference Methods for Estimating Long Term Health Effects of Air Quality Regulations 66.unknown 4909-RFA11-1/12-3 No 26,203 Johns Hopkins University - Estimation of the Risks to Human Health of PM and PM components 66.unknown 2000912086 No 15,722 Subtotal of 66.unknown 66.unknown 41,925 Health Effects Institute - Effect of Air Pollution Control on Mortality and Hospital Admissions in Ireland 66.500 4694-RFA02-1--03-7 No (2,279) Health Effects Institute - New Statistical Approaches to Semiparametric Regression with Application to Air Pollution Research 66.500 4731-RFPA04-6/05 No (1) Health Effects Institute - Statistical Learning Methods for the Effects of Multiple Air Pollution Constituents 66.500 4781-RFA09-1-09-2 No 31,213 Subtotal of 66.500 66.500 28,933 University of Pittsburgh - Community Stressors and Susceptibility to Air Pollution in Urban Asthma 66.509 0023157-40713-2 No 46,338 Subtotal of 66.509 66.509 46,338 University of Tennessee - 2006-2008 GEOS-CHEM Modeling for EPA-GSA Proposal Contract OR 13810-001.01 No 13,535 Subtotal of Contract Contract 13,535 Total EPA Subawards Received 130,731 General Services Administration Council for Logistics Research, Inc. - US Russia Security Program Tuition Support Contract CLR-09-5012-010 No (1,500) Subtotal of Contract Contract (1,500) Total General Services Administration Subaward Received (1,500) Institute of Museum and Library Services California Academy of Sciences - Connecting Content: A Collaboration to link Field Notes to Specimens and Published Literature: Archives and Specimens from the Birds of the Cambridge Region 45.unknown No Award Number No 10,443 California Academy of Sciences - Flora of the Metropolitan Park 45.unknown No Award Number No 6,084 Subtotal of 45.unknown 45.unknown 16,526 Total Institute of Museum and Library Services Subawards Received 16,526 NASA Space Telescope Science Institute - A Complete Optical and NIR Atmospheric Transmission Spectrum of the Exoplanet HD1B9733b 43.unknown HST-GO-11740.04-A No 460 Jet Propulsion Laboratory - Assessing OCO-2 Predicted Sensitivity and Errors 43.unknown 1448707 No 22,681 Atmospheric & Environmental Research, Inc - Constraints on Regional Methane Fluxes through Integration of Satellite Aircraft and Ground-Bas Observations with Models 43.unknown A15397 No 18,945 Jet Propulsion Laboratory - CoRO T-Exo-7b: Confirming the First Transiting Rocky Planet 43.unknown 1379662 No 231 Regents of the University of Michigan - Development of the AIRMOSS Level 4 Net Ecosystem Exchange (NEE) products using the ED2 terrestrial biosphere model 43.unknown 3001735171 No 219,852 Regents of the University of California - Los Angeles - Estimation and Attribution of Global CO2 Surface Fluxes Using Satellite Observation of CO2 and CO from TES, GOSAT, and MOPITT 43.unknown 2095 G NA056 No 65,715 Regenst of the University of California - San Diego - Gravitational Tests via Lunar Laser Ranging: APOLLO Analyses and Acquisition 43.unknown 10323360 No 32,839 Southwest Research Institute - Juno Project 43.unknown 699042X No 7,750 National Space Biomedical Rsch Inst/Baylor Coll of Med - National Space Biomedical Research Institute Core Research Program 43.unknown NCC9-58-I No (1,482) Massachusetts Institute of Technology - Requirements for the Development and Maintenance of Multicellular Life 43.unknown 5710002514 No 124,844 Jet Propulsion Laboratory - RSA Covering- PID 540, 541, 542, 546, 70031, 70148 43.unknown 1418711 No 35,562 Jet Propulsion Laboratory - Solving the Mystery of the Largest Transiting Exoplanet 43.unknown 1324368 No 3 Massachusetts Institute of Technology - The Requirements for Development and Maintenance of Multicellular Life 43.unknown 5710002311 No 81,347 Smithsonian - A long Multiwavelength Study of GRS 1915+105: Accretion/Ejection Physics of the Disk Wind and Radio Jet 43.unknown GO1-12058A No 57,213 Smithsonian - An In-Depth Study of the Nearest Gamma-Ray Bursts 43.unknown GO9-0071D No 1,113 Smithsonian - Cycle 11: Rapid Observations of Short Gamma Ray Bursts: Accurate Positions Hold the Key to the Progenitor Population 43.unknown GO0-11078X No 34,969 Smithsonian - Quiescent Low Mass X-Ray Binaries and Cataclysmic Variables in the Globular Cluster NGC 6304 43.unknown GO0-11063X No 8,087 Smithsonian - The Energetics and Environment of 'Naked' Supernovae 43.unknown GO9-0085A No 22,306 Subtotal of 43.unknown 43.unknown 732,435 Smithsonian Astrophysical Observatory - A Chandra HETGS Study of 4U1323-619: Binary Wind Properties, X-ray Burst, Distance and Studies of Interstellar Medium 43.001 G02-13055X No 26,406 Smithsonian Astrophysical Observatory - A Fresh New Approach to the Study of Massive Star Explosions 43.001 SV1-81028 No 3,965 California Institute of Technology - A Search for Exomoons 43.001 2-1090928 No 94,616 Smithsonian Astrophysical Observatory - Black Hole Growth and Its link with Galaxy Evolution 43.001 PF0-110076 No 102,340 Smithsonian Astrophysical Observatory - Collisionless Shocks in Astrophysics 43.001 PF8-90059 No 13,951 Smithsonian Astrophysical Observatory - Completing the Galatic Bulge Latitude Survey (BLS) 43.001 GO9-0102X No 282 Jet Propulsion Laboratory - Confirmation and Characterization of Kepler Mission Exoplanets: The Era of Rock and Ice Exoplanets 43.001 1379867 No 194,335 California Institute of Technology - Constraining Fluxes of Carbon with Total Column Measurements of CO2 and CH4 43.001 65P-1090638 No 27,714 Smithsonian Astrophysical Observatory - Cycle 10: Rapid Observations of Short Gamma Ray Bursts: Accurate Positions Hold the Key to the Progenitor Population 43.001 GO9-0066X No 13,819 California Institute of Technology - Detection and Characterization of Plants around the Lowest-Mass Stars 43.001 2-1089011 No 24,672 Columbia University - Development of a Self-Consistent Model for Spatial and Temporal Sea-Level Variations that Integrates Data on Cryospheric Mass Change, Ocean Dynamics, and Solid-Earth Loading 43.001 2 Acct5-22342 No 100,966 90
University of Wisconsin - Development of CLARREO Prototype Instrument 43.001 G074771 No (1,265) Smithsonian Astrophysical Observatory - Electromagnetic and Gravitational Wave Signatures of Supermassive Black Hole Mergers 43.001 PF9-00063 No 109,008 Massachusetts Institute of Technology - Evaluating Neoproterozoic Environmental Change 43.001 5710002901 No 53,737 Monterey Bay Aquarium Research Institute - Exploration of deep-sea and hydrothermal vent microbial communities using the Environmental Sample Processor (ESP): Integration of geochemical sensing, autonomous sample acquisition and processing, 43.001 PO 0910170 No 159,964 Space Telescope Science Institute - Identification of Thermal Emission Component in GRB Prompt Emission: A New Tool for Understanding Underlying GRB Physics 43.001 46627 No 4,433 Space Telescope Science Institute - Mapping Galactic Structure, Formation, and Evolution with Pan-STARRS 43.001 HST-HF-51255.01-A No 53,045 Smithsonian Astrophysical Observatory - Measuring Emission Geometry, Interstellar Dust, and Distance with Chandra HETGS Observations of EXO 2030+375 43.001 G02-13053X No 9,546 Space Telescope Science Institute - Near-Field Cosmology with Extragalactic Globular Clusters 43.001 HST-HF-51237.01-A No 863 Smithsonian Astrophysical Observatory - Nonthermal Particle Acceleration in Pulsar Wind Nebulae and Trans-Relativistic Shocks 43.001 PFl -120090 No 36,804 Smithsonian Astrophysical Observatory - Rapid Observations of Short Gamma-Ray Bursts: Accurate Positions Hold the Key to the Progenitor Population 43.001 GO1-12072X No 4,877 Massachusetts Institute of Technology - Requirements for the development and maintenance of multicellular life 43.001 5710002465 No 93,995 Smithsonian Astrophysical Observatory - Studying binary evolution in the oldest open clusters: Collinder 261 43.001 GO0-11110X No 9,379 Massachusetts Institute of Technology - The Cryogenian Carbon Cycle in Mongolia 43.001 5710002900 No 77,494 Smithsonian Astrophysical Observatory - The Energetics and Environments of Type Ibc Supernovae 43.001 GOl-12090X No 24,088 California Institute of Technology - The Evolution and Physical Properties of Young Stellar Objects Throughout the Milky Way Galaxy 43.001 2-1085683 No 44,538 Jet Propulsion Laboratory - Unveiling the Galaxy Counterparts of the Damped Lyman-Alpha Absorbers using GRB-DLA's 43.001 1352815 No 1 Space Telescope Science Institute - Weak Lensing Mass Calibration of SZ-Selected Clusters 43.001 HST-GO-12246.01-A No 68,163 Smithsonian - An In-Depth Study of the Nearest Gamma-Ray Bursts GRB 43.001 GO0-11083D No 152 Smithsonian - Census of the Normal Spiral Arm Region 43.001 GO1-12068B No 54,794 Smithsonian - Constraining the Spectrum of HLX-1 in Outburst 43.001 DD0-11050X No (1,285) Subtotal of 43.001 43.001 1,405,397 University of Colorado at Boulder - Inverse Modeling and Attainment Analysis for Improved Decision Support of PM2.5 Air Quality 43.002 1547390 No 54,355 University of Colorado at Boulder - Lunar University Node for Astrophysics Research (LUNAR): Exploring the Cosmos from the Moon 43.002 1545654 No 26,553 Subtotal of 43.002 43.002 80,908 Jet Propulsion Laboratory - Carbon in Arctic Reservoirs Vulnerability Experiment 43.006 1423751 No 82,328 Jet Propulsion Laboratory - Carbon in Arctic Reservoirs Vulnerability Experiment 43.006 1444889 No 161,229 Subtotal of 43.006 43.006 243,557 California Institute of Technology - High-Resolution Mars Polar Stratigraphy and Paleoclimate Proxies 43.AAA 65P-1089456 No 25,010 Subtotal of 43.AAA 43.AAA 25,010 EOS Photonics, Inc. - Frequency modulated Integrated Cavity Output Spectroscopy: A General Technique for Trace Gas and Isotope Measurement with Unprecedented Sensitivity Contract A15854 No 20,142 Cornell University - Mars Exploration Rover (MER) Athena Payload and Science Investigation Contract 39361-6448 No 25,164 Subtotal of Contract Contract 45,306 Total NASA Subawards Received 2,532,613 National Science Foundation Children's Hospital Boston - Programmable Second Skin to Re-educate Injured Nervous Systems 47.unknown 80295 No 201,897 Subtotal of 47.unknown 47.unknown 201,897 University of Colorado - A New Approach for Directed Genome Engineering 47.041 1547883 No 142,556 Pennsylvania State University - Creating Opportunities for Adaptation Based on PULSE 47.041 4256-HU-8264 No 38,484 Northwestern University - Cyber-Enabled Discovery in Neuromechanical Systems 47.041 SP0007393-PROJ0002372 No 54,340 Massachusetts Institute of Technology - EFRI-COPN: Dynamics of Neural Networks on a Planar Patch-Clamp Array: Training, Identification, and Control 47.041 5710002456 No 136,621 Pennsylvania State University - EFRI: Creating Opportunities for Adaptation Based on PULSE 47.041 4232-HSPH-NSF-8264 No 92,807 Virginia Polytechnic Institute and State University - Multifunctional Materials Exhibiting Distributed Actuation, Sensing, and Control: Uncovering the Hierarchical Control of Fish for Developing Smarter Materials 47.041 478175-19838 No 46,983 Regents of the University of California - Berkeley - NIRT: Molecular Spin-active Nanoelectronics 47.041 SA5329-11206 No (6,489) Georgia Institute of Technology/Georgia Tech Research Corpor - NNIN Research Experiences for Teachers 47.041 R0848-G2 No 26,647 University of Texas - Optics on a Nanoscale Using Polaritonic and Plasmonic Materials 47.041 2610009563 No 284 Cornell University - REU Site: National Nanotechnology Infrastructure Network REU Program 47.041 52120-8448 No (6,002) Massachusetts Institute of Technology - Scalable Nanomanufacturing: Digital Optofluidic Self Assembly of Heterogeneous Metamaterials 47.041 5710003007 No 61,454 Regents of the University of California - Berkeley - SynBERC: Synthetic Biology Engineering Research Center 47.041 SA5283-11210 No 496,956 Subtotal of 47.041 47.041 1,084,641 91
Regents of the University of California - San Diego - A Comprehensive Probe of Gravity via Lunar Laser Ranging 47.049 10272676 No 44,525 Yale University - ACME: Advanced Cold Molecule Electron Electric Dipole Moment Search 47.049 C10D10472 No 889,782 Massachusetts Institute of Technology - Center for Ultracold Atoms 47.049 5710002067 No 520,479 Massachusetts Institute of Technology - Center for Ultracold Atoms 47.049 5710003095 No 768,083 Northwestern University - Chirality in Aerosol Chemistry 47.049 SP0013325-PROJ0003568 No 88,191 Regents of the University of New Mexico - Partnership for Rearch and Education in Materials bet. Harvard University and University of New Mexico 47.049 986008-87D7 No (17,786) Purdue University - Quantum Information for Quantum Chemistry: Phase I 47.049 4101-38947 No 77,943 Institute for Advanced Studies - The Astrophysics of Hydrogen and Helium 47.049 7412-3229 No 59,475 Subtotal of 47.049 47.049 2,430,692 University of Washington - Determining the Limits to Life in Submarine Hydrothermal Systems: Active Sulfide Deposits as Natural Laboratories. 47.050 300418 No 54,581 Board of Regents of University of Arizona - Long-Term Vulnerability of natural and Human Ecosystem to Climate and Fire Regime Changes in Southwestern Forests 47.050 11759 No 21,406 Columbia University - PLIOcene MAXimun sealevel (PLIOMAX): Dynamic ice sheet-earth response in a warmer world 47.050 1 (Acct 5-25162) No 17,985 University of Southern California - SCEC Collaborative 2011 47.050 117472 No 248,722 Subtotal of 47.050 47.050 342,694 Arizona State University - A Toolkit to Evaluate the Effect of Multitouch Interaction of Musculoskeletal System and Design Safe Multitouch Systems 47.070 10-401 No 72,190 Worcester Polytechnic Institute - BPC-DP: Deploying a Vertically-Integrated Computing Curriculum to At-Risk Students 47.070 11-202610-02 No 4,998 Computing Research Association - CIFellows Project 47.070 CIF-D-020 No 101,995 Computing Research Association - CIFellows Project: Utilizing Provenance Data to Improve System Management 47.070 CIF-C-223 No 135,098 Computing Research Association - CIFellowship: Understanding Gene Expression Differences 47.070 CIF-A-358 No 9,781 Tufts University - III-CXT-Medium: Interdisciplinary Machine Learning Research and Education 47.070 NSF409 No 47,298 Subtotal of 47.070 47.070 371,360 Regents of the University of California - Berkeley - Collaborative Proposal: Harnessing the Power of Herbaria to Understand the Changing Flora of California: A Biodiversity Hotspot in Peril 47.074 7364 No 17,417 Massachusetts Institute of Technology - Culturing the Uncultured: Custom Microfluidic Systems for Growth and Isolation of Environmental Microbes 47.074 5710002843 No 101,768 Cornell University - Long-term Ecological Research at the Hubbard Brook Experimental Forest 47.074 61468-9774 No 6,931 Subtotal of 47.074 47.074 126,116 Regents of the University of Minnesota - IPUM International - Preservation of Census Microdata 47.075 H000546701 No 26,802 New York University - IRADS: Transitions, Culture and Development 47.075 F6070-01 No 10,642 Boston University - NSF-CELEST: Fluid Allocation of Attentional Resources 47.075 4500000283 No 96,955 National Bureau of Economic Research - DAT: Scientists and Engineers as Agents of Technologyal Progress: Measuring the Returns to R and D and the Economic Impact of Science and Engineering Workers 47.075 283520000791977000 No 21,086 Subtotal of 47.075 47.075 155,485 Museum of Science - Creating Communities of Learners for Informal Cognitive Science Education 47.076 4552-HU-01 No 17,002 Smithsonian Astrophysical Observatory - Investigating a Framework for STEM-Reading to Support Secondary School Students with Reading Disabilities 47.076 SV2-82004 No 31,732 Subtotal of 47.076 47.076 48,734 Board of Regents of University of Arizona - PIRE: Carbon, Water and Vegetation Dynamics of Amazon Forests Under Climatic Variability and Change 47.079 Y482857 No 131,841 University at Albany (State University of New York) - The Children of Immigration in Schools 47.079 30407 No (17,672) Subtotal of 47.079 47.079 114,169 Board of Regents of University of Arizona - Collaborative Research: Tracking Galaxy Growth with 200,000 Spectroscopic Redshifts 47.082 22011 Yes 59,167 University of Colorado at Boulder - Did the First Angiosperms Lack an Embryo-Nourishing Endosperm 47.082 1549093 Yes 104,382 Stanford University - MRI-MR2: Development of POLAR-1, an Expandable 5,000-detector CMB Polarimeter 47.082 25319680-46990-B Yes (726) Cornell University - NNIN: National Nanotechnology Infrastructure Network 47.082 44771-7479 No 834,501 Subtotal of 47.082 47.082 997,324 LSST Corporation - Development of flat fielding calibration optics Contract C44073L No 79,230 Subtotal of Contract Contract 79,230 Total National Science Foundation Subawards Received 5,952,342 92
Social Security Administration Rand Corporation - Financial Literacy Research Consortium: Understanding and Improving Financial Literacy with Respect to Health Care Expenditures in Retirement 96.007 9920110039 No 152,387 Subtotal of 96.007 96.007 152,387 Total Social Security Administration Subaward Received 152,387 Total Research and Development and Research Training Subawards Received 74,753,399 Total Research and Development and Research Training Cluster Cluster 608,033,345 Student Financial Assistance Cluster Direct Award Department of Education Federal SEOG 2011-2012 84.007 P007A1061874 No 2,213,859 Subtotal of 84.007 84.007 2,213,859 Federal Pell Grant 2010-2011 84.063 P063P100187 No 10,151 Federal Pell Grant 2011-2012 84.063 P063P100187 No 5,345,115 Subtotal of 84.063 84.063 5,355,266 Federal Academic Competitiveness Grant (ACG) 2010-2011 84.375 P376S100187 No (750) Subtotal of 84.375 84.375 (750) National Smart Grant (NSG) 2010-2011 84.376 P375A100187 No (8,000) Subtotal of 84.376 84.376 (8,000) Teacher Education Assistance for College and Higher Education Grant (TEACH) 84.379 P379T110187 No 2,000 Teacher Education Assistance for College and Higher Education Grant (TEACH) 84.379 P379T120187 No 12,000 Subtotal of 84.379 84.379 14,000 Federal Work Study 84.033 Not available 1,606,212 Subtotal of 84.033 84.033 1,606,212 Total Student Financial Assistance Cluster Direct Awards 9,180,587 Total Student Financial Assistance Cluster 9,180,587 Head Start Cluster Direct Award Department of Health and Human Services Beyond Barriers: The Relationship between Head Start Parent's Social Capital, their Involvement and Children's Preschool Competencies 93.600 90YR0048 No 6,423 Beyond Barriers: The Relationship between Head Start Parent's Social Capital, their Involvement and Children's Preschool Competencies 93.600 90YR0048/02 No 12,513 Validating Measures for Tracking Vocabulary Development of English Language Learners 93.600 90YF006403 No 99,364 Subtotal of 93.600 118,301 Total Department of Health and Human Services Direct Awards 118,301 Total Head Start Cluster Direct Awards 118,301 Subawards Received Department of Health and Human Services Administration for Children and Families - Mechanisms, Moderators, Methods, and Measurement in the Head Start Impact Study: informing I-lead Start for the Future 93.600 F7009-02 No 38,276 Administration for Children and Families - National Center on Parent, Family, and Community Engagement 93.600 375030 No 586,219 Subtotal of 93.600 93.600 624,495 Total Department of Health and Human Services Subawards Received 624,495 Total Head Start Cluster Subawards Received 624,495 Total Head Start Cluster 742,796 93
Community Services Block Grants Cluster Subawards Received Department of Health and Human Services University of Southern California - Live-attenuated KSHV as vaccine candidate 93.710 H48669 Yes 12,015 Subtotal of 93.710 12,015 Total Department of Health and Human Services Subaward Received 12,015 Total Community Services Block Grants Subaward Received 12,015 Total Community Services Block Grants Cluster 12,015 Other Programs Direct Awards Agency for International Development Inter-University Partnerships for Strengthening Health Systems in Indonesia: Building New Capacity for Mental Health Care 98.unknown AID-497-A-11-00017 No 100,365 IPA for Assignment as the Scientific Director for the Development Innovation Ventures Team 98.unknown No Award Number No 109,429 The Higher Education Network Ring Initiative (HENRI) 98.unknown AID-497-A-11-00002 No 213,602 Subtotal of 98.unknown 98.unknown 423,396 Total Agency for International Development Direct Awards 423,396 Department of Defense Acquisition of a Microscope-Based Trace Element Analysis System 12.300 N00014-11-1-0868 No 248,108 Subtotal of 12.300 12.300 248,108 Semiconductor Based, Plasmon Mediated, Terahertz Sources and Detectors 12.800 FA9550-10-1-0285 No 41,235 Subtotal of 12.800 12.800 41,235 Curriculum Development for the National Guard Homeland Security Institute Contract W912SV-12-C-0002 No 9,025 General and Flag Officer Homeland Security Executive Officer Training Contract W912SV-12-P-0107 No 126,115 Minerva Scholar on Culture and Religious Change in the Islamic World Contract No Award Number No 185,140 Subtotal of Contract Contract 320,280 Total Department of Defense Direct Awards 609,623 Department of Education National Resource Centers for Center for Middle Eastern Studies 84.015A P015A100113 No 153,771 National Resource Centers for Davis Center for Russian and Eurasian Studies 84.015A P015A100139 No 190,363 National Resource Centers for Committee on African Studies 84.015A P015A100004 No 253,266 National Resource Centers for East Asian Studies 84.015A P015A100032-12 No 139,522 NRC Portion- Comprehensive National Resource Center 84.015A P015A060130-09 No (324) Subtotal of 84.015A 84.015A 736,598 Foreign Language and Area Studies Fellowships for Committee on African Studies 84.015B P015B100004-12 No 266,805 Foreign Language and Area Studies Fellowships for Center for Middle Eastern Studies 84.015B P015B100113-12 No 230,042 Foreign Language and Area Studies Fellowships for East Asia Center 84.015B P015B100032-12 No 165,700 Foreign Language and Area Studies for Davis Center for Russian and Eurasian Studies 84.015B P015B100139-12 No 379,590 Subtotal of 84.015B 84.015B 1,042,137 Enhanced Language Instruction for African Studies (ELIAS) 84.017A P017A090329 No 76,028 Subtotal of 84.017A 84.017A 76,028 Fulbright-Hays Doctoral Dissertation Research Abroad Program Application 84.022A P022A100008C No 8,000 Subtotal of 84.022A 84.022A 8,000 94
Jacob Javits Fellowship 84.170B P170B080009-11 No 97,950 Jacob Javits Fellowship 84.170B P170B090005-11 No 141,925 Jacob K. Javits Fellowship 84.170B P170B070036-11 No 43,975 Jacob K. Javits Fellowship 84.170B P17B100010-11 No 258,850 Jacob K. Javits Fellowships 84.170B P170B060019-10 No 5,000 Subtotal of 84.170B 84.170B 547,700 Africa's Sources of Knowledge Digital Library (ASK-DL) 84.337A P337A90009-10 No 49,113 Subtotal of 84.337A 84.337A 49,113 Total Department of Education Direct Awards 2,459,576 Department of Homeland Security National Fire Academy Educational Program 97.019 EMW-2011-GR-00077 No 20,056 Subtotal of 97.019 97.019 20,056 Total Department of Homeland Security Direct Awards 20,056 Department of State Disability, the Law, Rights, and Civil Society in China 19.345 S-LMAQM-10-GR-525-TTH No 200,373 Subtotal of 19.345 19.345 200,373 FY2011 Vietnam Fulbright Economics Teaching Program 19.401 S-ECAAE-11-GR-006(JJ) No 541,485 FY2012 Vietnam Economics Teaching Program 19.401 S-ECAAE-12-GR-016(DS) No 1,632,944 Subtotal of 19.401 19.401 2,174,429 Total Department of State Direct Awards 2,374,802 Department of the Interior Peabody at Harvard University Historic Alaska Native Kayaks and Related Collections 15.904 ST-03-10-0013-10 No 111,819 Subtotal of 15.904 15.904 111,819 NAGPRA Consultation/Documentation Grant for Eastern Massachusetts Collections at the Peabody Museum of Archaeology and Ethnology at Harvard University 15.922 25-11-GP-550 No 56,389 Subtotal of 15.922 15.922 56,389 Total Department of the Interior Direct Awards 168,208 Department of Health and Human Services GTF.CCC Travel Fund 93.unknown No Award Number No 16,028 Scientific Paper on Child Maltreatment 93.unknown 200-2007-M-20224 No (1,485) Subtotal of 93.unknown 93.unknown 14,543 Linking Assessment and Measurement to Performance in PHEP Systems (LAMPS) 93.061 5P01TP000307-04revised No 1,406,965 Subtotal of 93.061 93.061 1,406,965 Implementation of Programs for the Prevention, Care and Treatment of HIV/AIDS in the United Republic of Tanzania 93.067 5U2GPS001966-02Revised No 5,789,151 Subtotal of 93.067 93.067 5,789,151 Preparedness and Emergency Response Learning Centers (PERLC) 93.069 5U90TP000417-02rev No 603,100 Subtotal of 93.069 93.069 603,100 Schizophrenia International Research Society Scientific Conference 93.242 5R13MH082446-04 REVISED No 38,596 Subtotal of 93.242 93.242 38,596 95
Rapid Expansion of Antiretroviral Therapy Programs 93.266 6U51HA02522-08-08 No 18,205,292 Subtotal of 93.266 93.266 18,205,292 Harvard Clinical and Translational Science Center (UL1) 93.350 8UL1TR000170-05 No 1,137,674 Subtotal of 93.350 93.350 1,137,674 Harvard Clinical and Translational Science Center (UL1) 93.389 7UL1TR000170-05 No 20,972,386 Phase II: Opening the Pipeline for Native High Schools 93.389 5R25RR020406-05 REVISED No 70,511 Subtotal of 93.389 93.389 21,042,897 Conferences on Emerging Statistical Issues in Biomedical Research 93.393 2R13CA124365-06 No 22,475 Subtotal of 93.393 93.393 22,475 (MASS CONECT) Mass. Community Networks 93.399 5U01CA114644-05rev No 66,140 Subtotal of 93.399 93.399 66,140 ARRA - Public Health Traineeship Program 93.405 1 A0AHP16414-01-00 Yes 36,434 Subtotal of 93.405 93.405 36,434 Harvard Clinical and Translational Science Center- NCRR ARRA Supplement- Translational (Imaging) 93.701 3UL1RR025758-02S3 Yes 849,440 Subtotal of 93.701 93.701 849,440 Conferences on Emerging Statistical Issues in Biomedical Research 93.837 5R13CA124365-05 No (550) Subtotal of 93.837 93.837 (550) Scholarships for Disadvantaged Students (SDS) 93.925 1 T08HP22343-01-00 No 36,313 Subtotal of 93.925 93.925 36,313 Public Health Traineeship 93.964 5A03HP01165-16-00 No 28,336 Subtotal of 93.964 93.964 28,336 CAHPS - Seer Linkage Contract HHSN261201100299P No 8,678 Subtotal of Contract Contract 8,678 Total Department of Health and Human Services Direct Awards 49,285,485 EPA Organization of the 5th GEOS-Chem Scientific and Users Meeting 66.510 X3-83493101-0 No 5,968 Subtotal of 66.510 66.510 5,968 Total EPA Direct Awards 5,968 Institute of Museum and Library Services Integrating Archival Resources to Improve Curation of an Exceptional Woody Plant Collection 45.301 MA-05-10-0395-10 No 72,003 Subtotal of 45.301 45.301 72,003 Simple Verified Distributed Preservation: A Policy Based Archival Replication System for Libraries, Archives, and Museums using a Virtual Private LOCKSS Network 45.312 LG-05-09-0041-09 No 251,743 Subtotal of 45.312 45.312 251,743 Total Institute of Museum and Library Services Direct Awards 323,746 National Endowment for the Arts Engaging New Americans: Explorations in Art, Self, and our Democratic Heritage 45.024 10-4400-7104 No 34,024 Subtotal of 45.024 45.024 34,024 Total National Endowment for the Arts Direct Award 34,024 96
National Endowment for the Humanities The American Republic Initiative at Harvard University 45.130 CZ-50178-08 No (65,104) Subtotal of 45.130 45.130 (65,104) China Biographical Database Project 45.149 PW-50438-09 No 27,283 Proposal for Phase 2 of the Peabody Museum's Initiative to Digitize, Re-house, Catalog and Create Online Access to its Core Negative Photograph Collection 45.149 PW-50560-10 No 106,849 Women's Worlds in Qajar Iran: A Digital Archive and Website 45.149 PW-50478-09 No 3,666 Women's Worlds in Qajar Iran: A Digital Archive and Website 45.149 PW-51027-12 No 65,338 Subtotal of 45.149 45.149 203,136 African American Struggles for Freedom and Civil Rights 1865-1965 45.163 EH-50235-10 No 45,551 Golden Compasses as Moral Compasses: The Ethics and Aesthetics of Fairy Tales and Fantasy 45.163 FV-50293-11 No 40,868 Subtotal of 45.163 45.163 86,419 Prints and the Pursuit of Knowledge in Early Modern Europe 45.164 GI-50097-10 No 206,630 Subtotal of 45.164 45.164 206,630 Total National Endowment for the Humanities Direct Awards 431,082 National Security Agency STARTALK Arabic Institute for the Next Generation 12.900 H98230-12-1-0051 No 61,699 Subtotal of 12.900 12.900 61,699 Total National Security Agency Direct Award 61,699 Total Other Programs Direct Awards 56,197,664 Other Programs Subawards Received Agency for International Development Asia Foundation - Emergency Management and Case Teaching in China Contract 31485.201 No 59,073 Subtotal of Contract Contract 59,073 Total Agency for International Development Subaward Received 59,073 Department of Commerce Seacost Science Center - Families by the Seaside: Building a Community-Based Outdoor Ocean-Science Learning Experience 11.008 NEOSEC20105 No 25,000 Subtotal of 11.008 11.008 25,000 Total Department of Commerce Subaward Received 25,000 Department of Defense Spaulding Rehabilitation Hospital - Improving Recovery after Stroke via Electrical Stimulation of Proprioceptors 12.unknown 500247 No 48,999 Subtotal of 12.unknown 12.unknown 48,999 Total Department of Defense Subaward Received 48,999 Department of Education Boston Plan for Excellence - Boston Teacher Residency - Preparing and Supporting Effective Teachers in and for Boston's Turnaround Schools 84.unknown No Award Number Yes (2,589) Subtotal of 84.unknown 84.unknown (2,589) University of Notre Dame - Mobility, Society, and Governance in North America 84.116N 201082 No 3,148 Subtotal of 84.116N 84.116N 3,148 Southwest Educational Development Laboratory - Coordination Center to Provide Technical Assistance to the Parental Information and Resource Centers (PIRCs) Contract P.O. 56945 No 86,489 Southwest Educational Development Laboratory - Coordination Center to Provide Technical Assistance to the Parental Information and Resource Centers (PIRCs) Contract PO 56110 No (225) Commonwealth of Massachusetts/Department of Education - Supporting the Conditions for School Effectiveness Contract CT DOE 125100 HARVARDDRTTT062 No 271,280 Subtotal of Contract Contract 357,544 Total Department of Education Subawards Received 358,103 97
Department of Energy Battelle Memorial Institute - Battelle Contract No. 98441 Contract 98441 No 305,348 Subtotal of Contract Contract 305,348 Total Department of Energy Subaward Received 305,348 Department of State Institute for War and Peace Reporting - Digital Free Flow - Online Freedom in the Middle East 19.unknown No Award Number No 20,000 Subtotal of 19.unknown 19.unknown 20,000 Total Department of State Subaward Received 20,000 Department of Health and Human Services Hispanic Association of Colleges and Universities - Supporting Growth of the Mobile Health Care Sector to Help Reduce Health Disparities 93.004 No Award Number No 77,957 Subtotal of 93.004 93.004 77,957 AIDS Prevention Initiative in Nigeria, Ltd/Gte. - Capacity Building and Technical Assistance Activities 93.067 No Award Number No 98,700 Subtotal of 93.067 93.067 98,700 Silent Spring Institute - Ethical and Legal Challenges in Communicating Individual Biomonitoring and Personal Exposure Results to Study Participants: Guidance for Researchers and Institutional Review Boards 93.113 No Award Number No 28,695 Subtotal of 93.113 93.113 28,695 Boston University - New England Alliance Public Workforce Development 93.249 RA208317NGN No 73,778 Subtotal of 93.249 93.249 73,778 Children's Hospital Corporation - Comparative Phenotypic, Functional, and Molecular Analysis of ESC and ipsc 93.701 323054 Yes 23,899 Tufts University - NCRR ARRA Supplement -- Community Engagement 93.701 HSZ901 Yes 37,515 Subtotal of 93.701 93.701 61,414 Brigham and Women's Hospital - Epidemiology and Transmission Dynamics of MDR/XDR Tuberculosis 93.855 103086 No 85,375 Subtotal of 93.855 93.855 85,375 Dimock Community Health Center - Boston Pediatric and Family AIDS Project Contract B9681 No 9,000 Booz Allen Hamilton - Open-i Contract 101180SB23 No 74,146 Commonwealth of Massachusetts/Department of Public Health - Technical Assistance Services to Mass Dept of Public Health Injury Prevention Contract No Award Number No 27,571 Subtotal of Contract Contract 110,717 Total Department of Health and Human Services Subawards Received 536,636 Federal Emergency Management Agency Commonwealth of Massachusetts, MEMA Disaster Relief Asst. - MEMA Snow removal proposal January 11-12, 2011 Snowstorm-FEMA-1959-DR Contract CTFEMA1959HARVA00411 No 293,141 Subtotal of Contract Contract 293,141 Total Federal Emergency Management Agency Subaward Received 293,141 Library of Congress Regents of the University of Michigan - Data Preservation Alliance for the Social Sciences (Data-PASS) 42.unknown 3001208403 No (1) Subtotal of 42.unknown 42.unknown (1) Total Library of Congress Subaward Received (1) Social Security Administration Rand Corporation - Financial Literacy Research 96.007 9920100024 No 118,352 Subtotal of 96.007 96.007 118,352 Total Social Security Administration Subaward Received 118,352 Total Other Programs Subawards Received 1,764,651 Total Other Programs 57,962,314 Grand Total $ 675,931,057 98
Notes to June 30, 2012 1. Basis of Presentation The accompanying (the Schedule ) includes the expenditures of Harvard University (the University ) under programs of the federal government for the year ended June 30, 2012. The information in this schedule is presented in accordance with the requirements of U.S. Office of Management and Budget (OMB) Circular A-133, Audits of States, Local Governments and NonProfit Organizations. Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of, the basic financial statements of the University. Negative amounts represent adjustments or credits to amounts reported as expenditures in prior years. CFDA numbers and pass-through numbers are provided when available. For purposes of the Schedule, Federal awards include all grants, contracts and similar agreements entered into directly between the University with agencies and departments of the Federal government and all subawards to the University by nonfederal organizations pursuant to Federal grants, contracts and similar agreements. The term Revised accompanying the award numbers on the Schedule represents a revised Notice of Grant Award (NGA). 2. Summary of Significant Accounting Policies Expenditures reported in the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in OMB Circular A-21, Cost Principles for Educational Institutions, wherein certain types of expenditures are not allowable or are limited to reimbursement. 3. Facilities and Administrative Costs The University recovers facilities and administrative costs associated with sponsored agreements pursuant to separate arrangements negotiated with the University s Federal cognizant agency by each of the Medical School, School of Public Health, and the University Area. Predetermined facilities and administrative rates have been negotiated through June 30, 2013 for the Medical School and the University Area. The rates are provisional for the School of Public Health through June 30, 2013. Facilities and administrative cost recoveries associated with training programs generally represent the maximum administrative overhead allowance allowed by the sponsors. The University also recovers administrative cost allowances from certain campus-based student financial assistance programs. 99
Notes to June 30, 2012 4. Awards to Subrecipients Certain Federal funds are provided to subrecipient organizations by the University. The following expenditures incurred by these subrecipients are reimbursed by the University and included on the Schedule for the year ended June 30, 2012. Program or Cluster CFDA # Amount Rapid Expansion of Antiretroviral Therapy Programs 93.266 $ 10,341,434 FY2011 Vietnam Fulbright Economics Teaching Program 19.401 26,136 Simple Verified Distributed Preservation: A Policy Based Archival Replication System for Libraries, 45.312 168,768 Archives, and Museums using a Virtual Private LOCKSS Network National Resource Centers for East Asian Studies 84.015A 42,829 Linking Assessment and Measurement to Performance in PHEP Systems (LAMPS) 93.061 850,584 Implementation of Programs for the Prevention, Care and Treatment of HIV/AIDS in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR) 93.067 4,859,887 Preparedness and Emergency Response Learning Centers (PERLC) 93.069 90,456 Harvard Clinical and Translational Science Center (UL1) 93.389 14,742,512 (MASS CONECT) Mass. Community Networks 93.399 60,682 Harvard Clinical and Translational Science Center- NCRR ARRA Supplement- Translational 93.701 711,011 (Imaging) NCRR ARRA Supplement -- Community Engagement 93.701 36,629 The Higher Education Network Ring Initiative (HENRI) 98.unknown 140,976 Research and Development and Research Training Cluster Various 104,136,744 Total $ 136,208,648 5. Federal Student Loan Programs The Federal student loan programs listed below are administered directly by the University and balances and transactions relating to these programs are included in the University s basic financial statements. The balance of loans outstanding at June 30, 2012 consists of: CFDA # Amount Perkins 84.038 $ 71,445,085 FFEL (Includes FISL Sub Stafford, Unsub Stafford, PLUS and SLS) 84.032 913,274 HPSL/LDS/PCL 93.342 7,651,099 Total Federal Student Loans $ 80,009,458 The University recovered an administrative cost allowance from the Perkins Loan Program (CFDA # 84.038) of $534,221 for the year ended June 30, 2012. This CFDA # has been closed by the Department of Education because there are no further Federal Capital Contributions to the Perkins Loan Program planned. A new CFDA # (CFDA # 84.037) was created in 2011 by the Department of Education for Perkins Loans Cancellations. The Perkins Loan Program principal cancelled for the year ended June 30, 2012 is $318,780. 100
Notes to June 30, 2012 Loans made by the University to eligible students under the Federal student loan programs during the year ended June 30, 2012 are summarized as follows: CFDA # Amount Perkins 84.038 $ 8,371,891 Net Direct Subsidized Stafford 84.032 36,718,505 Net Direct Unsubsidized Stafford 84.032 48,020,805 Net Direct PLUS 84.032 5,317,099 Net Direct Grad PLUS 84.032 45,180,804 HPSL/PCL 93.342 171,000 LDS 93.342 1,223,574 $ 145,003,678 101
Part III Reports on Internal Control and Compliance
Report of Independent Auditors on Internal Control over Financial Reporting and on Compliance and Other Matters Based on an Audit of Financial Statements Performed in Accordance with Government Auditing Standards To the Board of Overseers of Harvard College: We have audited the financial statements of Harvard University (the University ) as of and for the year ended June 30, 2012, and have issued our report thereon dated November 2, 2012. We conducted our audit in accordance with auditing standards generally accepted in the United States of America and the standards applicable to financial audits contained in Government Auditing Standards, issued by the Comptroller General of the United States. Internal Control Over Financial Reporting In planning and performing our audit, we considered the University s internal control over financial reporting as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements, but not for the purpose of expressing an opinion on the effectiveness of the University s internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the University s internal control over financial reporting. A deficiency in internal control exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent, or detect and correct misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control, such that there is a reasonable possibility that a material misstatement of the entity s financial statements will not be prevented, or detected and corrected on a timely basis. Our consideration of internal control over financial reporting was for the limited purpose described in the first paragraph of this section and was not designed to identify all deficiencies in internal control over financial reporting that might be deficiencies, significant deficiencies, or material weaknesses. We did not identify any deficiencies in internal control over financial reporting that we consider to be material weaknesses, as defined above. Compliance and Other Matters As part of obtaining reasonable assurance about whether the University s financial statements are free of material misstatement, we performed tests of its compliance with certain provisions of laws, regulations, contracts and grant agreements, noncompliance with which could have a direct and material effect on the determination of financial statement amounts. However, providing an opinion on compliance with those provisions was not an objective of our audit and, accordingly, we do not express such an opinion. The results of our tests disclosed no instances of noncompliance or other matters that are required to be reported under Government Auditing Standards. We noted certain matters that we reported to management of the University in a separate letter dated December 2, 2012. PricewaterhouseCoopers LLP, 125 High Street, Boston, MA 02110 T: (617) 530 5000, F: (617) 530 5001, www.pwc.com/us
This report is intended solely for the information and use of the University s Joint Committee on Inspection, management and federal awarding agencies and pass-through entities, and is not intended to be and should not be used by anyone other than these specified parties. November 2, 2012 103
Report of Independent Auditors on Compliance with Requirements That Could Have a Direct and Material Effect on Each Major Program and on Internal Control Over Compliance in Accordance with OMB Circular A-133 To the Board of Overseers of Harvard College: Compliance We have audited the compliance of Harvard University (the University ) with the types of compliance requirements described in the U.S. Office of Management and Budget (OMB) Circular A-133 Compliance Supplement that could have a direct and material effect on each of its major federal programs for the year ended June 30, 2012. The University s major federal programs are identified in the summary of auditor s results section of the accompanying schedule of findings and questioned costs. Compliance with the requirements of laws, regulations, contracts and grants applicable to each of its major federal programs is the responsibility of the University s management. Our responsibility is to express an opinion on the University s compliance based on our audit. We conducted our audit of compliance in accordance with auditing standards generally accepted in the United States of America; the standards applicable to financial audits contained in Government Auditing Standards, issued by the Comptroller General of the United States; and OMB Circular A-133, Audits of States, Local Governments, and NonProfit Organizations. Those standards and OMB Circular A-133 require that we plan and perform the audit to obtain reasonable assurance about whether noncompliance with the types of compliance requirements referred to above that could have a direct and material effect on a major federal program occurred. An audit includes examining, on a test basis, evidence about the University s compliance with those requirements and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. Our audit does not provide a legal determination of the University s compliance with those requirements. In our opinion, the University complied, in all material respects, with the requirements referred to above that could have a direct and material effect on its major federal programs for the year ended June 30, 2012. However, the results of our auditing procedures disclosed instances of noncompliance with those requirements, which are required to be reported in accordance with OMB Circular A-133 and which are described in the accompanying schedule of findings and questioned costs as items 2012-1 through 2012-4. PricewaterhouseCoopers LLP, 125 High Street, Boston, MA 02110 T: (617) 530 5000, F: (617) 530 5001, www.pwc.com/us
Internal Control Over Compliance Management of the University is responsible for establishing and maintaining effective internal control over compliance with the requirements of laws, regulations, contracts, and grants applicable to federal programs. In planning and performing our audit, we considered the University s internal control over compliance with the requirements that could have a direct and material effect on a major federal program in order to determine the auditing procedures for the purpose of expressing our opinion on compliance and to test and report on internal control over compliance in accordance with OMB Circular A-133, but not for the purpose of expressing an opinion on the effectiveness of internal control over compliance. Accordingly we do not express an opinion on the effectiveness of the University s internal control over compliance. A deficiency in internal control over compliance exists when the design or operation of a control over compliance does not allow management or employees, in the normal course of performing their assigned functions, to prevent, or detect and correct noncompliance with a type of compliance requirement of a federal program on a timely basis. A material weakness in internal control over compliance is a deficiency, or combination of deficiencies, in internal control over compliance, such that there is a reasonable possibility that material noncompliance with a type of compliance requirement of a federal program will not be prevented, or detected and corrected on a timely basis. Our consideration of internal control over compliance was for the limited purpose described in the first paragraph of this section and was not designed to identify all deficiencies in internal control over compliance that might be deficiencies, significant deficiencies, or material weaknesses. We did not identify any deficiencies in internal control over compliance that we consider to be material weaknesses, as defined above. The University s responses to the findings identified in our audit are described in the accompanying schedule of findings and questioned costs. We did not audit the University s responses and, accordingly, we express no opinion on them. This report is intended solely for the information and use of the University s Joint Committee on Inspection, management and federal awarding agencies and pass-through entities and is not intended to be and should not be used by anyone other than these specified parties. March 15, 2013 105